<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Multiple Sclerosis on VitaminDWiki</title><link>/categories/multiple-sclerosis.html</link><description>Recent content in Multiple Sclerosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 12 Feb 2024 00:00:00 +0000</lastBuildDate><atom:link href="/categories/multiple-sclerosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Poor Vitamin D Receptor increases the risk of Multiple Sclerosis in people of European descent</title><link>/posts/poor-vitamin-d-receptor-increases-the-risk-of-multiple-sclerosis-in-people-of-european-descent.html</link><pubDate>Mon, 12 Feb 2024 00:00:00 +0000</pubDate><guid>/posts/poor-vitamin-d-receptor-increases-the-risk-of-multiple-sclerosis-in-people-of-european-descent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#evidence-supports-a-causal-association-between-allele-specific-vitamin-d-receptor-binding-and-multiple-sclerosis-among-europeans">Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#how-does-the-incidence-of-multiple-sclerosis-vary-with-race">How does the incidence of multiple sclerosis vary with race?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="evidence-supports-a-causal-association-between-allele-specific-vitamin-d-receptor-binding-and-multiple-sclerosis-among-europeans">Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans&lt;/h4>
&lt;p>PNAS 121 (8) &lt;a href="https://doi.org/10.1073/pnas.2302259121">https://doi.org/10.1073/pnas.2302259121&lt;/a> PDF is behind a paywall&lt;/p>
&lt;p>Cameron Adams, Ali Manouchehrinia, Hong L. Quach, +6, and Lisa F. Barcellos &lt;a href="mailto:lbarcellos@berkeley.edu">lbarcellos@berkeley.edu&lt;/a>&lt;/p>
&lt;p>There is evidence for a causal association between 25-hydroxyvitamin D (25(OH)D) serum levels and multiple sclerosis (MS), but the underlying mechanisms are unknown. We conducted a Mendelian Randomization study to estimate causal associations between vitamin D receptor (VDR) binding at a locus and MS susceptibility using genetic instrumental variables constructed from variants previously associated with allele-specific VDR-binding (VDR-binding variant; VDR-BV) and serum 25(OH)D. Two VDR-BV (rs2881514; rs2531804) were independently associated with MS and rs2881514 demonstrated significant interaction with 25(OH)D, providing evidence for a causal association between rs2881514 and MS. Our results demonstrate that genetic variation in individual VDR binding sites contributes to MS and are relevant to other autoimmune diseases for which a role for vitamin D has been implicated.&lt;/p></description></item><item><title>People with Multiple Sclerosis have blunted responses to Vitamin D supplementation</title><link>/posts/people-with-multiple-sclerosis-have-blunted-responses-to-vitamin-d-supplementation.html</link><pubDate>Wed, 17 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/people-with-multiple-sclerosis-have-blunted-responses-to-vitamin-d-supplementation.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#transcriptomics-identifies-blunted-immunomodulatory-effects-of-vitamin-d-in-people-with-multiple-sclerosis">Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#9-related-items-in-vitamindwiki">9 related items in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#several-health-problems-have-a-blunted-response-to-vitamin-d-supplementation">Several Health problems have a blunted response to Vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strange-that-studies-have-not-tried-activating-the-vdr-in-people-with-ms">Strange that studies have not tried activating the VDR in people with MS&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="transcriptomics-identifies-blunted-immunomodulatory-effects-of-vitamin-d-in-people-with-multiple-sclerosis">Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis&lt;/h4>
&lt;p>Scientific Reports Vol 14, Article number: 1436 (2024) &lt;a href="https://doi.org/10.1038/s41598-024-51779-0">https://doi.org/10.1038/s41598-024-51779-0&lt;/a>&lt;/p>
&lt;p>Wei Z. Yeh, Rodney Lea, Jim Stankovich, Sandeep Sampangi, Louise Laverick, Anneke Van der Walt, Vilija Jokubaitis, Melissa Gresle &amp;amp; Helmut Butzkueven&lt;/p></description></item><item><title>Multiple Sclerosis treatment not helped by small doses of vitamin D (yet again) – meta-analysis</title><link>/posts/multiple-sclerosis-treatment-not-helped-by-small-doses-of-vitamin-d-yet-again-meta-analysis.html</link><pubDate>Fri, 12 Jan 2024 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treatment-not-helped-by-small-doses-of-vitamin-d-yet-again-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d3-as-an-add-on-treatment-for-multiple-sclerosis-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials">Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d3-as-an-add-on-treatment-for-multiple-sclerosis-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials">Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials&lt;/h4>
&lt;p>Mult Scler Relat Disord . 2024 Jan 6:82:105433. &lt;a href="https://doi.org/10.1016/j.msard.2024.105433">doi: 10.1016/j.msard.2024.105433&lt;/a> PDF I behind a paywall&lt;/p>
&lt;p>João Vitor Mahler 1, Marina Solti 2, Samira Luísa Apóstolos-Pereira 3, Tarso Adoni 3, Guilherme Diogo Silva 3, Dagoberto Callegaro 3&lt;/p></description></item><item><title>Central Nervous System protection by Vitamin D</title><link>/posts/central-nervous-system-protection-by-vitamin-d.html</link><pubDate>Thu, 21 Dec 2023 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-protection-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#molecular-regulation-of-the-cns-by-vitamin-d">Molecular Regulation of the CNS by Vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="molecular-regulation-of-the-cns-by-vitamin-d">Molecular Regulation of the CNS by Vitamin D&lt;/h4>
&lt;p>Physiol Res 2023 Dec 17;72(S4):S339-S356.&lt;/p>
&lt;p>L Máčová 1, R Kancheva, M Bičíková&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/cns-d.png" alt="image" width="800">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/neuroprotective-d.png" alt="image" width="800">
&lt;p>&lt;strong>&lt;span style="color:#096;">Factors that are up-regulated are marked in green&lt;/span>&lt;br>
&lt;span style="color:#F06;">factors that are down-regulated are in red&lt;/span>.&lt;/strong>&lt;/p>
&lt;p>Vitamin D is a lipid-soluble vitamin that can be found in some foods. It is also produced endogenously (in the presence of ultraviolet light), transported through the blood to the targets organs and this is the reason to consider vitamin D as a hormone. It is known that vitamin D has genomic and non-genomic effects.&lt;/p></description></item><item><title>Blood–brain barrier dysfunction in multiple sclerosis (improved by vitamin D, etc.)</title><link>/posts/bloodbrain-barrier-dysfunction-in-multiple-sclerosis-improved-by-vitamin-d-etc.html</link><pubDate>Sat, 16 Dec 2023 00:00:00 +0000</pubDate><guid>/posts/bloodbrain-barrier-dysfunction-in-multiple-sclerosis-improved-by-vitamin-d-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#bloodbrain-barrier-dysfunction-in-multiple-sclerosis-causes-consequences-and-potential-effects-of-therapies">Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#31600-hits-for-blood-brain-barrier-vitamin-d-in-google-scholar---april-2025">31,600 hits for &amp;ldquo;blood brain barrier&amp;rdquo; &amp;ldquo;vitamin d&amp;rdquo; in Google Scholar - April 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-brain-in-vitamindwiki">See Brain in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-in-vitamindwiki">See also in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="bloodbrain-barrier-dysfunction-in-multiple-sclerosis-causes-consequences-and-potential-effects-of-therapies">Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies&lt;/h4>
&lt;p>Lancet January, 2024DOI:https://doi.org/10.1016/S1474-4422(23)00377-0 PDF behind paywall&lt;/p>
&lt;p>Bettina Zierfuss, PhD, Catherine Larochelle, MD PhD, Prof Alexandre Prat, MD PhD&lt;/p>
&lt;p>Summary&lt;/p>
&lt;p>Established by brain endothelial cells, the &lt;strong>blood–brain barrier&lt;/strong> (BBB) regulates the trafficking of molecules, restricts immune cell entry into the CNS, and has an active role in neurovascular coupling (the regulation of cerebral blood flow to support neuronal activity). In the early stages of multiple sclerosis, around the time of symptom onset, inflammatory BBB damage is accompanied by pathogenic immune cell infiltration into the CNS. In the later stages of multiple sclerosis, dysregulation of neurovascular coupling is associated with grey matter atrophy.&lt;/p></description></item><item><title>COVID infections or vaccinations may increase Multiple Sclerosis (if low D) - several studies</title><link>/posts/covid-infections-or-vaccinations-may-increase-multiple-sclerosis-if-low-d-several-studies.html</link><pubDate>Thu, 23 Nov 2023 00:00:00 +0000</pubDate><guid>/posts/covid-infections-or-vaccinations-may-increase-multiple-sclerosis-if-low-d-several-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-potential-role-of-sars-cov-2-infection-and-vaccines-in-multiple-sclerosis-onset-and-reactivation-a-case-series-and-literature-review---july-2023">The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review - July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#covid-19-and-multiple-sclerosis-a-complex-relationship-possibly-aggravated-by-low-vitamin-d-levels---feb-2023">COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels - Feb 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-is-associated-with-worse-covid-19-outcomes-compared-to-the-general-population-a-population-based-study---nov-2023">Multiple sclerosis is associated with worse COVID-19 outcomes compared to the general population: A population-based study - Nov 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#new-onset-multiple-sclerosis-post-covid-19-vaccination-and-correlation-with-possible-predictors-in-a-case-control-study---march-2023">New Onset Multiple Sclerosis Post-COVID-19 Vaccination and Correlation With Possible Predictors in a Case-Control Study - March 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vaccination-and-multiple-sclerosis---dr-campbell-youtube-may-2023">Vaccination and multiple sclerosis - Dr. Campbell, YouTube May 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-potential-role-of-sars-cov-2-infection-and-vaccines-in-multiple-sclerosis-onset-and-reactivation-a-case-series-and-literature-review---july-2023">The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review - July 2023&lt;/h4>
&lt;p>Viruses . 2023 Jul 18;15(7):1569. &lt;a href="https://doi.org/10.3390/v15071569.">doi: 10.3390/v15071569.&lt;/a>&lt;/p></description></item><item><title>Many Neurological Diseases fought by Vitamin D</title><link>/posts/many-neurological-diseases-fought-by-vitamin-d.html</link><pubDate>Thu, 26 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/many-neurological-diseases-fought-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-in-neurological-diseases">Vitamin D in Neurological Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#315-clinical-trials-of-neurological-diseases-and-vitamin-d---oct-2023">315 clinical trials of neurological diseases and Vitamin D - Oct 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-in-neurological-diseases">Vitamin D in Neurological Diseases&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2023, 24(1), 87; &lt;a href="https://doi.org/10.3390/ijms24010087">https://doi.org/10.3390/ijms24010087&lt;/a>&lt;/p>
&lt;p>by Domenico Plantone 1,*ORCID,Guido Primiano 2,3ORCID,Carlo Manco 1,Sara Locci 1,Serenella Servidei 2,3ORCID andNicola De Stefano 1&lt;/p>
&lt;p>1 Centre for Precision and Translational Medicine, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy&lt;/p>
&lt;p>2 Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy&lt;/p></description></item><item><title>Autoimmune diseases caused in first day after COVID Vaccination</title><link>/posts/autoimmune-diseases-caused-in-first-day-after-covid-vaccination.html</link><pubDate>Tue, 17 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-caused-in-first-day-after-covid-vaccination.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#covid-19-vaccines-immediate-onset-autoimmune-disease-adverse-events-in-vaers">COVID-19 vaccines immediate onset Autoimmune Disease adverse events in VAERS&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="covid-19-vaccines-immediate-onset-autoimmune-disease-adverse-events-in-vaers">COVID-19 vaccines immediate onset Autoimmune Disease adverse events in VAERS&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://darrellricke.substack.com/p/covid-19-vaccines-immediate-onset?utm_source=cross-post&amp;amp;publication_id=735472&amp;amp;post_id=138024521&amp;amp;utm_campaign=583200&amp;amp;isFreemail=false&amp;amp;r=ofo3r&amp;amp;utm_medium=email">Substack&lt;/a> Oct 16&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ae-table.jpg" alt="image" width="500"></description></item><item><title>Obese are 50% more likely to develop or have severe MS (Vitamin D not mentioned)</title><link>/posts/obese-are-50-percent-more-likely-to-develop-or-have-severe-ms-vitamin-d-not-mentioned.html</link><pubDate>Sat, 14 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/obese-are-50-percent-more-likely-to-develop-or-have-severe-ms-vitamin-d-not-mentioned.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#obesity-linked-to-multiple-ills-in-ms-study">Obesity linked to multiple ills in MS study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="obesity-linked-to-multiple-ills-in-ms-study">Obesity linked to multiple ills in MS study&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.mdedge.com/neurology/article/265902/multiple-sclerosis/obesity-linked-multiple-ills-ms-study?ecd=WNL_EVE_231014_mdedge&amp;amp;icd=login_success_email_match_norm">MD Edge&lt;/a>&lt;/strong>&lt;/p>
&lt;p>They seem unaware that&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Obese people are more likely to have low vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>People with lower vitamin D are more likely to get MS&lt;/p>
&lt;/li>
&lt;/ol></description></item><item><title>Multiple Sclerosis risk factors - Vitamin D was the only one you can easily change</title><link>/posts/multiple-sclerosis-risk-factors-vitamin-d-was-the-only-one-you-can-easily-change.html</link><pubDate>Mon, 11 Sep 2023 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-vitamin-d-was-the-only-one-you-can-easily-change.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#multi-criterial-model-for-weighting-biological-risk-factors-in-multiple-sclerosis-clinical-and-health-insurance-implications">Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="multi-criterial-model-for-weighting-biological-risk-factors-in-multiple-sclerosis-clinical-and-health-insurance-implications">Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications&lt;/h4>
&lt;p>Healthcare (Basel) . 2023 Aug 29;11(17):2420. &lt;a href="https://doi.org/10.3390/healthcare11172420.">doi: 10.3390/healthcare11172420.&lt;/a>&lt;/p>
&lt;p>Roberto De Masi 1 2, Stefania Orlando 2, Chiara Leo 3, Matteo Pasca 1, Luca Anzilli 3, Maria Carmela Costa 4&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-vit-d.jpg" alt="image" width="600">
&lt;p>The etiology of Multiple Sclerosis (MS) remains undetermined. Its pathogenic risk factors are thought to play a negligible role individually in the development of the disease, instead assuming a pathogenic role when they interact with each other. Unfortunately, the statistical weighting of this pathogenic role in predicting MS risk is currently elusive, preventing clinical and health insurance applications. Here, we aim to develop a population-based multi-criterial model for weighting biological risk factors in MS; also, to calculate the individual MS risk value useful for health insurance application. Accordingly, among 596 MS patients retrospectively assessed at the time of diagnosis,&lt;/p></description></item><item><title>Doctor got MS and was later cured by high-dose Vitamin D</title><link>/posts/doctor-got-ms-and-was-later-cured-by-high-dose-vitamin-d.html</link><pubDate>Thu, 10 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/doctor-got-ms-and-was-later-cured-by-high-dose-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#narrative-by-satya-l-nahu-md--from-grassrootshealthhttpswwwgrassrootshealthnetblogvitamin-d-changed-life-doctor-ms-journey-interviewutm_sourcenewsletter-mainutm_mediumemailutm_campaignnewsletters">Narrative by Satya L. Nahu, MD ( &lt;a href="https://www.grassrootshealth.net/blog/vitamin-d-changed-life-doctor-ms-journey-interview/?utm_source=newsletter-main&amp;amp;utm_medium=email&amp;amp;utm_campaign=Newsletters">from GrassrootsHealth&lt;/a>)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#q-and-a-with-dr-nahu">Q and A with Dr. Nahu&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="narrative-by-satya-l-nahu-md--from-grassrootshealthhttpswwwgrassrootshealthnetblogvitamin-d-changed-life-doctor-ms-journey-interviewutm_sourcenewsletter-mainutm_mediumemailutm_campaignnewsletters">Narrative by Satya L. Nahu, MD ( &lt;a href="https://www.grassrootshealth.net/blog/vitamin-d-changed-life-doctor-ms-journey-interview/?utm_source=newsletter-main&amp;amp;utm_medium=email&amp;amp;utm_campaign=Newsletters">from GrassrootsHealth&lt;/a>)&lt;/h3>
&lt;img src="https://www.grassrootshealth.net/wp-content/uploads/2023/08/dr-nahu-1-e1691533792747-200x300.jpg" alt="image">
&lt;p>My story with Vitamin D began in 2012, at the time of my Multiple Sclerosis diagnosis. I was 31, and already a doctor as I had just finished my second specialization (Cardiology) a few months prior. It was suddenly and without warning that I woke up with intense tingling in both hands, which spread up both arms in addition to the sensation of shocks in the spine when flexing the neck. Fatigue, days later, was associated with the condition. Around 30 days after symptoms began, the diagnosis was made, through the addition of magnetic resonance imaging of my entire central nervous system (brain and spinal cord), collection of cerebrospinal fluid and blood laboratory tests.&lt;/p></description></item><item><title>Epstein-Barr Virus may be a prerequisite for Multiple Sclerosis</title><link>/posts/epstein-barr-virus-may-be-a-prerequisite-for-multiple-sclerosis.html</link><pubDate>Thu, 10 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-may-be-a-prerequisite-for-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#risk-factors-for-multiple-sclerosis-in-the-context-of-epstein-barr-virus-infection">Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="risk-factors-for-multiple-sclerosis-in-the-context-of-epstein-barr-virus-infection">Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection&lt;/h4>
&lt;p>Front Immunol. 2023 Jul 24;14:1212676. &lt;a href="https://doi.org/10.3389/fimmu.2023.1212676">doi: 10.3389/fimmu.2023.1212676&lt;/a>&lt;/p>
&lt;p>Anna Karin Hedström 1&lt;/p>
&lt;p>&lt;strong>Table of contents&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ebv-toc.jpg" alt="image" width="350">
&lt;p>&lt;strong>Combined Risk Factors for MS&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-risk-factors.jpg" alt="image" width="350">
&lt;p>Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV infection, genetic predisposition, and various environmental and lifestyle factors that negatively affect immune control of the infection. Evidence of gene-environment interactions and epigenetic modifications triggered by environmental factors in genetically susceptible individuals supports this view. This review gives a short introduction to EBV and host immunity and discusses evidence indicating EBV as a prerequisite for MS. The role of genetic and environmental risk factors, and their interactions, in MS pathogenesis is reviewed and put in the context of EBV infection. Finally, possible preventive measures are discussed based on the findings presented.&lt;/p></description></item><item><title>Multiple Sclerosis prevention with high-dose vitamin D (in rats in this case)</title><link>/posts/multiple-sclerosis-prevention-with-high-dose-vitamin-d-in-rats-in-this-case.html</link><pubDate>Tue, 08 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-prevention-with-high-dose-vitamin-d-in-rats-in-this-case.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-dan-effective-antioxidant-in-an-animal-model-of-progressive-multiple-sclerosis---july-2023">Vitamin D—An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis - July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-in-multiple-sclerosislessons-from-animal-studies---oct-2021">Vitamin D in Multiple Sclerosis—Lessons From Animal Studies - Oct 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-dan-effective-antioxidant-in-an-animal-model-of-progressive-multiple-sclerosis---july-2023">Vitamin D—An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis - July 2023&lt;/h4>
&lt;p>Nutrients 2023, 15(15), 3309; &lt;a href="https://doi.org/10.3390/nu15153309">https://doi.org/10.3390/nu15153309&lt;/a>&lt;/p>
&lt;p>by Michaela Tanja Haindl 1ORCID,Muammer Üçal 2ORCID,Willibald Wonisch 3ORCID,Michaela Lang 1,4,Marta Nowakowska 2ORCID,Milena Z. Adzemovic 5,Michael Khalil 1ORCID,Christian Enzinger 1 and Sonja Hochmeister 1,*&lt;/p>
&lt;p>1 Department of Neurology, Medical University of Graz, 8036 Graz, Austria&lt;/p></description></item><item><title>Global burden of brain disorders surpasses cardiovascular disease and cancer</title><link>/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer.html</link><pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/global-burden-of-brain-disorders-surpasses-cardiovascular-disease-and-cancer.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#from-mdedgehttpswwwmdedgecomneurologyarticle264086neurologyglobal-burden-brain-disorders-surpasses-cardiovascular-diseaseecdwnl_eve_230715_mdedge">From &lt;a href="https://www.mdedge.com/neurology/article/264086/neurology/global-burden-brain-disorders-surpasses-cardiovascular-disease?ecd=WNL_EVE_230715_mdedge">MDEdge&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-inhaled-thru-the-nose-gets-some-directly-to-the-brain">Vitamin D inhaled thru the nose gets some directly to the brain&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="from-mdedgehttpswwwmdedgecomneurologyarticle264086neurologyglobal-burden-brain-disorders-surpasses-cardiovascular-diseaseecdwnl_eve_230715_mdedge">From &lt;a href="https://www.mdedge.com/neurology/article/264086/neurology/global-burden-brain-disorders-surpasses-cardiovascular-disease?ecd=WNL_EVE_230715_mdedge">MDEdge&lt;/a>&lt;/h4>
&lt;p>Brain disorders, including mental illness, neurologic conditions, and stroke, account for more than 15% of all health loss worldwide – more than either cardiovascular disease or cancer – at huge cost to health care systems and society, an analysis of data from the most recent Global Burden of Disease (GBD) study shows.&lt;/p>
&lt;p>“The burden of brain conditions will increase as populations continue to grow and age,” said study presenter Shayla Smith, MPH, an epidemiologist at the Institute for Health Metrics and Evaluation, the University of Washington, Seattle, in a press release.&lt;/p></description></item><item><title>How Multiple Sclerosis might be prevented by Vitamin D</title><link>/posts/how-multiple-sclerosis-might-be-prevented-by-vitamin-d.html</link><pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/how-multiple-sclerosis-might-be-prevented-by-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-in-neuroprotection-in-multiple-sclerosis-an-update">The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-is-associated-with-poor-genes">Multiple Sclerosis is associated with poor genes&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-role-of-vitamin-d-in-neuroprotection-in-multiple-sclerosis-an-update">The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update&lt;/h4>
&lt;p>Nutrients. 2023 Jun 30;15(13):2978. &lt;a href="https://doi.org/10.3390/nu15132978.">doi: 10.3390/nu15132978.&lt;/a>&lt;/p>
&lt;p>Amarpreet Sangha 1, Michaela Quon 1, Gerald Pfeffer 2 3, Sarah-Michelle Orton 1&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/prevent-ms.jpg" alt="image" width="800">
&lt;p>Multiple sclerosis (MS) is a complex neurological condition that involves both inflammatory demyelinating and neurodegenerative components. MS research and treatments have traditionally focused on immunomodulation, with less investigation of neuroprotection, and this holds true for the role of vitamin D in MS. Researchers have already established that vitamin D plays an anti-inflammatory role in modulating the immune system in MS. More recently, researchers have begun investigating the potential neuroprotective role of vitamin D in MS. The active form of vitamin D, 1,25(OH)2D3, has a range of neuroprotective properties, which may be important in remyelination and/or the prevention of demyelination. The most notable finding relevant to MS is that 1,25(OH)2D3 promotes stem cell proliferation and drives the differentiation of neural stem cells into oligodendrocytes, which carry out remyelination. In addition, 1,25(OH)2D3 counteracts neurodegeneration and oxidative stress by suppressing the activation of reactive astrocytes and M1 microglia. 1,25(OH)2D3 also promotes the expression of various neuroprotective factors, including neurotrophins and antioxidant enzymes. 1,25(OH)2D3 decreases blood-brain barrier permeability, reducing leukocyte recruitment into the central nervous system. These neuroprotective effects, stimulated by 1,25(OH)2D3, all enhance neuronal survival. This review summarizes and connects the current evidence supporting the vitamin D-mediated mechanisms of action for neuroprotection in MS.&lt;/p></description></item><item><title>Multiple Sclerosis fatigue reduced by weekly Vitamin D (50,000 IU)</title><link>/posts/multiple-sclerosis-fatigue-reduced-by-weekly-vitamin-d-50000-iu.html</link><pubDate>Sat, 15 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-fatigue-reduced-by-weekly-vitamin-d-50000-iu.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effect-of-vitamin-d-supplementation-on-fatigue-in-multiple-sclerosis-a-systematic-review-and-meta-analysis">Effect of Vitamin D Supplementation on Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#note-the-50000-iu-study-included-aerobic-exercise">Note: The 50,000 IU study included aerobic exercise&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effect-of-vitamin-d-supplementation-on-fatigue-in-multiple-sclerosis-a-systematic-review-and-meta-analysis">Effect of Vitamin D Supplementation on Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Nutrients. 2023 Jun 24;15(13):2861. &lt;a href="https://doi.org/10.3390/nu15132861.">doi: 10.3390/nu15132861.&lt;/a>&lt;/p>
&lt;p>Purificación López-Muñoz 1 2, Ana Isabel Torres-Costoso 1 3, Rubén Fernández-Rodríguez 3, María José Guzmán-Pavón 1, Sergio Núñez de Arenas-Arroyo 3, Julián Ángel Basco-López 1 2, Sara Reina-Gutiérrez 3&lt;/p></description></item><item><title>Multiple Sclerosis treated equally by UVB and weekly 50,000 IU of Vitamin D – RCT</title><link>/posts/multiple-sclerosis-treated-equally-by-uvb-and-weekly-50000-iu-of-vitamin-d-rct.html</link><pubDate>Sun, 18 Jun 2023 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-equally-by-uvb-and-weekly-50000-iu-of-vitamin-d-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#efficacy-of-ultraviolet-b-radiation-versus-vitamin-d3-on-postural-control-and-cognitive-functions-in-relapsing-remitting-multiple-sclerosis-a-randomized-controlled-study">Efficacy of ultraviolet B radiation versus vitamin D3 on postural control and cognitive functions in relapsing-remitting multiple sclerosis: A randomized controlled study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="efficacy-of-ultraviolet-b-radiation-versus-vitamin-d3-on-postural-control-and-cognitive-functions-in-relapsing-remitting-multiple-sclerosis-a-randomized-controlled-study">Efficacy of ultraviolet B radiation versus vitamin D3 on postural control and cognitive functions in relapsing-remitting multiple sclerosis: A randomized controlled study&lt;/h4>
&lt;p>J Bodyw Mov Ther. 2023 Jul;35:49-56. &lt;a href="https://doi.org/10.1016/j.jbmt.2023.04.069">doi: 10.1016/j.jbmt.2023.04.069&lt;/a> PDF is behind a paywall&lt;/p>
&lt;p>Shimaa Abdelalim Essa 1, Ahmed Elokda 2, Dalia Mosaad 3, Wael Shendy 4, Maged Abdel-Nasser 5, Asmaa Mohamed Ebraheim 6, Hadeel Mohammad 7, Alaa Elmazny 8, Eman Magdy 9&lt;/p></description></item><item><title>Get Multiple Sclerosis while younger if have a poor CYP24A1 vitamin D gene</title><link>/posts/get-multiple-sclerosis-while-younger-if-have-a-poor-cyp24a1-vitamin-d-gene.html</link><pubDate>Tue, 16 May 2023 00:00:00 +0000</pubDate><guid>/posts/get-multiple-sclerosis-while-younger-if-have-a-poor-cyp24a1-vitamin-d-gene.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-cyp24a1-gene-variant-rs2762943-is-associated-with-low-serum-125-dihydroxyvitamin-d-levels-in-multiple-sclerosis-patients">The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-has-been-increasing-at-younger-ages">Multiple Sclerosis has been increasing at younger ages&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-cyp24a1-gene-variant-rs2762943-is-associated-with-low-serum-125-dihydroxyvitamin-d-levels-in-multiple-sclerosis-patients">The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients&lt;/h4>
&lt;p>Eur J Neurol . 2023 May 14. &lt;a href="https://doi.org/10.1111/ene.15866">doi: 10.1111/ene.15866&lt;/a>&lt;/p>
&lt;p>Sunny Malhotra # 1, Luciana Midaglia # 1, Omar Chuquisana 2, Nikolaos A Patsopoulos 3 4 5, Roser Ferrer 6, Marina Giralt 6, Nicolas Fissolo 1, Elia Gil-Varea 1, Juan Carlos Triviño 7, Jan D Lünemann 2, Xavier Montalban 1, Manuel Comabella 1&lt;/p></description></item><item><title>Multiple Sclerosis is again not fought by 5,000 IU vitamin D daily (need at least 10X more) – RCT</title><link>/posts/multiple-sclerosis-is-again-not-fought-by-5000-iu-vitamin-d-daily-need-at-least-10x-more-rct.html</link><pubDate>Mon, 01 May 2023 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-again-not-fought-by-5000-iu-vitamin-d-daily-need-at-least-10x-more-rct.html</guid><description>&lt;ul>
&lt;li>
&lt;p>Fighting MS with Vitamin D needs some combination of:&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Larger Vitamin D doses: &amp;gt;50,000 IU if taken daily&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Gut-friendly form of vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Magnesium - increases effective IU by 30%&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Take Vitamin D with evening meal - increases effective IU by 30%&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D Receptor activators: i.e. Resveratrol, Curcumin&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Take Vitamin D non-daily - say weekly - gets past any Vitamin D Receptor limitation&lt;/p>
&lt;/li>
&lt;/ul>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#high-dose-vitamin-d3-supplementation-in-relapsing-remitting-multiple-sclerosis-a-randomised-clinical-trial">High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="high-dose-vitamin-d3-supplementation-in-relapsing-remitting-multiple-sclerosis-a-randomised-clinical-trial">High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial&lt;/h4>
&lt;p>EClinicalMedicine. 2023 Apr 13;59:101957. &lt;a href="https://doi.org/10.1016/j.eclinm.2023.101957">doi: 10.1016/j.eclinm.2023.101957&lt;/a>&lt;/p></description></item><item><title>How Vitamin D fights Alzheimer’s, Parkinson’s, Multiple Sclerosis and Epilepsy</title><link>/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy.html</link><pubDate>Sat, 22 Apr 2023 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-fights-alzheimers-parkinsons-multiple-sclerosis-and-epilepsy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#molecular-insights-into-the-pathogenic-impact-of-vitamin-d-deficiency-in-neurological-disorders">Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="molecular-insights-into-the-pathogenic-impact-of-vitamin-d-deficiency-in-neurological-disorders">Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders&lt;/h4>
&lt;p>Biomed Pharmacother. 2023 Apr 19;162:114718. &lt;a href="https://doi.org/10.1016/j.biopha.2023.114718">doi: 10.1016/j.biopha.2023.114718&lt;/a>&lt;/p>
&lt;p>Md Jamir Anwar 1, Sattam Khulaif Alenezi 2, Ahmad Hamad Alhowail 3&lt;/p>
&lt;h5 id="charts-of-impact-of-vitamin-d">Charts of impact of Vitamin D&lt;/h5>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/alz-and-d.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/pd-vit-d.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-and-d.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/epilepsy.jpg" alt="image" width="900">
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/toc-insights.jpg" alt="image" width="600">
&lt;p>Neurological disorders are the major cause of disability, leading to a decrease in quality of life by impairing cognitive, sensorimotor, and motor functioning. Several factors have been proposed in the pathogenesis of neurobehavioral changes, including nutritional, environmental, and genetic predisposition. Vitamin D (VD) is an environmental and nutritional factor that is widely distributed in the central nervous system&amp;rsquo;s subcortical grey matter, neurons of the substantia nigra, hippocampus, thalamus, and hypothalamus. It is implicated in the regulation of several brain functions by preserving neuronal structures. It is a hormone rather than a nutritional vitamin that exerts a regulatory role in the pathophysiology of several neurological disorders, including Alzheimer&amp;rsquo;s disease, Parkinson&amp;rsquo;s disease, epilepsy, and multiple sclerosis.&lt;/p></description></item><item><title>How Vitamin D fights neurodegeneration (Multiple Sclerosis, Alzheimer’s, Dementia, etc)</title><link>/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc.html</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/how-vitamin-d-fights-neurodegeneration-multiple-sclerosis-alzheimers-dementia-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-neurodegenerative-diseases">Vitamin D and neurodegenerative diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-neurodegenerative-diseases">Vitamin D and neurodegenerative diseases&lt;/h4>
&lt;p>Heliyon &lt;a href="https://doi.org/10.1016/j.heliyon.2023.e12877">https://doi.org/10.1016/j.heliyon.2023.e12877&lt;/a>&lt;/p>
&lt;p>Weixia Wang 1 YijinLi 1 Xianfang Meng 1&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/neurodegeneration.jpg" alt="image" width="700">
&lt;p>Neurodegenerative diseases, featured by progressive loss of structure or function of neurons, are considered incurable at present. Movement disorders like tremor and postural instability, cognitive or behavioral disorders such as memory impairment are the most common symptoms of them and the growing patient population of neurodegenerative diseases poses a serious threat to public health and a burden on economic development. Hence, it is vital to prevent the occurrence of the diseases and delay their progress. Vitamin D can be transformed into a hormone in vivo with both genomic and non-genomic actions, exerting diverse physiological effects.&lt;/p></description></item><item><title>Diseases treated by high-dose Vitamin D - many studies</title><link>/posts/diseases-treated-by-high-dose-vitamin-d-many-studies.html</link><pubDate>Sun, 04 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/diseases-treated-by-high-dose-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#testimonials-of-20-diseases-treated-by-coimbra-protocol">Testimonials of 20 diseases treated by Coimbra protocol&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#web---misc">Web - misc&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="testimonials-of-20-diseases-treated-by-coimbra-protocol">Testimonials of 20 diseases treated by Coimbra protocol&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.coimbraprotocol.com/testimonials-1">URL&lt;/a>   &lt;a href="/posts/beyond-vitamin-d-book-of-testimonials-on-high-dose-coimbra-protocol-aug-2021">Book - 2021&lt;/a>&lt;/strong>&lt;/p>
&lt;p>As of Oct 2022 the diseases include&lt;/p>
&lt;p>71 Multiple sclerosis&lt;/p>
&lt;p>7 Rheumatoid arthritis&lt;/p>
&lt;p>7 Atopic dermatitis&lt;/p>
&lt;p>4 Myasthenia gravis&lt;/p>
&lt;p>3 Vitiligo&lt;/p>
&lt;p>3 Psoriasis&lt;/p>
&lt;p>2 Neuromyelitis Optica (NMO) or Devic&amp;rsquo;s disease&lt;/p>
&lt;p>2 Lupus&lt;/p>
&lt;p>2 Lyme disease&lt;/p>
&lt;p>2 Sjogren&amp;rsquo;s syndrome&lt;/p>
&lt;p>1 Spongiotic dermatitis&lt;/p>
&lt;p>1 Fibromyalgia&lt;/p>
&lt;p>1 Alopecia&lt;/p>
&lt;p>1 Schleroderma&lt;/p>
&lt;p>1 Sjogren&amp;rsquo;s syndrome&lt;/p></description></item><item><title>Brain and Vitamin D - many studies</title><link>/posts/brain-and-vitamin-d-many-studies.html</link><pubDate>Tue, 18 Oct 2022 00:00:00 +0000</pubDate><guid>/posts/brain-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#nervous-system-disorders-now-the-top-cause-of-illness---march-2024">Nervous system disorders now the top cause of illness - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#brain-problems-reduced-in-both-fetus-and-adult-by-vitamin-d--oct-2022">Brain problems reduced in both fetus and adult by Vitamin D – Oct 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#brain-and-vitamin-d-chart---2023">Brain and Vitamin D chart - 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#microglia-and-brain-disorders-the-role-of-vitamin-d-and-its-receptor---july-2023">Microglia and Brain Disorders: The Role of Vitamin D and Its Receptor - July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-a-fetus-with-adequate-vitamin-d-will-have-fewer-brain-problems">It appears that a fetus with adequate Vitamin D will have fewer brain problems&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-an-adult-with-adequate-vitamin-d-will-have-fewer-brain-problems">It appears that an adult with adequate Vitamin D will have fewer brain problems&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-fails-to-mention-that-vitamin-d-levels-in-cells-can-be-much-less-than-that-in-blood-gene-problems">Study fails to mention that Vitamin D levels in cells can be much less than that in blood (gene problems)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="nervous-system-disorders-now-the-top-cause-of-illness---march-2024">Nervous system disorders now the top cause of illness - March 2024&lt;/h4>
&lt;p>&lt;a href="https://www.yahoo.com/news/surging-nerve-system-disorders-now-000902683.html?utm_source=substack&amp;amp;utm_medium=email">Surging nervous system disorders now top cause of illness: study&lt;/a>&lt;/p></description></item><item><title>Autoimmune diseases fought by Vitamin D, especially if have more than 40 ng</title><link>/posts/autoimmune-diseases-fought-by-vitamin-d-especially-if-have-more-than-40-ng.html</link><pubDate>Wed, 14 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-fought-by-vitamin-d-especially-if-have-more-than-40-ng.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#an-update-on-the-effects-of-vitamin-d-on-the-immune-system-and-autoimmune-diseases">An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="an-update-on-the-effects-of-vitamin-d-on-the-immune-system-and-autoimmune-diseases">An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases&lt;/h4>
&lt;p>Int J Mol Sci. 2022 Aug 29;23(17):9784 &lt;a href="https://doi.org/10.3390/ijms23179784.">doi: 10.3390/ijms23179784.&lt;/a>&lt;/p>
&lt;p>Claudia Sîrbe 1 2 , Simona Rednic 3 4 , Alina Grama 1 2 , Tudor Lucian Pop 1 2&lt;/p>
&lt;p>&lt;strong>PDF Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/toc-autoimmune.jpg" alt="image" width="500">
&lt;p>Vitamin D intervenes in calcium and phosphate metabolism and bone homeostasis. Experimental studies have shown that 1,25-dihydroxyvitamin D (calcitriol) generates immunologic activities on the innate and adaptive immune system and endothelial membrane stability. Low levels of serum 25-hydroxyvitamin D (25(OH)D) are associated with an increased risk of developing immune-related diseases such as psoriasis, type 1 diabetes, multiple sclerosis, and autoimmune diseases. Various clinical trials describe the efficacy of supplementation of vitamin D and its metabolites for treating these diseases that result in variable outcomes. Different disease outcomes are observed in treatment with vitamin D as high inter-individual difference is present with complex gene expression in human peripheral blood mononuclear cells. However, it is still not fully known what level of serum 25(OH)D is needed. The current recommendation is to increase vitamin D intake and have enough sunlight exposure to have serum 25(OH)D at a level of 30 ng/mL (75 nmol/L) and &lt;strong>better at 40-60 ng/mL (100-150 nmol/L) to obtain the optimal health benefits of vitamin D.&lt;/strong>&lt;/p></description></item><item><title>A Simple Protocol Is Stopping the Progression of MS</title><link>/posts/a-simple-protocol-is-stopping-the-progression-of-ms.html</link><pubDate>Mon, 29 Aug 2022 00:00:00 +0000</pubDate><guid>/posts/a-simple-protocol-is-stopping-the-progression-of-ms.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.theepochtimes.com/a-simple-protocol-is-stopping-the-progression-of-ms_4676266.html">The Epoch times&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Nice narrative overview&lt;/p>
&lt;p>&lt;strong>A portion of it = Treatment for All Autoimmune Diseases&lt;/strong>&lt;/p>
&lt;p>The Coimbra protocol seems to be just as effective at lowering and ceasing symptoms of other progressive autoimmune diseases. This is because the dysregulated immune system is brought into balance by vitamin D, believed to have a role in T lymphocyte cell production. T cells are produced in response to fighting disease and pathogens.&lt;/p></description></item><item><title>Multiple Sclerosis treated by Vitamin D (includes dose-response)</title><link>/posts/multiple-sclerosis-treated-by-vitamin-d-includes-dose-response.html</link><pubDate>Mon, 11 Jul 2022 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-by-vitamin-d-includes-dose-response.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#full-spectrum-of-vitamin-d-immunomodulation-in-multiple-sclerosis-mechanisms-and-therapeutic-implications">Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="full-spectrum-of-vitamin-d-immunomodulation-in-multiple-sclerosis-mechanisms-and-therapeutic-implications">Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications&lt;/h4>
&lt;p>Brain Commun. 2022 Jun 30;4(4):fcac171. &lt;a href="https://doi.org/10.1093/braincomms/fcac171.">doi: 10.1093/braincomms/fcac171.&lt;/a> eCollection 2022.&lt;/p>
&lt;p>Manon Galoppin 1, Saniya Kari 2, Sasha Soldati 3, Arindam Pal 3, Manon Rival 1, Britta Engelhardt 3, Anne Astier 2, Eric Thouvenot 1&lt;/p>
&lt;h5 id="vitamin-d-dose-response-chart-for-low-doses">Vitamin D dose response chart (for low doses)&lt;/h5>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-trial-doses.jpg" alt="image" width="350">
&lt;p>Vitamin D deficiency has been associated with the risk of multiple sclerosis, disease activity and progression. Results from in vitro experiments, animal models and analysis of human samples from randomized controlled trials provide comprehensive data illustrating the pleiotropic actions of Vitamin D on the immune system. They globally result in immunomodulation by decreasing differentiation of effector T and B cells while promoting regulatory subsets. Vitamin D also modulates innate immune cells such as macrophages, monocytes and dendritic cells, and acts at the level of the blood-brain barrier reducing immune cell trafficking. Vitamin D exerts additional activity within the central nervous system reducing microglial and astrocytic activation. The immunomodulatory role of Vitamin D detected in animal models of multiple sclerosis has suggested its potential therapeutic use for treating multiple sclerosis. In this review, we focus on recent published data describing the biological effects of Vitamin D in animal models of multiple sclerosis on immune cells, blood-brain barrier function, activation of glial cells and its potential neuroprotective effects. Based on the current knowledge, we also discuss optimization of therapeutic interventions with Vitamin D in patients with multiple sclerosis, as well as new technologies allowing in-depth analysis of immune cell regulations by vitamin D.&lt;/p></description></item><item><title>36% of Multiple Sclerosis patients got worse after mild to severe COVID</title><link>/posts/36-percent-of-multiple-sclerosis-patients-got-worse-after-mild-to-severe-covid.html</link><pubDate>Fri, 17 Jun 2022 00:00:00 +0000</pubDate><guid>/posts/36-percent-of-multiple-sclerosis-patients-got-worse-after-mild-to-severe-covid.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#covid-19-severity-is-associated-with-worsened-neurological-outcomes-in-multiple-sclerosis-and-related-disorders">COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#people-with-multiple-sclerosis-have-learned-to-take-vitamin-d">People with Multiple Sclerosis have learned to take Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#suspect-that-many-msers-taking-lots-of-vitamin-d-never-even-entered-the-hospital">Suspect that many MSers taking lots of vitamin D never even entered the hospital&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="covid-19-severity-is-associated-with-worsened-neurological-outcomes-in-multiple-sclerosis-and-related-disorders">COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders&lt;/h4>
&lt;p>Mult Scler Relat Disord. 2022 Jun 6;63:103946. &lt;a href="https://doi.org/10.1016/j.msard.2022.103946">doi: 10.1016/j.msard.2022.103946&lt;/a>&lt;/p>
&lt;p>Sarah E Conway 1, Brian C Healy 2, Jonathan Zurawski 1, Christopher Severson 1, Tamara Kaplan 1, Lynn Stazzone 1, Kristin Galetta 1, Tanuja Chitnis 1, Maria K Houtchens 3&lt;/p></description></item><item><title>Multiple Sclerosis 2.8 X more likely if poor Vitamin D Binding Protein</title><link>/posts/multiple-sclerosis-28-x-more-likely-if-poor-vitamin-d-binding-protein.html</link><pubDate>Wed, 18 May 2022 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-28-x-more-likely-if-poor-vitamin-d-binding-protein.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#free-vitamin-d-3-index-and-vitamin-d-binding-protein-in-multiple-sclerosis---a-presymptomatic-case-control-study---may-2022">Free Vitamin D 3 Index and Vitamin D-binding protein in multiple sclerosis - a presymptomatic case-control study - May 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#another-ms-and-binding-study---june-2023">Another MS and binding study - June 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="free-vitamin-d-3-index-and-vitamin-d-binding-protein-in-multiple-sclerosis---a-presymptomatic-case-control-study---may-2022">Free Vitamin D 3 Index and Vitamin D-binding protein in multiple sclerosis - a presymptomatic case-control study - May 2022&lt;/h4>
&lt;p>Eur J Neurol. 2022 May 18. &lt;a href="https://doi.org/10.1111/ene.15407">doi: 10.1111/ene.15407&lt;/a>&lt;/p>
&lt;p>Viktor Grut 1, Martin Biström 1, Jonatan Salzer 1, Pernilla Stridh 2 3, Anna Lindam 4, Lucia Alonso-Magdalena 5, Oluf Andersen 6, Daniel Jons 6, Martin Gunnarsson 7, Magnus Vrethem 8, Johan Hultdin # 9, Peter Sundström # 1&lt;/p></description></item><item><title>Coimbra protocol using high-dose Vitamin D is safe</title><link>/posts/coimbra-protocol-using-high-dose-vitamin-d-is-safe.html</link><pubDate>Sun, 10 Apr 2022 00:00:00 +0000</pubDate><guid>/posts/coimbra-protocol-using-high-dose-vitamin-d-is-safe.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#safety-data-in-patients-with-autoimmune-diseases-during-treatment-with-high-doses-of-vitamin-d3-according-to-the-coimbra-protocol">Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the “Coimbra Protocol”&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-same-study-is-also-in-vitamindwiki-at-coimbra-protocol-using-vitamin-d-is-safe-and-effective-for-multiple-sclerosis-and-autoimmune-diseases--april-2022postscoimbra-protocol-using-vitamin-d-is-safe-and-effective-for-multiple-sclerosis-an-immune-diseases">The same study is also in VitaminDWiki at: &lt;a href="/posts/coimbra-protocol-using-vitamin-d-is-safe-and-effective-for-multiple-sclerosis-an-immune-diseases">Coimbra Protocol (using Vitamin D) is safe and effective for Multiple Sclerosis and Autoimmune diseases – April 2022&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="safety-data-in-patients-with-autoimmune-diseases-during-treatment-with-high-doses-of-vitamin-d3-according-to-the-coimbra-protocol">Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the “Coimbra Protocol”&lt;/h4>
&lt;p>Nutrients 2022, 14(8), 1575; &lt;a href="https://doi.org/10.3390/nu14081575">https://doi.org/10.3390/nu14081575&lt;/a>&lt;/p>
&lt;p>Ulrich Amon 1, Raul Yaguboglu 1. Madeleine Ennis 2. Michael F. Holick 3. And Julian Amon 1&lt;/p></description></item><item><title>Beyond the Coimbra Protocol - 2020</title><link>/posts/beyond-the-coimbra-protocol-2020.html</link><pubDate>Tue, 22 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/beyond-the-coimbra-protocol-2020.html</guid><description>&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>Revolutions, like the Coimbra Protocol for Multiple Sclerosis, often need to evolve.&lt;/p>
&lt;p>The Coimbra Protocol appears to not be correct for everyone.&lt;/p>
&lt;p>Some people need different brands and different amounts of some of the nutrients.&lt;/p>
&lt;p>Some people have problems with heavy metals, some foods. and need probiotics.&lt;/p>
&lt;p>The text below this box was written by Michael Cawley, who has splintered off from the protocol.&lt;/p>
&lt;p>Wonder how many need this: 1%?, 10%?&lt;/p></description></item><item><title>Gene variants can reduce Vitamin D response by 1.7X (14,000 IU daily, Multiple Sclerosis)</title><link>/posts/gene-variants-can-reduce-vitamin-d-response-by-17x-14000-iu-daily-multiple-sclerosis.html</link><pubDate>Sun, 13 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/gene-variants-can-reduce-vitamin-d-response-by-17x-14000-iu-daily-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-related-genetic-polymorphisms-affect-serological-response-to-high-dose-vitamin-d-supplementation-in-multiple-sclerosis">Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-related-genetic-polymorphisms-affect-serological-response-to-high-dose-vitamin-d-supplementation-in-multiple-sclerosis">Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis&lt;/h4>
&lt;p>PLoS ONE 16(12): e0261097. &lt;a href="https://doi.org/10.1371/journal">https://doi.org/10.1371/journal&lt;/a>. pone.0261097&lt;/p>
&lt;p>Mimpen M, Rolf L, Poelmans G, van den Ouweland J, Hupperts R, Damoiseaux J, etal.&lt;/p>
&lt;p>&lt;strong>Low Response: Vitamin D Binding Protein&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/high-dose-low-esponse.jpg" alt="image" width="500">
&lt;p>&lt;strong>High Response: CYP27B1&lt;br>
  Note : very few people with MS seem to have the G/G form&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis Risk factors include virus such as Human Herpesvirus 6A – many studies</title><link>/posts/multiple-sclerosis-risk-factors-include-virus-such-as-human-herpesvirus-6a-many-studies.html</link><pubDate>Mon, 28 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-include-virus-such-as-human-herpesvirus-6a-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#human-herpesvirus-6a-is-a-risk-factor-for-multiple-sclerosis---2022">Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis - 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-herpesvirus-6a-and-6b-in-multiple-sclerosis-and-epilepsy---2020">The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#herpesviruses-are-extremely-prevelant">Herpesviruses are extremely prevelant&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#human-herpesvirus-6--multiple-sclerosis-27000-publications-as-of-feb-2022">Human herpesvirus 6 &amp;ldquo;multiple sclerosis&amp;rdquo; 27,000 publications as of Feb 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hhv-6-foundation">hhv-6 Foundation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-linking-hhv-6-with-multiple-sclerosis-2014---cited-by-111-studies-as-of-feb-2022">Evidence linking HHV-6 with multiple sclerosis (2014) - cited by 111 studies as of Feb 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="human-herpesvirus-6a-is-a-risk-factor-for-multiple-sclerosis---2022">Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis - 2022&lt;/h4>
&lt;p>Review Front Immunol . 2022 Feb 10;13:840753. &lt;a href="https://doi.org/10.3389/fimmu.2022.840753.">doi: 10.3389/fimmu.2022.840753.&lt;/a> eCollection 2022.&lt;/p></description></item><item><title>An opportunity - use Vitamin D to treat Multiple Sclerosis (has been used for 14 years)</title><link>/posts/an-opportunity-use-vitamin-d-to-treat-multiple-sclerosis-has-been-used-for-14-years.html</link><pubDate>Fri, 11 Feb 2022 00:00:00 +0000</pubDate><guid>/posts/an-opportunity-use-vitamin-d-to-treat-multiple-sclerosis-has-been-used-for-14-years.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#is-there-a-window-of-opportunity-for-the-therapeutic-use-of-vitamin-d-in-multiple-sclerosis">Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="is-there-a-window-of-opportunity-for-the-therapeutic-use-of-vitamin-d-in-multiple-sclerosis">Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?&lt;/h3>
&lt;p>Neural Regen Res . 2022 Sep;17(9):1945-1954. &lt;a href="https://doi.org/10.4103/1673-5374.335139.">doi: 10.4103/1673-5374.335139.&lt;/a>&lt;/p>
&lt;p>Sofia Fernanda Goncalves Zorzella-Pezavento 1, Luiza Ayumi Nishiyama Mimura 1, Marina Bonifácio Denadai 1, William Danilo Fernandes de Souza 1, Thais Fernanda de Campos Fraga-Silva 1, Alexandrina Sartori 1&lt;/p>
&lt;p>&lt;strong>EAE in Mice is similar to MS in humans&lt;/strong>&lt;/p></description></item><item><title>Vitamin D is a biomarker for autoimmune, neurological and psychiatric diseases</title><link>/posts/vitamin-d-is-a-biomarker-for-autoimmune-neurological-and-psychiatric-diseases.html</link><pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-a-biomarker-for-autoimmune-neurological-and-psychiatric-diseases.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#serum-vitamin-d-as-a-biomarker-in-autoimmune-psychiatric-and-neurodegenerative-diseases">Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="serum-vitamin-d-as-a-biomarker-in-autoimmune-psychiatric-and-neurodegenerative-diseases">Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases&lt;/h4>
&lt;p>Diagnostics 2022, 12, 130. https:// doi.org/ 10.3390/diagnostics12010130&lt;/p>
&lt;p>&lt;strong>Autoimmune&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto1.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto2.jpg" alt="image" width="900">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/auto3.jpg" alt="image" width="900">
&lt;p>&lt;strong>Depression Schizophrenia&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mdd1.jpg" alt="image" width="800">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mdd2.jpg" alt="image" width="800">
&lt;p>Giulia Bivona , Caterina Maria Gambino 1,+, Bruna Lo Sasso 1, Concetta Scazzone 1, Rosaria Vincenza Giglio 1, Luisa Agnello 1 and Marcello Ciaccio 1,2/*&lt;/p>
&lt;p>Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, University of Palermo, 90127 Palermo, Italy; &lt;a href="mailto:giulia.bivona@unipa.it">giulia.bivona@unipa.it&lt;/a> (G.B.); &lt;a href="mailto:cmgambino@libero.it">cmgambino@libero.it&lt;/a> (C.M.G.); &lt;a href="mailto:bruna.losasso@unipa.it">bruna.losasso@unipa.it&lt;/a> (B.L.S.); &lt;a href="mailto:concetta.scazzone@unipa.it">concetta.scazzone@unipa.it&lt;/a> (C.S.); &lt;a href="mailto:giglio.rosaria.vincenza@gmail.com">giglio.rosaria.vincenza@gmail.com&lt;/a> (R.V.G.); &lt;a href="mailto:luisa.agnello@unipa.it">luisa.agnello@unipa.it&lt;/a> (L.A.)&lt;/p></description></item><item><title>White Matter Hyperintensities (brain) 1.8X more likely if 10 ng less vitamin D - meta-analysis</title><link>/posts/white-matter-hyperintensities-brain-18x-more-likely-if-10-ng-less-vitamin-d-meta-analysis.html</link><pubDate>Mon, 31 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/white-matter-hyperintensities-brain-18x-more-likely-if-10-ng-less-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="impact-of-25-hydroxy-vitamin-d-on-white-matter-hyperintensity-in-elderly-patients-a-systematic-review-and-meta-analysis">Impact of 25-Hydroxy Vitamin D on White Matter Hyperintensity in Elderly Patients: A Systematic Review and Meta-Analysis&lt;/h4>
&lt;p>Front Neurol. 2022 Jan 14;12:721427. &lt;a href="https://doi.org/10.3389/fneur.2021.721427.">doi: 10.3389/fneur.2021.721427.&lt;/a>&lt;/p>
&lt;p>Yilei Zhao 1, Jingfeng Xu 1, Zhan Feng 1, Jincheng Wang 1&lt;/p>
&lt;p>Some studies show that low serum vitamin D levels are associated with white matter hyperintensity (WMH), while other studies report no association. This meta-analysis aimed to investigate the presence of an association between serum 25-hydroxy vitamin D &lt;span>[25(OH)D]&lt;/span> levels and WMH. PubMed, Embase, the Cochrane Library, CNKI, WANFANG, and VIP were searched for available papers published up to December 2020. The outcomes were the odds ratios (ORs) with 95% confidence intervals (CIs) for the association between different vitamin D statuses and WMH. All meta-analyses were performed using a random-effects model. Five studies (4393 patients) were included. Compared with sufficient 25(OH)D levels, 25(OH)D deficiency was not associated with WMH (OR = 1.67, 95%CI: 0.92-3.04; I2 = 70.2%, P heterogeneity = 0.009), nor was 25(OH)D insufficiency (OR = 1.21, 95%CI: 0.89-1.65; I2 = 48.1%, P heterogeneity = 0.103).&lt;/p></description></item><item><title>Two highly-rated guidelines for people with Multiple Sclerosis include Vitamin D</title><link>/posts/two-highly-rated-guidelines-for-people-with-multiple-sclerosis-include-vitamin-d.html</link><pubDate>Wed, 19 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/two-highly-rated-guidelines-for-people-with-multiple-sclerosis-include-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#lifestyle-and-complementary-therapies-in-multiple-sclerosis-guidelines-systematic-review">Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="lifestyle-and-complementary-therapies-in-multiple-sclerosis-guidelines-systematic-review">Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review&lt;/h4>
&lt;p>Acta Neurologica Scandinavica 2022 January 17 &lt;a href="https://doi.org/10.1111/ane.13574">https://doi.org/10.1111/ane.13574&lt;/a> PDF costs $15&lt;/p>
&lt;p>Management of multiple sclerosis (MS) may comprise clinical interventions and self-management strategies, including complementary therapies and modifiable lifestyle factors such as exercise and smoking cessation. Lifestyle modifications and complementary therapies with proven safety and efficacy are essential as part of best-practice MS management, especially when faced with limited access to healthcare services. However, it is unclear to what extent MS clinical practice guidelines and consensus statements address these strategies. A systematic review was conducted, wherein MEDLINE, EMBASE, PsycINFO, CINAHL, Scopus, Web of Science, guideline databases and developer sites were searched for guidelines and consensus statements that addressed lifestyle modifications and complementary therapies of interest. Two researchers independently screened articles, extracted data and assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation version II. &lt;strong>Thirty-one guidelines and consensus statement&lt;/strong> s were included.&lt;/p></description></item><item><title>Epstein-Barr virus increases risk of Multiple Sclerosis by 32X</title><link>/posts/epstein-barr-virus-increases-risk-of-multiple-sclerosis-by-32x.html</link><pubDate>Sat, 15 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/epstein-barr-virus-increases-risk-of-multiple-sclerosis-by-32x.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epstein-barr-virus-a-likely-leading-cause-of-multiple-sclerosishttpswwwmdedgecomneurologyarticle250759multiple-sclerosisepstein-barr-virus-likely-leading-cause-multiplechannel393133fecd3dwnl_eve_220115_mdedge-mdedge">&lt;a href="https://www.mdedge.com/neurology/article/250759/multiple-sclerosis/epstein-barr-virus-likely-leading-cause-multiple?channel=39313%3Fecd%3DWNL_eve_220115_mdedge">Epstein-Barr virus a likely leading cause of multiple sclerosis&lt;/a> MDEdge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-viruses-also-increase-the-risk-of-multiple-sclerlosis">Other viruses also increase the risk of Multiple Sclerlosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#anticipate-future-publications-documenting-that-virually-all-people-with-cfs-or-long-haul-previously-had-ebv">Anticipate future publications documenting that virually all people with CFS or Long-Haul previously had EBV&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epstein-barr-virus-a-likely-leading-cause-of-multiple-sclerosishttpswwwmdedgecomneurologyarticle250759multiple-sclerosisepstein-barr-virus-likely-leading-cause-multiplechannel393133fecd3dwnl_eve_220115_mdedge-mdedge">&lt;a href="https://www.mdedge.com/neurology/article/250759/multiple-sclerosis/epstein-barr-virus-likely-leading-cause-multiple?channel=39313%3Fecd%3DWNL_eve_220115_mdedge">Epstein-Barr virus a likely leading cause of multiple sclerosis&lt;/a> MDEdge&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;EBV is common and infects about 95% of adults. Most individuals are already infected with the virus by age 18 or 20 years, making it difficult to study uninfected populations, said Dr. Ascherio.&amp;rdquo;&lt;/p></description></item><item><title>COVID death rate was 3X lower in those with Multiple Sclerosis (85 pcnt were taking Vitamin D)</title><link>/posts/covid-death-rate-was-3x-lower-in-those-with-multiple-sclerosis-85-pcnt-were-taking-vitamin-d.html</link><pubDate>Wed, 12 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/covid-death-rate-was-3x-lower-in-those-with-multiple-sclerosis-85-pcnt-were-taking-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#characteristics-of-covid-19-in-patients-with-multiple-sclerosis---jan-2022">Characteristics of COVID-19 in patients with multiple sclerosis - Jan 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="characteristics-of-covid-19-in-patients-with-multiple-sclerosis---jan-2022">Characteristics of COVID-19 in patients with multiple sclerosis - Jan 2022&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders 57 (2022) 103437 - Authors from Iran &lt;a href="https://doi.org/10.1016/j.msard.2021.103437">https://doi.org/10.1016/j.msard.2021.103437&lt;/a>&lt;/p>
&lt;p>&lt;strong>Study obeserved, but did not comment on the fact that&lt;br>
    &lt;span style="color:Black;background-color:Yellow;">85% of MSers were taking Vitamin D&lt;/span>&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-covid.jpg" alt="image" width="300">
&lt;p>Background: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study&lt;/p>
&lt;p>Multiple rclercste	of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.&lt;/p></description></item><item><title>Mutiple Sclerosis half as likely in children spending 30 to 60 minutes per day in the sun</title><link>/posts/mutiple-sclerosis-half-as-likely-in-children-spending-30-to-60-minutes-per-day-in-the-sun.html</link><pubDate>Fri, 10 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/mutiple-sclerosis-half-as-likely-in-children-spending-30-to-60-minutes-per-day-in-the-sun.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#association-between-time-spent-outdoors-and-risk-of-multiple-sclerosis">Association Between Time Spent Outdoors and Risk of Multiple Sclerosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="association-between-time-spent-outdoors-and-risk-of-multiple-sclerosis">Association Between Time Spent Outdoors and Risk of Multiple Sclerosis&lt;/h4>
&lt;p>Neurology Dec 2021, 10.1212/WNL.0000000000013045&lt;/p>
&lt;p>Prince Sebastian, View ORCID ProfileNicolas Cherbuin, View ORCID ProfileLisa F Barcellos, Shelly Roalstad, Charles Casper, Janace Hart, Gregory S Aaen, View ORCID ProfileLauren Krupp, View ORCID ProfileLeslie Benson, Mark Gorman, Meghan Candee, Tanuja Chitnis, Manu Goyal, Benjamin Greenberg, Soe Mar, Moses Rodriguez, View ORCID ProfileJennifer Rubin, Teri Schreiner, View ORCID ProfileAmy Waldman, View ORCID ProfileBianca Weinstock-Guttman, Jennifer Graves, View ORCID ProfileEmmanuelle Waubant, View ORCID ProfileRobyn Lucas, US Network of Pediatric Multiple Sclerosis Centers&lt;/p></description></item><item><title>Multiple Sclerosis treated by Vitamin D, recommends investigating high dose Coimbra</title><link>/posts/multiple-sclerosis-treated-by-vitamin-d-recommends-investigating-high-dose-coimbra.html</link><pubDate>Wed, 06 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-by-vitamin-d-recommends-investigating-high-dose-coimbra.html</guid><description>&lt;p>&lt;strong>Impact of Vitamin D Supplementation on Multiple Sclerosis&lt;/strong>&lt;/p>
&lt;p>Cureus DOI: 10.7759/cureus.18487&lt;/p>
&lt;p>Fenil Gandhi 1 , Sharan Jhaveri 2 , Chaithanya Avanthika 3 4 , Abhishek Singh 5 , Nidhi Jain 6 &lt;a href="mailto:doctornidhijain@gmail.com">doctornidhijain@gmail.com&lt;/a> , Azouba Gulraiz 7 , Pratiksha Shah 8 , Fareeha Nasir 9&lt;/p>
&lt;ol>
&lt;li>Internal Medicine, Shree Krishna Hospital, Anand, IND 2. Internal Medicine, Nathiba Hargovandas Lakhmichand Municipal Medical College, Ahmedabad, IND 3. Medicine and Surgery, Karnataka Institute of Medical Sciences, Hubli, IND 4. Pediatrics, Karnataka Institute of Medical Sciences, Hubli, IND 5. Internal Medicine, Mount Sinai Morningside, New York City, USA 6. Internal Medicine, Sir Ganga Ram Hospital, New Delhi, IND 7. Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA 8. Vascular Surgery, Shree Krishna Hospital, Anand, IND 9. Internal Medicine, Harlem Hospital Center, New York City, USA&lt;/li>
&lt;/ol>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction-and-background">Introduction And Background&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#review">Review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-as-an-immunomodulator">Vitamin D as an immunomodulator&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#diagnostic-and-treatment-protocols-currently-in-use-for-multiple-sclerosis-ms">Diagnostic and treatment protocols currently in use for multiple sclerosis (MS)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#instrument-based-diagnostics-span53-56span">Instrument-based diagnostics &lt;span>[53-56]&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#treatment-of-multiple-sclerosis">Treatment of multiple sclerosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/vit-d-ms.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis risk increased if both Epstein-Bar Virus and low sun (vitamin D)</title><link>/posts/multiple-sclerosis-risk-increased-if-both-epstein-bar-virus-and-low-sun-vitamin-d.html</link><pubDate>Thu, 26 Aug 2021 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-increased-if-both-epstein-bar-virus-and-low-sun-vitamin-d.html</guid><description/></item><item><title>Vitamin D cost-effectively treats Multiple Sclerosis</title><link>/posts/vitamin-d-cost-effectively-treats-multiple-sclerosis.html</link><pubDate>Fri, 09 Jul 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-cost-effectively-treats-multiple-sclerosis.html</guid><description/></item><item><title>Multiple Sclerosis patients had fewer COVID-19 problems (Note: many MSers take Vitamin D)</title><link>/posts/multiple-sclerosis-patients-had-fewer-covid-19-problems-note-many-msers-take-vitamin-d.html</link><pubDate>Fri, 30 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-had-fewer-covid-19-problems-note-many-msers-take-vitamin-d.html</guid><description>&lt;h4 id="26-studies-cited-this-study-as-of-june-2022">26 studies cited this study as of June 2022&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://scholar.google.com/scholar?cites=9622456919726906517&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">Google Scholar&lt;/a>&lt;/strong>&lt;/p>
&lt;/div>
&lt;p>Various cohorts of patients with multiple sclerosis (MS) and COVID-19 have been described. So far, limited information is available regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in patients with MS. The objective of this study was to test for SARS-CoV-2 antibodies in a large MS cohort to evaluate asymptomatic infections and immunological responses to COVID-19.&lt;/p>
&lt;p>Methods&lt;/p>
&lt;p>This is a prospective cohort study conducted at the MS Center Amsterdam in Amsterdam, the Netherlands. On July 31, 2020, all adult patients with a current diagnosis of MS who had visited the MS Center Amsterdam in the past 2 years were invited to participate. The database was closed on December 18, 2020. The study was approved by the Medical Ethical Committee of the VU University Medical Center, and all patients provided written informed consent. The STROBE reporting guideline was followed.&lt;/p></description></item><item><title>Vitamin D and Multiple Sclerosis – book chapter</title><link>/posts/vitamin-d-and-multiple-sclerosis-book-chapter.html</link><pubDate>Fri, 30 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-book-chapter.html</guid><description/></item><item><title>Autoimmune and high-dose vitamin D (Dr. Coimbra) - Dr. Mahtani video and transcript</title><link>/posts/autoimmune-and-high-dose-vitamin-d-dr-coimbra-dr-mahtani-video-and-transcript.html</link><pubDate>Sun, 11 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/autoimmune-and-high-dose-vitamin-d-dr-coimbra-dr-mahtani-video-and-transcript.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-renu-mahtani">DR. RENU MAHTANI&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#a-few-of-the-slides">A few of the slides&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#transcript">Transcript&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#her-website-she-also-does-internet-consultations-in-english-and-hindi">Her website (she also does internet consultations in English and Hindi)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#my-journey-through-psoriasis-copied-from-her-website">My journey through Psoriasis&amp;hellip; (copied from her website)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dr-coimbra--in-vitamindwiki">Dr. Coimbra in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dr-coimbra-on-covid-19---videos">Dr. Coimbra on COVID-19 - videos&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dr-mahtani-concerning-covid-19-in-vitamindwiki">Dr. Mahtani concerning COVID-19 in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="dr-renu-mahtani">DR. RENU MAHTANI&lt;/h3>
&lt;p>&lt;strong>&lt;a href="https://www.youtube.com/watch?v=80C4HMjcOgo&amp;amp;ab_channel=RenuMahtani">COIMBRA PROTOCOL: VITAMIN D THERAPY FOR AUTOIMMUNE DISORDERS&lt;br>
    - EXPLAINED BY DR. RENU MAHTANI MD FMNM&lt;/a> 33 minute video&lt;/strong>&lt;/p>
&lt;p>&lt;strong>A very brief introduction to Dr. Coimbra high-dose vitamin D protocol by VitaminDWiki&lt;/strong>&lt;/p></description></item><item><title>Vitamin D Resistance hypothesis confirmed by Coimbra high-dose vitamin D protocol</title><link>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</link><pubDate>Wed, 07 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-resistance-hypothesis-confirmed-by-coimbra-high-dose-vitamin-d-protocol.html</guid><description>&lt;p>&lt;strong>Vitamin D resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol&lt;/strong>&lt;/p>
&lt;p>Frontiers in Immunology – Hypothesis and Theory &lt;a href="https://doi.org/10.3389/fimmu.2021.655739">doi: 10.3389/fimmu.2021.655739&lt;/a>&lt;/p>
&lt;p>Dirk Lemke1&amp;rsquo; Rainer Johannes Klement2 &lt;a href="mailto:rainer_klement@gmx.de">rainer_klement@gmx.de&lt;/a>，Felix Schweiger3, Beatrix Schweiger3 and Jorg Spitz4&lt;/p>
&lt;p>1 Praxis Dr. Beatrix Schweiger, Bensheim, Germany, 2 Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, Schweinfurt, Germany, 3 Praxis Dr. Beatrix Schweiger, Waldkirch, Germany, 4Akademie fur menschliche Medizin und evolutionare Gesundheit, Schlangenbad, Germany&lt;/p></description></item><item><title>Multiple Sclerosis varies with latitude while young</title><link>/posts/multiple-sclerosis-varies-with-latitude-while-young.html</link><pubDate>Fri, 12 Mar 2021 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-varies-with-latitude-while-young.html</guid><description/></item><item><title>Vitamin D supplementation increases the genes that repair Multiple Sclerosis</title><link>/posts/vitamin-d-supplementation-increases-the-genes-that-repair-multiple-sclerosis.html</link><pubDate>Wed, 03 Mar 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-supplementation-increases-the-genes-that-repair-multiple-sclerosis.html</guid><description/></item><item><title>People with Multiple Sclerosis taking at least 5,000 IU of Vitamin D felt much better</title><link>/posts/people-with-multiple-sclerosis-taking-at-least-5000-iu-of-vitamin-d-felt-much-better.html</link><pubDate>Sat, 06 Feb 2021 00:00:00 +0000</pubDate><guid>/posts/people-with-multiple-sclerosis-taking-at-least-5000-iu-of-vitamin-d-felt-much-better.html</guid><description/></item><item><title>UK people with Multiple Sclerosis are 3X more likely to take Vitamin D</title><link>/posts/uk-people-with-multiple-sclerosis-are-3x-more-likely-to-take-vitamin-d.html</link><pubDate>Sun, 18 Oct 2020 00:00:00 +0000</pubDate><guid>/posts/uk-people-with-multiple-sclerosis-are-3x-more-likely-to-take-vitamin-d.html</guid><description>&lt;h4 id="remote-testing-of-vitamin-d-levels-across-the-uk-ms-population--a-case-control-study">Remote testing of vitamin D levels across the UK MS population – a case control study&lt;/h4>
&lt;p>preprint Oct 16, 2020&lt;/p>
&lt;p>Nicola Vickaryous PhD1, Mark Jitlal MSc1, Benjamin Meir Jacobs MRCP1, Rod Middleton BSc2,&lt;/p>
&lt;p>Siddharthan Chandran PhD FRCP3, Niall John James MacDougall MD MRCP4,5, Gavin Giovannoni PhD&lt;/p>
&lt;p>FRCP1,6,7 and Ruth Dobson PhD MRCP1,7*&lt;/p>
&lt;p>1: Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London, UK&lt;/p>
&lt;p>2: UKMS Register, Swansea University Medical School, UK&lt;/p></description></item><item><title>Multiple Sclerosis 42X more likely if light brown skin and smoke (both associated with low vitamin D)</title><link>/posts/multiple-sclerosis-42x-more-likely-if-light-brown-skin-and-smoke-both-associated-with-low-vitamin-d.html</link><pubDate>Thu, 30 Jul 2020 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-42x-more-likely-if-light-brown-skin-and-smoke-both-associated-with-low-vitamin-d.html</guid><description/></item><item><title>Immunologic Effects of Vitamin D on Human Health and Disease - Holick</title><link>/posts/immunologic-effects-of-vitamin-d-on-human-health-and-disease-holick.html</link><pubDate>Wed, 15 Jul 2020 00:00:00 +0000</pubDate><guid>/posts/immunologic-effects-of-vitamin-d-on-human-health-and-disease-holick.html</guid><description>&lt;h3 id="physiology-of-vitamin-d">Physiology of Vitamin D&lt;/h3>
&lt;h4 id="sources-synthesis-and-metabolism-of-vitamin-d">Sources, Synthesis, and Metabolism of Vitamin D&lt;/h4>
&lt;p>Human gets vitamin D from sunlight, diet, and supplements. There are two major forms of vitamin D: vitamin D2 and vitamin D3. Vitamin D2 is synthesized from ergosterol and found in yeast, sun dried and ultraviolet irradiated mushrooms, and plants. Vitamin D3 is synthesized endogenously from 7-dehydrocholesterol in the skin and found naturally in cod liver oil and oily fish. After entering the circulation, vitamin D (D represents either or both vitamin D2 and vitamin D3) is metabolized by the vitamin D-25-hydroxylase (CYP2R1) in the liver to 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span>. 25(OH)D is further metabolized by the enzyme 25-hydroxyvitamin D-1a-hydroxylase (CYP27B1) to the active form, 1,25-dihydroxyvitamin D &lt;span>[1,25(OH)2D]&lt;/span> &lt;sup>[2,6]&lt;/sup>. 1,25(OH)2D exerts its physiologic functions in the target tissue by binding to the vitamin D receptor (VDR) in the nucleus where it leads to up- or down- regulation of a multitude of genes &lt;sup>[7]&lt;/sup>. It should be noted that the main site of conversion of 25(OH)D into the systemically bioavailable 1,25(OH)2D is the kidneys. CYP27B1 is also expressed by many other tissues including activated macrophages, parathyroid glands, microglia, breast, colon, and keratinocytes where 1,25(OH)2D is produced and exerts its autocrine and paracrine functions &lt;sup>[1,4,5]&lt;/sup>.&lt;/p></description></item><item><title>Multiple Sclerosis 2X-3X more likely if poor Vitamin D Receptor – Meta-analysis</title><link>/posts/multiple-sclerosis-2x-3x-more-likely-if-poor-vitamin-d-receptor-meta-analysis.html</link><pubDate>Wed, 26 Feb 2020 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-2x-3x-more-likely-if-poor-vitamin-d-receptor-meta-analysis.html</guid><description>&lt;h4 id="similar-conclusion-18x-in-a-paper-published-feb-2021__">Similar conclusion (1.8X) in a paper published Feb 2021__&lt;/h4>
&lt;p>**Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis&lt;/p>
&lt;p>Pharmacogenet Genomics. 2021 Feb 1;31(2):40-47. &lt;a href="https://doi.org/10.1097/FPC.0000000000000420.">doi: 10.1097/FPC.0000000000000420.&lt;/a>&lt;/p>
&lt;p>Bárbara Cancela Díez 1, Cristina Pérez-Ramírez 2, María Del Mar Maldonado-Montoro 3, María Isabel Carrasco-Campos 1, Almudena Sánchez Martín 1, Laura Elena Pineda Lancheros 1, Fernando Martínez-Martínez 4, Miguel Ángel Calleja-Hernández 2, María Carmen Ramírez-Tortosa 5, Alberto Jiménez-Morales 1&lt;/p>
&lt;p>Objectives: Multiple sclerosis (MS) is a neurodegenerative chronic inflammatory. Mutations in the vitamin D receptor (VDR) gene can substantially affect serum vitamin D levels or alter its functionality, and can consequently increase susceptibility to developing MS. The objective of this study was to evaluate the association between polymorphisms in the VDR gene and risk of MS in a (Spanish) Caucasian population.&lt;/p></description></item><item><title>Cognitive speed of Multiple Sclerosis patients increased if Vitamin D increased even a little bit</title><link>/posts/cognitive-speed-of-multiple-sclerosis-patients-increased-if-vitamin-d-increased-even-a-little-bit.html</link><pubDate>Fri, 14 Feb 2020 00:00:00 +0000</pubDate><guid>/posts/cognitive-speed-of-multiple-sclerosis-patients-increased-if-vitamin-d-increased-even-a-little-bit.html</guid><description>&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/darwish-2020---serum-vitamin-d-level-is-associated-with-speed-of-processing-in-multiple-sclerosis-patients---sciencedirect.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/sdmt-increased-if-d-increased.jpg" alt="image" width="300">
&lt;p>Multiple Sclerosis (MS) is often associated with low serum 25(OH)D levels, as well as cognitive dysfunctions. The relationship between 25(OH)D and the most commonly affected cognitive domain in MS; processing speed, is poorly explored. The purpose of this study is to: (1) assess the effect of serum 25(OH)D change on processing speed in MS, and (2) explore the relationship between serum 25(OH)D and brain volume changes in MS. A retrospective chart review was conducted, data from 299 patients were extracted (baseline), of whom 163 had follow-up measurements (after at least a 9-month interval). The Symbol Digits Modalities Test (SDMT) was used as a measure of processing speed. MRI data was available from 78 individuals at baseline, and 70 at follow-up. SDMT scores and brain volumes (Cerebellum (total, grey, and white), intracranial, Grey Matter (GM), and White Matter (WM)) were compared based on 25(OH)D levels and their changes towards follow-up.&lt;/p></description></item><item><title>Multiple Sclerosis: 10 percent fewer relapses for each 10 ng higher level of vitamin D – Meta-analysis</title><link>/posts/multiple-sclerosis-10-percent-fewer-relapses-for-each-10-ng-higher-level-of-vitamin-d-meta-analysis.html</link><pubDate>Thu, 30 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-10-percent-fewer-relapses-for-each-10-ng-higher-level-of-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="note-20000-ms-patients-on-dr-coimbra-protocol-are-being-treated-by-span-stylecolorf00150-ngspan-of-vitamin-d">Note: &amp;gt;20,000 MS patients on Dr. Coimbra Protocol are being treated by &lt;span style="color:#F00;">150 ng&lt;/span> of Vitamin D&lt;/h4></description></item><item><title>Why Do Multiple Sclerosis and Migraine Coexist</title><link>/posts/why-do-multiple-sclerosis-and-migraine-coexist.html</link><pubDate>Mon, 27 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/why-do-multiple-sclerosis-and-migraine-coexist.html</guid><description>&lt;h4 id="clipped-from-pdf">Clipped from PDF&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;While migraine affects approximately 11.7% (Lipton et al., 2007) of the general population, studies have found migraine in 19.8-82% of MS patients, and migraine is also the most commonly observed type of headache in cases of MS (Nicoletti et al., 2008; Vacca et al., 2007)&amp;rdquo;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;This coexistence is important because the rate of relapse was reported to increase in MS patients with migraine (Kowalec et al., 2017), and this relationship may also have negative effects on patients (Marrie, 2017)&amp;rdquo;&lt;/p></description></item><item><title>53 Multiple Sclerosis patients somewhat helped by 10,000 IU of vitamin D (vs, 30,000 virtually cured by 10X as much)</title><link>/posts/53-multiple-sclerosis-patients-somewhat-helped-by-10000-iu-of-vitamin-d-vs-30000--by-10x-as-much.html</link><pubDate>Sat, 25 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/53-multiple-sclerosis-patients-somewhat-helped-by-10000-iu-of-vitamin-d-vs-30000--by-10x-as-much.html</guid><description>&lt;h4 id="high-dose-vitamin-d-supplementation-in-multiple-sclerosis--results-from-the-randomized-evidims-efficacy-of-vitamin-d-supplementation-in-multiple-sclerosis-trial">High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial&lt;/h4>
&lt;p>J Multiple Sclerosis Journal – Experimental, Translational and Clinical, &lt;a href="https://doi.org/10.1177/2055217320903474">https://doi.org/10.1177/2055217320903474&lt;/a>&lt;/p>
&lt;p>an Dörr*†, Priscilla Bäcker-Koduah*, Klaus-Dieter Wernecke, &amp;hellip;&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>This EVIDIMS Randomized Controlled trial used 20,400 IU of Vitamin D every second day&lt;/p>
&lt;p>Some success was achieved (see table below)&lt;/p>
&lt;hr>
&lt;p>Dr. Coimbra&amp;rsquo;s protocol customizes the treatment for each MS patient&lt;/p></description></item><item><title>Low Vitamin D is a causal factor for Multiple Sclerosis (Mendelian analysis)</title><link>/posts/low-vitamin-d-is-a-causal-factor-for-multiple-sclerosis-mendelian-analysis.html</link><pubDate>Thu, 16 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-is-a-causal-factor-for-multiple-sclerosis-mendelian-analysis.html</guid><description>&lt;p>&lt;strong>&lt;a href="/posts/vitamin-d-receptor-activation-can-be-increased-by-any-of-resveratrol-hsoverview--lping-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D Receptor)) activation can be increased by any of: ((Resveratrol)), ~hs~((Overview: Omega-3 many benefits include helping vitamin D">Omega-3&lt;/a>,  &lt;a href="/posts/magnesium-and-vitamin-d">Magnesium&lt;/a>,  &lt;a href="/posts/zinc-and-vitamin-d">Zinc&lt;/a>,   &lt;a href="/posts/quercetin-a-flavonoid-helps-activate-the-vitamin-d-receptor-many-studies">Quercetin&lt;/a>,   &lt;a href="/categories/better-than-daily">non-daily Vit D&lt;/a>,  &lt;a href="/posts/curcumin-may-increase-vitamin-d-in-tissues-activates-vitamin-d-receptor">Curcumin&lt;/a>, intense exercise,   Ginger,   Essential oils, etc&lt;/strong>   &lt;strong>Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators&lt;/strong>&lt;/p>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/low-d-causes-ms.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Objective: To update the causal estimates for the effects of adult body mass index (BMI), childhood BMI, and vitamin D status on multiple sclerosis (MS) risk.&lt;/p></description></item><item><title>Multiple Sclerosis relapses cut in half by 100,000 IU of Vitamin D every 2 weeks– RCT 2019</title><link>/posts/multiple-sclerosis-relapses-cut-in-half-by-100000-iu-of-vitamin-d-every-2-weeks-rct-2019.html</link><pubDate>Thu, 09 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapses-cut-in-half-by-100000-iu-of-vitamin-d-every-2-weeks-rct-2019.html</guid><description>&lt;p>Hupperts R, et al.&lt;/p>
&lt;p>Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a.&lt;/p>
&lt;p>Neurology. 2019 Nov 12;93(20):e1906-e1916.&lt;/p>
&lt;p>Summary(link is external), Read the full article(link is external)&lt;/p>
&lt;hr>
&lt;p>Camu W, et al.&lt;/p>
&lt;p>Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE).&lt;/p>
&lt;p>Neurol Neuroimmunol Neuroinflamm. 2019 Aug 6;6(5). pii: e597.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/ms-100-000-iu-bi-weekly.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Post hoc analysis – from PDF&lt;/strong>&lt;/p>
&lt;p>There were 39 dropouts, almost 3 times higher than initially estimated. Drug-related dropouts were the most frequent cause. The corrected ARRc, used to avoid the potential bias of early dropout on ARR estimate, was significantly lower in the cholecalciferol group both in the ITT (rR = 0.502, 95% CI 0.326–0.764; p = 0.001) and in the completers’ population (rR = 0.395, 95% CI 0.186–0.801; p = 0.01).&lt;/p></description></item><item><title>Multiple Sclerosis 40 percent more likely if mother had low vitamin D – meta-analysis</title><link>/posts/multiple-sclerosis-40-percent-more-likely-if-mother-had-low-vitamin-d-meta-analysis.html</link><pubDate>Sat, 04 Jan 2020 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-40-percent-more-likely-if-mother-had-low-vitamin-d-meta-analysis.html</guid><description/></item><item><title>Not a single case of multiple sclerosis in 15,000,000 people (plant-based diets)</title><link>/posts/not-a-single-case-of-multiple-sclerosis-in-15000000-people-plant-based-diets.html</link><pubDate>Sun, 29 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/not-a-single-case-of-multiple-sclerosis-in-15000000-people-plant-based-diets.html</guid><description>&lt;h4 id="plant-based-diets-for-multiple-sclerosishttpsnutritionfactsorg20130521plant-based-diets-for-multiple-sclerosis-dr-greger">&lt;a href="https://nutritionfacts.org/2013/05/21/plant-based-diets-for-multiple-sclerosis/">Plant-Based Diets for Multiple Sclerosis&lt;/a> Dr. Greger&lt;/h4>
&lt;p>He also mentions a study of 144 Mser’s who were put on a low meat and fat diet.&lt;/p>
&lt;p>95% had ZERO remissions in 34 years – 1990 10.1016/0140-6736(90)91533-g&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://scholar.google.com/scholar?cites=8342944012056095521&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">247 Google Scholar citations of that study as of Dec 2019&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://nutritionfacts.org/2014/07/22/how-to-treat-multiple-sclerosis-with-diet/">How to Treat Multiple Sclerosis with Diet&lt;/a> July 2014&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;But if they started slacking on their diet—even years in, their disease could become reactivated. They felt so great that some felt that they could cheat a little bit, since they had their disease so well under control. But eating just eight grams of saturated fat more a day was accompanied by a striking increase in disability and a near tripling of their death rate.&amp;rdquo;&lt;/p></description></item><item><title>Sun reduces risk of Multiple Sclerosis via both Vitamin D and another way</title><link>/posts/sun-reduces-risk-of-multiple-sclerosis-via-both-vitamin-d-and-another-way.html</link><pubDate>Sun, 29 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/sun-reduces-risk-of-multiple-sclerosis-via-both-vitamin-d-and-another-way.html</guid><description/></item><item><title>Risk of Multiple Sclerosis varies with the Vitamin D Receptor – meta-analysis</title><link>/posts/risk-of-multiple-sclerosis-varies-with-the-vitamin-d-receptor-meta-analysis.html</link><pubDate>Thu, 26 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/risk-of-multiple-sclerosis-varies-with-the-vitamin-d-receptor-meta-analysis.html</guid><description>&lt;p>&lt;strong>&lt;a href="/posts/vitamin-d-receptor-is-associated-in-over-58-autoimmune-studies">Vitamin D Receptor is associated in over 58 autoimmune studies&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/vitamin-d-receptor-activation-can-be-increased-by-any-of-resveratrol-hsoverview--lping-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D Receptor)) Activation can be increased by any of: ((Resveratrol)), ~hs~((Overview: Omega-3 many benefits include helping vitamin D">Omega-3&lt;/a>,  &lt;a href="/posts/magnesium-and-vitamin-d">Magnesium&lt;/a>, &lt;a href="/posts/zinc-and-vitamin-d">Zinc&lt;/a>.  &lt;a href="/posts/quercetin-a-flavonoid-helps-activate-the-vitamin-d-receptor-many-studies">Quercetin&lt;/a>,  &lt;a href="/categories/better-than-daily">non-daily Vit D&lt;/a>.  &lt;a href="/posts/curcumin-may-increase-vitamin-d-in-tissues-activates-vitamin-d-receptor">Curcumin&lt;/a>, intense exercise,  Ginger,  Essential oils, etc&lt;/strong>   &lt;strong>Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators&lt;/strong>&lt;/p>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/ms-vdr-meta.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-vdr.jpg" alt="image" width="400">
&lt;p>Background&lt;/p>
&lt;p>The association between the Vitamin D Receptor (VDR) gene polymorphism and the risk of Multiple sclerosis (MS) has been evaluated in several researches. However, the findings were inconsistent and inconclusive. Therefore, we set out a meta-analysis of all eligible published case-control studies to obtain an exact evaluation of the association between VDR gene polymorphisms and MS.&lt;/p></description></item><item><title>Multiple Sclerosis incidence is still associated with latitude</title><link>/posts/multiple-sclerosis-incidence-is-still-associated-with-latitude.html</link><pubDate>Thu, 19 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-incidence-is-still-associated-with-latitude.html</guid><description>&lt;h4 id="latitude-continues-to-be-significantly-associated-with-the-prevalence-of-multiple-sclerosis-an-updated-meta-analysis">Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.&lt;/h4>
&lt;p>J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1193-1200. &lt;a href="https://doi.org/10.1136/jnnp-2018-320189">doi: 10.1136/jnnp-2018-320189&lt;/a>&lt;/p>
&lt;p>Simpson S Jr1,2, Wang W3,4, Otahal P2, Blizzard L2, van der Mei IAF2, Taylor BV2.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-receptor-is-associated-in-over-58-autoimmune-studies">Vitamin D Receptor is associated in over 58 autoimmune studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Vitamin D remyelinates rats (perhaps remyelinates human MS)</title><link>/posts/vitamin-d-remyelinates-rats-perhaps-remyelinates-human-ms.html</link><pubDate>Sun, 15 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-remyelinates-rats-perhaps-remyelinates-human-ms.html</guid><description>&lt;h4 id="vitamin-d-increases-remyelination-by-promoting-oligodendrocyte-lineage-differentiation">Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation.&lt;/h4>
&lt;p>Brain Behav. 2019 Dec 13:e01498. &lt;a href="https://doi.org/10.1002/brb3.1498.">doi: 10.1002/brb3.1498.&lt;/a>&lt;/p>
&lt;p>Gomez-Pinedo U1, Cuevas JA1, Benito-Martín MS1, Moreno-Jiménez L1, Esteban-Garcia N1, Torre-Fuentes L1, Matías-Guiu JA1, Pytel V1, Montero P1, Matías-Guiu J1.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>Founder of VitaminDWiki had wondered for 8 years how high-dose Vitamin D could remyelinate those with Multiple Sclerosis&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/dr-coimbra-explains-his-treatment-with-high-dose-vitamin-d-for-multiple-sclerosis">Dr. Coimbra explains his treatment with high dose vitamin D for multiple sclerosis – Feb 2015&lt;/a>&lt;/p></description></item><item><title>Resveratrol treats Multiple Sclerosis and other autoimmune diseases – many studies</title><link>/posts/resveratrol-treats-multiple-sclerosis-and-other-autoimmune-diseases-many-studies.html</link><pubDate>Mon, 09 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/resveratrol-treats-multiple-sclerosis-and-other-autoimmune-diseases-many-studies.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">Resveratrol, Vitamin D and Omega-3 should synergistically treat Multiple Sclerosis&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>A few recent Vitamin D and MS studies&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-treated-when-use-high-doses-of-vitamin-d-meta-analysis">Multiple Sclerosis treated when use high doses of vitamin D – meta-analysis May 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-32-percent-less-likely-among-those-with-more-than-32-ng-of-vitamin-d">Multiple Sclerosis 32 percent less likely among those with more than 32 ng of vitamin D – Dec 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-omega-3-eight-studies-as-of">Multiple Sclerosis and Omega-3 – eight studies as of Aug 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-society-continues-to-fund-vitamin-d-research">Multiple Sclerosis Society continues to fund Vitamin D research -Oct 2018&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis 32 percent less likely among those with more than 32 ng of vitamin D</title><link>/posts/multiple-sclerosis-32-percent-less-likely-among-those-with-more-than-32-ng-of-vitamin-d.html</link><pubDate>Sat, 07 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-32-percent-less-likely-among-those-with-more-than-32-ng-of-vitamin-d.html</guid><description>&lt;h4 id="high-serum-concentration-of-vitamin-d-may-protect-against-multiple-sclerosis">High serum concentration of vitamin D may protect against multiple sclerosis&lt;/h4>
&lt;p>Multiple Sclerosis Journal – Experimental, Translational and Clinical &lt;a href="https://doi.org/10.1177/2055217319892291">https://doi.org/10.1177/2055217319892291&lt;/a>&lt;/p>
&lt;p>Martin Biström, Lucia Alonso-Magdalena, Oluf Andersen, &amp;hellip;&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>Swedish case-control study compared 670 people who got MS vs 670 who did not get MS&lt;/p>
&lt;p>Vitamin D levels were taken about 8 years before the MS&lt;/p>
&lt;p>15.5% of those WITH MS previously had &amp;gt;30 ng of vitamin D&lt;/p>
&lt;p>20.5% of those WITHOUT MS previously had &amp;gt;30 ng of Vitamin D&lt;/p></description></item><item><title>The use of high dose Vitamin D (Coimbra Protocol) for multiple sclerosis in Germany – 2019</title><link>/posts/the-use-of-high-dose-vitamin-d-coimbra-protocol-for-multiple-sclerosis-in-germany-2019.html</link><pubDate>Tue, 26 Nov 2019 00:00:00 +0000</pubDate><guid>/posts/the-use-of-high-dose-vitamin-d-coimbra-protocol-for-multiple-sclerosis-in-germany-2019.html</guid><description/></item><item><title>Multiple Sclerosis and Vitamin D chapter (Coimbra and Brazil not mentioned)</title><link>/posts/multiple-sclerosis-and-vitamin-d-chapter-coimbra-and-brazil-not-mentioned.html</link><pubDate>Wed, 30 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-chapter-coimbra-and-brazil-not-mentioned.html</guid><description/></item><item><title>UV helped EAE mice (MS) designed to not respond to Vitamin D</title><link>/posts/uv-helped-eae-mice-ms-designed-to-not-respond-to-vitamin-d.html</link><pubDate>Wed, 23 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/uv-helped-eae-mice-ms-designed-to-not-respond-to-vitamin-d.html</guid><description>&lt;h4 id="uv-light-suppression-of-eae-a-mouse-model-of-multiple-sclerosis-is-independent-of-vitamin-d-and-its-receptor">UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor.&lt;/h4>
&lt;p>Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 201913294. &lt;a href="https://doi.org/10.1073/pnas.1913294116.">doi: 10.1073/pnas.1913294116.&lt;/a>&lt;/p>
&lt;p>Irving AA1, Marling SJ1, Seeman J2, Plum LA1, &lt;strong>DeLuca&lt;/strong> HF3.&lt;/p>
&lt;p>1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.&lt;/p>
&lt;p>2 Product Development, Organic Lab, DiaSorin Inc., Stillwater, MN 55082.&lt;/p>
&lt;p>3 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706; &lt;a href="mailto:deluca@biochem.wisc.edu">deluca@biochem.wisc.edu&lt;/a>.&lt;/p></description></item><item><title>A Multiple Sclerosis hypothesis supported by EAE data</title><link>/posts/a-multiple-sclerosis-hypothesis-supported-by-eae-data.html</link><pubDate>Tue, 01 Oct 2019 00:00:00 +0000</pubDate><guid>/posts/a-multiple-sclerosis-hypothesis-supported-by-eae-data.html</guid><description>&lt;h4 id="latitude-vitamin-d-melatonin-and-gut-microbiota-act-in-concert-to-initiate-multiple-sclerosis-a-new-mechanistic-pathway">Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway.&lt;/h4>
&lt;p>Front Immunol. 2018 Oct 30;9:2484. &lt;a href="https://doi.org/10.3389/fimmu.2018.02484.">doi: 10.3389/fimmu.2018.02484.&lt;/a> eCollection 2018.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;a href="/posts/uv-helped-eae-mice-ms-designed-to-not-respond-to-vitamin-d">UV helped EAE mice (MS) designed to not respond to Vitamin D – Oct 2019&lt;/a>&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=melatonin&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Melatonin occurs 387 times in VitaminDWiki as of Oct 2019&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/melatonin-interacts-with-vitamin-d-in-multiple-sclerosis-patients">Melatonin interacts with Vitamin D in Multiple Sclerosis patients&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://scholar.google.com/scholar?cites=4306188809122350524&amp;amp;as_sdt=5,48&amp;amp;sciodt=0,48&amp;amp;hl=en">Referenced by 3 studies as of Oct 2019&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>The contribution of gut barrier changes to multiple sclerosis pathophysiology&lt;/p></description></item><item><title>Multiple Sclerosis 40 percent less likely if consume tinned fish (Vitamin D and Omega-3)</title><link>/posts/multiple-sclerosis-40-percent-less-likely-if-consume-tinned-fish-vitamin-d-and-omega-3.html</link><pubDate>Mon, 30 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-40-percent-less-likely-if-consume-tinned-fish-vitamin-d-and-omega-3.html</guid><description/></item><item><title>High-dose Vitamin D for Multiple Sclerosis is OK while pregnant</title><link>/posts/high-dose-vitamin-d-for-multiple-sclerosis-is-ok-while-pregnant.html</link><pubDate>Tue, 10 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/high-dose-vitamin-d-for-multiple-sclerosis-is-ok-while-pregnant.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.facebook.com/groups/629001147449412/?multi_permalinks=953470118335845&amp;amp;notif_id=1567994040041034&amp;amp;notif_t=group_highlights&amp;amp;ref=notif">Facebook – Michael Cawley&lt;/a>&lt;/strong>&lt;/p>
&lt;p>The doses of Vitamin D3 for my MS patients during pregnancy ranges from 44,000 iu - 70,000 iu per day.&lt;/p>
&lt;p>All mothers delivered healthy babies and labor was free of complications i.e no pre eclampsia. no birth defects, no autism etc.&lt;/p>
&lt;p>Although MS relapses are very common in the 6 months after pregnancy , not one patient using &amp;ldquo;Personalized Vitamin D3&amp;rdquo; suffered a relapse.&lt;/p></description></item><item><title>Multiple Sclerosis and Omega-3 – eight studies as of</title><link>/posts/multiple-sclerosis-and-omega-3-eight-studies-as-of.html</link><pubDate>Tue, 03 Sep 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-omega-3-eight-studies-as-of.html</guid><description/></item><item><title>Pre-Multiple Sclerosis 40 percent less likely if eat canned fish</title><link>/posts/pre-multiple-sclerosis-40-percent-less-likely-if-eat-canned-fish.html</link><pubDate>Sat, 10 Aug 2019 00:00:00 +0000</pubDate><guid>/posts/pre-multiple-sclerosis-40-percent-less-likely-if-eat-canned-fish.html</guid><description>&lt;h4 id="plot-of-data-by-grassroots-healthhttpcampaignr20constantcontactcomrenderm1102722411090cac274f0bb-78b7-427e-8344-f62008517990">&lt;a href="http://campaign.r20.constantcontact.com/render?m=1102722411090&amp;amp;ca=c274f0bb-78b7-427e-8344-f62008517990">Plot of data by Grassroots Health&lt;/a>&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/grhfish.jpg" alt="image" width="690">
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/ms-fish-sci-hub.pdf">Download the PDF from Sci-Hub via VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Black LJ1, Zhao Y2, Peng YC2, Sherriff JL2, Lucas RM3,4, van der Mei I5; Ausimmune Investigator Group, Pereira G2., Collaborators (13)&lt;/p>
&lt;p>1 School of Public Health, Curtin University, Bentley, WA, 6102, Australia. &lt;a href="mailto:lucinda.black@curtin.edu.au">lucinda.black@curtin.edu.au&lt;/a>.&lt;/p>
&lt;p>2 School of Public Health, Curtin University, Bentley, WA, 6102, Australia.&lt;/p>
&lt;p>3 National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, 1200, Australia.&lt;/p></description></item><item><title>Alemtuzumab treatment of autoimmune diseases has many side effects, Vitamin D should prevent most of them</title><link>/posts/alemtuzumab-treatment-of-autoimmune-diseases-has-many-side-effects-vitamin-d-sho-nt-most-of-them.html</link><pubDate>Sat, 13 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/alemtuzumab-treatment-of-autoimmune-diseases-has-many-side-effects-vitamin-d-sho-nt-most-of-them.html</guid><description>&lt;h4 id="vitamin-d-supplementation-for-the-prevention-or-depletion-of-side-effects-of-therapy-with-alemtuzumab-in-multiple-sclerosis">Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis&lt;/h4>
&lt;p>Therapeutics and Clinical Risk Management Volume 2019:15 Pages 891—904, DOI &lt;a href="https://doi.org/10.2147/TCRM.S188941">https://doi.org/10.2147/TCRM.S188941&lt;/a>&lt;/p>
&lt;p>Hans-Klaus Goischke&lt;/p>
&lt;p>Independent Research, Internal Medicine, Rehabilitation Medicine, Social Medicine, Bad Brückenau, Bavaria, Germany&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>Alemtuzumab appears to be a chemotherapy drug used to treat Multiple Sclerosis and various Cancers&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Many of the diseases can be prevented and/or treated by Vitamin D without the use of Alemtuzumab&lt;/strong>&lt;/p></description></item><item><title>Recent brain problems appears to be associated with neurofilament light chains (would aide Vitamin D MS. Alz studies)</title><link>/posts/recent-brain-problems-appears-to-be-associated-with-neurofilament-light-chains-w--ms-alz-studies.html</link><pubDate>Sat, 13 Jul 2019 00:00:00 +0000</pubDate><guid>/posts/recent-brain-problems-appears-to-be-associated-with-neurofilament-light-chains-w--ms-alz-studies.html</guid><description>&lt;h4 id="vitamin-d-supplementation-as-add-on-therapy-in-multiple-sclerosisbalance-between-benefit-and-risk-a-commentary-on-vitamin-d-supplementation-in-central-nervous-system-demyelinating-diseaseenough-is-enough">Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis—Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2019, 20,1513; doi:10.3390/ijms20061513&lt;/p>
&lt;p>Hans-Klaus Goischke, Hochwaldstrasse 2, D-97769 Bad Brückenau, Germany; &lt;a href="mailto:hkem.goischke@t-online.de">hkem.goischke@t-online.de&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>It is great when we can get quick feedback on how well Vitamin D dosing is treating any disease&lt;/strong>&lt;/p>
&lt;h3 id="see-also">See also&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.quanterix.com/products-technology/assays/nf-light?gclid=CjwKCAjwgqbpBRAREiwAF046JQWlFwPkgJveMvi5AGwHW9YkjICDAzfzwxgMmuTmnrwiK-IxvCaszBoCQHsQAvD_BwE">Quanterix sells a sNFL test&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://n.neurology.org/content/92/15_Supplement/S56.006">Neurofilament Light Chains as a Marker of Concurrent and Future Active Disease in Relapsing Multiple Sclerosis: An Analysis of Baseline Data From the Phase 3 Ozanimod Clinical Trials (S56.006) April 2019&lt;/a>&lt;/p></description></item><item><title>Most of Coimbra Protocol supplements in a capsule taken 4 times a day</title><link>/posts/most-of-coimbra-protocol-supplements-in-a-capsule-taken-4-times-a-day.html</link><pubDate>Sat, 15 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/most-of-coimbra-protocol-supplements-in-a-capsule-taken-4-times-a-day.html</guid><description>&lt;h4 id="sold-by-dr-pinkleton-in-seattlehttpswwwdoctorpinkletoncomshop">&lt;a href="https://www.doctorpinkleton.com/shop">Sold by Dr. Pinkleton in Seattle&lt;/a>&lt;/h4>
&lt;p>&lt;strong>She is on the list of CP trained doctors (NW portion of the US)&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cp-map-world.jpg" alt="image" width="400">
&lt;p>$52/ bottle lasts 30 days&lt;br>
All supplement, no filler&lt;br>
Does not include the Vitamin D&lt;br>
Appears to include most of the rest of the supplements&lt;/p>
&lt;p> &lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cp.jpg" alt="image" width="500"></description></item><item><title>Successful high dose vitamin D (Coimbra Protocol) should be evaluated</title><link>/posts/successful-high-dose-vitamin-d-coimbra-protocol-should-be-evaluated.html</link><pubDate>Sun, 09 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/successful-high-dose-vitamin-d-coimbra-protocol-should-be-evaluated.html</guid><description/></item><item><title>Multiple Sclerosis and Vitamin D Receptor super enhancers</title><link>/posts/multiple-sclerosis-and-vitamin-d-receptor-super-enhancers.html</link><pubDate>Wed, 22 May 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-receptor-super-enhancers.html</guid><description>&lt;h4 id="press-release-for-the-study">Press Release for the study&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://msra.org.au/news/genetic-links-with-vitamin-d/">NEW GENETIC LINKS WITH VITAMIN D DISCOVERED IN MS&lt;/a>&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;They identified five MS risk genes that were strongly regulated by vitamin D super-enhancers, that is cells either made far more or less of these genes when vitamin D was present. These genes were involved in a range of functions, including immune response and inflammation in the brain. &amp;quot;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;The team also specifically investigated a particular gene called ZMIZ1 to see if it was controlled by vitamin D super-enhancers. ZMIZ1 is already of interest in MS as it has previously been shown that cells in people with MS produce a very different level of this gene compared to people without MS. The researchers found that the ZMIZ1 gene was regulated by vitamin D super-enhancers.&amp;rdquo;&lt;/p></description></item><item><title>Personalized Vitamin D treatment of Multiple Sclerosis - Michael Cawley</title><link>/posts/personalized-vitamin-d-treatment-of-multiple-sclerosis-michael-cawley.html</link><pubDate>Thu, 28 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/personalized-vitamin-d-treatment-of-multiple-sclerosis-michael-cawley.html</guid><description>&lt;p>Irish Acupuncturist and Nutritionist MIchael Cawley reversed 20 years of his MS symptoms with Coimbra Protocol.&lt;/p>
&lt;p>He was then invited to San Paulo, Brazil by Dr.Cicero Coimbra MD (2017) and was added to list of Coimbra Protocol Practioners.&lt;/p>
&lt;p>&lt;strong>Upon clinical application of Coimbra Protocol he made several important discoveries&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Many MS patients became worse on high doses of Vitamin D3 that had halted and reversed his own illness.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>In large numbers of MS sufferer’s Vitamin D3 above 500 iu per kg of Vitamin D3 can worsen Multiple Sclerosis symptoms, while 400 - 500 iu per kg of body weight of Vitamin D can ease symptoms significantly. This worsening of symptoms is misdiagnosed as a multiple sclerosis “flare”, usually adding more D3 makes matters worse.&lt;/p></description></item><item><title>Immunological effects of vitamin D and their relations to autoimmunity</title><link>/posts/immunological-effects-of-vitamin-d-and-their-relations-to-autoimmunity.html</link><pubDate>Tue, 19 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/immunological-effects-of-vitamin-d-and-their-relations-to-autoimmunity.html</guid><description>&lt;p>J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30033-2. &lt;a href="https://doi.org/10.1016/j.jaut.2019.03.002.">doi: 10.1016/j.jaut.2019.03.002.&lt;/a>&lt;/p>
&lt;p>Yamamoto E1, Jørgensen TN2.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/autoimmunity-sci-hub.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Animal Model of Autoimmunity&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/autoimmunity-animal.jpg" alt="image" width="900">
&lt;p>Vitamin D deficiency is an established risk factor for many autoimmune diseases and the anti-inflammatory properties of vitamin D underscore its potential therapeutic value for these diseases. However, results of vitamin D3 supplementation clinical trials have been varied. To understand the clinical heterogeneity, we reviewed the pre-clinical data on vitamin D activity in four common autoimmune diseases:&lt;/p></description></item><item><title>Asthma 3X more likely if have Multiple Sclerosis (both have low Vitamin D)</title><link>/posts/asthma-3x-more-likely-if-have-multiple-sclerosis-both-have-low-vitamin-d.html</link><pubDate>Fri, 08 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/asthma-3x-more-likely-if-have-multiple-sclerosis-both-have-low-vitamin-d.html</guid><description>&lt;h4 id="asthma-prevalence-three-times-higher-in-mshttpswwwmedscapecomviewarticle910031srcrsshttpwwwmedscapecomviewarticle910031srcrss-medscape">&lt;a href="https://www.medscape.com/viewarticle/910031?src=rsshttp://www.medscape.com/viewarticle/910031?src=rss">Asthma Prevalence Three Times Higher in MS&lt;/a> Medscape&lt;/h4>
&lt;p>&lt;strong>Presented at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019&lt;/strong>&lt;/p>
&lt;p>Used the electronic health record information available in the IBM Explorys EPM: Explore database&lt;/p>
&lt;p>141,880 people with MS – 19% had asthma&lt;/p>
&lt;p>56,416,790 without MS – 6.6 % had asthma&lt;/p>
&lt;p>2.97- &lt;span>[CI]&lt;/span>, 2.96, 2.97, P &amp;lt; .0001).&lt;/p>
&lt;p>“&amp;ldquo;It is unknown why there is this increase,&amp;rdquo; Briggs explained. &amp;ldquo;We do know that MS and asthma share several common risk factors, including tobacco smoke, &lt;strong>vitamin D insufficiency&lt;/strong> , and obesity. There is also evidence for some overlap in their genetic risk factors.&amp;rdquo;&lt;/p></description></item><item><title>Sugary drinks associated with 5X worse Multiple Sclerosis (reduces vitamin D levels)</title><link>/posts/sugary-drinks-associated-with-5x-worse-multiple-sclerosis-reduces-vitamin-d-levels.html</link><pubDate>Tue, 05 Mar 2019 00:00:00 +0000</pubDate><guid>/posts/sugary-drinks-associated-with-5x-worse-multiple-sclerosis-reduces-vitamin-d-levels.html</guid><description>&lt;h4 id="sugary-drinks-may-up-disability-in-mshttpswwwmedpagetodaycommeetingcoverageaan78382vpass1medpage-today">&lt;a href="https://www.medpagetoday.com/meetingcoverage/aan/78382?vpass=1">Sugary Drinks May Up Disability in MS&lt;/a>MedPage today&lt;/h4>
&lt;ul>
&lt;li>“An an analysis of 135 people with MS, those ranked in the highest quartile for sugar-sweetened beverage (SSB) intake had five-fold higher odds for severe disability versus mild-to-moderate disability (OR 5.01, 95% CI 1.03-24.37, P=0.01 for trend),”&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>Does not mention that Sugary drinks ==&amp;gt; Reduced Vitamin D&lt;/strong>&lt;/p>
&lt;p>To be presented at a May 2019 AAN conference&lt;/p>
&lt;hr>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/bad-effects-of-fructose-diet-offset-by-vitamin-d-supplementation-mice">Bad effects of fructose diet offset by Vitamin D supplementation (mice) - June 2019&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis depression reduced by 10,000 IU of vitamin D</title><link>/posts/multiple-sclerosis-depression-reduced-by-10000-iu-of-vitamin-d.html</link><pubDate>Sun, 03 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-depression-reduced-by-10000-iu-of-vitamin-d.html</guid><description/></item><item><title>Comparing High-dose vitamin D therapies</title><link>/posts/comparing-high-dose-vitamin-d-therapies.html</link><pubDate>Fri, 01 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/comparing-high-dose-vitamin-d-therapies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#comparing-high-dose-protocols">Comparing high-dose protocols&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-cofactors-in-a-nutshellpostsvitamin-d-cofactors-in-a-nutshell-has-thefollowing">&lt;a href="/posts/vitamin-d-cofactors-in-a-nutshell">Vitamin D Cofactors in a nutshell&lt;/a> has the following&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#overview-toxicity-of-vitamin-dpostsoverview-toxicity-of-vitamin-d-has-thefollowing">&lt;a href="/posts/overview-toxicity-of-vitamin-d">Overview Toxicity of vitamin D&lt;/a> has the following&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-alsovitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="comparing-high-dose-protocols">Comparing high-dose protocols&lt;/h4>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>&lt;/td>
 &lt;td>Dr. Coimbra&lt;br>books ((High-Dose Vitamin D Therapy – book July 2018&lt;/td>
 &lt;td>2018)) ((Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/td>
 &lt;td>2016))&lt;/td>
 &lt;td>Dr. Somerville&lt;br>&lt;a href="/posts/optimal-dose" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 10434">Optimal Dose&lt;/a>&lt;/td>
 &lt;td>((Sleep problems cured by vitamin D, etc. – workshops and patient workbooks – Gominak 2018&lt;/td>
 &lt;td>Dr. Gominak))&lt;/td>
 &lt;td>((Cluster and Migraine headache treatment protocol - Sept 2023&lt;/td>
 &lt;td>Mr. Batcheller))&lt;/td>
 &lt;td>((The End of Alzheimer&amp;rsquo;s and Dementia if adjust Vitamin D, B-12, Iron, Omega-3, etc.&lt;/td>
 &lt;td>Dr. Bredsen))&lt;br>End of Alz.&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Health problem&lt;/td>
 &lt;td>Multiple Sclerosis&lt;br>autoimmune, PD&lt;/td>
 &lt;td>sleep, flu, pain, &lt;br>obesity, etc.&lt;/td>
 &lt;td>Sleep&lt;/td>
 &lt;td>Cluster, Migraine &lt;br>Headaches&lt;/td>
 &lt;td>Alzheimer&amp;rsquo;s &lt;br>Park. being added&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Number of people&lt;br> (2019)&lt;/td>
 &lt;td>30,000 &lt;br>&lt;a href="https://www.betterplace.org/en/projects/74058-coimba-protocol-vitamin-d-high-dose-therapy-stops-autoimmune-diseases#:~:text=since%202002%20this%20therapy%20has%20already%20helped%20more%20than%2030%2C000%20people%20worldwide%20to%20stop%20their%20disease%20and%20gain%20back%20quality%20of%20life">by 2022&lt;/a>&lt;/td>
 &lt;td>5,000&lt;/td>
 &lt;td>5,000&lt;/td>
 &lt;td>9,000 &lt;br>(2024)&lt;/td>
 &lt;td>&amp;gt;5,000 (2020)&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Vitamin D target&lt;/td>
 &lt;td>PTH is target &lt;br>typ: 150ng&lt;/td>
 &lt;td>100-140+ ng&lt;/td>
 &lt;td>60-80 ng&lt;/td>
 &lt;td>PTH is target&lt;br>typ: 80 ng&lt;/td>
 &lt;td>40-60 ng&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Vitamin D daily dose&lt;br>(K = 1,000 IU)&lt;/td>
 &lt;td>20K - 200K&lt;br> 1,000 IU/kg&lt;/td>
 &lt;td>30K&lt;/td>
 &lt;td>2K + monthly&lt;br> test increasing &lt;br>dose until goal&lt;/td>
 &lt;td>4K - 40K&lt;br>110 IU/kg&lt;/td>
 &lt;td>?&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Overview: Omega-3 many benefits include helping vitamin D&lt;/td>
 &lt;td>Omega-3)) &lt;strong>&lt;span style="color:#F00;">✻&lt;/span>&lt;/strong>&lt;/td>
 &lt;td>O-3&lt;/td>
 &lt;td>O-3&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>O-3&lt;/td>
 &lt;td>O-3&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Overview Magnesium and vitamin D&lt;/td>
 &lt;td>Magnesium)) &lt;strong>&lt;span style="color:#F00;">✻&lt;/span>&lt;/strong>&lt;/td>
 &lt;td>Mg&lt;/td>
 &lt;td>Mg&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>Mg (400 mg)&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Overview Vitamin K and Vitamin D&lt;/td>
 &lt;td>Vitamin K2))&lt;/td>
 &lt;td>K2 (no longer?)&lt;/td>
 &lt;td>K2&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>K2&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Vitamin B&amp;hellip;&lt;/td>
 &lt;td>B2, B9, ((Vitamin B12&lt;/td>
 &lt;td>B12))&lt;/td>
 &lt;td>B3&lt;/td>
 &lt;td>B50-B100 &lt;br> 3 months&lt;/td>
 &lt;td>B50&lt;/td>
 &lt;td>B12&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Zinc and Vitamin D&lt;/td>
 &lt;td>Zinc)) &lt;strong>&lt;span style="color:#F00;">✻&lt;/span>&lt;/strong>&lt;/td>
 &lt;td>Zn&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>Zn&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Vitamin D and Boron&lt;/td>
 &lt;td>Boron)) *** ?**&lt;/td>
 &lt;td>B&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>B&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Calcium hazards and bioavailability&lt;/td>
 &lt;td>Calcium))&lt;br>Minimize rock-based Ca&lt;/td>
 &lt;td>Decrease Ca&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>Ca&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>((Vitamin D and Vitamin A&lt;/td>
 &lt;td>Vitamin A))&lt;br> avoid extremes&lt;/td>
 &lt;td>avoid A&lt;/td>
 &lt;td>avoid A&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>A&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Other&lt;/td>
 &lt;td>Choline&lt;br> Selenium&lt;br>Co-Q 10&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>Co-Q 10&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>Loading dose&lt;br>Days instead of months&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>- - -&lt;/td>
 &lt;td>Loading&lt;br>&amp;ldquo;Cluster Balm&amp;rdquo;&lt;/td>
 &lt;td>-&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;!-- ~tc~ end ~/tc~ -->
&lt;p>&lt;strong>Most highly successful uses of high-dose Vitamin D have a lot in common&lt;/strong>&lt;/p></description></item><item><title>High-dose vitamin D forum – for Multiple Sclerosis and many other diseases</title><link>/posts/high-dose-vitamin-d-forum-for-multiple-sclerosis-and-many-other-diseases.html</link><pubDate>Fri, 04 Jan 2019 00:00:00 +0000</pubDate><guid>/posts/high-dose-vitamin-d-forum-for-multiple-sclerosis-and-many-other-diseases.html</guid><description>&lt;p>&lt;strong>Here are some of the 127 topics in the MS forum&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/high-dose-vitamin-d-forum.jpg" alt="image" width="500">
&lt;h3 id="overview-toxicity-of-vitamin-dpostsoverview-toxicity-of-vitamin-d-note-chart-was-updated-due-to-coimbra-protocol">&lt;a href="/posts/overview-toxicity-of-vitamin-d">Overview Toxicity of vitamin D&lt;/a> Note: Chart was updated due to Coimbra Protocol&lt;/h3>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;!-- ~tc~ (alias(High dose vitamin D forum – for Multiple Sclerosis and many other diseases – Jan 2019)) ~/tc~ --></description></item><item><title>CYP2R1 gene problem increases Multiple Sclerosis risk by 1.4X</title><link>/posts/cyp2r1-gene-problem-increases-multiple-sclerosis-risk-by-14x.html</link><pubDate>Sun, 16 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/cyp2r1-gene-problem-increases-multiple-sclerosis-risk-by-14x.html</guid><description/></item><item><title>Multiple Sclerosis increases risk of Psoriasis by 1.9X (both associated with low vitamin D) – meta-analysis</title><link>/posts/multiple-sclerosis-increases-risk-of-psoriasis-by-19x-both-associated-with-low-v-d-meta-analysis.html</link><pubDate>Thu, 13 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-increases-risk-of-psoriasis-by-19x-both-associated-with-low-v-d-meta-analysis.html</guid><description>&lt;h4 id="association-of-multiple-sclerosis-with-psoriasis-a-systematic-review-and-meta-analysis-of-observational-studies">Association of Multiple Sclerosis with Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies&lt;/h4>
&lt;p>American Journal of Clinical Dermatology, pp 1–8; DOI &lt;a href="https://doi.org/10.1007/s40257-018-0399-9">https://doi.org/10.1007/s40257-018-0399-9&lt;/a>&lt;/p>
&lt;p>Chia-Yu Liu Tao-Hsin Tung Chin-Yu Lee Kuo-Hsuan Chang Shu-Hui Wang Ching-Chi Chi&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>High Dose Vitamin D has been proven to treat both auto-immune diseases (along with many others)&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/35000-iu-vitamin-d-daily-for-6-months-helped-all-psoriasis-suffers-106-ng-brazil">35,000 IU vitamin D daily for 6 months helped ALL psoriasis suffers (106 ng) – Brazil March 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-coimbra-protocol-high-dose-vitamin-d-by-one-of-the-120-doctors-of-20000-patients">Multiple Sclerosis - Coimbra Protocol (high-dose Vitamin D) - by one of the 120 doctors of 20,000 patients - Dec 2018&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis - Coimbra Protocol (high-dose Vitamin D) - by one of the 120 doctors of 20,000 patients</title><link>/posts/multiple-sclerosis-coimbra-protocol-high-dose-vitamin-d-by-one-of-the-120-doctors-of-20000-patients.html</link><pubDate>Fri, 07 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-coimbra-protocol-high-dose-vitamin-d-by-one-of-the-120-doctors-of-20000-patients.html</guid><description>&lt;h4 id="original-in-portuguesehttpprotocolocoimbrapta-falacia-da-ausencia-de-evidencia-do-protocolo-coimbrafbclidiwar0zdqj-5izvmgl9gkzno1t3hobwwz1y8w5i0p8cvr_ifhqu4o0rygsryry">&lt;a href="http://protocolocoimbra.pt/a-falacia-da-ausencia-de-evidencia-do-protocolo-coimbra/?fbclid=IwAR0zdqj-5iZvmgl9GkZno1t3hoBWwz1y8W5I0P8cvR_IfHqU4O0rYgSryrY">Original in Portuguese&lt;/a>&lt;/h4>
&lt;p>&lt;strong>A few of the many Coimbra articles on VitaminDWiki&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/interview-of-dr-coimbra-ms-autoimmune-vitamin-d-b2-ca-mg-pth-etc-perhaps-2018">Interview of Dr. Coimbra: MS, Autoimmune, Vitamin D, B2, Ca, Mg, PTH etc. – perhaps 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-has-treated-multiple-sclerosis-and-autoimmune-diseases-for-16-years-coimbra">Vitamin D has treated Multiple Sclerosis and autoimmune diseases for 16 years – Coimbra April 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dr-coimbra-interview-covering-vitamin-d-magnesium-folate-vaccines">Dr. Coimbra interview covering Vitamin D, Magnesium, Folate, Vaccines - Oct 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-coimbra-protocol-stories-on-facebook">Multiple Sclerosis Coimbra Protocol stories on Facebook&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dr-coimbra-discusses-vitamin-d-magnesium-folic-acid-b12-autism-depression-etc">Dr. Coimbra discusses Vitamin D, Magnesium, Folic Acid, B12, Autism, Depression, etc – Sept 2018&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis incidence varies with latitude (noted in Brazil too)</title><link>/posts/multiple-sclerosis-incidence-varies-with-latitude-noted-in-brazil-too.html</link><pubDate>Fri, 07 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-incidence-varies-with-latitude-noted-in-brazil-too.html</guid><description>&lt;h4 id="prevalence-of-multiple-sclerosis-in-brazil-a-systematic-review">Prevalence of multiple sclerosis in Brazil: A systematic review&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders, Vol 4, # 6, November 2015, Pages 572-579, &lt;a href="https://doi.org/10.1016/j.msard.2015.08.004">https://doi.org/10.1016/j.msard.2015.08.004&lt;/a>&lt;/p>
&lt;p>panelAna Beatriz Calmon Nogueirada Gama PereiraabMaria ClineteSampaio LacativaacFernanda Ferreira Chavesda Costa PereiraadRegina MariaPapais Alvarengaae&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/smile-ms-brazil.jpg" alt="image" width="600">
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>This meta-analysis based on 19 published crude prevalence studies from Brazil has shown that the prevalence of multiple sclerosis is low compared with western countries on the northern hemisphere.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>In Brazil there is a strong and statistical significant latitudinal gradient with higher prevalence at high southern latitudes. This gradient could not be explained alone by racial differences between the regions.&lt;/p></description></item><item><title>Vitamin D and neurological diseases such as stroke, Vascular Dementia, PD, MS</title><link>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</link><pubDate>Thu, 06 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-neurological-diseases-such-as-stroke-vascular-dementia-pd-ms.html</guid><description>&lt;p>&lt;strong>Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact&lt;/strong>&lt;/p>
&lt;p>International Journal of Molecular Sciences, 2018, 19, 2245; doi:10.3390/ijms19082245&lt;/p>
&lt;p>Rita Moretti &lt;a href="mailto:moretti@units.it">moretti@units.it&lt;/a>, Maria Elisa Morelli © and Paola Caruso&lt;/p>
&lt;p>Neurology Clinic, Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy; &lt;a href="mailto:mariaelisa.morelli@gmail.com">mariaelisa.morelli@gmail.com&lt;/a> (M.E.M.); &lt;a href="mailto:caruso.paola1983@libero.it">caruso.paola1983@libero.it&lt;/a> (P.C.)&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/vdr-neurological-diseases.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-multiple-sclerosis-role-in-the-susceptibility-activity-and-treatment-of-the-disease">Vitamin D Deficiency and Multiple Sclerosis: Role in the Susceptibility, Activity, and Treatment of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiencies-and-ischemic-stroke">Vitamin D Deficiencies and Ischemic Stroke&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-and-neurodegenerative-diseases">Vitamin D Deficiency and Neurodegenerative Diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>It is widely known that vitamin D receptors have been found in neurons and glial cells, and their highest expression is in the hippocampus, hypothalamus, thalamus and subcortical grey nuclei, and substantia nigra. Vitamin D helps the regulation of neurotrophin, neural differentiation, and maturation, through the control operation of growing factors synthesis (i.e., neural growth factor &lt;span>[NGF]&lt;/span> and glial cell line-derived growth factor (GDNF), the trafficking of the septohippocampal pathway, and the control of the synthesis process of different neuromodulators (such as acetylcholine &lt;span>[Ach]&lt;/span>, dopamine &lt;span>[DA]&lt;/span>, and gamma-aminobutyric &lt;span>[GABA]&lt;/span>). Based on these assumptions, we have written this review to summarize the potential role of vitamin D in neurological pathologies. This work could be titanic and the results might have been very fuzzy and even incoherent had we not conjectured to taper our first intentions and devoted our interests towards three mainstreams, demyelinating pathologies, vascular syndromes, and neurodegeneration. As a result of the lack of useful therapeutic options, apart from the disease-modifying strategies, the role of different risk factors should be investigated in neurology, as their correction may lead to the improvement of the cerebral conditions. We have explored the relationships between the gene-environmental influence and long-term vitamin D deficiency, as a risk factor for the development of different types of neurological disorders, along with the role and the rationale of therapeutic trials with vitamin D implementation.&lt;/p></description></item><item><title>Interview of Dr. Coimbra: MS, Autoimmune, Vitamin D, B2, Ca, Mg, PTH etc. – perhaps 2018</title><link>/posts/interview-of-dr-coimbra-ms-autoimmune-vitamin-d-b2-ca-mg-pth-etc-perhaps-2018.html</link><pubDate>Sun, 02 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/interview-of-dr-coimbra-ms-autoimmune-vitamin-d-b2-ca-mg-pth-etc-perhaps-2018.html</guid><description>&lt;p>&lt;strong>VITAMIN D - REMEDIES FOR MS AND AUTOIMMUNE DISEASES?&lt;/strong>&lt;/p>
&lt;p>Translated from German by Google&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://www.vitamind.net/interviews/coimbra-ms-autoimmun/?fbclid=IwAR26RpFvceKZypWREhYZQtr27ch5MusydLLsA3uVzszwAQ0GWbZ753ia2sk%20">Original has several charts in German&lt;/a>&lt;/strong> VitaminD.Net&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-has-treated-multiple-sclerosis-and-autoimmune-diseases-for-16-years-coimbra">Vitamin D has treated Multiple Sclerosis and autoimmune diseases for 16 years – Coimbra April 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dr-coimbra-interview-covering-vitamin-d-magnesium-folate-vaccines">Dr. Coimbra interview covering Vitamin D, Magnesium, Folate, Vaccines - Oct 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-coimbra-protocol-stories-on-facebook">Multiple Sclerosis Coimbra Protocol stories on Facebook&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dr-coimbra-discusses-vitamin-d-magnesium-folic-acid-b12-autism-depression-etc">Dr. Coimbra discusses Vitamin D, Magnesium, Folic Acid, B12, Autism, Depression, etc – Sept 2018&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis Society continues to fund Vitamin D research</title><link>/posts/multiple-sclerosis-society-continues-to-fund-vitamin-d-research.html</link><pubDate>Wed, 10 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-society-continues-to-fund-vitamin-d-research.html</guid><description>&lt;h4 id="national-ms-society-awards-12m-to-40-research-projects-in-us-and-elsewherehttpsmultiplesclerosisnewstodaycom20181008national-ms-society-awards-12-m-to-40-new-research-projects-in-globally">&lt;a href="https://multiplesclerosisnewstoday.com/2018/10/08/national-ms-society-awards-12-m-to-40-new-research-projects-in-globally/">National MS Society Awards $12M to 40 Research Projects in US and Elsewhere&lt;/a>&lt;/h4>
&lt;p>&amp;ldquo;A team led by Anne-Louise Ponsonby at the Australian National University was also given support. These researchers will examine how the environment — including exposure to sunlight, vitamin D, and infections — might impact genes and possibly trigger disease onset.&amp;rdquo;&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/new-research-fall-2018.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Clipped from PDF&lt;/strong>&lt;/p>
&lt;p>Anne-Louise Ponsonby, PhD, The Australian National University. Canberra, Australia&lt;/p></description></item><item><title>Multiple Sclerosis treated by fingolimod has better outcome if high vitamin D</title><link>/posts/multiple-sclerosis-treated-by-fingolimod-has-better-outcome-if-high-vitamin-d.html</link><pubDate>Wed, 10 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-by-fingolimod-has-better-outcome-if-high-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis and Vitamin D – Cochrane review</title><link>/posts/multiple-sclerosis-and-vitamin-d-cochrane-review.html</link><pubDate>Tue, 02 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-cochrane-review.html</guid><description/></item><item><title>Problem with vitamin C if high dose Vitamin D for MS and have gene problem</title><link>/posts/problem-with-vitamin-c-if-high-dose-vitamin-d-for-ms-and-have-gene-problem.html</link><pubDate>Thu, 06 Sep 2018 00:00:00 +0000</pubDate><guid>/posts/problem-with-vitamin-c-if-high-dose-vitamin-d-for-ms-and-have-gene-problem.html</guid><description>&lt;h4 id="facebookhttpswwwfacebookcomgroupsvitamindprotocolnorthamerica1776325512436163">&lt;a href="https://www.facebook.com/groups/vitamindprotocolnorthamerica/1776325512436163/">Facebook&lt;/a>&lt;/h4>
&lt;p>Some important information from Christina Kiening German advocate for the Coimbra Protocol who works closely with Dr. Coimbra:&lt;/p>
&lt;p>Please remember to keep your Protocol Doctor informed of all medicines (#pharmaceutical, #herbal, #naturopathic, etc) and/or food supplements and #vitamins that you take #parallel to the Coimbra Protocol. There may be harmful #interactions you are unaware of. Even if you have taken a medication for years without side effects before you started the Coimbra Protocol, your Protocol Doctor needs to be informed to make sure it won&amp;rsquo;t cause any #complications when #combined with the Coimbra Protocol.&lt;/p></description></item><item><title>Multiple Sclerosis Coimbra Protocol stories on Facebook</title><link>/posts/multiple-sclerosis-coimbra-protocol-stories-on-facebook.html</link><pubDate>Fri, 31 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-coimbra-protocol-stories-on-facebook.html</guid><description>&lt;p>&lt;strong>See also&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/high-dose-vitamin-d-forum-for-multiple-sclerosis-and-many-other-diseases">High-dose vitamin D forum – for Multiple Sclerosis and many other diseases – Jan 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-vitamin-d-50000-facebook-members-in-13-languages">Multiple Sclerosis and Vitamin D ~ 50,000 Facebook members in 13 languages – Jan 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol">Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-has-already-cleared-100-percent-of-lesions-from-over-1000-ms-patients-in-brazil">Vitamin D has already cleared 100 percent of lesions from over 1,000 MS patients in Brazil&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-has-treated-multiple-sclerosis-and-autoimmune-diseases-for-16-years-coimbra">Vitamin D has treated Multiple Sclerosis and autoimmune diseases for 16 years – Coimbra April 2018&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis – walking and self-care problems associated with low vitamin D</title><link>/posts/multiple-sclerosis-walking-and-self-care-problems-associated-with-low-vitamin-d.html</link><pubDate>Thu, 23 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-walking-and-self-care-problems-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="assessment-of-biochemical-and-densitometric-markers-of-calcium-phosphate-metabolism-in-the-groups-of-patients-with-multiple-sclerosis-selected-due-to-the-serum-level-of-vitamin-d3">Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3&lt;/h4>
&lt;p>BioMed Research International. Volume 2018, Article ID 9329123, 9 pages, &lt;a href="https://doi.org/10.1155/2018/9329123">https://doi.org/10.1155/2018/9329123&lt;/a>&lt;/p>
&lt;p>Natalia Niedziela,1 &lt;a href="mailto:natalia@niedziela.org">natalia@niedziela.org&lt;/a> Krystyna Pierzchała,1 Jolanta Zalejska-Fiolka,2 Jacek T. Niedziela,3 Ewa Romuk,2 Magdalena Torbus-Paluszczak,1 and Monika Adamczyk-Sowa1&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 Department of Neurology, SMDZ in Zabrze, Medical University of Silesia in Katowice, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland&lt;/p></description></item><item><title>High-Dose Vitamin D Therapy – book</title><link>/posts/high-dose-vitamin-d-therapy-book.html</link><pubDate>Fri, 17 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/high-dose-vitamin-d-therapy-book.html</guid><description>&lt;h4 id="how-not-to-die-with-true-high-dose-vitamin-d-therapy-coimbras-protocol-and-the-secrets-of-safe-high-dose-vitamin-d3-and-vitamin-k2-supplementation">How Not To Die With True High-Dose Vitamin D Therapy: Coimbra’s Protocol and the Secrets of Safe High-Dose Vitamin D3 and Vitamin K2 Supplementation&lt;/h4>
&lt;p>&lt;a href="https://www.amazon.com/gp/product/B07F7LPWML/ref=dbs_a_def_rwt_bibl_vppi_i0">Amazon English Kindle $5&lt;/a> Kindle unlimited is $0&lt;/p>
&lt;p>&lt;a href="https://www.amazon.com/gp/product/B07BNVCTZN/ref=dbs_a_def_rwt_hsch_vapi_taft_p1_i2">Amazon Portuguese $5&lt;/a> Kindle unlimited is $0. Portuguese version was published in May 2018&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/how-not-to-die.jpg" alt="image" width="150">
&lt;h4 id="updates---augmentingupdating-his-book-by-blogging">Updates - Augmenting/updating his book by blogging&lt;/h4>
&lt;p>&lt;strong>&amp;ldquo;Recent&amp;rdquo; as of Aug 2021&lt;/strong>&lt;/p>
&lt;p>The (Improved) Vitamin D Hammer: Beating the Flu in 72 Hours (Dec 2019)&lt;/p></description></item><item><title>Multiple Sclerosis – 3X higher incidence in women, previously 1X, wonder why</title><link>/posts/multiple-sclerosis-3x-higher-incidence-in-women-previously-1x-wonder-why.html</link><pubDate>Thu, 02 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-3x-higher-incidence-in-women-previously-1x-wonder-why.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#initially-came-across-this-report-which-mentioned--changing-ms-sex-ratio">Initially came across this report which mentioned changing MS sex ratio&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#temporal-trends-in-the-incidence-of-multiple-sclerosis---a-systematic-review">Temporal trends in the incidence of multiple sclerosis - A systematic review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#argentina-multiple-sclerosis-sex-ratio-18-x-in-1940---27-x-in-1990">Argentina multiple sclerosis sex ratio 1.8 X in 1940 ==&amp;gt; 2.7 X in 1990&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#100-years-ago-men-got-ms-more-often-than-women">100 years ago men got MS more often than women&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sex-ratio-of-multiple-sclerosis-and-clinical-phenotypehttpswwwncbinlmnihgovpubmed19968710---april-2010">&lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/19968710">Sex ratio of multiple sclerosis and clinical phenotype&lt;/a> - April 2010&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-sex-ratio-increasing---especially-if-more-northern-or-rr">Multiple Sclerosis sex ratio increasing - especially if more Northern or &lt;strong>RR&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sex-ratio-of-multiple-sclerosis---2013">Sex Ratio of Multiple Sclerosis - 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#questions-by-the-founder-of-vitamindwiki">Questions by the founder of VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hypothesis-placentas-cause-more-autoimmune-diseases-in-females">Hypothesis: Placentas cause more autoimmune diseases in females&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="initially-came-across-this-report-which-mentioned--changing-ms-sex-ratio">Initially came across this report which mentioned changing MS sex ratio&lt;/h4>
&lt;p>&lt;strong>Environmental factors and multiple sclerosis - 2008&lt;/strong>&lt;/p></description></item><item><title>Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra</title><link>/posts/vitamin-d-is-the-real-multiple-sclerosis-therapy-not-an-alternative-therapy-coimbra.html</link><pubDate>Wed, 25 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-the-real-multiple-sclerosis-therapy-not-an-alternative-therapy-coimbra.html</guid><description>&lt;h4 id="coimbra-protocol">Coimbra Protocol&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.google.com/maps/d/u/0/viewer?mid=1fATZJUEhOsYYJdBY41h48FBkLaQ&amp;amp;ll=19.192120392882064%2C-24.66098360000003&amp;amp;z=2">Google Map of Doctors&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol">Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016">Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-is-the-real-multiple-sclerosis-therapy-not-an-alternative-therapy-coimbra">Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra July 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/guide-for-patients-on-high-doses-of-vitamin-d-coimbra-2017">Guide for patients on high doses of Vitamin D – Coimbra 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/how-to-get-lots-of-magnesium-especially-needed-for-coimbra-ms-and-autoimmune-protocol">How to get lots of Magnesium – especially needed for Coimbra MS and Autoimmune Protocol&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis relapse rate reduced by half if add some vitamin D</title><link>/posts/multiple-sclerosis-relapse-rate-reduced-by-half-if-add-some-vitamin-d.html</link><pubDate>Sat, 14 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapse-rate-reduced-by-half-if-add-some-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-supplementation-differentially-affects-seasonal-multiple-sclerosis-disease-activity">Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity.&lt;/h4>
&lt;p>Brain Behav. 2017 Jul 11;7(8):e00761. &lt;a href="https://doi.org/10.1002/brb3.761.">doi: 10.1002/brb3.761.&lt;/a> eCollection 2017 Aug.&lt;/p>
&lt;p>Miclea A1,2, Miclea M1, Pistor M2, Hoepner A3, Chan A4, Hoepner R4.&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/vitamin-d-supplementation-differentially-affects-seasonal-multiple-sclerosis.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>OBJECTIVES:&lt;/p>
&lt;p>Low ultraviolet-B (UVB) radiation causes hypovitaminosis D, which is a known risk factor for multiple sclerosis (MS) and associated with MS disease activity. Our objective is to test whether vitamin D supplementation is most effective in lowering disease activity during the period of the year with low UVB radiation and consequently low serum 25-hydroxyvitamin D3 (25(OH)D3) concentration.&lt;/p></description></item><item><title>Multiple Sclerosis rates are highest in Canada (far from equator)</title><link>/posts/multiple-sclerosis-rates-are-highest-in-canada-far-from-equator.html</link><pubDate>Fri, 13 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-rates-are-highest-in-canada-far-from-equator.html</guid><description>&lt;h4 id="multiple-sclerosis-in-canada-understanding-why-ms-rates-are-the-highest-herehttpsglobalnewscanews4191203multiple-sclerosis-canada-understanding-why-ms-rates-are-the-highest-here">&lt;a href="https://globalnews.ca/news/4191203/multiple-sclerosis-canada-understanding-why-ms-rates-are-the-highest-here/">Multiple sclerosis in Canada: Understanding why MS rates are the highest here&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Good overview to MS has several short videos in a 5 part series&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Used to take years to diagnose MS, now can be done in days&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-symptoms.jpg" alt="image" width="400">
&lt;hr>
&lt;h4 id="ms-prevelance--statistica-2015-datahttpswwwstatistacomstatistics372361prevalence-rate-of-ms-in-select-countries20">&lt;a href="https://www.statista.com/statistics/372361/prevalence-rate-of-ms-in-select-countries/%20">MS prevelance – Statistica 2015 data&lt;/a>&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-2015-statistica.jpg" alt="image" width="600">
&lt;hr>
&lt;h4 id="a-visual-look-at-new-worldwide-multiple-sclerosis-prevalence-datahttpswwwvitamindcouncilorga-visual-look-at-new-worldwide-multiple-sclerosis-prevalence-data-vitamin-d-council-2013">&lt;a href="https://www.vitamindcouncil.org/a-visual-look-at-new-worldwide-multiple-sclerosis-prevalence-data/">A visual look at new worldwide multiple sclerosis prevalence data&lt;/a> Vitamin D Council 2013]&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-vdc.jpg" alt="image" width="800">
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-treated-when-use-high-doses-of-vitamin-d-meta-analysis">Multiple Sclerosis treated when use high doses of vitamin D – meta-analysis May 2018 &lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis varies with race and sex in mice too</title><link>/posts/multiple-sclerosis-varies-with-race-and-sex-in-mice-too.html</link><pubDate>Sat, 07 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-varies-with-race-and-sex-in-mice-too.html</guid><description>&lt;h4 id="sex-specific-gene-by-vitamin-d-interactions-regulate-susceptibility-to-cns-autoimmunity">Sex-specific gene-by-vitamin D interactions regulate susceptibility to CNS autoimmunity&lt;/h4>
&lt;p>Front. Immunol. | &lt;a href="https://doi.org/10.3389/fimmu.2018.01622">doi: 10.3389/fimmu.2018.01622&lt;/a>&lt;/p>
&lt;p>Dimitry N. Krementsov1*, Loredana Asarian2, Qian Fang2, Mahalia McGill1 and Cory Teuscher2&lt;/p>
&lt;p>1 Biomedical and Health Sciences, University of Vermont, United States&lt;/p>
&lt;p>2 Medicine, University of Vermont College of Medicine, United States&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-high-incidence-in-black-women-than-whites-perhaps-vitamin-d">Multiple Sclerosis: high incidence in black women than whites (perhaps vitamin D) – May 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis">Multiple Sclerosis: number needed to treat with vitamin D may be as low as 1.3 – Meta-analysis Oct 2013&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis 30 X more likely if: organic solvent AND poor genes AND smoking</title><link>/posts/multiple-sclerosis-30-x-more-likely-if-organic-solvent-and-poor-genes-and-smoking.html</link><pubDate>Fri, 06 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-30-x-more-likely-if-organic-solvent-and-poor-genes-and-smoking.html</guid><description>&lt;h4 id="mix-of-organic-solvent-exposure-smoking-and-genes-raise-risk-of-ms-by-30-fold-study-sayshttpsmultiplesclerosisnewstodaycom20180706exposure-to-solvents-smoking-and-genetic-susceptibility-sharply-increases-ms-risk-study-says-ms-news-today">&lt;a href="https://multiplesclerosisnewstoday.com/2018/07/06/exposure-to-solvents-smoking-and-genetic-susceptibility-sharply-increases-ms-risk-study-says/">Mix of Organic Solvent Exposure, Smoking and Genes Raise Risk of MS by 30 Fold, Study Says&lt;/a> MS News Today&lt;/h4>
&lt;p>&lt;strong>&lt;span style="color:#00F;">Note: Viatamin D Receptor genes and Vitamin D are not considered by the study on this page&lt;/span>&lt;/strong>&lt;/p>
&lt;h4 id="organic-solvents-and-ms-susceptibility-interaction-with-ms-risk-hla-genes--july-2018">Organic solvents and MS susceptibility Interaction with MS risk HLA genes – July 2018&lt;/h4>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/organic-solvents-and-ms-susceptibility.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-30x.jpg" alt="image" width="700"></description></item><item><title>Multiple Sclerosis treated by 50,000 IU Vitamin D bi-weekly plus Omega-3 – RCT</title><link>/posts/multiple-sclerosis-treated-by-50000-iu-vitamin-d-bi-weekly-plus-omega-3-rct.html</link><pubDate>Fri, 06 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-by-50000-iu-vitamin-d-bi-weekly-plus-omega-3-rct.html</guid><description>&lt;h4 id="high-dose-ω-3-fatty-acid-plus-vitamin-d3-supplementation-affects-clinical-symptoms-and-metabolic-status-of-patients-with-multiple-sclerosis-a-randomized-controlled-clinical-trial">High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial&lt;/h4>
&lt;p>The Journal of Nutrition, nxy116, &lt;a href="https://doi.org/10.1093/jn/nxy116">https://doi.org/10.1093/jn/nxy116&lt;/a>&lt;/p>
&lt;p>Ebrahim Kouchaki Maryam Afarini Javad Abolhassani Naghmeh Mirhosseini Fereshteh Bahmani Seyed Ali Masoud Zatollah Asemi&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>Short 12 week trial using 50,000 IU of vitamin D bi-weekly&lt;br>
In conjuction with 2 × 1000 mg/d ω-3 fatty acid (we assume the Omega-3 was daily)&lt;br>
This was a radomized controlled trial of Vit D + Omega-3 vs placebo&lt;br>
Nice to see trials like this starting to use more than monotherapy&lt;br>
    ( e.g. just Vitamin D OR just Omega-3)&lt;br>
Would expect even more benefit if trial had lasted longer - say 6 months&lt;br>
Would expect even more benefit if trial had used more vitamin D&lt;br>
Note: MS has been cured in &amp;gt; 2,000 people with daily doses ranging from 20,000 - 140,000 IU&lt;br>
    = approximately 140,000 - 1,960,000 IU if given bi-weekly&lt;br>
    = &lt;span style="color:#00F;">3X - 39X&lt;/span> more Vitamin D than used in this study&lt;/strong>&lt;/p></description></item><item><title>Replies to doctor’s comments about high dose Vitamin D for Multiple Sclerosis</title><link>/posts/replies-to-doctors-comments-about-high-dose-vitamin-d-for-multiple-sclerosis.html</link><pubDate>Wed, 27 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/replies-to-doctors-comments-about-high-dose-vitamin-d-for-multiple-sclerosis.html</guid><description>&lt;p>&lt;strong>Argumentation assistance in discussions with doctors (translated from German)&lt;/strong>&lt;/p>
&lt;p>MARTIN STEHLE · WEDNESDAY, NOVEMBER 16, 2016 &lt;a href="https://www.facebook.com/notes/gruppe-coimbraprotokoll-vitamin-d-gegen-autoimmunerkrankungen/argumentationshilfe-bei-diskussionen-mit-%C3%A4rzten/1607451586224359/%20">Facebook&lt;/a>&lt;/p>
&lt;p>The usual experience of MS patients who want to get their doctor and neurologist for the Coimbra protocol is disappointing. Instead of openness and curiosity for a new, proven approach for years, neurologists show rejection.&lt;/p>
&lt;p>In order to facilitate discussion with them, this document lists the common arguments that neurologists have made, as well as the best answers.&lt;/p></description></item><item><title>Multiple Sclerosis 2X more likely if low winter UV</title><link>/posts/multiple-sclerosis-2x-more-likely-if-low-winter-uv.html</link><pubDate>Sat, 23 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-2x-more-likely-if-low-winter-uv.html</guid><description>&lt;h4 id="it-appears-that-latitude-has-been-considered-a-proxy-for-winter-uvb-for-a-long-time">It appears that latitude has been considered a proxy for winter UVB for a long time&lt;/h4>
&lt;p>&lt;strong>Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States.&lt;/strong>&lt;/p>
&lt;p>Photochem Photobiol. 2005 Nov-Dec;81(6):1276-86. DOI: 10.1562/2005-01-24-RA-424&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/off-topic-10-ways-to-find-medical-studies-on-the-web">PDF is available free at Sci-Hub&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Grant WB1, Garland CF, Holick MF.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;quot; Latitude is assumed to be an index of wintertime vitamin D status as determined by serum 25(OH)D levels&amp;quot;&lt;/p></description></item><item><title>Guide for patients on high doses of Vitamin D – Coimbra 2017</title><link>/posts/guide-for-patients-on-high-doses-of-vitamin-d-coimbra-2017.html</link><pubDate>Thu, 21 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/guide-for-patients-on-high-doses-of-vitamin-d-coimbra-2017.html</guid><description>&lt;p>&lt;strong>by Dr. Cícero Galli Coimbra&lt;/strong>&lt;/p>
&lt;p>Discovered by VitaminDWiki June 2019 at&lt;/p>
&lt;p>&lt;a href="http://www.thisisms.com/forum/coimbra-high-dose-vitamin-d-protocol-f57/topic28976.html">http://www.thisisms.com/forum/coimbra-high-dose-vitamin-d-protocol-f57/topic28976.html&lt;/a>&lt;/p>
&lt;p>&amp;ldquo;This Is MS Multiple Sclerosis Community: Knowledge &amp;amp; Support&lt;/p>
&lt;p>Welcome to the world&amp;rsquo;s leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years,&lt;/p>
&lt;p>This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.&amp;rdquo;&lt;/p>
&lt;p>The forum has a LOT of Coimbra information.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;p>&lt;strong>&lt;a href="https://VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=coimbra&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for COIMBRA&lt;/a> 488 items as of Nov 2018&lt;/strong>&lt;/p></description></item><item><title>Zinc deficiency is a risk factor for autoimmunity and multiple sclerosis – 2017</title><link>/posts/zinc-deficiency-is-a-risk-factor-for-autoimmunity-and-multiple-sclerosis-2017.html</link><pubDate>Thu, 14 Jun 2018 00:00:00 +0000</pubDate><guid>/posts/zinc-deficiency-is-a-risk-factor-for-autoimmunity-and-multiple-sclerosis-2017.html</guid><description>&lt;h4 id="zinc-in-multiple-sclerosis-a-systematic-review-and-meta-analysis--june-2016">Zinc in Multiple Sclerosis: A Systematic Review and Meta-Analysis – June 2016&lt;/h4>
&lt;p>ASN Neuro. 2016 Jun 9;8(3). pii: 1759091416651511. &lt;a href="https://doi.org/10.1177/1759091416651511.">doi: 10.1177/1759091416651511.&lt;/a> Print 2016 Jun.&lt;/p>
&lt;p>Bredholt M1, Frederiksen JL2.&lt;/p>
&lt;p>1 Department of Neurology, Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark &lt;a href="mailto:mikkelbredholt@hotmail.com">mikkelbredholt@hotmail.com&lt;/a>.&lt;/p>
&lt;p>2 Department of Neurology, Rigshospitalet - Glostrup, University of Copenhagen, Glostrup, Denmark.&lt;/p>
&lt;p>In the last 35 years, zinc (Zn) has been examined for its potential role in the disease multiple sclerosis (MS). This review gives an overview of the possible role of Zn in the pathogenesis of MS as well as a meta-analysis of studies having measured Zn in serum or plasma in patients with MS. Searching the databases PubMed and EMBASE as well as going through reference lists in included articles 24 studies were found measuring Zn in patients with MS. Of these, 13 met inclusion criteria and were included in the meta-analysis. The result of the meta-analysis shows a reduction in serum or plasma Zn levels in patients with MS with a 95% CI of &lt;span>[-3.66, -0.93]&lt;/span> and a p value of .001 for the difference in Zn concentration in μM. One of six studies measuring cerebrospinal fluid, Zn levels found a significant increase in patients with MS with controls. The studies measuring whole blood and erythrocyte Zn levels found up to several times higher levels of Zn in patients with MS compared with healthy controls with decreasing levels during attacks in relapsing-remitting MS patients. Future studies measuring serum or plasma Zn are encouraged to analyze their data through homogenous MS patient subgroups on especially age, sex, and disease subtype since the difference in serum or plasma Zn in these subgroups have been found to be significantly different. It is hypothesized that local alterations of Zn may be actively involved in the pathogenesis of MS.&lt;/p></description></item><item><title>How to get lots of Magnesium – especially needed for Coimbra MS and Autoimmune Protocol</title><link>/posts/how-to-get-lots-of-magnesium-especially-needed-for-coimbra-ms-and-autoimmune-protocol.html</link><pubDate>Mon, 28 May 2018 00:00:00 +0000</pubDate><guid>/posts/how-to-get-lots-of-magnesium-especially-needed-for-coimbra-ms-and-autoimmune-protocol.html</guid><description>&lt;p>&lt;strong>Dr. Combra protocol apparently greatly increased (fall 2017) the amount of Magnesium to be supplemented daily&lt;/strong>&lt;/p>
&lt;p>You want much more than the RDA for Magnesium element, which is about 400 milligrams&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Vitamin D consumes Magnesium (Mg)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The more Vitamin D which is consumed the more Magnesium is needed&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Without increased Magnesium levels a high level of vitamin D can cause all sorts of health problems – such as severe constipation&lt;/p></description></item><item><title>MS not treated by Vitamin D (a few old studies using small doses) – Meta-analysis</title><link>/posts/ms-not-treated-by-vitamin-d-a-few-old-studies-using-small-doses-meta-analysis.html</link><pubDate>Sun, 27 May 2018 00:00:00 +0000</pubDate><guid>/posts/ms-not-treated-by-vitamin-d-a-few-old-studies-using-small-doses-meta-analysis.html</guid><description>&lt;h4 id="the-efficacy-of-vitamin-d-in-multiple-sclerosis-a-meta-analysis">The efficacy of vitamin D in multiple sclerosis: A meta-analysis&lt;/h4>
&lt;p>hengChaoa1 HeLiangb1 LiuLinglinga ZhuJieac JinTaoa&lt;/p>
&lt;p>Multiple Sclerosis and Related Disorders, Volume 23, July 2018, Pages 56-61, &lt;a href="https://doi.org/10.1016/j.msard.2018.05.008">https://doi.org/10.1016/j.msard.2018.05.008&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>It examined only 6 studies&lt;/p>
&lt;p>The most recent study was from 5 years before&lt;/p>
&lt;p>Doses sizes included 3,000 IU average (20,000 Weekly)&lt;/p>
&lt;p>The meta-analysis, as is typical, ignored dose sizes&lt;/p>
&lt;p>This meta-analysis also ignored the type of Vitamin D used (0.5 microgram of Calcitriol)&lt;/p></description></item><item><title>Vitamin D is the only dietary supplement which significantly benefits MS – JAMA</title><link>/posts/vitamin-d-is-the-only-dietary-supplement-which-significantly-benefits-ms-jama.html</link><pubDate>Sun, 20 May 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-the-only-dietary-supplement-which-significantly-benefits-ms-jama.html</guid><description>&lt;h4 id="vitamin-d-the-only-dietary-supplement-showing-significant-benefit-for-mshttpswwwneurologyadvisorcommultiple-sclerosis-advisorvitamin-supplement-diet-msarticle76546420-neurology-advisor-may-2018-reporting-on-jama-article">&lt;a href="https://www.neurologyadvisor.com/multiple-sclerosis-advisor/vitamin-supplement-diet-ms/article/765464/%20">Vitamin D: The Only Dietary Supplement Showing Significant Benefit for MS&lt;/a> Neurology Advisor May 2018, reporting on JAMA article&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>“Of these, only vitamin D&amp;rsquo;s associations were found to be significant enough to merit clinical application. Vitamins B2, B3, B5, B6, B9, C, and E showed no effects on individuals with MS.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Of dietary supplements, creatine, curcumin, green tea extract, and resveratrol showed no effect in subjects with MS.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Caffeine, carnitine, coenzyme Q10, ginkgo biloba, lipoic acid, polyunsaturated fatty acids, and probiotics showed some effects, but none were significant.”&lt;/p></description></item><item><title>Multiple Sclerosis treated when use high doses of vitamin D – meta-analysis</title><link>/posts/multiple-sclerosis-treated-when-use-high-doses-of-vitamin-d-meta-analysis.html</link><pubDate>Wed, 16 May 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treated-when-use-high-doses-of-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="the-efficacy-of-vitamin-d-in-multiple-sclerosis-a-meta-analysis">The efficacy of vitamin D in multiple sclerosis: a meta-analysis&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders, online 12 May 2018, &lt;a href="https://doi.org/10.1016/j.msard.2018.05.008">https://doi.org/10.1016/j.msard.2018.05.008&lt;/a>&lt;/p>
&lt;p>Chao Zhenga, 1, Liang Heb, 1, Lingling Liua, Jie Zhua, c, Tao Jina, ,&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>This Meta-analysis concluded that across all sizes of dosing that Vitamin D did not help&lt;/p>
&lt;/li>
&lt;li>
&lt;p>However, the trials which used large doses did find big benefits&lt;/p>
&lt;ul>
&lt;li>40,000 IU/day, 300,000 IU per month&lt;/li>
&lt;/ul>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-relapsing-remitting-rate-reduced-30-percent-by-addition-of-14-min-d-daily-rct">Multiple Sclerosis Relapsing-Remitting rate reduced 30 percent by addition of 14,000 IU vitamin D daily – RCT Nov 2016&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis Coimbra Protocol with Vitamin D - increased walking</title><link>/posts/multiple-sclerosis-coimbra-protocol-with-vitamin-d-increased-walking.html</link><pubDate>Sat, 12 May 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-coimbra-protocol-with-vitamin-d-increased-walking.html</guid><description>&lt;h4 id="comment-on-one-of-dozens-of-coimbra-forums-on-facebook-httpswwwfacebookcomphotophpfbid10155877751183303setgm1613616365373746type3theaterifg1">&lt;a href="https://www.facebook.com/photo.php?fbid=10155877751183303&amp;amp;set=gm.1613616365373746&amp;amp;type=3&amp;amp;theater&amp;amp;ifg=1">Comment on one of dozens of Coimbra forums on Facebook &lt;/a>&lt;/h4>
&lt;p>&lt;strong>Note: This is one example of how MSers improve on the protocol&lt;/strong>&lt;/p>
&lt;h4 id="started-vitamin-d-protocol-nov-2017">Started Vitamin D Protocol Nov 2017&lt;/h4>
&lt;h4 id="1-of-daily-steps-jan-2018">1. of daily steps Jan 2018&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-jan-2018.jpg" alt="image" width="400">
&lt;h4 id="1-of-daily-steps-april-2018">1. of daily steps April 2018&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-april-2018.jpg" alt="image" width="400">
&lt;hr>
&lt;h4 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis">Multiple Sclerosis: number needed to treat with vitamin D may be as low as 1.3 – Meta-analysis Oct 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-helped-some-by-10000-iu-of-vitamin-d-daily-avg-for-3-months-rct">Multiple sclerosis helped some by 10,000 IU of vitamin D daily avg. for 3 months – RCT Sept 2016&lt;/a>&lt;/p></description></item><item><title>Vitamin D has treated Multiple Sclerosis and autoimmune diseases for 16 years – Coimbra</title><link>/posts/vitamin-d-has-treated-multiple-sclerosis-and-autoimmune-diseases-for-16-years-coimbra.html</link><pubDate>Tue, 17 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-has-treated-multiple-sclerosis-and-autoimmune-diseases-for-16-years-coimbra.html</guid><description>&lt;h3 id="presentation-in-english-at-vitamin-d-symposium-in-germany-april-2018">Presentation in English at Vitamin D Symposium in Germany April 2018&lt;/h3>
&lt;h4 id="youtube-videohttpswwwyoutubecomwatchvjquqjpxdrkyfeatureyoutube">&lt;a href="https://www.youtube.com/watch?v=jquQjPxdRKY&amp;amp;feature=youtu.be">YouTube Video&lt;/a>&lt;/h4>
&lt;p>    Introduction is in German. Presentation is in English, and can be translated to many other languages&lt;/p>
&lt;h4 id="notes-on-presentation-not-in-the-same-order-as-presentation">Notes on presentation (not in the same order as presentation)&lt;/h4>
&lt;p>&lt;strong>Protocol was developed over 16 years (since 2002)&lt;/strong>&lt;/p>
&lt;h4 id="dr-coimbra-has-recently-applied-his-protocol-to">Dr. Coimbra has recently applied his protocol to&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>Autism&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Pregnancy&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h4 id="span-stylecolorf0010000-iu-during-pregnancy-span">&lt;span style="color:#F00;">10,000 IU during pregnancy &lt;/span>&lt;/h4>
&lt;p>&lt;strong>| | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; |
| | 10,000 IU | normally |
| Raise head | 22 days | 90 days |
| Start to speak | 2.5 months | 12 months |
| Count to 20 | 18 months | 24 months |
| Learn foreign language | 36 months | ?? |&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis risk reduced by a third in those getting a lot of ALA (fatty acid)</title><link>/posts/multiple-sclerosis-risk-reduced-by-a-third-in-those-getting-a-lot-of-ala-fatty-acid.html</link><pubDate>Thu, 05 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-by-a-third-in-those-getting-a-lot-of-ala-fatty-acid.html</guid><description>&lt;h4 id="polyunsaturated-fatty-acids-and-the-risk-of-multiple-sclerosis">Polyunsaturated fatty acids and the risk of multiple sclerosis.&lt;/h4>
&lt;p>Multiple Sclerosis Journal, 23(14), 1830-1838, 2017. &lt;a href="https://doi.org/10.1177/1352458517691150">https://doi.org/10.1177/1352458517691150&lt;/a>&lt;/p>
&lt;p>Kjetil Bjørnevik - University of Bergen&lt;/p>
&lt;p>Tanuja Chitnis - Brigham and Women&amp;rsquo;s Hospital&lt;/p>
&lt;p>Alberto Ascherio - Harvard University&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>Less than 6% of ALA is metabolized to EPA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The upper level EPA food intake of the 150,000 women was 8% of their upper ALA intake&lt;/p>
&lt;/li>
&lt;li>
&lt;p>So, the ALA benefit might actually have been due to the resulting EPA in the body&lt;/p></description></item><item><title>Multiple Sclerosis half as likely if get plenty of sunshine (not a news item)</title><link>/posts/multiple-sclerosis-half-as-likely-if-get-plenty-of-sunshine-not-a-news-item.html</link><pubDate>Thu, 08 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-half-as-likely-if-get-plenty-of-sunshine-not-a-news-item.html</guid><description>&lt;ul>
&lt;li>&lt;a href="/posts/increase-latitude-leads-to-decreased-vitamin-d-which-leads-to-increased-risk-of-ms" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Increase latitude leads to decreased Vitamin D, which leads to increased risk of MS">Increase latitude leads to decreased Vitamin D, which leads to increased risk of MS&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;/blockquote>
&lt;p>&lt;strong>Note: About a 10X difference of MS with latitude BEFORE air conditioning&lt;/strong>&lt;/p>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/neurology2017839183.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://campaign.r20.constantcontact.com/render?m=1102722411090&amp;amp;ca=5459bda4-be91-4380-b929-867019a6570a">Chart of data by Grassroots Health&lt;/a>&lt;/strong>&lt;/p>
&lt;p>__&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-uv-2018.jpg" alt="image" width="800">&lt;/p>
&lt;p>Objective To examine sun exposure and multiple sclerosis (MS) over the life course (ages 5–15 and 16–20 years, every 10 years thereafter).&lt;/p></description></item><item><title>Multiple Sclerosis – many reasons to believe Vitamin D can prevent and treat it</title><link>/posts/multiple-sclerosis-many-reasons-to-believe-vitamin-d-can-prevent-and-treat-it.html</link><pubDate>Tue, 06 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-many-reasons-to-believe-vitamin-d-can-prevent-and-treat-it.html</guid><description>&lt;h4 id="ms-and-prevention-in-vitamindwiki">MS and Prevention in VitaminDWiki&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/ms-prevention-by-uv-is-2x-better-than-prevention-by-vitamin-d-levels">MS prevention by UV is 2X better than prevention by vitamin D levels – Jan 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-alzheimers-and-parkinsons-need-more-than-30-ng-of-vitamin-d-review">Multiple Sclerosis, Alzheimer’s and Parkinson’s need more than 30 ng of Vitamin D – review Nov 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-multiple-sclerosisfrom-epidemiology-to-prevention">Vitamin D and multiple sclerosis—from epidemiology to prevention – June 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-prevention-by-vitamin-d-10-year-30-million-dollar-trial">Multiple Sclerosis prevention by Vitamin D: 10 year, 30 million dollar trial - Sept 2013&lt;/a>&lt;/p>
&lt;ul>
&lt;li>5,000 IU is one leg of the trial&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial">Prevention with vitamin D in Multiple Sclerosis is logical – editorial April 2013&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis patients have 3X less Vitamin K2 in their blood</title><link>/posts/multiple-sclerosis-patients-have-3x-less-vitamin-k2-in-their-blood.html</link><pubDate>Fri, 02 Mar 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-have-3x-less-vitamin-k2-in-their-blood.html</guid><description/></item><item><title>Rate of vitamin D supplementation by Blacks increases 16X after getting Multiple Sclerosis</title><link>/posts/rate-of-vitamin-d-supplementation-by-blacks-increases-16x-after-getting-multiple-sclerosis.html</link><pubDate>Fri, 23 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/rate-of-vitamin-d-supplementation-by-blacks-increases-16x-after-getting-multiple-sclerosis.html</guid><description>&lt;h4 id="vitamin-d-binding-protein-polymorphisms-25-hydroxyvitamin-d-sunshine-and-multiple-sclerosis">Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis&lt;/h4>
&lt;p>Nutrients 2018,10,184; doi:10.3390/nu10020184&lt;/p>
&lt;p>Annette Langer-Gould h*, Robyn M. Lucas , Anny H. Xiang , Jun Wu 3, Lie H. Chen 3,&lt;/p>
&lt;p>Edlin Gonzales 3, Samantha Haraszti 3,4, Jessica B. Smith 3, Hong Quach and Lisa F. Barcellos 5&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Los Angeles Medical Center, Neurology Department, Southern California Permanente Medical Group, 1505 N Edgemont Street, Los Angeles, CA 90027, USA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>College of Medicine, Biology &amp;amp; Environment, Australian National University, Canberra, ACT 2000, Australia; &lt;a href="mailto:robyn.lucas@anu.edu.au">robyn.lucas@anu.edu.au&lt;/a>&lt;/p></description></item><item><title>Vitamin D does not reduce the risk of Multiple Sclerosis – FDA incorrect conclusion</title><link>/posts/vitamin-d-does-not-reduce-the-risk-of-multiple-sclerosis-fda-incorrect-conclusion.html</link><pubDate>Mon, 15 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-does-not-reduce-the-risk-of-multiple-sclerosis-fda-incorrect-conclusion.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.medscape.com/viewarticle/891307?src=rss">FDA Denies Health Claim for Vitamin D to Prevent MS&lt;/a> Jan 2018&lt;/strong>&lt;/p>
&lt;p>    &lt;strong>The Bayer Corporation petitioned the FDA to make the following claim&lt;/strong>&lt;/p>
&lt;p>        &lt;strong>&lt;span style="color:#00F;">“Vitamin D may reduce the risk of multiple sclerosis (MS).”&lt;/span>&lt;/strong>&lt;/p>
&lt;p>    &lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/fda-ms-detailed-response.pdf">Download the FDA response from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>7 studies (see below) have found a ~2X less risk of Multiple Sclerosis for people with higher vitamin D levels&lt;/strong>&lt;/p>
&lt;p>&lt;strong>VitaminDWiki believes the claim that &lt;span style="color:#00F;">“Vitamin D may reduce the risk of multiple sclerosis (MS).”&lt;/span> is valid&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis 40% more likely in obese than in overweight (Mendelian randomization)</title><link>/posts/multiple-sclerosis-40-percent-more-likely-in-obese-than-in-overweight-mendelian-randomization.html</link><pubDate>Sat, 13 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-40-percent-more-likely-in-obese-than-in-overweight-mendelian-randomization.html</guid><description/></item><item><title>Multiple Sclerosis risk reduced 40% in 92,000 women taking more than 400 IU of vitamin D – 2004</title><link>/posts/multiple-sclerosis-risk-reduced-40-percent-in-92000-women-taking-more-than-400-iu-of-vitamin-d-2004.html</link><pubDate>Sat, 13 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-40-percent-in-92000-women-taking-more-than-400-iu-of-vitamin-d-2004.html</guid><description>&lt;h4 id="vitamin-d-intake-and-incidence-of-multiple-sclerosis">Vitamin D intake and incidence of multiple sclerosis&lt;/h4>
&lt;p>Neurology January 12, 2004, DOI: &lt;a href="https://doi.org/10.1212/01.WNL.0000101723.79681.38">https://doi.org/10.1212/01.WNL.0000101723.79681.38&lt;/a>&lt;/p>
&lt;p>K. L. Munger, S. M. Zhang, E. O’Reilly, M. A. Hernán, M. J. Olek, W. C. Willett and A. Ascherio&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/risk-of-going-from-pre-ms-to-ms-reduced-68-percent-with-7100-iu-vitamin-d-rct">Risk of going from pre-MS to MS reduced 68 percent with 7100 IU vitamin D – RCT Dec 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-6x-more-likely-to-progress-quickly-if-low-vitamin-d">Multiple Sclerosis 6X more likely to progress quickly if low vitamin D – Aug 2016&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis and Vitamin D – chapter and entire MS book</title><link>/posts/multiple-sclerosis-and-vitamin-d-chapter-and-entire-ms-book.html</link><pubDate>Thu, 21 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-chapter-and-entire-ms-book.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-an-update">Vitamin D and Multiple Sclerosis: An Update.&lt;/h4>
&lt;p>Zahoor I2, Haq E2.&lt;/p>
&lt;p>Chapter 5 of MULTIPLE SCLEROSIS: Perspectives in Treatment and Pathogenesis &lt;span>[Internet]&lt;/span>. Brisbane (AU): Codon Publications; 2017 Nov&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1 Department of Neural &amp;amp; Behavioral Sciences, Pennsylvania State University College of Medicine Hershey, Pennsylvania, USA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2 Bioinformatics Centre, University of Kashmir, Srinagar, India&lt;/p>
&lt;/li>
&lt;/ul>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol">Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis increasing in teens – at least 2X in 9 years</title><link>/posts/multiple-sclerosis-increasing-in-teens-at-least-2x-in-9-years.html</link><pubDate>Tue, 19 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-increasing-in-teens-at-least-2x-in-9-years.html</guid><description>&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>Became aware of it by the Dec 2017 abstract, then was able to get details from a 2016 study&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Risk factors include lower vitamin D and increased weight (which also lowers vitamin D&lt;/p>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-much-less-likely-for-children-who-are-thin-and-tanned">Multiple Sclerosis much less likely for children who are thin and tanned - April 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a> Adult MS may be increasing faster than for teens&lt;/p>
&lt;/li>
&lt;/ul>
&lt;/div>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#hospital-admission-rates-for-pediatric-multiple-sclerosis-in-the-united-states-using-the-pediatric-health-information-system-phis--2016">Hospital admission rates for pediatric multiple sclerosis in the United States using the Pediatric Health Information System (PHIS) – 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pediatric-onset-multiple-sclerosis-a-single-center-study--dec-2017">Pediatric-Onset Multiple Sclerosis: A Single Center Study – Dec 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="hospital-admission-rates-for-pediatric-multiple-sclerosis-in-the-united-states-using-the-pediatric-health-information-system-phis--2016">Hospital admission rates for pediatric multiple sclerosis in the United States using the Pediatric Health Information System (PHIS) – 2016&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders, September 2016, Pages 5 - 10&lt;/p></description></item><item><title>Multiple Sclerosis is reduced by Vitamin D supplementation (even without Coimbra) – review</title><link>/posts/multiple-sclerosis-is-reduced-by-vitamin-d-supplementation-even-without-coimbra-review.html</link><pubDate>Mon, 18 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-reduced-by-vitamin-d-supplementation-even-without-coimbra-review.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-a-comprehensive-review">Vitamin D and Multiple Sclerosis: A Comprehensive Review.&lt;/h4>
&lt;p>Neurol Ther. 2017 Dec 14. &lt;a href="https://doi.org/10.1007/s40120-017-0086-4.">doi: 10.1007/s40120-017-0086-4.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Sintzel MB1, Rametta M2, Reder AT3 &lt;a href="mailto:areder@neurology.bsd.uchicago.edu">areder@neurology.bsd.uchicago.edu&lt;/a>&lt;/p>
&lt;p>1 Medical Communication Services, Erlenbach, Zurich, Switzerland.&lt;/p>
&lt;p>2 Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.&lt;/p>
&lt;p>3 Department of Neurology, University of Chicago, Chicago, IL, USA.&lt;/p>
&lt;p>&lt;strong>A few images from the review&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-review-f3.jpg" alt="image" width="700">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-review-f7.jpg" alt="image" width="500">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/ms-review-f8.jpg" alt="image" width="700">
&lt;h4 id="span-stylecolorf00note-coimbra-protocol-typically-has-a-vitamin-d-goal--375-nmol-150-ngspan">&lt;span style="color:#F00;">Note: Coimbra protocol typically has a vitamin D goal= = 375 nmol (150 ng)&lt;/span>&lt;/h4>
&lt;p>&lt;strong>&lt;span style="color:#F00;">Red added by VitaminDWiki&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>Clinically Isolated Syndrome progresses to Multiple Sclerosis, unless UVB treatments – RCT</title><link>/posts/clinically-isolated-syndrome-progresses-to-multiple-sclerosis-unless-uvb-treatments-rct.html</link><pubDate>Sat, 16 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/clinically-isolated-syndrome-progresses-to-multiple-sclerosis-unless-uvb-treatments-rct.html</guid><description>&lt;h4 id="see-also-web">See also Web&lt;/h4>
&lt;ul>
&lt;li>&lt;a href="http://www.thelancet.com/journals/laneur/article/PIIS1474442205700715/abstract">Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis&lt;/a> Lancet, May 2005&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>&amp;ldquo;. . .only 30–70% of patients with a CIS develop MS&amp;rdquo; - vs 100% in the study on this page&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>&lt;a href="https://www.medscape.com/viewarticle/767488">Low Vitamin D Predicts MS in Clinically Isolated Syndromes&lt;/a> July 2012 Medscape&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>&amp;ldquo;The patients in the lowest quartile of vitamin D levels experienced the highest rate of conversion to CDMS; the rate decreased through the third quartile, but for unexplained reasons, the rate of conversion among patients with the highest vitamin D levels was not much different from that of patients with the lowest level (see table below)&amp;rdquo;&lt;/p></description></item><item><title>Alzheimer’s, Parkenson’s, and Multiple Sclerosis – vitamin D may prevent and treat</title><link>/posts/alzheimers-parkensons-and-multiple-sclerosis-vitamin-d-may-prevent-and-treat.html</link><pubDate>Thu, 07 Dec 2017 00:00:00 +0000</pubDate><guid>/posts/alzheimers-parkensons-and-multiple-sclerosis-vitamin-d-may-prevent-and-treat.html</guid><description/></item><item><title>Extended breastfeeding cut in half the risk of Multiple Sclerosis</title><link>/posts/extended-breastfeeding-cut-in-half-the-risk-of-multiple-sclerosis.html</link><pubDate>Mon, 27 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/extended-breastfeeding-cut-in-half-the-risk-of-multiple-sclerosis.html</guid><description>&lt;h4 id="breastfeeding-ovulatory-years-and-risk-of-multiple-sclerosis">Breastfeeding, ovulatory years, and risk of multiple sclerosis&lt;/h4>
&lt;p>Neurology 10.1212/WNL.0000000000004207, http://​dx.​doi.​org/​10.​1212/​WNL.​0000000000004207&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>Speculation by VitaminDWiki: Breastfeeding &amp;gt; 15 months increases the time between pregnancies, which allows time for the restoration of maternal Vitamin D, which decreases the risk of future MS.&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>This possibility does not appear to be discussed in the study.&lt;/p>
&lt;/blockquote>
&lt;ul>
&lt;li>The study noticed that having previous birth 5-10 years previously resulted in a 3X reduction in the risk of future MS – but this was only a trend (not statistically significant)&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>Again, a long time to restore vitamin D levels between pregnancies&lt;/p></description></item><item><title>Vitamin D and Multiple Sclerosis, Alzheimer's, Parkinson's ,Dementia, and ALS - review</title><link>/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review.html</link><pubDate>Thu, 23 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review.html</guid><description/></item><item><title>Inflammation and immune responses to Vitamin D (perhaps need to measure active vitamin D)</title><link>/posts/inflammation-and-immune-responses-to-vitamin-d-perhaps-need-to-measure-active-vitamin-d.html</link><pubDate>Wed, 22 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/inflammation-and-immune-responses-to-vitamin-d-perhaps-need-to-measure-active-vitamin-d.html</guid><description>&lt;p>&lt;strong>Summary table on effects of calcitriol on immune and inflammatory cells&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/inflammatory-t1.jpg" alt="image">
&lt;h4 id="concluding-remarks---clipped-from-pdf">Concluding remarks - clipped from PDF&lt;/h4>
&lt;p>There is a growing body of evidence that VitD, especially its active metabolite, plays a key role in modulating the physiological activity of the immune system. This emergent role has stimulated a florid line of research aimed at associating the level of VitD with pathological situations wherein the immune system may be altered, such as in autoimmunity and inflammation.&lt;/p></description></item><item><title>Multiple Sclerosis, Alzheimer’s and Parkinson’s need more than 30 ng of Vitamin D – review</title><link>/posts/multiple-sclerosis-alzheimers-and-parkinsons-need-more-than-30-ng-of-vitamin-d-review.html</link><pubDate>Tue, 21 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-alzheimers-and-parkinsons-need-more-than-30-ng-of-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases&lt;/strong>&lt;/p>
&lt;p>EPMA Journal Nov 2017 &lt;a href="https://doi.org/10.1007/s13167-017-0120-8">https://doi.org/10.1007/s13167-017-0120-8&lt;/a>&lt;/p>
&lt;p>    (EPMA Journal is a journal of predictive, preventive and personalized medicine)&lt;/p>
&lt;p>Priscilla Koduah 	• Friedemann Paul • Jan-Markus Dorr&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>Low vitamin D prevents and treats each disease&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-multiple-sclerosis-alzheimers-parkinsons-dementia-and-als-review">Vitamin D and Multiple Sclerosis, Alzheimer&amp;rsquo;s, Parkinson&amp;rsquo;s ,Dementia, and ALS - review Nov 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-alzheimers-cognition-and-vitamin-d">Overview Alzheimer&amp;rsquo;s-Cognition and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-parkinsons-and-vitamin-d">Overview Parkinson&amp;rsquo;s and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p></description></item><item><title>947,000 people in the US had Multiple Sclerosis 2008-2010</title><link>/posts/947000-people-in-the-us-had-multiple-sclerosis-2008-2010.html</link><pubDate>Mon, 20 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/947000-people-in-the-us-had-multiple-sclerosis-2008-2010.html</guid><description>&lt;h4 id="nearly-1-million-americans-have-multiple-sclerosis-nmss-prevalence-study-findshttpsmultiplesclerosisnewstodaycom20171120nearly-1-million-americans-have-multiple-sclerosis-nmss-prevalence-study-finds">&lt;a href="https://multiplesclerosisnewstoday.com/2017/11/20/nearly-1-million-americans-have-multiple-sclerosis-nmss-prevalence-study-finds/">Nearly 1 Million Americans Have Multiple Sclerosis, NMSS Prevalence Study Finds&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>“An estimated 947,000 people in the U.S. have multiple sclerosis (MS) — more than double the long-accepted figure of 400,000 — according to a newly completed study organized and funded by the National Multiple Sclerosis Society (NMSS).”&lt;/li>
&lt;/ul>
&lt;p>Poster was presented at international MS conference in France&lt;/p>
&lt;ul>
&lt;li>
&lt;p>$1 million study for working group of 15 to 20 epidemiologists, statisticians and neurologists meeting virtually every week&lt;/p></description></item><item><title>Autoimmune diseases associated with low Vitamin D and Vitamin D Receptor</title><link>/posts/autoimmune-diseases-associated-with-low-vitamin-d-and-vitamin-d-receptor.html</link><pubDate>Sun, 12 Nov 2017 00:00:00 +0000</pubDate><guid>/posts/autoimmune-diseases-associated-with-low-vitamin-d-and-vitamin-d-receptor.html</guid><description/></item><item><title>Multiple Sclerosis stem cell treatment (HSCT) probably not benefit from 200,000 IU of vitamin D – RCT 2020</title><link>/posts/multiple-sclerosis-stem-cell-treatment-hsct-probably-not-benefit-from-200000-iu--amin-d-rct-2020.html</link><pubDate>Wed, 25 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-stem-cell-treatment-hsct-probably-not-benefit-from-200000-iu--amin-d-rct-2020.html</guid><description>&lt;h4 id="efficacy-and-safety-of-high-dose-vitamin-d-supplementation-in-patients-undergoing-hscthttpsclinicaltrialsgovct2shownct03320915sfpd_d14">&lt;a href="https://clinicaltrials.gov/ct2/show/NCT03320915?sfpd_d=14">Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT&lt;/a>&lt;/h4>
&lt;p>1, 2, or 3 treatments of 200,000 IU of vitamin D in a year&lt;/p>
&lt;p>    3 treatments: 600,000 IU/year = 1,600/day = not much, and not very frequent&lt;/p>
&lt;p>Dr. Coimbra in Brazil uses about 60,000 IU of Vitamin D/day, about 40X more to &amp;ldquo;cure&amp;rdquo;&lt;/p>
&lt;p>&lt;a href="https://www.nationalmssociety.org/About-the-Society/News/Final-5-Year-Results-Published-from-Study-of-B">Final 5-Year Results Published from Study of Bone Marrow Stem Cell Transplantation in Relapsing MS&lt;/a> Feb 2017&lt;/p></description></item><item><title>Having several concussions as a teenager doubled the risk of Multiple Sclerosis</title><link>/posts/having-several-concussions-as-a-teenager-doubled-the-risk-of-multiple-sclerosis.html</link><pubDate>Wed, 18 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/having-several-concussions-as-a-teenager-doubled-the-risk-of-multiple-sclerosis.html</guid><description>&lt;h4 id="concussion-in-adolescence-and-risk-of-multiple-sclerosis">Concussion in adolescence and risk of multiple sclerosis.&lt;/h4>
&lt;p>Ann Neurol. 2017 Sep 4. &lt;a href="https://doi.org/10.1002/ana.25036.">doi: 10.1002/ana.25036.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Montgomery S1,2,3, Hiyoshi A1, Burkill S2,4, Alfredsson L5,6, Bahmanyar S2,4, Olsson T7.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>Based on 80,000 Swedish teens who visited a hospital for a concussion&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Less risk of MS if only a single concussion or younger than a teenager&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>Some details of study are at:&lt;br>
&lt;a href="https://www.nytimes.com/2017/10/18/well/move/concussions-in-teenagers-tied-to-multiple-sclerosis-risk.html?_r=0">Concussions in Teenagers Tied to Multiple Sclerosis Risk&lt;/a> NYT Oct 2017&lt;/strong>&lt;/p></description></item><item><title>Lymphatic system discovered in brain (what about Multiple Sclerosis, Alzheimer’s, Omega-3 and Vitamin D)</title><link>/posts/lymphatic-system-discovered-in-brain-what-about-multiple-sclerosis-alzheimers-omega-3-and-vitamin-d.html</link><pubDate>Sat, 07 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/lymphatic-system-discovered-in-brain-what-about-multiple-sclerosis-alzheimers-omega-3-and-vitamin-d.html</guid><description>&lt;h4 id="scientists-somehow-just-discovered-a-new-system-of-vessels-in-our-brainshttpswwwtheatlanticcomhealtharchive201710scientists-somehow-just-discovered-a-new-system-of-vessels-in-our-brains542037utm_sourcefeed-atlantic-oct-2017">&lt;a href="https://www.theatlantic.com/health/archive/2017/10/scientists-somehow-just-discovered-a-new-system-of-vessels-in-our-brains/542037/?utm_source=feed">Scientists Somehow Just Discovered a New System of Vessels in Our Brains&lt;/a> Atlantic Oct 2017&lt;/h4>
&lt;p>&lt;strong>“It is unclear what they do—but they likely play a central role in aging and disease.&amp;quot;&lt;/strong>&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/lymph-brain.jpg" alt="image" width="400">
&lt;ul>
&lt;li>
&lt;p>“Doctors practicing today have been taught that there are no lymphatic vessels inside the skull.”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Senior investigator Daniel Reich, who is very interested in Multiple Sclerosis, followed up on the discovery of lymph system in brains (glymphatic system) of mice in 2015&lt;/p></description></item><item><title>Multiple Sclerosis risk a decade later was 2X higher if low vitamin D (12 ng vs 20 ng)</title><link>/posts/multiple-sclerosis-risk-a-decade-later-was-2x-higher-if-low-vitamin-d-12-ng-vs-20-ng.html</link><pubDate>Wed, 13 Sep 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-a-decade-later-was-2x-higher-if-low-vitamin-d-12-ng-vs-20-ng.html</guid><description>&lt;h4 id="25-hydroxyvitamin-d-deficiency-and-risk-of-ms-among-women-in-the-finnish-maternity-cohort">25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort&lt;/h4>
&lt;p>Neurology Journal online Sept 13, 2017, http:/​/​dx.​doi.​org/​10.​1212/​WNL.​0000000000004489&lt;/p>
&lt;p>Kassandra L. Munger, ScD, Kira Hongell, MD, Julia Åivo, MD, Merja Soilu-Hänninen, MD, PhD, Heljä-Marja Surcel, PhD and Alberto Ascherio, MD, DrPH&lt;/p>
&lt;p>Correspondence to Dr. Munger: &lt;a href="mailto:kgorham@hsph.harvard.edu">kgorham@hsph.harvard.edu&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>Clearly low vitamin D is a possible cause for MS, not the other way around&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-patients-have-15-ng-lower-levels-of-vitamin-d-meta-analysis">Multiple sclerosis patients have 15 ng lower levels of vitamin D – meta-analysis June 2014&lt;/a>&lt;/p></description></item><item><title>Active form of vitamin D directly protects the blood–brain barrier in multiple sclerosis</title><link>/posts/active-form-of-vitamin-d-directly-protects-the-bloodbrain-barrier-in-multiple-sclerosis.html</link><pubDate>Sat, 26 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/active-form-of-vitamin-d-directly-protects-the-bloodbrain-barrier-in-multiple-sclerosis.html</guid><description>&lt;p>Clinical and Experimental Neuroimmunology, First published: 22 August 2017, DOI: 10.1111/cen3.12398&lt;/p>
&lt;p>Shiori Takahashi, Toshihiko Maeda, Yasuteru Sano, Hideaki Nishihara, Yukio Takeshita, Fumitaka Shimizu, Takashi Kanda&lt;/p>
&lt;p>Objectives&lt;/p>
&lt;p>The active form of vitamin D, 1α,25-dihydroxyvitamin D3 (1α,25-&lt;span>[OH]&lt;/span>2D3), is reported to have protective effects for multiple sclerosis (MS), but the precise mechanisms of this effect on MS remain unclear. We hypothesized that 1α,25-(OH)2D3 has protective effects on the blood–brain barrier (BBB) in MS.&lt;/p></description></item><item><title>Multiple Sclerosis 6X more likely to progress quickly if low vitamin D</title><link>/posts/multiple-sclerosis-6x-more-likely-to-progress-quickly-if-low-vitamin-d.html</link><pubDate>Fri, 18 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-6x-more-likely-to-progress-quickly-if-low-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis more likely if poor vitamin D genes - 22nd study</title><link>/posts/multiple-sclerosis-more-likely-if-poor-vitamin-d-genes-22nd-study.html</link><pubDate>Fri, 04 Aug 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-more-likely-if-poor-vitamin-d-genes-22nd-study.html</guid><description/></item><item><title>Multiple Sclerosis risk of relapse reduced by 13 percent for every 2.5 ng higher level of vitamin D (under age 37)</title><link>/posts/multiple-sclerosis-risk-of-relapse-reduced-by-13-percent-for-every-25-ng-higher---d-under-age-37.html</link><pubDate>Tue, 18 Jul 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-of-relapse-reduced-by-13-percent-for-every-25-ng-higher---d-under-age-37.html</guid><description/></item><item><title>Multiple Sclerosis risk reduced 30 percent for additional 10 ng of vitamin D at birth</title><link>/posts/multiple-sclerosis-risk-reduced-30-percent-for-additional-10-ng-of-vitamin-d-at-birth.html</link><pubDate>Tue, 04 Jul 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-30-percent-for-additional-10-ng-of-vitamin-d-at-birth.html</guid><description/></item><item><title>Vitamin D and Sun conference – Germany</title><link>/posts/vitamin-d-and-sun-conference-germany.html</link><pubDate>Sun, 28 May 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-sun-conference-germany.html</guid><description>&lt;p>&lt;strong>THE JOINT INTERNATIONAL SYMPOSIA &amp;ldquo;VITAMIN D IN PREVENTION AND THERAPY&amp;rdquo; AND &amp;ldquo;BIOLOGIC EFFECTS OF LIGHT&amp;rdquo;&lt;/strong>&lt;/p>
&lt;p>21-23 June, 2017, Schlossberg Hotel, Homburg/Saar, Germany&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/june-2017-conference.pdf">Click here to download all of the talks and posters from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-light-conference">Vitamin D and light conference – June 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/exposing-some-blood-to-ultraviolet-light-has-treated-various-health-problems-the-tics-came-along">Exposing some blood to Ultraviolet light has treated various health problems, then antibiotics came along – April 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/uv-produces-more-than-vitamin-d">UV produces more than vitamin D – Aug 2011&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis risk reduced 30 percent by each additional 10 ng of vitamin D at birth (1500 Danes)</title><link>/posts/multiple-sclerosis-risk-reduced-30-percent-by-each-additional-10-ng-of-vitamin-d-at-birth-1500-danes.html</link><pubDate>Fri, 19 May 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-30-percent-by-each-additional-10-ng-of-vitamin-d-at-birth-1500-danes.html</guid><description>&lt;h4 id="neonatal-vitamin-d-status-and-risk-of-multiple-sclerosis-a-population-based-case-control-study">Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.&lt;/h4>
&lt;p>Neurology. 2017 Jan 3;88(1):44-51. &lt;a href="https://doi.org/10.1212/WNL.0000000000003454">doi: 10.1212/WNL.0000000000003454&lt;/a>&lt;/p>
&lt;p>Nielsen NM1, Munger KL2, Koch-Henriksen N2, Hougaard DM2, Magyari M2, Jørgensen KT2, Lundqvist M2, Simonsen J2, Jess T2, Cohen A2, Stenager E2, Ascherio A2.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:650px"> **Twice as likely if &lt; 8 ng vs > 20 ng** 
&lt;p>&lt;strong>Alternately: 10 ng increase in vitamin D level ==&amp;gt; 30% less likely to get MS&lt;/strong>&lt;/p>
&lt;h4 id="see-also-ms-prevention-in-vitamindwiki">See also MS PREVENTION in VitaminDWiki&lt;/h4>
&lt;p>&lt;a href="/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d">Genes make Multiple Sclerosis 2X more likely unless get more vitamin D - Aug 2015&lt;/a>&lt;/p></description></item><item><title>Fewer Multiple Sclerosis lesions when supplemented with Vitamin D – meta-analysis</title><link>/posts/fewer-multiple-sclerosis-lesions-when-supplemented-with-vitamin-d-meta-analysis.html</link><pubDate>Wed, 17 May 2017 00:00:00 +0000</pubDate><guid>/posts/fewer-multiple-sclerosis-lesions-when-supplemented-with-vitamin-d-meta-analysis.html</guid><description/></item><item><title>High dose vitamin D to treat Multiple Sclerosis etc. – protocol</title><link>/posts/high-dose-vitamin-d-to-treat-multiple-sclerosis-etc-protocol.html</link><pubDate>Thu, 27 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/high-dose-vitamin-d-to-treat-multiple-sclerosis-etc-protocol.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.coimbraprotocol.com/%20">https://www.coimbraprotocol.com/ &lt;/a> ENGLISH&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://coimbraprotokoll.de/">http://coimbraprotokoll.de/&lt;/a> GERMAN&lt;/strong>&lt;/p>
&lt;h4 id="english-website-is-divided-into">English website is divided into&lt;/h4>
&lt;p>The Protocol&lt;/p>
&lt;p>General Information&lt;/p>
&lt;p>Book &amp;amp; Videos&lt;/p>
&lt;p>Testimonials&lt;/p>
&lt;h4 id="sample-portions-of-protocol-section">Sample portions of protocol section&lt;/h4>
&lt;p>&lt;strong>Some of the tests required by the protocol include, but are not limited to:&lt;/strong>&lt;/p>
&lt;p>​PTH&lt;/p>
&lt;p>24H Calciuria&lt;/p>
&lt;p>B12 vitamin&lt;/p>
&lt;p>25(OH)D3&lt;/p>
&lt;p>Total and Ionized Calcium&lt;/p>
&lt;p>Urea and Creatinine&lt;/p>
&lt;p>Albumin&lt;/p>
&lt;p>Ferritin&lt;/p>
&lt;p>Serum Phosphate&lt;/p>
&lt;p>24H Phosphaturia&lt;/p>
&lt;p>TSH and ST4&lt;/p>
&lt;p>Bone Densitometry&lt;/p>
&lt;p>&lt;strong>What is the recommended diet for the Coimbra Protocol?&lt;/strong>&lt;/p>
&lt;p>The diet restrictions are related exclusively to the amount of calcium the foods contain. Dairy and calcium enriched foods must be avoided, nuts should be consumed in moderation. Again, every patient is different, so the test results will ultimately determine if the diet is being correctly followed or if more restrictions are needed. Also, patients need to drink 2.5 L of liquids a day, to ensure that the kidneys will be able to eliminate excess calcium without difficulty.&lt;/p></description></item><item><title>Multiple sclerosis (relapsing-remitting) increases activation of Vitamin D Receptor by 6.6 X</title><link>/posts/multiple-sclerosis-relapsing-remitting-increases-activation-of-vitamin-d-receptor-by-66-x.html</link><pubDate>Sun, 23 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapsing-remitting-increases-activation-of-vitamin-d-receptor-by-66-x.html</guid><description>&lt;h4 id="deciphering-the-role-of-dna-methylation-in-multiple-sclerosis-emerging-issueshttpswwwncbinlmnihgovpmcarticlespmc5014764--sept-2016-free-pdf-online">&lt;a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014764/">Deciphering the role of DNA methylation in multiple sclerosis: emerging issues&lt;/a> Sept 2016, Free PDF online&lt;/h4>
&lt;hr>
&lt;h4 id="dna-methylation-a-new-player-in-multiple-sclerosishttpswwwncbinlmnihgovpubmed27314687-june-2016">&lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/27314687">DNA Methylation: a New Player in Multiple Sclerosis&lt;/a> June 2016&lt;/h4></description></item><item><title>Multiple Sclerosis much less likely for children who are thin and tanned</title><link>/posts/multiple-sclerosis-much-less-likely-for-children-who-are-thin-and-tanned.html</link><pubDate>Sun, 23 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-less-likely-for-children-who-are-thin-and-tanned.html</guid><description>&lt;h4 id="1-researchspeak-genomics-confirms-what-we-know-regarding-vitamin-d-and-obesity-and-ms-riskhttpmultiple-sclerosis-researchblogspotcom201704researchspeak-genomics-confirms-what-wehtml">&lt;a href="http://multiple-sclerosis-research.blogspot.com/2017/04/researchspeak-genomics-confirms-what-we.html">1. ResearchSpeak: genomics confirms what we know regarding vitamin D and obesity and MS risk&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Thin and tanned; the childhood phenotype that reduces their chances of getting MS&lt;/strong>&lt;/p>
&lt;p>&lt;strong>A review of &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/28356466?dopt=Abstract">Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS&lt;/a> - March 2017&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>28% less likely to get MS if higher level of vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>17% more likely to ger pediatric MS onset if have high BMI&lt;/p></description></item><item><title>Multiple Sclerosis - subtle early signs – should probably take vitamin D</title><link>/posts/multiple-sclerosis-subtle-early-signs-should-probably-take-vitamin-d.html</link><pubDate>Mon, 06 Mar 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-subtle-early-signs-should-probably-take-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis is more likely if poor Vitamin D Receptor (4X Mexico, 3X Iran)</title><link>/posts/multiple-sclerosis-is-more-likely-if-poor-vitamin-d-receptor-4x-mexico-3x-iran.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-more-likely-if-poor-vitamin-d-receptor-4x-mexico-3x-iran.html</guid><description/></item><item><title>Off Topic: Some disabled people (MS, Parkinson, blind, deaf etc) are using second life</title><link>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</guid><description>&lt;h4 id="great-articlehttpsbackchannelcomfirst-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9pia9rk6v620">&lt;a href="https://backchannel.com/first-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9#.pia9rk6v6%20">Great article&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>800,000 users each month&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Second Life has many disability groups&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The Virtual Ability group has thousand members, and hosts a dozen or so events per week, including games, live piano concerts, dance parties and self-help workshops&lt;/p>
&lt;/li>
&lt;li>
&lt;p>For some of the people the experiencing of a virtual ability results in an improved ability in real life&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h3 id="httpsecondlifecomhttpsecondlifecom">&lt;a href="http://secondlife.com/">http://secondlife.com/&lt;/a>&lt;/h3>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/second-life.jpg" alt="image" width="500"></description></item><item><title>Multiple Sclerosis Relapsing-Remitting rate reduced 30 percent by addition of 14,000 IU vitamin D daily – RCT</title><link>/posts/multiple-sclerosis-relapsing-remitting-rate-reduced-30-percent-by-addition-of-14-min-d-daily-rct.html</link><pubDate>Sat, 21 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapsing-remitting-rate-reduced-30-percent-by-addition-of-14-min-d-daily-rct.html</guid><description>&lt;h4 id="a-phase-ii-study-of-the-efficacy-and-safety-of-high-dose-cholecalciferol-vitamin-d3-oil-as-add-on-therapy-in-subjects-with-relapsing-remitting-multiple-sclerosis-receiving-subcutaneous-interferon-β-1a-solar">A Phase II Study of the Efficacy and Safety of High-Dose Cholecalciferol (Vitamin D3) Oil as Add-on Therapy in Subjects with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon β-1a: SOLAR&lt;/h4>
&lt;p>J. Smolders1,2, R. Hupperts1, R. Vieth3, T. Holmøy4, K. Marhardt5, M. Schluep6, J. Killestein7, F. Barkhof7,8, L.M.E. Grimaldi9, M. Beelke10&lt;/p>
&lt;p>&lt;strong>Poster presented at Presented at European Charcot Foundation (ECF) 2016; November 24–28, 2016; Baveno, Italy&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/ms-helped-by-14-000-iu-daily.pdf">Download the PDF-Poster from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Doctor got multiple sclerosis, rejected then embraced Coimbra protocol for herself and patients</title><link>/posts/doctor-got-multiple-sclerosis-rejected-then-embraced-coimbra-protocol-for-herself-and-patients.html</link><pubDate>Thu, 19 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/doctor-got-multiple-sclerosis-rejected-then-embraced-coimbra-protocol-for-herself-and-patients.html</guid><description/></item><item><title>Mendelian proof that low vitamin D (due to 3 genes) increase risk of MS by 20 percent</title><link>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</link><pubDate>Sun, 15 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</guid><description/></item><item><title>Multiple Sclerosis and Vitamin D ~ 50,000 Facebook members in 13 languages</title><link>/posts/multiple-sclerosis-and-vitamin-d-50000-facebook-members-in-13-languages.html</link><pubDate>Tue, 10 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-50000-facebook-members-in-13-languages.html</guid><description>&lt;h4 id="coimbra">Coimbra&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.google.com/maps/d/u/0/viewer?mid=1fATZJUEhOsYYJdBY41h48FBkLaQ&amp;amp;ll=19.192120392882064%2C-24.66098360000003&amp;amp;z=2">Google Map of Doctors&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol">Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016">Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-is-the-real-multiple-sclerosis-therapy-not-an-alternative-therapy-coimbra">Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra July 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/guide-for-patients-on-high-doses-of-vitamin-d-coimbra-2017">Guide for patients on high doses of Vitamin D – Coimbra 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/how-to-get-lots-of-magnesium-especially-needed-for-coimbra-ms-and-autoimmune-protocol">How to get lots of Magnesium – especially needed for Coimbra MS and Autoimmune Protocol&lt;/a>&lt;/p></description></item><item><title>Autoimmune risk gene ZMIZ1 is associated with both MS and Vitamin D</title><link>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</link><pubDate>Thu, 05 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis relapse in children is twice as likely having a Vitamin D Gene score of 6</title><link>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</link><pubDate>Thu, 22 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</guid><description/></item><item><title>Multiple sclerosis risk factors include vitamin D</title><link>/posts/multiple-sclerosis-risk-factors-include-vitamin-d.html</link><pubDate>Sun, 11 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-include-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis suppressed by an Ultraviolet wavelength not associated with Vitamin D (mice)</title><link>/posts/multiple-sclerosis-suppressed-by-an-ultraviolet-wavelength-not-associated-with-vitamin-d-mice.html</link><pubDate>Sat, 03 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-suppressed-by-an-ultraviolet-wavelength-not-associated-with-vitamin-d-mice.html</guid><description/></item><item><title>A gestational dose of vitamin D per day keeps the MS doctor away (2X reduction)</title><link>/posts/a-gestational-dose-of-vitamin-d-per-day-keeps-the-ms-doctor-away-2x-reduction.html</link><pubDate>Fri, 02 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/a-gestational-dose-of-vitamin-d-per-day-keeps-the-ms-doctor-away-2x-reduction.html</guid><description/></item><item><title>Multiple Sclerosis Conference had scores of Vitamin D presentations</title><link>/posts/multiple-sclerosis-conference-had-scores-of-vitamin-d-presentations.html</link><pubDate>Fri, 30 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-conference-had-scores-of-vitamin-d-presentations.html</guid><description/></item><item><title>Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016</title><link>/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016.html</link><pubDate>Wed, 28 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016.html</guid><description/></item><item><title>Multiple Sclerosis much more likely if poor Vitamin D Receptor – several studies</title><link>/posts/multiple-sclerosis-much-more-likely-if-poor-vitamin-d-receptor-several-studies.html</link><pubDate>Mon, 26 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-more-likely-if-poor-vitamin-d-receptor-several-studies.html</guid><description>&lt;h4 id="vitamin-d-receptor-gene-polymorphisms-are-associated-with-multiple-sclerosis-in-mexican-adults---may-2017">Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults - May 2017&lt;/h4>
&lt;p>Journal of Neuroimmunology, Volume 306, 15 May 2017, Pages 20–24, &lt;a href="https://doi.org/10.1016/j.jneuroim.2017.01.009">https://doi.org/10.1016/j.jneuroim.2017.01.009&lt;/a>&lt;/p>
&lt;p>Víctor Hugo Bermúdez-Moralesa, Geny Fierrosa, Roberto Lopez Lopeza, Gaby Martínez-Navaa, Mario Flores-Aldanab, José Flores-Riverac, Carlos Hernández-Girónd, ,&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Multiple sclerosis (MS) is the most prevalent autoimmune inflammatory demyelinating disease of the central nervous system (CNS) in young adults. More than 50 genomic regions have been associated with MS susceptibility.&lt;/p></description></item><item><title>Multiple Sclerosis and small doses of Vitamin D – meta-review</title><link>/posts/multiple-sclerosis-and-small-doses-of-vitamin-d-meta-review.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-small-doses-of-vitamin-d-meta-review.html</guid><description>&lt;ul>
&lt;li>
&lt;p>They consider &amp;gt;1,000 IU to be “high dose”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>For MS high dose should be 20X higher&lt;/p>
&lt;/li>
&lt;/ul>
&lt;ol>
&lt;li>
&lt;p>More than one nutrient is used by Dr. Coimbra&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Dose size varies with the patient (not one size fits all)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>No randomized controlled trials for Dr. Coimbra – all patients are treated, not just half&lt;/p>
&lt;/li>
&lt;/ol>
&lt;ul>
&lt;li>They thus gnore the success at CURING &amp;gt; 1,000 MS patients by Dr. Coimbra with Vitamin D, etc.&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>The words Coimbra or Brazil do not occur even once in the meta-review&lt;/p></description></item><item><title>Multiple Sclerosis helped by UV – possibly via cytokines, etc.</title><link>/posts/multiple-sclerosis-helped-by-uv-possibly-via-cytokines-etc.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-helped-by-uv-possibly-via-cytokines-etc.html</guid><description/></item><item><title>Multiple sclerosis helped some by 10,000 IU of vitamin D daily avg. for 3 months – RCT</title><link>/posts/multiple-sclerosis-helped-some-by-10000-iu-of-vitamin-d-daily-avg-for-3-months-rct.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-helped-some-by-10000-iu-of-vitamin-d-daily-avg-for-3-months-rct.html</guid><description/></item><item><title>Multiple sclerosis in children – low vitamin D is a potential factor</title><link>/posts/multiple-sclerosis-in-children-low-vitamin-d-is-a-potential-factor.html</link><pubDate>Wed, 31 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-in-children-low-vitamin-d-is-a-potential-factor.html</guid><description/></item><item><title>Testimonial on curing Multiple Sclerosis with 20,000 IU of vitamin D</title><link>/posts/testimonial-on-curing-multiple-sclerosis-with-20000-iu-of-vitamin-d.html</link><pubDate>Tue, 23 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/testimonial-on-curing-multiple-sclerosis-with-20000-iu-of-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis and obesity share some gene problems (as well as low vitamin D)</title><link>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</link><pubDate>Thu, 30 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis – one person’s benefit of Vitamin D protocol by Dr. Coimbra</title><link>/posts/multiple-sclerosis-one-persons-benefit-of-vitamin-d-protocol-by-dr-coimbra.html</link><pubDate>Wed, 22 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-one-persons-benefit-of-vitamin-d-protocol-by-dr-coimbra.html</guid><description>&lt;p>&lt;strong>The following is translated from Portuguese on &lt;a href="https://www.facebook.com/groups/EscleroseMultiplaOTratamento/permalink/1201611816550711/%20">Facebook&lt;/a> June 2016&lt;/strong>&lt;/p>
&lt;p>This is Daniel Cunha, a journalist who has MS and has &lt;strong>produced the video &amp;quot; Vitamin D - for an alternative therapy.&amp;quot;&lt;/strong> Daniel has been on the Coimbra protocol for 6 years and this is an update on how his treatment is progressing.&lt;/p>
&lt;p>&amp;ldquo;My name is Daniel Cunha, I&amp;rsquo;m 30 years old and was diagnosed with MS at the end of 2009 after a major flare up, with a variety of neurological symptoms. I was admitted to the hospital, took corticoids and recovered completely after about a month and a half.&lt;/p></description></item><item><title>Multiple Sclerosis 60 percent less likely in those with more than 40 ng of vitamin D – 2006</title><link>/posts/multiple-sclerosis-60-percent-less-likely-in-those-with-more-than-40-ng-of-vitamin-d-2006.html</link><pubDate>Fri, 10 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-60-percent-less-likely-in-those-with-more-than-40-ng-of-vitamin-d-2006.html</guid><description/></item><item><title>Multiple Sclerosis 2X more likely if vitamin D deficient as a fetus decades earlier</title><link>/posts/multiple-sclerosis-2x-more-likely-if-vitamin-d-deficient-as-a-fetus-decades-earlier.html</link><pubDate>Tue, 10 May 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-2x-more-likely-if-vitamin-d-deficient-as-a-fetus-decades-earlier.html</guid><description/></item><item><title>Multiple Sclerosis associated with low vitamin D – by B-cells which produce antibodies</title><link>/posts/multiple-sclerosis-associated-with-low-vitamin-d-by-b-cells-which-produce-antibodies.html</link><pubDate>Fri, 29 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-associated-with-low-vitamin-d-by-b-cells-which-produce-antibodies.html</guid><description/></item><item><title>Vitamin D should be taken by all MS patients - Consortium of Multiple Sclerosis Centres</title><link>/posts/vitamin-d-should-be-taken-by-all-ms-patients-consortium-of-multiple-sclerosis-centres.html</link><pubDate>Tue, 26 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-should-be-taken-by-all-ms-patients-consortium-of-multiple-sclerosis-centres.html</guid><description>&lt;h3 id="experts-agree-on-vitamin-d-benefits-260416httpwwwms-ukorgapr37">&lt;a href="http://www.ms-uk.org/apr37">Experts agree on vitamin D benefits (26/04/16)&lt;/a>&lt;/h3>
&lt;p>&lt;strong>snips&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;There is, therefore, little doubt that vitamin D provides a range of valuable health effects — effects of importance to everyone, but of particular importance to people with MS.&amp;rdquo;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;lsquo;Studies showed that children who have lower vitamin D levels more often develop MS as adults.&amp;quot;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;To really conclude that vitamin D impacts the disease, randomized prospective clinical trials are needed. One such trial, the VIDAMS study, is currently underway. The study explores if high-dose supplements — 5000 IU per day . . . &amp;quot;&lt;/p></description></item><item><title>Multiple Sclerosis - low vitamin D, low sun, smoking are the largest modifiable factors</title><link>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</link><pubDate>Sat, 09 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</guid><description>&lt;h4 id="factors-associated-with-onset-relapses-or-progression-in-multiple-sclerosis-a-systematic-review">Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review&lt;/h4>
&lt;p>NeuroToxicology, April 2016, doi:10.1016/j.neuro.2016.03.020 &lt;strong>78 pages&lt;/strong>&lt;/p>
&lt;p>Kyla A. McKaya, Shayesteh Jahanfarb, Tom Duggana, Stacey Tkachuka, Helen Tremletta &lt;a href="mailto:helen.tremlett@ubc.ca">helen.tremlett@ubc.ca&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is a chronic disease of the central nervous system with an unidentified etiology. We systematically reviewed the literature on the possible risk factors associated with MS disease onset, relapses and progression from 1960-2012 by accessing six databases and including relevant&lt;/p></description></item><item><title>10 Diseases associated with Multiple Sclerosis are also associated with low Omega-3 and vitamin D</title><link>/posts/10-diseases-associated-with-multiple-sclerosis-are-also-associated-with-low-omega-3-and-vitamin-d.html</link><pubDate>Sun, 13 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/10-diseases-associated-with-multiple-sclerosis-are-also-associated-with-low-omega-3-and-vitamin-d.html</guid><description>&lt;h4 id="multiple-sclerosis---a-lifestyle-disease">Multiple sclerosis - A lifestyle disease?&lt;/h4>
&lt;p>Neurology Journal Editorial doi:http:/​/​dx.​doi.​org/​10.​1212/​WNL.​0000000000002487&lt;/p>
&lt;p>William B. Grant, PhD and Trond Riise, PhD&lt;/p>
&lt;p>&lt;strong>Publisher provided Free Excerpt&lt;/strong>&lt;/p>
&lt;p>Chronic diseases are the primary cause of disability, morbidity, and death in Western developed countries. Many of these diseases are related to environmental influences including diet, smoking, and other lifestyle factors. Public health measures address some of these factors, and studies strengthening the links between environmental factors and health can be useful in this regard.&lt;/p></description></item><item><title>Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol</title><link>/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol.html</link><pubDate>Wed, 09 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol.html</guid><description>&lt;h4 id="video-by-a-coimbra-patient">Video by a Coimbra Patient&lt;/h4>
&lt;p>&lt;a href="https://www.youtube.com/watch?v=Mb8mJ-L16Ik&amp;amp;feature=share">March 2015, 6 minutes&lt;/a>&lt;/p>
&lt;p>In Portuguese with English Captions&lt;/p>
&lt;hr>
&lt;h4 id="coimbra-protocol-in-spanish">Coimbra Protocol in Spanish&lt;/h4>
&lt;p>&lt;a href="http://www.tengoesclerosismultiple.com/">http://www.tengoesclerosismultiple.com/&lt;/a>&lt;/p>
&lt;p>&lt;strong>Short URL =&lt;/strong> is.gd/domene&lt;/p></description></item><item><title>Multiple Sclerosis much more likely if low vitamin D during pregnancy –many studies</title><link>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</link><pubDate>Mon, 07 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-19x-more-likely-if-low-vitamin-d-during-pregnancy--march-2016">Multiple Sclerosis 1.9X more likely if low vitamin D during pregnancy – March 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/h4>
&lt;p>&lt;strong>Gestational Vitamin D and Offspring Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/pregnancy-ms-meta.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis risk factors – Vitamin D, parasites, and EBV – 2015</title><link>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</link><pubDate>Tue, 05 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</guid><description>&lt;h4 id="multiple-sclerosis-and-environmental-factors-the-role-of-vitamin-d-parasites-and-epstein-barr-virus-infection">Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.&lt;/h4>
&lt;p>Acta Neurol Scand. 2015;132(199):46-55. &lt;a href="https://doi.org/10.1111/ane.12431.">doi: 10.1111/ane.12431.&lt;/a>&lt;/p>
&lt;p>Correale J1, Gaitán MI1.&lt;/p>
&lt;p>1Department of Neurology, Institute for Neurological Research Dr. Raúl Carrea, FLENI, Buenos Aires, Argentina.&lt;/p>
&lt;p>Pathogenic mechanisms underlying multiple sclerosis development have yet to be clearly identified, but considerable evidence indicates that autoimmunity plays an important role in the etiology of the disease. It is generally accepted that autoimmune diseases like MS arise from complex interactions between genetic susceptibility and environmental factors. Although environmental factors unequivocally influencing MS development have yet to be established, accumulating evidence singles out several candidates, including sunlight-UV exposure or vitamin D deficiency, viral infections, hygiene, and cigarette smoking. Vitamin D deficiency has been associated with different autoimmune diseases. Several investigations indicate 125 (OH)2 vitamin D plays a critical role in shaping T-cell response and inducing T cells with immunosuppressive properties. Likewise, helminth infections represent another potential environmental factor exerting immunomodulatory properties. Both epidemiological and experimental data provide evidence to support autoimmune down-regulation secondary to parasite infections in patients with MS, through regulatory T- and B-cell action, with effects extending beyond simple response to an infectious agent. Finally, different epidemiological studies have demonstrated that Epstein-Barr virus infection confers added risk of developing MS. Proposed mechanisms responsible for this association include activation and expansion of self-reactive T and B cells, lower threshold for self-tolerance breakdown, and enhanced autoreactive B-cell survival, all to be discussed in this review. Understanding environmental factors influencing propensity to MS will lead to new and more effective approaches to prevent and treat the disease.&lt;/p></description></item><item><title>Off topic: Cannabis and disease studies at GreenMedInfo</title><link>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</link><pubDate>Mon, 28 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</guid><description>&lt;h4 id="raw-cannabis-juice-helps-young-woman-ditch-40-medicationshttptvgreenmedinfocomraw-cannabis-juice-helps-young-woman-ditch-40-medications">&lt;a href="http://tv.greenmedinfo.com/raw-cannabis-juice-helps-young-woman-ditch-40-medications/">Raw Cannabis Juice Helps Young Woman Ditch 40 Medications&lt;/a>&lt;/h4>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>&lt;strong>Note – There is a BIG difference between cannabis products&lt;/strong>&lt;/p>
&lt;p>Most research - such as in the table below does not distinguish between THC and CBD&lt;/p>
&lt;p>In a nutshell :It appears that&lt;/p>
&lt;p>&lt;strong>| | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; |
| | THC | CBD |
| Benefit | Get high | Pain relief |
| Typical cannabis | 50% | 50% |
| High-grade cannabis | 90% | 10% |
| Pain relief cannabis | 5% | 95% |
| Legal in US states | &amp;lt;10% | 100% |&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis – more gray matter and fewer relapses if 10 ng more vitamin D</title><link>/posts/multiple-sclerosis-more-gray-matter-and-fewer-relapses-if-10-ng-more-vitamin-d.html</link><pubDate>Sat, 31 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-more-gray-matter-and-fewer-relapses-if-10-ng-more-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis vitamin D treatments – update</title><link>/posts/multiple-sclerosis-vitamin-d-treatments-update.html</link><pubDate>Fri, 23 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-vitamin-d-treatments-update.html</guid><description>&lt;h3 id="update-in-vitamin-d-and-multiple-sclerosis">Update in vitamin D and multiple sclerosis.&lt;/h3>
&lt;p>Neurosciences (Riyadh). 2015 Oct;20(4):329-335. &lt;a href="https://doi.org/10.17712/nsj.2015.4.20150357.">doi: 10.17712/nsj.2015.4.20150357.&lt;/a>&lt;/p>
&lt;p>Alharbi FM1.&lt;/p>
&lt;p>1Department of Neurology, College of Medicine, Qassim University, Buraidah, Kingdom of Saudi Arabia. E-mail: &lt;a href="mailto:fatimahali@qumed.edu.sa">fatimahali@qumed.edu.sa&lt;/a>.&lt;/p>
&lt;p>Multiple sclerosis (MS) is a common neurological disease, and its etiology remains unknown. In recent years, increasing attention has been paid to the possible association between MS and vitamin D deficiency. Here, we review the current literature between MS and vitamin D, &lt;strong>showing clear evidence that vitamin D deficiency is a risk factor for MS&lt;/strong> despite the lack of direct evidence for the effects of vitamin D in MS progression.&lt;/p></description></item><item><title>Multiple Sclerosis Treatment and Research -Vitamin D presentations at European Congress</title><link>/posts/multiple-sclerosis-treatment-and-research-vitamin-d-presentations-at-european-congress.html</link><pubDate>Mon, 19 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treatment-and-research-vitamin-d-presentations-at-european-congress.html</guid><description/></item><item><title>If born in the winter, 11 percent more likely to be vitamin D deficient as an adult</title><link>/posts/if-born-in-the-winter-11-percent-more-likely-to-be-vitamin-d-deficient-as-an-adult.html</link><pubDate>Sun, 27 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/if-born-in-the-winter-11-percent-more-likely-to-be-vitamin-d-deficient-as-an-adult.html</guid><description>&lt;h4 id="birth-season-and-vitamin-d-concentration-in-adulthood">Birth season and vitamin D concentration in adulthood&lt;/h4>
&lt;p>Annals of Translational Medicine, Vol 3, No 16 (September 2015) &lt;a href="https://doi.org/10.3978/j.issn.2305-5839.2015.09.30">doi: 10.3978/j.issn.2305-5839.2015.09.30&lt;/a>&lt;/p>
&lt;p>Giuseppe Lippi &lt;a href="mailto:glippi@ao.pr.it">glippi@ao.pr.it&lt;/a>, Patrizia Bonelli, Ruggero Buonocore, Rosalia Aloe&lt;/p>
&lt;p>Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy&lt;/p>
&lt;p>Contributions: (I) Conception and design: G Lippi; (II) Administrative support: G Lippi, P Bonelli; (III) Provision of study materials or patients: P Bonelli, R Aloe; (IV) Collection and assembly of data: P Bonelli, R Buonocore, R Aloe; (V) Data analysis and interpretation: P Bonelli, R Aloe; (VI) Manuscript writing: G Lippi, P Bonelli, R Aloe; (VII) Final approval of manuscript: G Lippi, P Bonelli, R Aloe.&lt;/p></description></item><item><title>Multiple Sclerosis risk reduced 46 percent by Omega-3 derived from fish (1 gram)</title><link>/posts/multiple-sclerosis-risk-reduced-46-percent-by-omega-3-derived-from-fish-1-gram.html</link><pubDate>Sat, 19 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-46-percent-by-omega-3-derived-from-fish-1-gram.html</guid><description>&lt;h4 id="higher-intake-of-omega-3-polyunsaturated-fatty-acids-is-associated-with-a-decreased-risk-of-a-first-clinical-diagnosis-of-central-nervous-system-demyelination-results-from-the-ausimmune-study">Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.&lt;/h4>
&lt;p>Mult Scler. 2015 Sep 11. pii: 1352458515604380. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Hoare S1, Lithander F2, van der Mei I3, Ponsonby AL4, Lucas R5; Ausimmune Investigator Group.&lt;/p>
&lt;p>.1National Centre for Epidemiology and Population Health, The Australian National University, Australia &lt;a href="mailto:samuelhoare7@gmail.com">samuelhoare7@gmail.com&lt;/a>.&lt;/p>
&lt;p>2The University of Canberra, Australia.&lt;/p></description></item><item><title>Vitamin D has already cleared 100 percent of lesions from over 1,000 MS patients in Brazil</title><link>/posts/vitamin-d-has-already-cleared-100-percent-of-lesions-from-over-1000-ms-patients-in-brazil.html</link><pubDate>Sun, 30 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-has-already-cleared-100-percent-of-lesions-from-over-1000-ms-patients-in-brazil.html</guid><description/></item><item><title>Genes make Multiple Sclerosis 2X more likely unless get more vitamin D</title><link>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</link><pubDate>Wed, 26 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#plos-editors-summary">(PLOS) Editors&amp;rsquo; Summary&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-sunlight-snps-with-multiple-sclerosis-susceptibility">Association of SUNLIGHT SNPs with Multiple Sclerosis Susceptibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mendelian-randomization-analysis-for-the-association-of-25ohd-with-multiple-sclerosis-risk">Mendelian Randomization Analysis for the Association of 25OHD with Multiple Sclerosis Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#59-references">59 References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#expert-reaction-to-new-study-on-vitamin-d-deficiency-and-ms">Expert reaction to new study on vitamin D deficiency and MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-positive-comments-on-study-in-neurology-today---sept-2015">Extensive positive comments on study in Neurology Today - Sept 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/h3>
&lt;p>PLOS ONE&lt;/p></description></item><item><title>Dr. Coimbra explains his treatment with high dose vitamin D for multiple sclerosis</title><link>/posts/dr-coimbra-explains-his-treatment-with-high-dose-vitamin-d-for-multiple-sclerosis.html</link><pubDate>Thu, 20 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/dr-coimbra-explains-his-treatment-with-high-dose-vitamin-d-for-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#youtube-videohttpswwwyoutubecomwatchvsokm6z1cdim20">&lt;a href="https://www.youtube.com/watch?v=soKM6z1cdiM%20">YouTube Video&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="youtube-videohttpswwwyoutubecomwatchvsokm6z1cdim20">&lt;a href="https://www.youtube.com/watch?v=soKM6z1cdiM%20">YouTube Video&lt;/a>&lt;/h2>
&lt;p>&lt;strong>Transcript from video&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>0:02My experience has been mostly with higher doses of Vitamin D.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:10Specifically answering the Multiple Sclerosis question,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:15it was around 2002 when we started prescribing 10.000 units of Vitamin D daily to patients with multiple sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:27due to literature data that had already been available, showing that Vitamin D is an immune-regulator,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:37regulating the autoimmune system, and not suppressing it,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:43stimulating the autoimmune system and efficiently helping it fight against infections,&lt;/p></description></item><item><title>Multiple Sclerosis patients need more vitamin D to get same blood level response</title><link>/posts/multiple-sclerosis-patients-need-more-vitamin-d-to-get-same-blood-level-response.html</link><pubDate>Thu, 20 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-need-more-vitamin-d-to-get-same-blood-level-response.html</guid><description/></item><item><title>Multiple Sclerosis web survey: 82 percent take vitamin D (2000-5000 IU), strong association with latitude</title><link>/posts/multiple-sclerosis-web-survey-82-percent-take-vitamin-d-2000-5000-iu-strong-asso-n-with-latitude.html</link><pubDate>Wed, 05 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-web-survey-82-percent-take-vitamin-d-2000-5000-iu-strong-asso-n-with-latitude.html</guid><description/></item><item><title>Vitamin D and multiple sclerosis—from epidemiology to prevention</title><link>/posts/vitamin-d-and-multiple-sclerosisfrom-epidemiology-to-prevention.html</link><pubDate>Fri, 26 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosisfrom-epidemiology-to-prevention.html</guid><description/></item><item><title>No multiple sclerosis relapses during pregnancy if 50,000 IU of Vitamin D weekly – RCT</title><link>/posts/no-multiple-sclerosis-relapses-during-pregnancy-if-50000-iu-of-vitamin-d-weekly-rct.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/no-multiple-sclerosis-relapses-during-pregnancy-if-50000-iu-of-vitamin-d-weekly-rct.html</guid><description/></item><item><title>Multiple Sclerosis incidence rate cut in half by 800 IU of vitamin D in cod liver oil</title><link>/posts/multiple-sclerosis-incidence-rate-cut-in-half-by-800-iu-of-vitamin-d-in-cod-liver-oil.html</link><pubDate>Fri, 08 May 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-incidence-rate-cut-in-half-by-800-iu-of-vitamin-d-in-cod-liver-oil.html</guid><description>&lt;h3 id="timing-of-use-of-cod-liver-oil-a-vitamin-d-source-and-multiple-sclerosis-risk-the-envims-study">Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.&lt;/h3>
&lt;p>Mult Scler. 2015 May 6. pii: 1352458515578770. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Cortese M1, Riise T2, Bjørnevik K3, Holmøy T4, Kampman MT5, Magalhaes S6, Pugliatti M7, Wolfson C8, Myhr KM9.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1The KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Norway/Department of Global Public Health and Primary Care, University of Bergen, Norway/Department of Nutrition, Harvard T.H. Chan School of Public Health, USA &lt;a href="mailto:Marianna.Cortese@igs.uib.no">Marianna.Cortese@igs.uib.no&lt;/a>.&lt;/p></description></item><item><title>Neuromyelitis optica (Devic's Disease is not MS) is also associated with low vitamin D</title><link>/posts/neuromyelitis-optica-devics-disease-is-not-ms-is-also-associated-with-low-vitamin-d.html</link><pubDate>Sat, 25 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/neuromyelitis-optica-devics-disease-is-not-ms-is-also-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="reduced-serum-vitamin-d-levels-in-neuromyelitis-optica">Reduced serum vitamin D levels in neuromyelitis optica&lt;/h4>
&lt;p>Neurological Sciences, April 2015 &lt;a href="https://doi.org/10.1007/s10072-015-2229-7">https://doi.org/10.1007/s10072-015-2229-7&lt;/a>&lt;/p>
&lt;p>Erdem Tüzün &lt;a href="mailto:drerdem@yahoo.com">drerdem@yahoo.com&lt;/a> (1), Özlem Küçükhüseyin (2), Murat Kürtüncü (3)&lt;/p>
&lt;p>Recai Türkoğlu (4), İlhan Yaylım (2)&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Neuroscience, Institute for Experimental Medical Research (DETAE), Istanbul University, Vakif Gureba Street, Capa, 34390, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Molecular Medicine, Institute for Experimental Medical Research (DETAE), Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey&lt;/p></description></item><item><title>Could Canada cause multiple sclerosis (MS increased 2X in 5 years)</title><link>/posts/could-canada-cause-multiple-sclerosis-ms-increased-2x-in-5-years.html</link><pubDate>Tue, 21 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/could-canada-cause-multiple-sclerosis-ms-increased-2x-in-5-years.html</guid><description>&lt;h3 id="could-canada-cause-multiple-sclerosishttpwwwmacleanscasocietyhealthcould-canada-cause-multiple-sclerosis-macleans">&lt;a href="http://www.macleans.ca/society/health/could-canada-cause-multiple-sclerosis/">Could Canada cause multiple sclerosis?&lt;/a> Macleans&lt;/h3>
&lt;p> &lt;/p>
&lt;p>&lt;strong>“Welcome to MS nation,” one billboard reads. “World leader in hockey, maple syrup and multiple sclerosis,”&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&amp;ldquo;Canadians as young as 2 years old are developing MS&amp;rdquo;&lt;/strong>&lt;/p>
&lt;p>Vitamin D is barely mentioned, but just two clicks deep finds finds a &lt;a href="https://www.youtube.com/watch?t=27&amp;amp;v=CFdp32AEnhI">90 second YouTube video on MS and Vitamin D&lt;/a>&lt;/p>
&lt;h3 id="snips-from-comments-on-the-article-are-interesting">Snips from comments on the article are interesting&lt;/h3>
&lt;ul>
&lt;li>
&lt;ol>
&lt;li>Last year they spent 40% of their $ 50 million on fundraising.&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;ol start="2">
&lt;li>Last year they spent another 40% on salaries.&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;ol start="3">
&lt;li>There are people working at the MS Society of Canada who make more than our Prime Minister…..&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;p>Their contribution to RESEARCH in their last fiscal period DECREASED by $1 million dollars, whilst their salaries INCREASED by pretty much the same amount.&lt;/p></description></item><item><title>People with health problems lacking noon sun (severe Multiple Sclerosis, etc.) have even lower levels of vitamin D</title><link>/posts/people-with-health-problems-lacking-noon-sun-severe-multiple-sclerosis-etc-have--ls-of-vitamin-d.html</link><pubDate>Sun, 15 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/people-with-health-problems-lacking-noon-sun-severe-multiple-sclerosis-etc-have--ls-of-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-is-associated-with-degree-of-disability-in-patients-with-fully-ambulatory-relapsing-remitting-multiple-sclerosis">Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.&lt;/h4>
&lt;p>Eur J Neurol. 2015 Mar;22(3):564-9. &lt;a href="https://doi.org/10.1111/ene.12617.">doi: 10.1111/ene.12617.&lt;/a> Epub 2014 Dec 20.&lt;/p>
&lt;p>Thouvenot E1, Orsini M, Daures JP, Camu W.&lt;/p>
&lt;p>BACKGROUND AND PURPOSE:&lt;/p>
&lt;p>Vitamin D deficiency is a recognized risk factor for multiple sclerosis (MS) and is associated with increased disease activity. It has also been proposed that the lower the vitamin D levels are, the higher is the handicap.&lt;/p></description></item><item><title>Hypothesis – Multiple Sclerosis risk increases with low UV, viral infections, and antibiotics in childhood</title><link>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</link><pubDate>Sat, 07 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</guid><description>&lt;h3 id="environmental-factors-in-multiple-sclerosis">Environmental factors in multiple sclerosis.&lt;/h3>
&lt;p>Presse Med. 2015 Mar 2. pii: S0755-4982(15)00064-0. &lt;a href="https://doi.org/10.1016/j.lpm.2015.01.001.">doi: 10.1016/j.lpm.2015.01.001.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Pantazou V1, Schluep M1, Du Pasquier R2.&lt;/p>
&lt;p>1CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland.&lt;/p>
&lt;p>2CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland; CHUV, University Hospital of Lausanne, Centre of Research in Clinical Neurosciences, Laboratory of Neuroimmunology, 1011 Lausanne, Switzerland. Electronic address: &lt;a href="mailto:renaud.du-pasquier@chuv.ch">renaud.du-pasquier@chuv.ch&lt;/a>.&lt;/p></description></item><item><title>Multiple Sclerosis is associated with about 1.5 X more Vitamin D Binding Protein</title><link>/posts/multiple-sclerosis-is-associated-with-about-15-x-more-vitamin-d-binding-protein.html</link><pubDate>Sun, 18 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-associated-with-about-15-x-more-vitamin-d-binding-protein.html</guid><description/></item><item><title>Multiple sclerosis patients have 15 ng lower levels of vitamin D – meta-analysis</title><link>/posts/multiple-sclerosis-patients-have-15-ng-lower-levels-of-vitamin-d-meta-analysis.html</link><pubDate>Tue, 16 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-have-15-ng-lower-levels-of-vitamin-d-meta-analysis.html</guid><description>&lt;h3 id="vitamin-d-status-and-the-risk-of-multiple-sclerosis-a-systematic-review-and-meta-analysis">Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis.&lt;/h3>
&lt;p>Neurosci Lett. 2014 Jun 6;570:108-13. &lt;a href="https://doi.org/10.1016/j.neulet.2014.04.021.">doi: 10.1016/j.neulet.2014.04.021.&lt;/a> Epub 2014 Apr 24.&lt;/p>
&lt;p>Duan S1, Lv Z2, Fan X1, Wang L1, Han F1, Wang H1, Bi S3.&lt;/p>
&lt;p>1Department of Neurology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.&lt;/p>
&lt;p>2Department of Rehabilitation, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.&lt;/p>
&lt;p>3Department of Neurology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China. Electronic address: &lt;a href="mailto:bisheng13224510036@163.com">bisheng13224510036@163.com&lt;/a>.&lt;/p></description></item><item><title>Brazillian petition to permit high vitamin D doses for autoimune diseases</title><link>/posts/brazillian-petition-to-permit-high-vitamin-d-doses-for-autoimune-diseases.html</link><pubDate>Sun, 12 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/brazillian-petition-to-permit-high-vitamin-d-doses-for-autoimune-diseases.html</guid><description>&lt;h4 id="brazilian-association-of-neurology-abn-manifesto-of-patients-with-diseases-autoimmune-making-of-high-doses-of-vitamin-d-usehttpwwwcitizengoorgensignit10291view">&lt;a href="http://www.citizengo.org/en/signit/10291/view">Brazilian Association of Neurology (ABN): MANIFESTO OF PATIENTS WITH DISEASES autoimmune MAKING OF HIGH DOSES OF VITAMIN D USE&lt;/a>&lt;/h4>
&lt;p>5,821 petitions as of Oct 12, 2014&lt;/p>
&lt;p>Many are patients of Dr. Cicero Galli Coimbra,&lt;/p>
&lt;p>who has has excellent success with decreasing autoimmune diseases such as&lt;/p>
&lt;p>Multiple Sclerosis and Psorasis&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/35000-iu-vitamin-d-daily-for-6-months-helped-all-psoriasis-suffers-106-ng-brazil">35,000 IU vitamin D daily for 6 months helped ALL psoriasis suffers (106 ng) – Brazil March 2013&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis is connected to Vitamin D by gene to gene interactions</title><link>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</link><pubDate>Tue, 07 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</guid><description>&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS.&lt;/h3>
&lt;p>Ann Clin Transl Neurol. 2014 Aug;1(8):605-17. &lt;a href="https://doi.org/10.1002/acn3.91.">doi: 10.1002/acn3.91.&lt;/a> Epub 2014 Aug 22.&lt;/p>
&lt;p>Munger KL1, Köchert K2, Simon KC1, Kappos L3, Polman CH4, Freedman MS5, Hartung HP6, Miller DH7, Montalbán X8, Edan G9, Barkhof F4, Pleimes D2, Sandbrink R10, Ascherio A1, Pohl C11.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1Harvard School of Public Health Boston, Massachusetts.&lt;/p>
&lt;p>2Bayer HealthCare Berlin, Germany.&lt;/p>
&lt;p>3University Hospital Basel Basel, Switzerland.&lt;/p></description></item><item><title>Multiple Sclerosis, gene expression, and vitamin D: Venn diagrams</title><link>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</link><pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</guid><description>&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/mechanism-ms.jpg" alt="image">
&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS&lt;/h3>
&lt;p>Annals of Clinical and Translational Neurology, Article first published online: 22 AUG 2014&lt;/p>
&lt;p>Kassandra L. Munger 1,†,*, Karl Köchert 2,†, Kelly C. Simon 1, Ludwig Kappos 3, Chris H. Polman 4, Mark S. Freedman 5, Hans P. Hartung 6, David H. Miller 7, Xavier Montalbán 8, Gilles Edan9, Frederik Barkhof4, Dirk Pleimes2, Rupert Sandbrink2,6, Alberto Ascherio1 and Christoph Pohl2,10&lt;/p></description></item><item><title>What does it mean to CURE, not just treat a disease like Multiple Sclerosis</title><link>/posts/what-does-it-mean-to-cure-not-just-treat-a-disease-like-multiple-sclerosis.html</link><pubDate>Sun, 24 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/what-does-it-mean-to-cure-not-just-treat-a-disease-like-multiple-sclerosis.html</guid><description>&lt;h3 id="why-havent-we-cured-ms-yethttpmultiple-sclerosis-researchblogspotcom201406why-havent-we-cured-ms-yethtml-dr-gavin-giovannoni">&lt;a href="http://multiple-sclerosis-research.blogspot.com/2014/06/why-havent-we-cured-ms-yet.html">Why haven&amp;rsquo;t we cured MS yet?&lt;/a> Dr. Gavin Giovannoni&lt;/h3>
&lt;p>Multiple Sclerosis Research June 2014&lt;/p>
&lt;p>Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;h3 id="a-few-of-the-slides">A few of the slides&lt;/h3>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cure-ms-1.jpg" alt="image" width="400">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cure-ms-2.jpg" alt="image" width="400">
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/cure-ms-3.jpg" alt="image" width="400">
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook">Autoimmune disorder patients in Brazil helped by vitamin D – video and Facebook – Nov 2012&lt;/a> MS CURED!&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Multiple Sclerosis and the Vitamin D Receptor – meta-analysis</title><link>/posts/multiple-sclerosis-and-the-vitamin-d-receptor-meta-analysis.html</link><pubDate>Sat, 12 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-the-vitamin-d-receptor-meta-analysis.html</guid><description/></item><item><title>Swallowing problems (dysphagia): in Multiple Sclerosis and Parkinson’s Disease (perhaps low vitamin D)</title><link>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</link><pubDate>Tue, 01 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</guid><description>&lt;ol>
&lt;li>July 2014: Noticed &lt;a href="http://www.slideshare.net/gavingiovannoni/dysphagia-survey-results?qid=fe376289-23e5-4072-a032-eb3680b23786&amp;amp;v=qf1&amp;amp;b=&amp;amp;from_search=4">survey on dysphagia and MS&lt;/a> by a researcher I am following concerning MS and Vitamin D&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>Posting is attached at bottom of this page&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Had to look up the definition of dysphagia&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=dysphagia+%22multiple+sclerosis%22">Searched PubMed for dysphagia &amp;ldquo;multiple sclerosis&amp;rdquo;&lt;/a> 101 items&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Dysphagia+%22Parkinson%27s+disease%22">Searched PubMed for Dysphagia &amp;ldquo;Parkinson&amp;rsquo;s disease&amp;rdquo;&lt;/a> 336 items as of July 2014&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Increasing report of dysphagia and MS (which might be indicative of decreasing levels of vitamin D)&lt;/p></description></item><item><title>Inflammatory diseases: review of vitamin D, with many tables</title><link>/posts/inflammatory-diseases-review-of-vitamin-d-with-many-tables.html</link><pubDate>Fri, 30 May 2014 00:00:00 +0000</pubDate><guid>/posts/inflammatory-diseases-review-of-vitamin-d-with-many-tables.html</guid><description>&lt;h3 id="introduction">Introduction&lt;/h3>
&lt;p>Vitamin D insufficiency or deficiency has increased in the general population and become an important public health issue.1 Vitamin D is mainly known for its favorable effects in calcium and bone metabolism. However, increasing numbers of studies have established that vitamin D insufficiency contributes to a number of diseases, suggesting a range of physiological functions of vitamin D.M Several clinical studies have confirmed that vitamin D plays a crucial role in modulating innate immune responses toward various pathogens.5 Moreover, recent studies indicate that vitamin D can regulate the adaptive immune response in various inflammatory and autoimmune diseases.6,7 These results suggest the beneficial effects of vitamin D supplementation in decreasing the risk and adverse outcomes of inflammatory diseases, although the precise effect remains to be elucidated in large clinical trials.&lt;/p></description></item><item><title>Epigenetics of Multiple Sclerosis</title><link>/posts/epigenetics-of-multiple-sclerosis.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/epigenetics-of-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/h4>
&lt;p>NeuroMolecular Medicine March 2014&lt;/p>
&lt;p>Cem İsmail Küçükali, Murat Kürtüncü, Arzu Çoban, Merve Çebi, Erdem Tüzün&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Neuroscience, Institute for Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>&lt;a href="mailto:drerdem@yahoo.com">drerdem@yahoo.com&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease characterized with autoimmune response against myelin proteins and progressive axonal loss. The heterogeneity of the clinical course and low concordance rates in monozygotic twins have indicated the involvement of complex heritable and environmental factors in MS pathogenesis. MS is more often transmitted to the next generation by mothers than fathers suggesting an epigenetic influence. One of the possible reasons of this parent-of-origin effect might be the human leukocyte antigen-DRB1*15 allele, which is the major risk factor for MS and regulated by epigenetic mechanisms such as DNA methylation and histone deacetylation. Moreover, major environmental risk factors for MS, vitamin D deficiency, smoking and Ebstein–Barr virus are all known to exert epigenetic changes.&lt;/p></description></item><item><title>Optic neuritis progession into Multiple Sclerosis reduced 68 percent by 50,000 IU of vitamin D weekly</title><link>/posts/optic-neuritis-progession-into-multiple-sclerosis-reduced-68-percent-by-50000-iu-of-vitamin-d-weekly.html</link><pubDate>Thu, 08 May 2014 00:00:00 +0000</pubDate><guid>/posts/optic-neuritis-progession-into-multiple-sclerosis-reduced-68-percent-by-50000-iu-of-vitamin-d-weekly.html</guid><description>&lt;p>&lt;strong>Update Oct 2017: &lt;a href="https://clinicaltrials.gov/ct2/show/NCT03302585?sfpd_d=14">Clinical trial &lt;/a> being started for Optic Neuritis and Vitamin D: 50,000 IU/d of oral vitamin D3 x 5 days followed by 10,000 IU/d of oral vitamin D3 x 85 days Results are due 2023&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#optic-neuritis-progession-into-multiple-sclerosis-reduced-68--by-50000-iu-of-vitamin-d-weekly--2013">Optic neuritis progession into Multiple Sclerosis reduced 68 % by 50,000 IU of vitamin D weekly- 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#all-optic-neuritis-subjects-had-low-vitamn-d-levels---oct-2022">All Optic Neuritis subjects had low vitamn D levels - Oct 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-prospective-cohort-study-of-vitamin-d-in-optic-neuritis-recovery---2017">A prospective cohort study of vitamin D in optic neuritis recovery - 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="optic-neuritis-progession-into-multiple-sclerosis-reduced-68--by-50000-iu-of-vitamin-d-weekly--2013">Optic neuritis progession into Multiple Sclerosis reduced 68 % by 50,000 IU of vitamin D weekly- 2013&lt;/h4>
&lt;p>&lt;strong>Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial&lt;/strong>&lt;/p></description></item><item><title>How UVB reduces autoimmune diseases such as Multiple Sclerosis</title><link>/posts/how-uvb-reduces-autoimmune-diseases-such-as-multiple-sclerosis.html</link><pubDate>Tue, 29 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/how-uvb-reduces-autoimmune-diseases-such-as-multiple-sclerosis.html</guid><description>&lt;h4 id="uvb-light-attenuates-the-systemic-immune-response-in-cns-autoimmunity">UVB light attenuates the systemic immune response in CNS autoimmunity&lt;/h4>
&lt;p>Johanna Breuer1,†, Nicholas Schwab PhD1,†, Tilman Schneider-Hohendorf PhD1, Martin Marziniak MD1,2, Hema Mohan PhD1, Urvashi Bhatia1, Catharina C. Groß PhD1, Björn E. Clausen PhD3, Carsten Weishaupt MD4, Thomas A. Luger MD4,5,6, Sven G. Meuth MD, PhD1,5,6, Karin Loser PhD4,5,6,* andHeinz Wiendl MD1,5,6,*&lt;/p>
&lt;p>Annals of Neurology, DOI: 10.1002/ana.24165&lt;/p>
&lt;p>Objective: Environmental conditions (e.g. latitude) play a critical role in the susceptibility and severity of many autoimmune disorders, including Multiple Sclerosis (MS). Here, we investigated the mechanisms underlying the beneficial effects of immune regulatory processes induced in the skin by moderate ultraviolet B (UVB) radiation on central nervous system (CNS) autoimmunity.&lt;/p></description></item><item><title>Multiple Sclerosis has strong associations with Vitamin D – London</title><link>/posts/multiple-sclerosis-has-strong-associations-with-vitamin-d-london.html</link><pubDate>Mon, 28 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-has-strong-associations-with-vitamin-d-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#span-stylecolorf00the-study-using-40000-iu-showed-a-huge-decrease-in-msspan">&lt;span style="color:#F00;">The study using 40,000 IU showed a huge decrease in MS&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00reduced-fracture-riskspan">&lt;span style="color:#F00;">Reduced fracture risk&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00fewer-ms-relapses-with-higher-vitamin-dspan">&lt;span style="color:#F00;">Fewer MS relapses with higher vitamin D&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00ms-vitamin-d-and-genes-25xspan">&lt;span style="color:#F00;">MS, Vitamin D, and Genes 2.5X&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00military-found-that-those-with--40ng-of-vitamin-d-were-half-as-likely-to-get-msspan">&lt;span style="color:#F00;">Military found that those with &amp;gt; 40ng of vitamin D were half as likely to get MS&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00less-occurance-of-ms-for-those-who-actually-supplemented-with-vitamin-dspan">&lt;span style="color:#F00;">Less occurance of MS for those who actually supplemented with Vitamin D&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00less-ms-if-migrate-to-a-sunner-climatespan">&lt;span style="color:#F00;">Less MS if migrate to a sunner climate&lt;/span>&lt;/a>&lt;/li>
 &lt;/ul>

 &lt;ul>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h1 id="vitamin-d-and-human-healthhttpmultiple-sclerosis-researchblogspotcom201404vitamin-d-and-human-healthhtml">&lt;a href="http://multiple-sclerosis-research.blogspot.com/2014/04/vitamin-d-and-human-health.html">Vitamin D and human health&lt;/a>&lt;/h1>
&lt;p>Posted by Gavin Giovannoni &lt;a href="mailto:giovannoni.pa@gmail.com">giovannoni.pa@gmail.com&lt;/a> April 28, 2014&lt;/p></description></item><item><title>Video by Dr. Coimbra – 95 percent of auto-immune cured with vitamin D in high doses</title><link>/posts/video-by-dr-coimbra-95-percent-of-auto-immune-cured-with-vitamin-d-in-high-doses.html</link><pubDate>Sat, 19 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/video-by-dr-coimbra-95-percent-of-auto-immune-cured-with-vitamin-d-in-high-doses.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#transcript-in-english-follows">Transcript in English follows&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;p>&lt;strong>Transcript, in original Italian, is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;h4 id="transcript-in-english-follows">Transcript in English follows&lt;/h4>
&lt;p>&lt;strong>auto-translated so there are various errors&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Text bolded by VitaminDWiki&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>0:12 The protocol was created by the following question:&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:16 at a given moment of my professional life,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:20 I felt very strongly the need to try to help change this idea&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:29 that neurology is a medical specialty made from brilliant diagnostic&lt;/p></description></item><item><title>Multiple Sclerosis patients who increased their vitamin D levels by 20 ng had better outcomes</title><link>/posts/multiple-sclerosis-patients-who-increased-their-vitamin-d-levels-by-20-ng-had-better-outcomes.html</link><pubDate>Sun, 16 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-who-increased-their-vitamin-d-levels-by-20-ng-had-better-outcomes.html</guid><description>&lt;h2 id="vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/h2>
&lt;p>JAMA Neurol. 2014;71(3):306-314. doi:10.1001/jamaneurol.2013.5993. Text Alberto Ascherio, MD, DrPH1; Kassandra L. Munger, ScD1; Rick White, MSc2; Karl Köchert, PhD3; Kelly Claire Simon, ScD1; Chris H. Polman, MD4; Mark S. Freedman, MD5; Hans-Peter Hartung, MD6; David H. Miller, MD7; Xavier Montalbán, MD8; Gilles Edan, MD9; Frederik Barkhof, MD4; Dirk Pleimes, MD10; Ernst-Wilhelm Radü, MD11; Rupert Sandbrink, MD3,6; Ludwig Kappos, MD11; Christoph Pohl, MD3,12&lt;/p></description></item><item><title>MS and vitamin D consensus from Brazil - 40-100 ng, not monotherapy</title><link>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</link><pubDate>Wed, 12 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#supplementation-and-therapeutic-use-of-vitamin-d-in-patients-with-multiple-sclerosis">Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-ms-and-eae">VITAMIN D, MS, AND EAE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#randomized-and-controlled-clinical-trials-with-vitamin-d-in-the-treatment-of-ms">RANDOMIZED AND CONTROLLED CLINICAL TRIALS WITH VITAMIN D IN THE TREATMENT OF MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-other-issues">VITAMIN D AND OTHER ISSUES&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#safety-profile">SAFETY PROFILE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d--side-effects">VITAMIN D – SIDE EFFECTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#final-considerations">FINAL CONSIDERATIONS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#acknowledgements">ACKNOWLEDGEMENTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/h3>
&lt;p>&lt;strong>Suspect it is because Dr. Coimbra:&lt;/strong>&lt;/p></description></item><item><title>Central Nervous System helped by Vitamin D – Review – 2013</title><link>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</guid><description>&lt;h2 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h2>
&lt;p>Pharmacological Reports 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw,&lt;/p>
&lt;p>Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis progressed more slowly if have 20 ng more vitamin D</title><link>/posts/multiple-sclerosis-progressed-more-slowly-if-have-20-ng-more-vitamin-d.html</link><pubDate>Wed, 22 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-progressed-more-slowly-if-have-20-ng-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comments-by-doctors-on-this-study">Comments by Doctors on this study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/h3>
&lt;p>JAMA Neurol. 2014 Jan 20. &lt;a href="https://doi.org/10.1001/jamaneurol.2013.5993.">doi: 10.1001/jamaneurol.2013.5993.&lt;/a>&lt;/p>
&lt;p>Ascherio A1, Munger KL1, White R2, Köchert K3, Simon KC1, Polman CH4, Freedman MS5, Hartung HP6, Miller DH7, Montalbán X8, Edan G9, Barkhof F4, Pleimes D10, Radü EW11, Sandbrink R12, Kappos L11, Pohl C13.&lt;/p></description></item><item><title>Fewer white spots in MRI brain scans if had more vitamin D</title><link>/posts/fewer-white-spots-in-mri-brain-scans-if-had-more-vitamin-d.html</link><pubDate>Fri, 17 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/fewer-white-spots-in-mri-brain-scans-if-had-more-vitamin-d.html</guid><description>&lt;h4 id="association-of-white-matter-hyperintensities-with-low-serum-25-hydroxyvitamin-d-levels">Association of White Matter Hyperintensities with Low Serum 25-Hydroxyvitamin D Levels&lt;/h4>
&lt;p>American Journal of Neuroradiology&lt;/p>
&lt;p>J.M. Prager, &lt;a href="mailto:jprager@northshore.org">jprager@northshore.org&lt;/a>, C. Thomas, W.J. Ankenbrandt, J.R. Meyer, Y. Gao, A. Ragin, S. Sidharthan, R. Hutten and Y.G. Wu&lt;/p>
&lt;p>From the Department of Radiology (J.M.P., W.J.A., J.R.M., R.H., Y.G.W.), NorthShore University Health System, Evanston, Illinois; Department of Endocrinology (C.T.), University of Chicago, Chicago, Illinois; Departments of Statistics (Y.G.) and Radiology (A.R.), Northwestern University, Evanston, Illinois; and Department of Radiology (S.S.), Monmouth Medical Center, Long Branch, New Jersey.&lt;/p></description></item><item><title>Hypothesis- birth rate variation with season may trump MS variation with vitamin D</title><link>/posts/hypothesis-birth-rate-variation-with-season-may-trump-ms-variation-with-vitamin-d.html</link><pubDate>Wed, 15 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-birth-rate-variation-with-season-may-trump-ms-variation-with-vitamin-d.html</guid><description>&lt;h3 id="confounding-in-association-studies-month-of-birth-and-multiple-sclerosis">Confounding in association studies: month of birth and multiple sclerosis&lt;/h3>
&lt;p>J Neurol, DOI 10.1007/s00415-014-7241-y&lt;/p>
&lt;p>Barnaby Fiddes, • James Wason, • Stephen Sawcer&lt;/p>
&lt;p>Received: 11 December 2013/Accepted: 2 January 2014&lt;/p>
&lt;p>Association studies form the backbone of biomedical research, with almost every effort in the field ultimately boiling down to a comparison between groups, coupled with some form of statistical test intended to determine whether or not any observed difference is more or less than would be expected by chance. Unfortunately, although the paradigm is powerful and frequently effective, it is often forgotten that false positive association can easily arise if there is any bias or systematic difference in the way in which study subjects are selected into the considered groups. To protect against such confounding, researchers generally try to match cases and controls for extraneous variables thought to correlate with the exposures of interest. However, if seemingly homogenously distributed exposures are actually more heterogeneous than appreciated, then matching may be inadequate and false positive results can still arise. In this review, we will illustrate these fundamental issues by considering the previously proposed relationship between month of birth and multiple sclerosis. This much discussed but false positive association serves as a reminder of just how heterogeneous even easily measured environmental risk factors can be, and how easily case&lt;/p></description></item><item><title>Vitamin D at CureTogether: Fibromyalgia, MS, Psoriasis, etc</title><link>/posts/vitamin-d-at-curetogether-fibromyalgia-ms-psoriasis-etc.html</link><pubDate>Wed, 25 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-at-curetogether-fibromyalgia-ms-psoriasis-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#curetogetherhttpcuretogethercomconditions-crowd-sources-information-on-a-wide-variety-of-health-concerns">&lt;a href="http://curetogether.com/conditions">CureTogether&lt;/a> crowd-sources information on a wide variety of health concerns&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#all-fibromyalgia-cures">All Fibromyalgia Cures&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia---just-vitamin-d-is-labledhttpcuretogethercomfibromyalgiaigtreatment-effectiveness-vs-popularity">&lt;a href="http://curetogether.com/fibromyalgia/ig/treatment-effectiveness-vs-popularity">Fibromyalgia - just vitamin D is labled&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#psoriasishttpcuretogethercompsoriasisigtreatment-effectiveness-vs-popularity-and-sunlight">&lt;a href="http://curetogether.com/psoriasis/ig/treatment-effectiveness-vs-popularity">Psoriasis&lt;/a> and sunlight&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosishttpcuretogethercommultiple-sclerosisigtreatment-effectiveness-vs-popularity">&lt;a href="http://curetogether.com/multiple-sclerosis/ig/treatment-effectiveness-vs-popularity">Multiple Sclerosis&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#crohns-disease">Crohn&amp;rsquo;s Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#opinions-of-vitamin-d-deficiency-treatmentshttpcuretogethercomvitamin-d-deficiencytreatments">&lt;a href="http://curetogether.com/vitamin-d-deficiency/treatments/">Opinions of Vitamin D deficiency treatments&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#symptoms-of-vitamin-d-deficiencyhttpcuretogethercomvitamin-d-deficiencysymptoms-sorted-by-popularity">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">Symptoms of Vitamin D Deficiency&lt;/a> Sorted by popularity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#symptom-severityhttpcuretogethercomvitamin-d-deficiencysymptoms">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">Symptom Severity&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#curetogether-categories-as-of-dec-2013">CureTogether categories as of Dec 2013&lt;/a>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#musculoskeletal">Musculoskeletal&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#digestive-system">Digestive System&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#skin-and-hair">Skin and Hair&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cardiovascular-and-blood">Cardiovascular and Blood&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#womens-health">Women&amp;rsquo;s Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#respiratory">Respiratory&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#infectious">Infectious&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#injuries">Injuries&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetic-disorders">Genetic Disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mental-health">Mental Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#neurological">Neurological&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#eyes-and-ears">Eyes and Ears&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#endocrine-and-metabolic">Endocrine and Metabolic&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mens-health">Men&amp;rsquo;s Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#urological">Urological&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sexual">Sexual&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#patientslikeme-is-somewhat-similarhttpswwwpatientslikemecomtreatmentsshow322-vitamin-d-side-effects-and-efficacybrandfoverview">&lt;a href="https://www.patientslikeme.com/treatments/show/322-vitamin-d-side-effects-and-efficacy?brand=f#overview">PatientsLikeMe is somewhat similar&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="curetogetherhttpcuretogethercomconditions-crowd-sources-information-on-a-wide-variety-of-health-concerns">&lt;a href="http://curetogether.com/conditions">CureTogether&lt;/a> crowd-sources information on a wide variety of health concerns&lt;/h2>
&lt;p>&lt;strong>Has been a part of 23andMe since July 2012&lt;/strong> (DNA prediction of health problems for $99 as of Dce 2013)&lt;/p></description></item><item><title>Review of clinical trials for Multiple Sclerosis with Vitamin D intervention – 2013</title><link>/posts/review-of-clinical-trials-for-multiple-sclerosis-with-vitamin-d-intervention-2013.html</link><pubDate>Thu, 28 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-clinical-trials-for-multiple-sclerosis-with-vitamin-d-intervention-2013.html</guid><description>&lt;h3 id="can-we-prevent-or-treat-multiple-sclerosis-by-individualised-vitamin-d-supply">Can we prevent or treat multiple sclerosis by individualised vitamin D supply?&lt;/h3>
&lt;p>EPMA Journal 2013, 4:4 doi:10.1186/1878-5085-4-4&lt;/p>
&lt;p>Jan Dörr 12 &lt;a href="mailto:jan-markus.doerr@charite.de">jan-markus.doerr@charite.de&lt;/a>, Andrea Döring 123 and Friedemann Paul 12&lt;/p>
&lt;p>1 NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany&lt;/p>
&lt;p>2 Clinical and Experimental Research Center for Multiple Sclerosis, Charité - Universitätsmedizin Berlin, Berlin, Germany&lt;/p>
&lt;p>3 Current address: Department of Neurology, DIAKO, Flensburg, Germany&lt;/p>
&lt;p>Apart from its principal role in bone metabolism and calcium homeostasis, vitamin D has been attributed additional effects including an immunomodulatory, anti-inflammatory, and possibly even neuroprotective capacity which implicates a possible role of vitamin D in autoimmune diseases like multiple sclerosis (MS). Indeed, several lines of evidence including epidemiologic, preclinical, and clinical data suggest that reduced vitamin D levels and/or dysregulation of vitamin D homeostasis is a risk factor for the development of multiple sclerosis on the one hand, and that vitamin D serum levels are inversely associated with disease activity and progression on the other hand. However, these data are not undisputable, and many questions regarding the preventive and therapeutic capacity of vitamin D in multiple sclerosis remain to be answered. In particular, available clinical data derived from interventional trials using vitamin D supplementation as a therapeutic approach in MS are inconclusive and partly contradictory. In this review, we summarise and critically evaluate the existing data on the possible link between vitamin D and multiple sclerosis in light of the crucial question whether optimization of vitamin D status may impact the risk and/or the course of multiple sclerosis.&lt;/p></description></item><item><title>Iran Multiple Sclerosis review finds huge increase in women (no mention of clothing)</title><link>/posts/iran-multiple-sclerosis-review-finds-huge-increase-in-women-no-mention-of-clothing.html</link><pubDate>Fri, 08 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/iran-multiple-sclerosis-review-finds-huge-increase-in-women-no-mention-of-clothing.html</guid><description>&lt;h3 id="epidemiology-of-multiple-sclerosis-in-iran-a-systematic-review">Epidemiology of Multiple Sclerosis in Iran: A Systematic Review&lt;/h3>
&lt;p>Etemadifar M.a, b · Sajjadi S.b, c · Nasr Z.b, c · Firoozeei T.S.b · Abtahi S.-H.b, c · Akbari M.d · Fereidan-Esfahani M.b,c,e&lt;/p>
&lt;p>A Department of Neurology, Medical School, b Isfahan Research Committee of Multiple Sclerosis (IRCOMS), c Medical Students&amp;rsquo; Research Committee, d Department of Epidemiology and Statistics, Isfahan University of Medical Science, and e Persia Research Center, Sady Hospital, Isfahan, Iran&lt;/p></description></item><item><title>Incidence of Multiple Sclerosis in Bulgaria increased 2X in 17 years, thinking about vitamin D</title><link>/posts/incidence-of-multiple-sclerosis-in-bulgaria-increased-2x-in-17-years-thinking-about-vitamin-d.html</link><pubDate>Thu, 07 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/incidence-of-multiple-sclerosis-in-bulgaria-increased-2x-in-17-years-thinking-about-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-immunomodulatory-potential-in-multiple-sclerosis">Vitamin D immunomodulatory potential in multiple sclerosis.&lt;/h2>
&lt;p>Folia Med (Plovdiv). 2013 Apr-Jun;55(2):5-9.&lt;/p>
&lt;p>Slavov GS, Trenova AG, Manova MG, Kostadinova II, Vasileva TV, Zahariev ZI.&lt;/p>
&lt;p>Department of Neurology, Medical University, Plovdiv, Bulgaria. &lt;a href="mailto:eorgi.slavov.15130@gmail.com">eorgi.slavov.15130@gmail.com&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is an autoimmune disease of unknown etiology whose treatment is of limited efficiency and therefore has a high social burden. As it has been suggested that myelin destruction model, the clinical manifestation and the potential of therapeutic response in MS are correlated, it is quite justifiable that we study various factors (genetic, hormonal, environmental) that take part in the autoimmune process in order to improve the control over the disrupted immune regulation. Results from epidemiological and clinical studies clearly suggest that changes in vitamin D serum concentrations are correlated with the magnitude of the risk of developing MS, the phases of relapse and remittance and with gender differences in vitamin D metabolism. Experimental and clinical studies also have established that 25-hydroxy vitamin D (25(OH)D) and 1,25-dihydroxy vitamin D (1,25(OH)2D) exert an immunomodulatory effect in the central nervous system and peripheral organs of the immune system. The standard reference range of vitamin D concentration in serum is 50-80 nmol/l- -it provides normal calcium metabolism. Issues that are discussed include the vitamin D serum concentration needed to suppress the aberrant immune response in MS patients; a subgroup of MS patients suitable for vitamin D treatment, the vitamin D being applied in optimally effective and safe dosage.&lt;/p></description></item><item><title>Multiple Sclerosis increased 10 percent in 5 years</title><link>/posts/multiple-sclerosis-increased-10-percent-in-5-years.html</link><pubDate>Mon, 28 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-increased-10-percent-in-5-years.html</guid><description/></item><item><title>Acute Multiple Sclerosis relapse associated with low bone mineral density (low vitamin D)</title><link>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</link><pubDate>Sat, 12 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</guid><description>&lt;h3 id="patients-with-an-acute-multiple-sclerosis-relapse-a-high-risk-group-for-osteopenia-and-osteoporosis">PATIENTS WITH AN ACUTE MULTIPLE SCLEROSIS RELAPSE: A HIGH RISK GROUP FOR OSTEOPENIA AND OSTEOPOROSIS&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.194&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Olwen Murphy⇓, Michael S Zandi, Nitzan Lindenberg, Elaine Murphy, Jeremy Chataway&lt;/p>
&lt;p>National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London.&lt;/p>
&lt;p>Objective To evaluate the bone health of a cohort of patients with an acute Multiple Sclerosis (MS) relapse and to develop an algorithm for the management of bone health in this patient group.&lt;/p></description></item><item><title>Update on Treating Multiple Sclerosis with high dose vitamin D</title><link>/posts/update-on-treating-multiple-sclerosis-with-high-dose-vitamin-d.html</link><pubDate>Sun, 29 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/update-on-treating-multiple-sclerosis-with-high-dose-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis prevention by Vitamin D: 10 year, 30 million dollar trial</title><link>/posts/multiple-sclerosis-prevention-by-vitamin-d-10-year-30-million-dollar-trial.html</link><pubDate>Sun, 22 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-prevention-by-vitamin-d-10-year-30-million-dollar-trial.html</guid><description>&lt;p>MS Research Australia&lt;/p>
&lt;p>The trial will be for MS prevention, not treatment - which looks very possible&lt;/p>
&lt;p>1000, 5000 &amp;amp; 10,000 IU of Vitamin D, + placebo&lt;/p>
&lt;p>&lt;a href="http://www.afr.com/p/australia2-0/major_ms_trial_to_throw_light_on_N4dXK1stpqkTETWNqo3JPP">CLICK HERE&lt;/a> for the story of the CEO who got MS, and then added funding to the study&lt;/p></description></item><item><title>Vitamin D may not be the only cause of Multiple Sclerosis in Scotland</title><link>/posts/vitamin-d-may-not-be-the-only-cause-of-multiple-sclerosis-in-scotland.html</link><pubDate>Sun, 18 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-may-not-be-the-only-cause-of-multiple-sclerosis-in-scotland.html</guid><description>&lt;h2 id="vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientisthttpwwwshetlandtimescouk20130818vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientist">&lt;a href="http://www.shetlandtimes.co.uk/2013/08/18/vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientist">Vitamin D not the sole cause of high MS rates in northern isles, says scientist&lt;/a>&lt;/h2>
&lt;p>August 18th, 2013 by Malachy Tallack&lt;/p>
&lt;p>Vitamin D deficiency is unlikely to be “the single explanatory factor” for the very high rates of multiple sclerosis (MS) in Orkney and Shetland, according to the scientist who has led research into the subject.&lt;/p>
&lt;p>Dr Jim Wilson was in Lerwick this week to discuss the initial results of the Northern Isles Vitamin D Study, which tested blood samples from 2,300 people in the islands.&lt;/p></description></item><item><title>Multiple Sclerosis: number needed to treat with vitamin D may be as low as 1.3 – Meta-analysis</title><link>/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis.html</link><pubDate>Wed, 24 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis.html</guid><description>&lt;h4 id="the-case-for-vitamin-d-supplementation-in-multiple-sclerosis">The case for vitamin D supplementation in multiple sclerosis&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders, Volume 2, Issue 4, October 2013, Pages 281–306 &lt;a href="https://doi.org/10.1016/j.msard.2012.12.008">https://doi.org/10.1016/j.msard.2012.12.008&lt;/a>&lt;/p>
&lt;p>Aravind Ganesh a, &lt;a href="mailto:aravindganeshy@yahoo.ca">aravindganeshy@yahoo.ca&lt;/a>; Sabrina Apel b, Luanne Metz c, Scott Patten d,&lt;/p>
&lt;ul>
&lt;li>
&lt;p>a Resident, Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9&lt;/p>
&lt;/li>
&lt;li>
&lt;p>b Undergraduate Medical Education, University of Calgary, 33 Discovery Rise SW Calgary, Alberta, Canada T3H 4N6&lt;/p>
&lt;/li>
&lt;li>
&lt;p>c Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9&lt;/p></description></item><item><title>Melatonin interacts with Vitamin D in Multiple Sclerosis patients</title><link>/posts/melatonin-interacts-with-vitamin-d-in-multiple-sclerosis-patients.html</link><pubDate>Sun, 21 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/melatonin-interacts-with-vitamin-d-in-multiple-sclerosis-patients.html</guid><description>&lt;h4 id="latitude-vitamin-d-melatonin-and-gut-microbiota-act-in-concert-to-initiate-multiple-sclerosis">Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis:&lt;/h4>
&lt;p>A New Mechanistic Pathway - 2018&lt;/p>
&lt;p>&lt;strong>See &lt;a href="/posts/a-multiple-sclerosis-hypothesis-supported-by-eae-data">A Multiple Sclerosis hypothesis supported by EAE data – Oct 2018&lt;/a>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="disruption-of-melatonin-circadian-rhythm-production-is-related-to-multiple-sclerosis-severity-a-preliminary-study---2015">Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study - 2015&lt;/h4>
&lt;p>&lt;strong>&amp;ldquo;In conclusion, disruption of melatonin circadian rhythm production is frequent among RRMS patients and seemingly related to higher disability and fatigue scores&amp;rdquo;     &lt;a href="https://doi.org/10.1016/j.jns.2015.03.040">doi: 10.1016/j.jns.2015.03.040&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Vitamin D and MS, ALS, Autism, Alzheimer’s and other nervous system diseases – review</title><link>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</link><pubDate>Sat, 13 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</guid><description>&lt;h2 id="review-the-role-of-vitamin-d-in-nervous-system-health-and-disease">Review: The role of vitamin D in nervous system health and disease&lt;/h2>
&lt;p>Neuropathology and Applied Neurobiology. Volume 39, Issue 5, pages 458–484, August 2013&lt;/p>
&lt;p>G. C. DeLuca 1,gabriele.deluca@ndcn.ox.ac.uk&lt;/p>
&lt;p>S. M. Kimball 3,&lt;/p>
&lt;p>J. Kolasinski 1,&lt;/p>
&lt;p>S. V. Ramagopalan 2,&lt;/p>
&lt;p>G. C. Ebers 1&lt;/p>
&lt;p>1 Nuffield Department of Clinical Neurosciences (Clinical Neurology), University of Oxford, Oxford&lt;/p>
&lt;p>2 Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK&lt;/p></description></item><item><title>Full-on Multiple Sclerosis was 3.3X more likely in patients with the lowest vitamin D levels</title><link>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</link><pubDate>Wed, 10 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</guid><description>&lt;h3 id="vitamin-d-levels-and-risk-of-multiple-sclerosis-in-patients-with-clinically-isolated-syndromes">Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.&lt;/h3>
&lt;p>Mult Scler. 2013 Jul 8.&lt;/p>
&lt;p>Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.&lt;/p>
&lt;p>Department of Neurology, San Raffaele Hospital, Milan, Italy.&lt;/p>
&lt;p>BACKGROUND: Growing evidence suggests that vitamin D deficiency may be one of the most important environmental factors for the development of multiple sclerosis (MS).&lt;/p>
&lt;p>OBJECTIVES: The objectives of this paper are to evaluate serum 25-hydroxyvitamin D (25(OH)D) levels in patients with clinically isolated syndromes (CIS) and to examine whether they are related to MS risk.&lt;/p></description></item><item><title>UV decreases Multiple Sclerosis via cis-urocanic acid (and via vitamin D)</title><link>/posts/uv-decreases-multiple-sclerosis-via-cis-urocanic-acid-and-via-vitamin-d.html</link><pubDate>Thu, 27 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/uv-decreases-multiple-sclerosis-via-cis-urocanic-acid-and-via-vitamin-d.html</guid><description>&lt;h2 id="modulation-of-multiple-sclerosis-by-sunlight-exposure-role-of-cis-urocanic-acid">Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid&lt;/h2>
&lt;p>Jorge Correale &lt;a href="mailto:jcorreale@fleni.org.ar">jcorreale@fleni.org.ar&lt;/a> , Mauricio F. Farez&lt;/p>
&lt;p>Received 16 March 2013; published online 24 June 2013.&lt;/p>
&lt;p>The role of cis-urocanic acid (UCA) as a UV-mediated immunomodulator in MS patients was investigated. Plasma levels of cis-UCA were significantly lower in MS patients compared to controls. Stimulation of MBP- and MOG-specific T cells in the presence of cis-UCA, significantly increased IL-10, and inhibited IFN-γ production. PBMCs cultured in the presence of cis-UCA increased CD4+CD25+FoxP3+ regulatory T cell percentages. Dendritic cells cultured in the presence of cis-UCA significantly reduced Ag presentation capacity. Finally, cis-UCA activated the 5-HT2A receptor, inducing the increase in phosphorylated forms of ERK 1/2 and JNK2. Thus, in addition to vitamin D, cis-UCA also appears to be an additional UV-mediated immunomodulator.&lt;/p></description></item><item><title>Increased risk of multiple sclerosis risk in African Americans due to genes</title><link>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</link><pubDate>Thu, 20 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</guid><description>&lt;h3 id="genetic-risk-variants-in-african-americans-with-multiple-sclerosis">Genetic risk variants in African Americans with multiple sclerosis&lt;/h3>
&lt;p>Neurology 10.1212/WNL.0b013e31829bfe2f&lt;/p>
&lt;p>Noriko Isobe, MD, PhD,&lt;/p>
&lt;p>Pierre-Antoine Gourraud, PhD, MPH,&lt;/p>
&lt;p>Hanne F. Harbo, MD, PhD,&lt;/p>
&lt;p>Stacy J. Caillier, BS,&lt;/p>
&lt;p>Adam Santaniello, BS,&lt;/p>
&lt;p>Pouya Khankhanian, BA,&lt;/p>
&lt;p>Martin Maiers, MS,&lt;/p>
&lt;p>Stephen Spellman, MBS,&lt;/p>
&lt;p>Nezih Cereb, MD,&lt;/p>
&lt;p>SooYoung Yang, PhD,&lt;/p>
&lt;p>Marcelo J. Pando, PhD,&lt;/p>
&lt;p>Laura Piccio, MD, PhD,&lt;/p>
&lt;p>Anne H. Cross, MD,&lt;/p>
&lt;p>Philip L. De Jager, MD, PhD,&lt;/p>
&lt;p>Bruce A.C. Cree, MD, PhD, MCR,&lt;/p></description></item><item><title>MS flu-like symptoms resulting from interferon-beta were reduced with vitamin D</title><link>/posts/ms-flu-like-symptoms-resulting-from-interferon-beta-were-reduced-with-vitamin-d.html</link><pubDate>Sat, 15 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/ms-flu-like-symptoms-resulting-from-interferon-beta-were-reduced-with-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-supplementation-for-patients-with-multiple-sclerosis-treated-with-interferon-beta">Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta:&lt;/h4>
&lt;p>a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties&lt;/p>
&lt;p>BMC Neurology 2013, 13:60 doi:10.1186/1471-2377-13-60; Published: 14 June 2013&lt;/p>
&lt;p>Daniel Golan, Basheer Halhal, Lea Glass-Marmor, Elsebeth Staun-Ram, Orit Rozenberg, Idit Lavi, Sara Dishon, Mira Barak, Sophia Ish-Shalom and Ariel Miller&lt;/p>
&lt;p>Background: Flu-like symptoms (FLS) are common side effects of interferon beta (IFN-beta) treatment in patients with Multiple Sclerosis (PwMS) and are associated with post-injection cytokine surge.&lt;/p></description></item><item><title>98 pcnt of genes that Vitamin D activates to reduce MS are also activated by Interferon</title><link>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</guid><description>&lt;h4 id="25-hydroxyvitamin-d-and-ms-activity-during-therapy-with-interferon-beta-1b">25-Hydroxyvitamin D and MS Activity During Therapy with Interferon Beta-1b&lt;/h4>
&lt;p>&lt;a href="https://cmscactrims.confex.com/cmscactrims/2013/webprogram/Paper1448.html%20">CMSC Conference, May 30, 2013 &lt;/a> Florida&lt;/p>
&lt;p>Alberto Ascherio, MD , Harvard University, Boston, MA&lt;/p>
&lt;p>Kassandra Munger, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Claire Simon, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Ludwig Kappos, MD , University Hospital, Basel Neurology, Basel, Switzerland, Basel, Switzerland&lt;/p>
&lt;p>Chris H Polman, MD , VU Medical Center, Amsterdam, Netherlands&lt;/p>
&lt;p>Mark Freedman, MD , University of Ottawa, Ottawa, ON, Canada&lt;/p></description></item><item><title>Vitamin D is important for the central nervous system and cognition</title><link>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</guid><description>&lt;h3 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h3>
&lt;p>Pharmacological Reports, 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw, Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>No association between Multiple Sclerosis relapses and being treated with vitamin D–meta-analysis</title><link>/posts/no-association-between-multiple-sclerosis-relapses-and-being-treated-with-vitamin-dmeta-analysis.html</link><pubDate>Thu, 23 May 2013 00:00:00 +0000</pubDate><guid>/posts/no-association-between-multiple-sclerosis-relapses-and-being-treated-with-vitamin-dmeta-analysis.html</guid><description>&lt;p>&lt;strong>This is most likely similar to many other meta-analysis which find no association when averaging the response by people getting no benefit from as little as 400 IU with those getting a lot of benefit from 10,000 IU&lt;/strong>&lt;/p>
&lt;h2 id="the-effect-of-vitamin-d-related-interventions-on-multiple-sclerosis-relapses-a-meta-analysis">The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis&lt;/h2>
&lt;p>Mult Scler May 22, 2013 1352458513489756&lt;/p>
&lt;p>Eleanor James, Ruth Dobson, Jens Kuhle, David Baker, Gavin Giovannoni, Sreeram V Ramagopalan&lt;/p>
&lt;p>Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK&lt;/p></description></item><item><title>Season of birth associated with Pneumonia (10 %) and Multiple Sclerosis (30 %)</title><link>/posts/season-of-birth-associated-with-pneumonia-10-percent-and-multiple-sclerosis-30-percent.html</link><pubDate>Fri, 17 May 2013 00:00:00 +0000</pubDate><guid>/posts/season-of-birth-associated-with-pneumonia-10-percent-and-multiple-sclerosis-30-percent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#no-effect-of-season-of-birth-on-risk-of-type-1-diabetes-cancer-schizophrenia-and-ischemic-heart-disease-while-some-variations-may-be-seen-for-pneumonia-and-multiple-sclerosis">No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="no-effect-of-season-of-birth-on-risk-of-type-1-diabetes-cancer-schizophrenia-and-ischemic-heart-disease-while-some-variations-may-be-seen-for-pneumonia-and-multiple-sclerosis">No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis&lt;/h4>
&lt;p>Dermato Endocrinology: Volume 5, Issue 2 April/May/June 2013&lt;/p>
&lt;p>Susanna við Streym, Lars Rejnmark, Leif Mosekilde and Peter Vestergaard&lt;/p></description></item><item><title>More hijab clothing may have resulted in 6X increase in Multiple Sclerosis in Tehran</title><link>/posts/more-hijab-clothing-may-have-resulted-in-6x-increase-in-multiple-sclerosis-in-tehran.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/more-hijab-clothing-may-have-resulted-in-6x-increase-in-multiple-sclerosis-in-tehran.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#what-is-causing-irans-spike-in-ms-cases">What is Causing Iran’s Spike in MS Cases?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="what-is-causing-irans-spike-in-ms-cases">What is Causing Iran’s Spike in MS Cases?&lt;/h4>
&lt;p>Vitamin D deficiency from lack of sunlight could be an unexpected long-term consequence of the Iranian revolution &lt;/p>
&lt;p>By Libby Copeland, Smithsonian magazine, May 2013&lt;/p>
&lt;p>Scientists have long recognized a link between lack of sunlight and multiple sclerosis.&lt;/p>
&lt;p>Multiple sclerosis has skyrocketed in Tehran, increasing almost sevenfold between 1989 and 2005. In Iran’s central province of Isfahan, the incidence nearly tripled from 2005 to 2009. Now Oxford University researchers suggest, for the first time, that the 1979 Iranian Revolution may deserve some of the blame for the extraordinary jump. They say the revolutionary mandate for modest dress and head coverings for women may have inadvertently fueled the increase by limiting their exposure to sunlight.&lt;/p></description></item><item><title>Multiple Sclerosis: high incidence in black women than whites (perhaps vitamin D)</title><link>/posts/multiple-sclerosis-high-incidence-in-black-women-than-whites-perhaps-vitamin-d.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-high-incidence-in-black-women-than-whites-perhaps-vitamin-d.html</guid><description>&lt;h2 id="incidence-of-multiple-sclerosis-in-multiple-racial-and-ethnic-groups">Incidence of multiple sclerosis in multiple racial and ethnic groups.&lt;/h2>
&lt;p>Neurology. 2013 May 7;80(19):1734-9. &lt;a href="https://doi.org/10.1212/WNL.0b013e3182918cc2.">doi: 10.1212/WNL.0b013e3182918cc2.&lt;/a>&lt;/p>
&lt;p>Langer-Gould A, Brara SM, Beaber BE, Zhang JL.&lt;/p>
&lt;p>From the Department of Research and Evaluation (A.L.-G., J.L.Z.), Kaiser Permanente, Southern California, Pasadena; and Neurology Department (A.L.-G., S.M.B., B.E.B.), Kaiser Permanente, Southern California Los Angeles Medical Center, CA.&lt;/p>
&lt;p>OBJECTIVE: To determine whether the incidence of multiple sclerosis (MS) varies by race/ethnicity in a multiethnic, population-based cohort.&lt;/p></description></item><item><title>Vitamin D and multiple sclerosis (technical, outline only)</title><link>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</link><pubDate>Thu, 25 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</guid><description>&lt;p>Journal of Clinical Neuroscience; Available online 26 March 2013&lt;/p>
&lt;p>Sarah Hewer a,&lt;/p>
&lt;p>Robyn Lucas b,&lt;/p>
&lt;p>Ingrid van der Mei c,&lt;/p>
&lt;p>Bruce V. Taylor c, &lt;a href="mailto:bruce.taylor@utas.edu.au">bruce.taylor@utas.edu.au&lt;/a>&lt;/p>
&lt;p>a Royal Hobart Hospital, Department of Neurology, Hobart, Tasmania, Australia&lt;/p>
&lt;p>b National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia&lt;/p>
&lt;p>c Menzies Research Institute Tasmania, University of Tasmania, Locked Bag 23, Hobart, Tasmania 7000, Australia&lt;/p>
&lt;p>The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area of significant research interest. We detail the current status of the ongoing research in this field, and note the lack of class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies of vitamin D supplementation in the prevention and/or treatment of MS. We have been able to &lt;strong>provide some guidelines for practitioners&lt;/strong> based on the substantial burden of supportive evidence for the use of vitamin D in MS as summarised here. These guidelines may provide some support to those clinicians who treat people with MS and their families.&lt;/p></description></item><item><title>Appears that Vitamin D can induce remission in recent Multiple Sclerosis</title><link>/posts/appears-that-vitamin-d-can-induce-remission-in-recent-multiple-sclerosis.html</link><pubDate>Fri, 19 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/appears-that-vitamin-d-can-induce-remission-in-recent-multiple-sclerosis.html</guid><description>&lt;h3 id="a-hrefpostsdr-coimbra-in-brazil-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-3857dr-coimbra-in-brazila">&lt;a href="/posts/dr-coimbra-in-brazil" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 3857">Dr. Coimbra, in Brazil&lt;/a>,&lt;/h3>
&lt;p>&lt;strong>Has found that large doses of vitamin D: 20,000 to 150,000 IU/day results in remission of recent cases of Multiple Sclerosis.&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Specifically: Recent lesions appeared partially repaired or disappeared on MRI scans after one and two years of treatment.&lt;/strong>&lt;/p>
&lt;hr>
&lt;h2 id="biomarkers-in-multiple-sclerosis-an-up-to-date-overview-jan-2013">Biomarkers in Multiple Sclerosis: An Up-to-Date Overview Jan 2013&lt;/h2>
&lt;p>&lt;strong>Shows that MRI is one of many MS biomarkers&lt;/strong>&lt;/p></description></item><item><title>Prevention with vitamin D in Multiple Sclerosis is logical – editorial</title><link>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-timing-of-sampling-treatment-and-prevention">Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.&lt;/h4>
&lt;p>Biomark Med. 2013 Apr;7(2):193-5. &lt;a href="https://doi.org/10.2217/bmm.13.10.">doi: 10.2217/bmm.13.10.&lt;/a> PMID: 23547812&lt;/p>
&lt;p>Sundström P, Salzer J.&lt;/p>
&lt;p>Department of Pharmacology &amp;amp; Clinical Neuroscience, Section of Neurology, Umeå University, 901 87 Umeå, Sweden. &lt;a href="mailto:peter.sundstrom@neuro.umu.se">peter.sundstrom@neuro.umu.se&lt;/a>.&lt;/p>
&lt;p>With today&amp;rsquo;s knowledge, it is the authors&amp;rsquo; view that enough scientific data exist to suggest that multiple sclerosis patients should be informed about the association between vitamin D levels and multiple sclerosis inflammatory disease activity&lt;/p></description></item><item><title>Multiple sclerosis associated with sun, not low vitamin D</title><link>/posts/multiple-sclerosis-associated-with-sun-not-low-vitamin-d.html</link><pubDate>Sun, 31 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-associated-with-sun-not-low-vitamin-d.html</guid><description>&lt;h2 id="interdependence-and-contributions-of-sun-exposure-and-vitamin-d-to-mri-measures-in-multiple-sclerosis">Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.&lt;/h2>
&lt;p>J Neurol Neurosurg Psychiatry. 2013 Feb 5.&lt;/p>
&lt;p>Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O&amp;rsquo;Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.&lt;/p>
&lt;p>Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, , Buffalo, New York, USA.&lt;/p>
&lt;p>PURPOSE: To assess the relationships of sun exposure history, supplementation and environmental factors to vitamin D levels in multiple sclerosis (MS) patients and to evaluate the associations between sun exposure and MRI measures.&lt;/p></description></item><item><title>Autoimmune disorder patients in Brazil helped by vitamin D – video and Facebook</title><link>/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook.html</link><pubDate>Mon, 04 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook.html</guid><description>&lt;h3 id="neat-social-media-spreads-the-word-of-the-benefits-of-vitamin-d3-and-vitamin-k2">Neat: Social media spreads the word of the benefits of Vitamin D3 (and Vitamin K2)&lt;/h3>
&lt;p>&lt;strong>Large doses: 20,000 to 150,000 IU/d&lt;/strong>&lt;/p>
&lt;p>The dose sizes are far larger than what what others are using to prevent MS, but this size is being used to TREAT MS.&lt;/p>
&lt;h3 id="facebook-page-by-the-patientshttpswwwfacebookcomgroups528624870516079-in-portuguese">&lt;a href="https://www.facebook.com/groups/528624870516079/">Facebook Page by the patients&lt;/a> in Portuguese&lt;/h3>
&lt;p>15,800 members as of Nov 2015&lt;/p>
&lt;h3 id="youtube-interview-of-the-doctorhttpwwwyoutubecomwatchvciwiwim4hnm">&lt;a href="http://www.youtube.com/watch?v=cIwIWim4hNM">YouTube interview of the doctor&lt;/a>&lt;/h3>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/jpeg/brazil.jpg" alt="image">
&lt;h3 id="youtube-videohttpwwwyoutubecomwatchveragu1xcy-u-in-portuguese-with-english-and-spanish-subtitles">&lt;a href="http://www.youtube.com/watch?v=erAgu1XcY-U">YouTube Video&lt;/a> In Portuguese with English and Spanish subtitles&lt;/h3>
&lt;p>The documentary was made by Daniel Cunha, a Brazilian journalist.&lt;/p></description></item><item><title>Small increase in Vitamin A metabolites cut new multiple sclerosis lesions in half</title><link>/posts/small-increase-in-vitamin-a-metabolites-cut-new-multiple-sclerosis-lesions-in-half.html</link><pubDate>Thu, 14 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/small-increase-in-vitamin-a-metabolites-cut-new-multiple-sclerosis-lesions-in-half.html</guid><description>&lt;h1 id="vitamin-a-yet-another-player-in-multiple-sclerosis-pathogenesis">Vitamin A: yet another player in multiple sclerosis pathogenesis?&lt;/h1>
&lt;p>Expert Review of Clinical Immunology February 2013, Vol. 9, No. 2, Pages 113-115 , DOI 10.1586/eci.12.105&lt;/p>
&lt;p>Massimo Filippi*, Paolo Preziosa and Maria A Rocca&lt;/p>
&lt;p>Evaluation of: Løken-Amsrud KI, Myhr KM, Bakke SJ et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult. Scler. doi:10.1177/1352458512457843 (2012) (Epub ahead of print).&lt;/p>
&lt;p>A combination of genetic and environmental factors probably plays a role in determining an increased susceptibility to multiple sclerosis (MS). Among these factors, vitamin D and A metabolites are likely to play a role given their immunomodulatory properties. Decreased serum vitamin D levels have been associated with clinical and MRI activity of MS. Løken-Amsrud et al. evaluated the association of retinol concentration with clinical and MRI measures of disease activity in MS patients over a 2-year period. Serum retinol levels correlated with MRI metrics of disease activity, but not with clinical findings. Following IFN-β-1a treatment, the association with MRI metrics was lost. These results support a role of vitamin A metabolites in influencing disease activity in MS.&lt;/p></description></item><item><title>Vitamin D: one sided debate is published in Multiple Sclerosis Journal</title><link>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</link><pubDate>Thu, 07 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</guid><description>&lt;h2 id="if-i-had-a-clinically-isolated-syndrome-with-mri-diagnostic-of-ms-i-would-take-vitamin-d-10000-iu-daily-no">If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: No&lt;/h2>
&lt;p>Mult Scler February 2013 vol. 19 no. 2 140-142&lt;/p>
&lt;p>Caroline Papeix, Catherine Lubetzki&lt;/p>
&lt;p>Université Pierre et Marie Curie AP-HP, France&lt;/p>
&lt;p>Catherine Lubetzki, Department of Neurology, Pitié-Salpêtrière Hospital, 75013 Paris, France. Email: &lt;a href="mailto:catherine.lubetzki@psl.aphp.fr">catherine.lubetzki@psl.aphp.fr&lt;/a>&lt;/p>
&lt;hr>
&lt;h3 id="observation-by-vitamindwiki">Observation by VitaminDWiki&lt;/h3>
&lt;p>We see MS professionals, with a lot a stake to keep the status quo (note the conflict of interest section) valiently state why vitamin D has not yet been absolutely proven, and can never be absolutely proven to help MS (people in the placebo group can get vitamin D from food and sun).&lt;/p></description></item><item><title>Vitamin D associated with reduced T-cell attacks in Multiple Sclerosis</title><link>/posts/vitamin-d-associated-with-reduced-t-cell-attacks-in-multiple-sclerosis.html</link><pubDate>Fri, 01 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-associated-with-reduced-t-cell-attacks-in-multiple-sclerosis.html</guid><description>&lt;h4 id="regulatory-role-of-vitamin-d-in-t-cell-reactivity-against-myelin-peptides-in-relapsing-remitting-multiple-sclerosis-patients">Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.&lt;/h4>
&lt;p>MC Neurol. 2012 Sep 24;12:103. &lt;a href="https://doi.org/10.1186/1471-2377-12-103.">doi: 10.1186/1471-2377-12-103.&lt;/a>&lt;/p>
&lt;p>Grau-López L, Granada ML, Raïch-Regué D, Naranjo-Gómez M, Borràs-Serres FE, Martínez-Cáceres E, Ramo-Tello C.&lt;/p>
&lt;p>Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, Badalona, Barcelona, 08916, Spain. &lt;a href="mailto:laiagrlo@gmail.com">laiagrlo@gmail.com&lt;/a>&lt;/p>
&lt;p>BACKGROUND: Low levels of plasma 25-hydroxyvitaminD (25(OH)D) are associated with a higher incidence of multiple sclerosis (MS) due to the immune suppressive properties of vitamin D.The aim of this study was to determine the correlation between plasma 25(OH)D concentrations and clinical and immunological variables in a cohort of multiple sclerosis patients.&lt;/p></description></item><item><title>Bone health not correlated with Vitamin D level in multiple sclerosis – review</title><link>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</guid><description>&lt;h1 id="bone-health-in-multiple-sclerosis">Bone health in multiple sclerosis&lt;/h1>
&lt;p>Osteoporos Int. 2011 Dec;22(12):2935-49. &lt;a href="https://doi.org/10.1007/s00198-011-1644-8.">doi: 10.1007/s00198-011-1644-8.&lt;/a> Epub 2011 May 21.&lt;/p>
&lt;p>Gibson JC, Summers GD.&lt;/p>
&lt;p>Level 2, Department of Rehabilitation Medicine, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK. &lt;a href="mailto:jeremy.gibson@nhs.net">jeremy.gibson@nhs.net&lt;/a>&lt;/p>
&lt;p>People who are disabled with multiple sclerosis (MS) may be at increased risk of osteoporosis. This review discusses issues relevant to bone health in MS and makes practical recommendations regarding prevention and screening for osteoporosis and fracture risk in MS. A search of the literature up until 5 April 2011 was performed using key search terms, and articles pertinent to bone health in MS were analysed. Bone mineral density (BMD) is reduced at the lumbar spine, hip and total body in MS, with the degree of reduction being greatest at the hip. A strong relationship exists between the disability level, measured by the Expanded Disability Status Score, and BMD at the lumbar spine and femoral neck, particularly the latter. The rate of loss of BMD also correlates with the level of disability. Pulsed corticosteroids for acute episodes of MS, even with a high cumulative steroid dose, do not significantly affect BMD, but an effect on fracture risk is yet to be elucidated.&lt;/p></description></item><item><title>Late-stage MS associated with protein in spinal cord which blocks vitamin D</title><link>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-binding-protein-in-cerebrospinal-fluid-is-associated-with-multiple-sclerosis-progression">Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.&lt;/h2>
&lt;p>Mol Neurobiol. 2013 Jan 22.&lt;/p>
&lt;p>Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S.&lt;/p>
&lt;p>Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong, 250012, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>Multiple sclerosis is a neurological disorder that presents with symptoms including inflammation, neurodegeneration, and demyelination of the central nervous system (CNS).&lt;/p></description></item><item><title>Vitamin D looks promising to deal with MS – review 2013</title><link>/posts/vitamin-d-looks-promising-to-deal-with-ms-review-2013.html</link><pubDate>Mon, 28 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-looks-promising-to-deal-with-ms-review-2013.html</guid><description>&lt;h1 id="can-we-prevent-or-treat-multiple-sclerosis-by-individualised-vitamin-d-supply">Can we prevent or treat multiple sclerosis by individualised vitamin D supply?&lt;/h1>
&lt;p>EPMA Journal 2013, 4:4 doi:10.1186/1878-5085-4-4. Published: 29 January 2013&lt;/p>
&lt;p>Jan Dörr, Andrea Döring and Friedemann Paul&lt;/p>
&lt;p>Abstract (provisional)&lt;/p>
&lt;p>Apart from its principal role in bone metabolism and calcium homeostasis, vitamin D has been attributed additional effects including an immunomodulatory, anti-inflammatory, and possibly even neuroprotective capacity which implicates a possible role of vitamin D in autoimmune diseases like multiple sclerosis (MS). Indeed, several lines of evidence including epidemiologic, preclinical, and clinical data suggest that reduced vitamin D levels and/or dysregulation of vitamin D homeostasis is a risk factor for the development of multiple sclerosis on the one hand, and that vitamin D serum levels are inversely associated with disease activity and progression on the other hand. However, these data are not undisputable, and many questions regarding the preventive and therapeutic capacity of vitamin D in MS remain to be answered. In particular, available clinical data derived from interventional trials using vitamin D supplementation as a therapeutic approach in MS are inconclusive and partly contradictory. In this review, we summarise and critically evaluate the existing data on the possible link between vitamin D and multiple sclerosis in light of the crucial question whether optimization of vitamin D status may impact the risk and/or the course of multiple sclerosis.&lt;/p></description></item><item><title>If low level of Vitamin A then 60 percent less likely to get MS (maybe Vitamin D not blocked)</title><link>/posts/if-low-level-of-vitamin-a-then-60-percent-less-likely-to-get-ms-maybe-vitamin-d-not-blocked.html</link><pubDate>Thu, 24 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/if-low-level-of-vitamin-a-then-60-percent-less-likely-to-get-ms-maybe-vitamin-d-not-blocked.html</guid><description>&lt;h4 id="vitamin-a-and-systemic-inflammation-as-protective-factors-in-multiple-sclerosis">Vitamin A and systemic inflammation as protective factors in multiple sclerosis&lt;/h4>
&lt;p>Mult Scler January 18, 2013 1352458512472752&lt;/p>
&lt;p>Jonatan Salzer 1 ; Göran Hallmans 2; Maria Nyström 1; Hans Stenlund 2; Göran Wadell 3; Peter Sundström 1&lt;/p>
&lt;p>1 Department of Pharmacology and Clinical Neuroscience, Section of Neurology at Umeå University, Sweden&lt;/p>
&lt;p>2 Department of Public Health and Clinical Medicine, Umeå University, Sweden&lt;/p>
&lt;p>3 Department of Clinical Microbiology, Umeå University, Sweden&lt;/p>
&lt;p>Jonatan Salzer, Department of Pharmacology and Clinical Neuroscience, Section of Neurology at Umeå University, SE-90187 Umeå, Sweden. Email: &lt;a href="mailto:jonatan.salzer@neuro.umu.se">jonatan.salzer@neuro.umu.se&lt;/a>&lt;/p></description></item><item><title>Vitamin D prevents multiple sclerosis through multiple mechanisms</title><link>/posts/vitamin-d-prevents-multiple-sclerosis-through-multiple-mechanisms.html</link><pubDate>Thu, 24 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-prevents-multiple-sclerosis-through-multiple-mechanisms.html</guid><description>&lt;h4 id="contribution-of-vitamin-d-insufficiency-to-the-pathogenesis-of-multiple-sclerosis">Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis&lt;/h4>
&lt;p>Therapeutic Advances in Neurological Disorders January 23, 2013 1756285612473513&lt;/p>
&lt;p>Charles Pierrot-Deseilligny &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>, Université Pierre et Marie Curie (Paris VI), Paris, France&lt;/p>
&lt;p>Jean-Claude Souberbielle. Université René Descartes (Paris V), Paris, France&lt;/p>
&lt;p>The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans.&lt;/p></description></item><item><title>Multiple Sclerosis more likely if mother had less than 25 ng of vitamin D</title><link>/posts/multiple-sclerosis-more-likely-if-mother-had-less-than-25-ng-of-vitamin-d.html</link><pubDate>Sat, 19 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-more-likely-if-mother-had-less-than-25-ng-of-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-as-a-protective-factor-in-multiple-sclerosis">Vitamin D as a protective factor in multiple sclerosis.&lt;/h4>
&lt;p>Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.&lt;/p>
&lt;p>Neurology. 2012 Nov 20;79(21):2140-5. &lt;a href="https://doi.org/10.1212/WNL.0b013e3182752ea8.">doi: 10.1212/WNL.0b013e3182752ea8.&lt;/a>&lt;/p>
&lt;p>Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå University, Umeå, Sweden. &lt;a href="mailto:jonatan.salzer@neuro.umu.se">jonatan.salzer@neuro.umu.se&lt;/a>&lt;/p>
&lt;p>OBJECTIVE: To examine the association between 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) levels and the risk of multiple sclerosis (MS) in blood samples collected prospectively and during gestation.&lt;/p>
&lt;p>METHODS: In this nested case-control study, 2 population-based biobanks with 291,500 samples from 164,000 persons collected since 1975 in the northern half of Sweden were used. We identified prospectively collected blood samples from MS cases (n = 192, controls matched 2:1) and gestational samples from pregnant mothers where the offspring had later developed MS (n = 37, control mothers matched 5:1). 25(OH)D levels were measured using an ELISA, and the risk of MS was analyzed using matched logistic regression.&lt;/p></description></item><item><title>Multiple Sclerosis and vitamin D – Systematic Review inconclusive</title><link>/posts/multiple-sclerosis-and-vitamin-d-systematic-review-inconclusive.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-systematic-review-inconclusive.html</guid><description>&lt;h2 id="a-systematic-review-of-randomized-double-blind-placebo-controlled-trials-examining-the-clinical-efficacy-of-vitamin-d-in-multiple-sclerosis">A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis&lt;/h2>
&lt;p>Neuro-epidemiology Vol. 40, No. 3, 2013&lt;/p>
&lt;p>Beatriz Pozuelo-Moyanoa, c, Julián Benito-Leóna –c &lt;a href="mailto:jbenitol@meditex.es">jbenitol@meditex.es&lt;/a>, Alex J. Mitchelld, Jesús Hernández-Gallegoa, c&lt;/p>
&lt;p>A Department of Neurology, University Hospital ‘12 de Octubre’,&lt;/p>
&lt;p>B Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, and&lt;/p>
&lt;p>C Department of Medicine, Complutense University, Madrid, Spain;&lt;/p>
&lt;p>D Department of Psycho-Oncology, Leicestershire Partnership Trust and University of Leicester, Leicester, UK&lt;/p></description></item><item><title>Risk of going from pre-MS to MS reduced 68 percent with 7100 IU vitamin D – RCT</title><link>/posts/risk-of-going-from-pre-ms-to-ms-reduced-68-percent-with-7100-iu-vitamin-d-rct.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/risk-of-going-from-pre-ms-to-ms-reduced-68-percent-with-7100-iu-vitamin-d-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#preventive-effect-of-vitamin-d3-supplementation-on-conversion-of-optic-neuritis-to-clinically-definite-multiple-sclerosis---a-double-blind-randomized-placebo-controlled-pilot-clinical-trial">Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: - a double blind, randomized, placebo-controlled pilot clinical trial.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strong-evidence--vitamin-d-prevents-ms-and-reduces-ms-symptoms">Strong evidence: Vitamin D PREVENTS MS and REDUCES MS symptoms&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#85-citations-of-this-study-as-of-june-2024">85 citations of this study as of June 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="preventive-effect-of-vitamin-d3-supplementation-on-conversion-of-optic-neuritis-to-clinically-definite-multiple-sclerosis---a-double-blind-randomized-placebo-controlled-pilot-clinical-trial">Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: - a double blind, randomized, placebo-controlled pilot clinical trial.&lt;/h4>
&lt;p>Acta Neurol Belg. 2012 Dec 19.&lt;/p></description></item><item><title>Vitamin D less than 3000 IU insufficient to reduce MS relapse rate – 5 RCT</title><link>/posts/vitamin-d-less-than-3000-iu-insufficient-to-reduce-ms-relapse-rate-5-rct.html</link><pubDate>Tue, 18 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-less-than-3000-iu-insufficient-to-reduce-ms-relapse-rate-5-rct.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="/posts/overview-ms-and-vitamin-d">Overview MS and vitamin D&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>often 5,000 IU to 10,000 IU&lt;/p>
&lt;/blockquote></description></item><item><title>Vitamin D can both prevent and treat Multiple Sclerosis – review</title><link>/posts/vitamin-d-can-both-prevent-and-treat-multiple-sclerosis-review.html</link><pubDate>Thu, 29 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-both-prevent-and-treat-multiple-sclerosis-review.html</guid><description>&lt;h4 id="role-of-vitamin-d-in-the-onset-progression-and-severity-of-multiple-sclerosis">Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.&lt;/h4>
&lt;p>Endocr Pract. 2012 Nov 27:1-22.&lt;/p>
&lt;p>Mesliniene S, Ramrattan L, Giddings S, Sheikh-Ali M.&lt;/p>
&lt;p>Division of Endocrinology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida.&lt;/p>
&lt;p>Objective: To review and assess the role of vitamin D on the onset, progression and relapse of multiple sclerosis (MS), based on evidence acquired from the analysis of preclinical, observational and interventional studies.&lt;/p></description></item><item><title>Hypothesis of Autoimmunity which includes Epstein-Barr Virus and Vitamin D Deficiency – 2012</title><link>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</guid><description>&lt;h4 id="cd8-t-cell-deficiency-epstein-barr-virus-infection-vitamin-d-deficiency-and-steps-to-autoimmunity-a-unifying-hypothesis">CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis&lt;/h4>
&lt;p>Autoimmune Diseases, Volume 2012 (2012), Article ID 189096, 16 pages, Review Article&lt;/p>
&lt;p>Michael P. Pender 1,2&lt;/p>
&lt;p>1 School of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia&lt;/p>
&lt;p>2 Department of Neurology, Royal Brisbane and Women&amp;rsquo;s Hospital, Brisbane, QLD 4029, Australia&lt;/p>
&lt;p>Received 18 August 2011; Revised 3 October 2011; Accepted 16 October 2011&lt;/p>
&lt;p>Academic Editor: Corrado Betterle&lt;/p></description></item><item><title>Review of Autoimmune diseases, solar radiation and vitamin D – Schwalfenberg 2012</title><link>/posts/review-of-autoimmune-diseases-solar-radiation-and-vitamin-d-schwalfenberg-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-autoimmune-diseases-solar-radiation-and-vitamin-d-schwalfenberg-2012.html</guid><description>&lt;h3 id="solar-radiation-and-vitamin-d-mitigating-environmental-factors-in-autoimmune-disease">Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease&lt;/h3>
&lt;p>Journal of Environmental and Public Health, Volume 2012 (2012), Article ID 619381, 9 pages, Review Article&lt;/p>
&lt;p>Gerry K. Schwalfenberg&lt;/p>
&lt;p>Department of Family Medicine, University of Alberta, Suite No. 301, 9509-156 Street, Edmonton, AB, Canada T6G 2M7&lt;/p>
&lt;p>Received 3 July 2011; Revised 29 November 2011; Accepted 13 December 2011&lt;/p>
&lt;p>This paper looks at the environmental role of vitamin D and solar radiation as risk reduction factors in autoimmune disease. Five diseases are considered: multiple sclerosis, type 1 diabetes, rheumatoid arthritis, autoimmune disease of the thyroid, and inflammatory bowel disease. Clinical relevant studies and factors that may indicate evidence that autoimmune disease is a vitamin D-sensitive disease are presented. Studies that have resulted in prevention or amelioration of some autoimmune disease are discussed. An example of the utility of supplementing vitamin D in an unusual autoimmune disease, idiopathic thrombocytic purpura, is presented.&lt;/p></description></item><item><title>Transgeneration vitamin D deficiency related to MS was found in mice</title><link>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</guid><description>&lt;h4 id="prenatal-vitamin-d-deficiency-induces-an-early-and-more-severe-experimental-autoimmune-encephalomyelitis-in-the-second-generation">Prenatal Vitamin D Deficiency Induces an Early and More Severe Experimental Autoimmune Encephalomyelitis in the Second Generation&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2012, 13(9), 10911-10919; doi:10.3390/ijms130910911&lt;/p>
&lt;p>Diana Andrea Fernandes de Abreu 1 , Véréna Landel 1 , Adrian G. Barnett 2 , John McGrath 3,4 , Darryl Eyles 3,4 and Francois Feron 1,*&lt;/p>
&lt;p>1 Neurobiology of Cell Interactions and Neurophysiopathology, Centre National de la Recherche Scientifique, UMR 7259, Aix Marseille Université, Marseille 13015, France&lt;/p></description></item><item><title>Epigenetics, vitamin D, and Multiple Sclerosis</title><link>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</link><pubDate>Wed, 21 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epigenetics---is-it-real-new-york-times-review-of-plos-genetics-article---july-2016">Epigenetics - is it real: New York Times review of PLOS Genetics article - July 2016&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/h2>
&lt;p>Nat Rev Neurol. 2012 Nov 20. &lt;a href="https://doi.org/10.1038/nrneurol.2012.226.">doi: 10.1038/nrneurol.2012.226.&lt;/a>&lt;/p>
&lt;p>Koch MW, Metz LM, Kovalchuk O.&lt;/p>
&lt;p>Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, 1403-29th Street N. W., Calgary, AB T2N 2T9, Canada.&lt;/p>
&lt;p>Epigenetic changes influence gene expression without altering the DNA sequence. DNA methylation, histone modification and microRNA-associated post-transcriptional gene silencing are three key epigenetic mechanisms. Multiple sclerosis (MS) is a disease of the CNS with both inflammatory and neurodegenerative features. Although studies on epigenetic changes in MS only began in the past decade, a growing body of literature suggests that epigenetic changes may be involved in the development of MS, possibly by mediating the effects of environmental risk factors, such as&lt;/p></description></item><item><title>Multiple Sclerosis</title><link>/posts/multiple-sclerosis.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ms-associations-with-autoimmune-33-uv-21-genetics-20-intervention-18-parkinson-15-high-dose-15-cognitive-14-pregnancy-11-receptor-10-lupus-9-ra-9-omega-9-virus-9-immunity-7-psoriasis-7-diabetes-6-gut-6-etc">MS associations with: Autoimmune 33; UV 21; Genetics 20; Intervention 18; Parkinson 15; High-Dose 15; Cognitive 14; Pregnancy 11; Receptor 10; Lupus 9; RA 9; Omega 9; Virus 9; Immunity 7; Psoriasis 7; Diabetes 6; Gut 6 etc.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ms-associations-with-autoimmune-33-uv-21-genetics-20-intervention-18-parkinson-15-high-dose-15-cognitive-14-pregnancy-11-receptor-10-lupus-9-ra-9-omega-9-virus-9-immunity-7-psoriasis-7-diabetes-6-gut-6-etc">MS associations with: Autoimmune 33; UV 21; Genetics 20; Intervention 18; Parkinson 15; High-Dose 15; Cognitive 14; Pregnancy 11; Receptor 10; Lupus 9; RA 9; Omega 9; Virus 9; Immunity 7; Psoriasis 7; Diabetes 6; Gut 6 etc.&lt;/h4></description></item><item><title>Multiple Sclerosis 23 percent more likely if born in April vs. Oct – meta-analysis</title><link>/posts/multiple-sclerosis-23-percent-more-likely-if-born-in-april-vs-oct-meta-analysis.html</link><pubDate>Thu, 15 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-23-percent-more-likely-if-born-in-april-vs-oct-meta-analysis.html</guid><description>&lt;h3 id="the-month-of-birth-effect-in-multiple-sclerosis-systematic-review-meta-analysis-and-effect-of-latitude">The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry doi:10.1136/jnnp-2012-303934&lt;/p>
&lt;p>Ruth Dobson1, Gavin Giovannoni1, Sreeram Ramagopalan1,2,3&lt;/p>
&lt;p>1 Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London UK&lt;/p>
&lt;p>2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK&lt;/p>
&lt;p>3 Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK&lt;/p>
&lt;p>Correspondence to: Dr Ruth Dobson, Queen Mary University of London, Blizard Institute, Newark Street, London E1 2AT; &lt;a href="mailto:ruth.dobson@qmul.ac.uk">ruth.dobson@qmul.ac.uk&lt;/a>&lt;/p></description></item><item><title>Environmental risk factors for MS include latitude and vitamin D</title><link>/posts/environmental-risk-factors-for-ms-include-latitude-and-vitamin-d.html</link><pubDate>Tue, 13 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/environmental-risk-factors-for-ms-include-latitude-and-vitamin-d.html</guid><description>&lt;h4 id="environmental-risk-factors-for-multiple-sclerosis-a-review-with-a-focus-on-molecular-mechanisms">Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms&lt;/h4>
&lt;p>Int J Mol Sci. 2012; 13(9): 11718–11752.&lt;/p>
&lt;p>Cullen O’Gorman,1,* Robyn Lucas,2 and Bruce Taylor 3&lt;/p>
&lt;p>1 School of Medicine, Griffith University, Gold Coast, Queensland 4222, Australia&lt;/p>
&lt;p>2 National Centre for Epidemiology and Population Health, the Australian National University, Canberra, Australian Capital Territory 0200, Australia; E-Mail: &lt;a href="mailto:robyn.lucas@anu.edu.au">robyn.lucas@anu.edu.au&lt;/a>&lt;/p>
&lt;p>3 Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania 7000, Australia; E-Mail: &lt;a href="mailto:bruce.taylor@utas.edu.au">bruce.taylor@utas.edu.au&lt;/a>&lt;/p></description></item><item><title>Vitamin D enabled a woman with MS to walk long distances again</title><link>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</link><pubDate>Thu, 01 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</guid><description>&lt;h1 id="effect-of-high-dose-vitamin-d3-intake-on-ambulation-muscular-pain-and-bone-mineral-density">Effect of High-Dose Vitamin D3 Intake on Ambulation, Muscular Pain and Bone Mineral Density&lt;/h1>
&lt;h2 id="in-a-woman-with-multiple-sclerosis-a-10-year-longitudinal-case-report">in a Woman with Multiple Sclerosis: A 10-Year Longitudinal Case Report&lt;/h2>
&lt;p>Int. J. Mol. Sci. 2012, 13(10), 13461-13483; doi:10.3390/ijms131013461&lt;/p>
&lt;p>Barbara M. van Amerongen 1,2, &lt;a href="mailto:b.m.van.amerongen@inter.nl.net">b.m.van.amerongen@inter.nl.net&lt;/a> and François Feron 3&lt;/p>
&lt;p>1 Department of Molecular Cell Biology and Immunology, VU University Medical Center,1017 MB Amsterdam, The Netherlands&lt;/p>
&lt;p>2 Department of Cariology Endodontology Pedodontology, Academic Centre for Dentistry, 1081 LA Amsterdam, Amsterdam, The Netherlands&lt;/p></description></item><item><title>Less MS (MRI) decline after raising Vitamin D levels – clinical trial</title><link>/posts/less-ms-mri-decline-after-raising-vitamin-d-levels-clinical-trial.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/less-ms-mri-decline-after-raising-vitamin-d-levels-clinical-trial.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryhttpwwwnews-medicalnetnews20121031vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryaspx-news-medicalnet">&lt;a href="http://www.news-medical.net/news/20121031/Vitamin-D-and-multiple-sclerosis-an-interview-with-Ellen-Mowry.aspx">Vitamin D and multiple sclerosis: an interview with Ellen Mowry&lt;/a> news Medical.Net&lt;/h4>
&lt;p>&lt;strong>Excellent interview&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Tracked 469 people with MS for 5 years&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Higher vitamin D was associated with fewer MS spots on MRI the next year.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h4 id="vitamin-d-status-predicts-new-brain-magnetic-resonance-imaging-activity-in-multiple-sclerosis">Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.&lt;/h4>
&lt;p>Ann Neurol. 2012 Aug;72(2):234-40. &lt;a href="https://doi.org/10.1002/ana.23591.">doi: 10.1002/ana.23591.&lt;/a>&lt;/p>
&lt;p>Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D.&lt;/p></description></item><item><title>Unsaturated Fatty acids important for both MS and Vitamin D</title><link>/posts/unsaturated-fatty-acids-important-for-both-ms-and-vitamin-d.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/unsaturated-fatty-acids-important-for-both-ms-and-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis not helped with half a microgram of calcitriol – 2012</title><link>/posts/multiple-sclerosis-not-helped-with-half-a-microgram-of-calcitriol-2012.html</link><pubDate>Sat, 27 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-not-helped-with-half-a-microgram-of-calcitriol-2012.html</guid><description>&lt;h4 id="effects-of-adjunct-low-dose-vitamin-d-on-relapsing-remitting-multiple-sclerosis-progression-preliminary-findings-of-a-randomized-placebo-controlled-trial">Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: !!Preliminary Findings of a Randomized Placebo-Controlled Trial&lt;/h4>
&lt;p>Multiple Sclerosis International, Volume 2012 (2012), Article ID 452541, 7 pages&lt;/p>
&lt;p>Vahid Shaygannejad,1 Mohsen Janghorbani,2 Fereshteh Ashtari,1 and Hamed Dehghan1&lt;/p>
&lt;p>1 Department of Neurology, Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan 8144503500, Iran&lt;/p>
&lt;p>2 Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan 8144503500, Iran&lt;/p></description></item><item><title>Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran</title><link>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</link><pubDate>Mon, 15 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</guid><description>&lt;p>There are two items on this page&lt;/p>
&lt;hr>
&lt;h3 id="multiple-sclerosis-and-the-iranian-revolution">MULTIPLE SCLEROSIS AND THE IRANIAN REVOLUTION&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.185&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Julia Pakpoor⇓,&lt;/p>
&lt;p>Sreeram Ramagopalan&lt;/p>
&lt;p>University of Oxford; Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>Multiple Sclerosis (MS) is a complex neurological disorder most likely caused by gene–environment interactions. There is a latitudinal gradient of MS prevalence and vitamin D deficiency has been strongly implicated in MS aetiology. Iran is a country of high levels of sunshine which has previously been considered a low–risk MS region. However, Iran has recently observed an &lt;strong>&lt;span style="color:#F00;">8.3–fold rise in the incidence of MS between 1989–2006&lt;/span>.&lt;/strong> 1 Previous studies have indicated a genetic predisposition to MS in the Iranian population but genetic changes are unlikely to account for the substantial rise in MS over the last few decades. Thus, we aimed to develop a novel hypothesis to explain the identification of Iran as a high–risk MS region. We believe that the influence of decreased sunshine exposure and vitamin D levels on MS risk needs to be strongly considered in the context of Iran&amp;rsquo;s history. In 1979 the Iranian Revolution took place and a country previously under great Western influences became an Islamic republic. It became a government requirement for women to wear loose–fitting clothing and the veil in public; it has previously been shown that veiled women have lower vitamin D levels compared to unveiled women. This significant cultural shift would not only potentially explain the observed increase in MS but notably, it would account for the increasing female preponderance of MS in Iran. Given that the average age of MS onset is 30 years old and that MS incidence in Iran just over 30 years following the revolution is the highest so far recorded, an association with the Iranian revolution and reduced subsequent vitamin D levels in particularly pregnant women is likely. Lifestyle changes such as urbanization and use of sunscreen may to some extent have contributed to increased vitamin D deficiency, but these are unlikely to contribute to the particularly high increase in MS observed in Iran as these changes occurred across the developed world and there is no evidence to suggest that they were particularly great in Iran. &lt;strong>A similar high incidence of MS has been observed among Iranian immigrants in countries at high latitude such as Sweden&lt;/strong> where Iranian immigrants have a reported greater prevalence of MS compared to the general population, &lt;strong>despite wearing a veil not being a requirement.&lt;/strong> Instead it is well–known that UVB exposure is lower in countries at high latitude and thus, a similar effect of increased MS incidence due to vitamin D deficiency may be observed among those in Iran wearing the veil and those resident in countries at high latitude, even if they are not wearing the veil. Therefore, vitamin D repletion is a critical public health issue for Iranians both within and outside Iran, and could help prevent an emerging MS epidemic in this population. More generally, this region is highly interesting for MS research and highlights that regions of exception to the latitudinal gradient of MS prevalence are an under–appreciated and very useful resource in evaluating MS aetiology.&lt;/p></description></item><item><title>MS helped by average daily 2800 IU vitamin D – RCT</title><link>/posts/ms-helped-by-average-daily-2800-iu-vitamin-d-rct.html</link><pubDate>Sat, 25 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/ms-helped-by-average-daily-2800-iu-vitamin-d-rct.html</guid><description/></item><item><title>Neurology J. had 4 items on Multiple Sclerosis and Vitamin D – review by MS Soc</title><link>/posts/neurology-j-had-4-items-on-multiple-sclerosis-and-vitamin-d-review-by-ms-soc.html</link><pubDate>Thu, 16 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/neurology-j-had-4-items-on-multiple-sclerosis-and-vitamin-d-review-by-ms-soc.html</guid><description/></item><item><title>2900 IU of vitamin D (20000 weekly) kept levels above 20 ng during the winter</title><link>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</link><pubDate>Thu, 02 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</guid><description>&lt;h4 id="what-is-needed-to-keep-persons-with-multiple-sclerosis-vitamin-d-sufficient-throughout-the-year">What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?&lt;/h4>
&lt;p>J Neurol. 2012 Aug 1.&lt;/p>
&lt;p>Steffensen LH, Brustad M, Kampman MT.&lt;/p>
&lt;p>Department of Neurology, University Hospital of North Norway, P.O. Box 33, 9038, Tromsø, Norway, &lt;a href="mailto:linn.hofsoy.steffensen@unn.no">linn.hofsoy.steffensen@unn.no&lt;/a>.&lt;/p>
&lt;p>Vitamin D sufficiency has been associated with lower risk of multiple sclerosis and may also have a favorable effect on the course of the disease.&lt;/p>
&lt;p>The aim of this work was to identify predictors of serum 25-hydroxy vitamin D (25&lt;span>[OH]&lt;/span>D) levels in persons with multiple sclerosis (MS) and to assess the effect of high-dose vitamin D(3) supplementation on vitamin D status.&lt;/p></description></item><item><title>3X more vitamin D from the sun if take MS drug Interferon-β</title><link>/posts/3x-more-vitamin-d-from-the-sun-if-take-ms-drug-interferon.html</link><pubDate>Fri, 27 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/3x-more-vitamin-d-from-the-sun-if-take-ms-drug-interferon.html</guid><description/></item><item><title>Multiple Sclerosis not affected by 2800 IU of vitamin D</title><link>/posts/multiple-sclerosis-not-affected-by-2800-iu-of-vitamin-d.html</link><pubDate>Thu, 19 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-not-affected-by-2800-iu-of-vitamin-d.html</guid><description/></item><item><title>Vitamin D reduces multiple sclerosis relapses, but not with interferon treatment</title><link>/posts/vitamin-d-reduces-multiple-sclerosis-relapses-but-not-with-interferon-treatment.html</link><pubDate>Thu, 14 Jun 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-reduces-multiple-sclerosis-relapses-but-not-with-interferon-treatment.html</guid><description>&lt;h2 id="two-publications-on-this-page-by-similar-set-of-authors">Two publications on this page by similar set of authors&lt;/h2>
&lt;h1 id="vitamin-d-and-disease-activity-in-multiple-sclerosis-before-and-during-interferon--treatment">Vitamin D and disease activity in multiple sclerosis before and during interferon-? treatment&lt;/h1>
&lt;p>Neurology June 12, 2012, 78 (24)&lt;/p>
&lt;p>Kristin I. Løken-Amsrud, MD, Trygve Holmøy, PhD, Søren J. Bakke, PhD, Antonie Giaever Beiske, PhD, Kristian S. Bjerve, PhD, Bård T. Bjørnarå, PhD, Harald Hovdal, MD, Finn Lilleås, PhD, Rune Midgard, PhD, Tom Pedersen, PhD, Jurate Šaltyt? Benth, PhD, Leiv Sandvik, PhD, Øivind Torkildsen, PhD, Stig Wergeland, MD and Kjell-Morten Myhr, PhD&lt;/p></description></item><item><title>MS clinical trial (EVIDIMS) to use 10,000 IU of vitamin D</title><link>/posts/ms-clinical-trial-evidims-to-use-10000-iu-of-vitamin-d.html</link><pubDate>Sat, 19 May 2012 00:00:00 +0000</pubDate><guid>/posts/ms-clinical-trial-evidims-to-use-10000-iu-of-vitamin-d.html</guid><description>&lt;h1 id="efficacy-of-vitamin-d-supplementation-in-multiple-sclerosis-evidims-trial-study-protocol-for-a-randomized-controlled-trial">Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.&lt;/h1>
&lt;p>Trials. 2012 Feb 8;13:15.&lt;/p>
&lt;p>Dörr J, Ohlraun S, Skarabis H, Paul F.&lt;/p>
&lt;p>NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany. &lt;a href="mailto:jan-markus.doerr@charite.de">jan-markus.doerr@charite.de&lt;/a>&lt;/p>
&lt;p>BACKGROUND: Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system in young adults. Despite the fact that numerous lines of evidence link both the risk of disease development and the disease course to the serum level of 25-hydroxyvitamin D it still remains elusive whether multiple sclerosis patients benefit from boosting the serum level of 25-hydroxyvitamin D, mainly because interventional clinical trials that directly address the therapeutic effects of vitamin D in multiple sclerosis are sparse. We here present the protocol of an interventional clinical phase II study to test the hypothesis, that high-dose vitamin D supplementation of multiple sclerosis patients is safe and superior to low-dose supplementation with respect to beneficial therapeutic effects.&lt;/p></description></item><item><title>MS relapse rate reduced 14 percent for each 4 ng increase in vitamin D</title><link>/posts/ms-relapse-rate-reduced-14-percent-for-each-4-ng-increase-in-vitamin-d.html</link><pubDate>Fri, 18 May 2012 00:00:00 +0000</pubDate><guid>/posts/ms-relapse-rate-reduced-14-percent-for-each-4-ng-increase-in-vitamin-d.html</guid><description>&lt;h1 id="relationship-between-25-oh-d-serum-level-and-relapse-rate-in-multiple-sclerosis-patients">Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients&lt;/h1>
&lt;h2 id="before-and-after-vitamin-d-supplementation">before and after vitamin D supplementation&lt;/h2>
&lt;p>Therapeutic Advances in Neurological Disorders May 17, 2012 1756285612447090&lt;/p>
&lt;p>Charles Pierrot-Deseilligny &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>&lt;/p>
&lt;p>Service de Neurologie 1, Hôpital de la Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie (Paris VI), Paris, France&lt;/p>
&lt;p>Sophie Rivaud-Péchoux: INSERM URMS 975, CNRS 7225, Université Pierre et Marie Curie (Paris VI), Paris, France&lt;/p>
&lt;p>Pierre Clerson: Orgamétrie biostatistiques, Roubaix, France&lt;/p></description></item><item><title>Hispanics with MS had lower levels of vitamin D which did not vary seasonally</title><link>/posts/hispanics-with-ms-had-lower-levels-of-vitamin-d-which-did-not-vary-seasonally.html</link><pubDate>Thu, 17 May 2012 00:00:00 +0000</pubDate><guid>/posts/hispanics-with-ms-had-lower-levels-of-vitamin-d-which-did-not-vary-seasonally.html</guid><description>&lt;h1 id="vitamin-d-levels-in-hispanics-with-multiple-sclerosis">Vitamin D levels in Hispanics with multiple sclerosis.&lt;/h1>
&lt;p>J Neurol. 2012 May 16.&lt;/p>
&lt;p>Amezcua L, Chung RH, Conti DV, Langer-Gould AM.&lt;/p>
&lt;p>Department of Neurology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA, &lt;a href="mailto:lamezcua@usc.edu">lamezcua@usc.edu&lt;/a>.&lt;/p>
&lt;p>Vitamin D has been associated with multiple sclerosis (MS) and several markers of disease state in whites. There are limited reports of vitamin D&amp;rsquo;s influence in MS in ethnic groups, such as in Hispanics. In this study, we compared vitamin D levels in Hispanics and whites with MS and tried to determine whether season or increasing disability influence hypovitaminosis D in Hispanics with MS. Serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels and clinical characteristics were compared in a cross-sectional sample of Hispanics (n = 80) and whites (n = 80) with MS recruited from the University of Southern California. Serum 25(OH)D levels were significantly lower in Hispanics than whites with MS (mean and standard deviation 25.1 ± 9.4 and 37.3 ± 19.8 ng/ml, respectively; p &amp;lt; 0.001). Hispanics were significantly more likely than whites to be vitamin D insufficient (?30 ng/ml; 70 vs. 41 %, respectively; p &amp;lt; 0.001) and deficient (?20 ng/ml; 40 vs. 14 %, respectively, p &amp;lt; 0.001). In Hispanics, serum 25(OH)D levels were not influenced by season (p = 0.8) or higher physical disability (EDSS ?6, p = 0.7). We found that the relationship between vitamin D and MS differs by Hispanic ethnicity. Hypovitaminosis D was significantly more common among Hispanics than among whites with MS, and the majority of Hispanics were vitamin D insufficient. Interestingly, there was no association between vitamin D levels and season or increasing disability in the Hispanics. Our findings imply that factors influencing vitamin D levels and possibly vitamin D requirements may vary by ethnicity in patients with MS. These results should be confirmed in larger, prospective multi-ethnic cohort studies.&lt;/p></description></item><item><title>5000 to 10000 IU vitamin D helped MS in a pilot study</title><link>/posts/5000-to-10000-iu-vitamin-d-helped-ms-in-a-pilot-study.html</link><pubDate>Fri, 30 Mar 2012 00:00:00 +0000</pubDate><guid>/posts/5000-to-10000-iu-vitamin-d-helped-ms-in-a-pilot-study.html</guid><description>&lt;h1 id="a-pilot-study-of-the-immunological-effects-of-high-dose-vitamin-d-in-healthy-volunteers">A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.&lt;/h1>
&lt;p>Mult Scler. 2012 Mar 28.&lt;/p>
&lt;p>Allen AC, Kelly S, Basdeo SA, Kinsella K, Mulready KJ, Mills KH, Tubridy N, Walsh C, Brady JJ, Hutchinson M, Fletcher JM.&lt;/p>
&lt;p>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland.&lt;/p>
&lt;p>Although vitamin D deficiency is considered an environmental factor in multiple sclerosis (MS), the immunological and clinical effects of vitamin D supplementation remain unclear.&lt;/p></description></item><item><title>MRI detects 32% less of one type of MS lesion for every 10 ng increased vitamin D</title><link>/posts/mri-detects-32-percent-less-of-one-type-of-ms-lesion-for-every-10-ng-increased-vitamin-d.html</link><pubDate>Tue, 20 Mar 2012 00:00:00 +0000</pubDate><guid>/posts/mri-detects-32-percent-less-of-one-type-of-ms-lesion-for-every-10-ng-increased-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-status-predicts-new-brain-mri-activity-in-multiple-sclerosis">Vitamin D status predicts new brain MRI activity in multiple sclerosis&lt;/h1>
&lt;p>Ellen M. Mowry M.D., M.C.R1,†,‡, &lt;a href="mailto:emowry1@jhmi.edu">emowry1@jhmi.edu&lt;/a>&lt;/p>
&lt;p>Emmanuelle Waubant M.D., Ph.D1,‡,&lt;/p>
&lt;p>Charles E. McCulloch Ph.D2,‡,&lt;/p>
&lt;p>Darin T. Okuda M.D3,‡,&lt;/p>
&lt;p>Alan A. Evangelista1,‡,&lt;/p>
&lt;p>Robin R. Lincoln B.S1,‡,&lt;/p>
&lt;p>Pierre-Antoine Gourraud Ph.D1,‡,&lt;/p>
&lt;p>Don Brenneman B.A1,‡,&lt;/p>
&lt;p>Mary C. Owen N.P1,‡,&lt;/p>
&lt;p>Pamela Qualley M.A1,‡,&lt;/p>
&lt;p>Monica Bucci M.D4,5,‡,&lt;/p>
&lt;p>Stephen L. Hauser M.D1,‡,&lt;/p>
&lt;p>Daniel Pelletier M.D1,6,‡,*&lt;/p>
&lt;p>1 MS Center, Department of Neurology, University of California, San Francisco, San Francisco, CA&lt;/p></description></item><item><title>MS Factoids</title><link>/posts/ms-factoids.html</link><pubDate>Thu, 23 Feb 2012 00:00:00 +0000</pubDate><guid>/posts/ms-factoids.html</guid><description>&lt;h1 id="general-information-about-multiple-sclerosishttpwwwthemcfoxcommultiple-sclerosisms-factsmultiple-sclerosis-factshtm-from-the-mc-foxcom">&lt;a href="http://www.themcfox.com/multiple-sclerosis/ms-facts/multiple-sclerosis-facts.htm">General Information about Multiple Sclerosis&lt;/a> from the MC Fox.com&lt;/h1>
&lt;h3 id="notelow-vitamin-d-increases-probability-of-ms-which-lowers-vitamin-d-levels-even-more--span-stylecolor00fvitamin-d-related-items-are-marked-in-bluespan-">(Note:low vitamin D increases probability of MS which lowers vitamin D levels even more. &lt;strong>&lt;span style="color:#00F;">Vitamin D related items are marked in blue&lt;/span>&lt;/strong> )&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>First Diagnosed in 1849&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The earliest known description of a person with possible Multiple Sclerosis dates from 14th century Holland&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Multiple Sclerosis is the most common progressive and disabling neurological condition in young adults&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Approx 2.5 million people worldwide, have Multiple Sclerosis&lt;/p></description></item><item><title>Will 10000 IU of vitamin D decrease MS - RCT</title><link>/posts/will-10000-iu-of-vitamin-d-decrease-ms-rct.html</link><pubDate>Thu, 09 Feb 2012 00:00:00 +0000</pubDate><guid>/posts/will-10000-iu-of-vitamin-d-decrease-ms-rct.html</guid><description/></item><item><title>MS prevention by UV is 2X better than prevention by vitamin D levels</title><link>/posts/ms-prevention-by-uv-is-2x-better-than-prevention-by-vitamin-d-levels.html</link><pubDate>Wed, 01 Feb 2012 00:00:00 +0000</pubDate><guid>/posts/ms-prevention-by-uv-is-2x-better-than-prevention-by-vitamin-d-levels.html</guid><description>&lt;h4 id="sunlight-is-associated-with-decreased-multiple-sclerosis-risk-no-interaction-with-human-leukocyte-antigen-drb115">Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15.&lt;/h4>
&lt;p>Eur J Neurol. 2012 Jan 31. &lt;a href="https://doi.org/10.1111/j.1468-1331.2011.03650.x.">doi: 10.1111/j.1468-1331.2011.03650.x.&lt;/a>&lt;/p>
&lt;p>Bäärnhielm M, Hedström AK, Kockum I, Sundqvist E, Gustafsson SA, Hillert J, Olsson T, Alfredsson L.&lt;/p>
&lt;p>Institute of Environmental Medicine, Karolinska Institutet, Stockholm Department of Clinical Neuroscience and Center for Molecular Medicine, Karolinska Institutet at Karolinska University Hospital, Stockholm Department of Molecular Medicine and Surgery, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.&lt;/p></description></item><item><title>Increased vitamin D should increase MS quality of life</title><link>/posts/increased-vitamin-d-should-increase-ms-quality-of-life.html</link><pubDate>Thu, 12 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/increased-vitamin-d-should-increase-ms-quality-of-life.html</guid><description>&lt;h4 id="vitamin-d-status-in-multiple-sclerosis-are-there-any-correlations-with-the-health-related-quality-of-life">Vitamin D status in multiple sclerosis: Are there any correlations with the health related quality of life&lt;/h4>
&lt;p>Neurology, Psychiatry and Brain Research&lt;/p>
&lt;p>Volume 18, Issue 1, January 2012, Pages 8–14&lt;/p>
&lt;p>Ayse Kutlua, &lt;a href="mailto:draysekutlu@yahoo.com">draysekutlu@yahoo.com&lt;/a> , Gözde D. Görürb, Hüsnü Efendia, Halil Ünalanc, Sezer ?ener Komsuo?lua&lt;/p>
&lt;p>a Kocaeli University, Faculty of Medicine, Department of Neurology, Kocaeli, Turkey&lt;/p>
&lt;p>b Kocaeli University, Faculty of Medicine, Department of Nuclear Medicine, Kocaeli, Turkey&lt;/p>
&lt;p>c Istanbul University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Istanbul, Turkey&lt;/p></description></item><item><title>Infectious mononucleosis and lack of UV linearly linked to MS in England</title><link>/posts/infectious-mononucleosis-and-lack-of-uv-linearly-linked-to-ms-in-england.html</link><pubDate>Thu, 08 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/infectious-mononucleosis-and-lack-of-uv-linearly-linked-to-ms-in-england.html</guid><description>&lt;h4 id="relationship-of-uv-exposure-to-prevalence-of-multiple-sclerosis-in-england">Relationship of UV exposure to prevalence of multiple sclerosis in England&lt;/h4>
&lt;p>Neurology. 2011 April 19; 76(16): 1410–1414. &lt;a href="https://doi.org/10.1212/WNL.0b013e318216715e">doi: 10.1212/WNL.0b013e318216715e&lt;/a>&lt;/p>
&lt;p>S.V. Ramagopalan, DPhil, A.E. Handel, BMBCh, G. Giovannoni, MD, S. Rutherford Siegel, PhD, G.C. Ebers, MD, FMedSci, &lt;a href="mailto:george.ebers@clneuro.ox.ac.uk">george.ebers@clneuro.ox.ac.uk&lt;/a> and G. Chaplin, MS &lt;a href="mailto:guc5@psu.edu">guc5@psu.edu&lt;/a>&lt;/p>
&lt;p>From the Wellcome Trust Centre for Human Genetics (S.V.R., A.E.H., G.C.E.) and Department of Clinical Neurology (S.V.R., A.E.H., G.C.E.), University of Oxford, Oxford; Blizard Institute of Cell and Molecular Science (S.V.R., G.G.), Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK; and Department of Anthropology (S.R.S., G.C.), The Pennsylvania State University, Philadelphia.&lt;/p></description></item><item><title>Mutation of Vitamin D gene (CYP27B1) is strongly tied to MS</title><link>/posts/mutation-of-vitamin-d-gene-cyp27b1-is-strongly-tied-to-ms.html</link><pubDate>Thu, 08 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/mutation-of-vitamin-d-gene-cyp27b1-is-strongly-tied-to-ms.html</guid><description>&lt;p>The researchers looked for the gene variant in more than 3,000 families of unaffected parents with a child with MS,&lt;/p>
&lt;p>and found 35 parents who carried one copy of this variant along with one normal copy.&lt;/p>
&lt;p>&lt;strong>In every one of these 35 cases, their child with MS had inherited the mutated version of the gene.&lt;/strong>&lt;/p>
&lt;p>The likelihood of this gene’s transmission being unconnected to the MS is billion to one against&lt;/p></description></item><item><title>Vitamin D is hot in MS research</title><link>/posts/vitamin-d-is-hot-in-ms-research.html</link><pubDate>Fri, 11 Nov 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-hot-in-ms-research.html</guid><description>&lt;h1 id="vitamin-d-and-multiple-sclerosis-correlation-causality-and-controversy">Vitamin d and multiple sclerosis: correlation, causality, and controversy.&lt;/h1>
&lt;p>Autoimmune Dis. 2010 Oct 5;2011:629538.&lt;/p>
&lt;p>Smolders J.&lt;/p>
&lt;p>Division of Clinical and Experimental Immunology, Department of Internal Medicine and School for Mental Health and Neuroscience, Maastricht University Medical Center, Universiteitssingel 50, P.O. Box 616, 6200 MD Maastricht, The Netherlands.&lt;/p>
&lt;p>Abstract&lt;/p>
&lt;p>The last years, many studies reported associations between correlates of vitamin D exposure and several correlates of multiple sclerosis (MS) disease activity. This review discusses studies on vitamin D status, Expanded Disability Status Scale (EDSS) score, and relapse activity of MS. Furthermore, several considerations for intervention studies on vitamin D supplementation in MS are provided.&lt;/p></description></item><item><title>MS worse with Vitamin D2</title><link>/posts/ms-worse-with-vitamin-d2.html</link><pubDate>Sat, 29 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/ms-worse-with-vitamin-d2.html</guid><description>&lt;h2 id="multiple-sclerosis-and-vitamin-dhttpwwwneurologyorgcontent7717e99short">&lt;a href="http://www.neurology.org/content/77/17/e99.short">Multiple sclerosis and vitamin D&lt;/a>&lt;/h2>
&lt;h2 id="random-controlled-trial-with-6000-iu-of-vitamin-d2">Random controlled trial with 6,000 IU of vitamin D2&lt;/h2>
&lt;p>While the high-dose group did reach higher levels of vitamin D, there were no significant differences between the groups in regard to MRI changes.&lt;/p>
&lt;p>The high-dose group actually had significantly more relapses and worse disability than the low-dose group at the end of the study&lt;/p>
&lt;p>PDF is attached to the bottom of this page&lt;/p>
&lt;hr>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/chance-of-a-fall-decreased-with-vitamin-d3-but-increased-with-d2">Chance of a fall decreased with vitamin D3 but increased with D2 – Oct 2011&lt;/a>&lt;/p></description></item><item><title>Why has the MS latitude gradient disappeared</title><link>/posts/why-has-the-ms-latitude-gradient-disappeared.html</link><pubDate>Sat, 15 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/why-has-the-ms-latitude-gradient-disappeared.html</guid><description>&lt;h4 id="why-does-the-northsouth-gradient-of-incidence-of-multiple-sclerosis-seem-to-have-disappeared-on-the-northern-hemisphere">Why does the north–south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?&lt;/h4>
&lt;p>Journal of the Neurological Sciences, doi:10.1016/j.jns.2011.09.003&lt;/p>
&lt;p>Nils Koch-Henriksen a, b, Per Soelberg Sorensen c, &lt;a href="mailto:pss@rh.dk">pss@rh.dk&lt;/a>&lt;/p>
&lt;p>a	Department of Neurology, Aarhus University Hospital in Aalborg, Denmark&lt;/p>
&lt;p>b	The Danish Multiple Sclerosis Registry, Neuroscience Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark&lt;/p>
&lt;p>c	Danish Multiple Sclerosis Center, University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark&lt;/p></description></item><item><title>CureTogether Vitamin D symptoms, treatments, and causes</title><link>/posts/curetogether-vitamin-d-symptoms-treatments-and-causes.html</link><pubDate>Fri, 14 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/curetogether-vitamin-d-symptoms-treatments-and-causes.html</guid><description>&lt;h1 id="curetogetherhttpcuretogethercomvitamin-d-deficiencysymptoms-is-an-excellent-source-on-100s-of-diseases">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">CureTogether&lt;/a> is an excellent source on 100&amp;rsquo;s of diseases&lt;/h1>
&lt;h3 id="a-hrefpostsspan-stylecolorf00click-herespan-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-4933span-stylecolorf00click-herespana-for-update-dec-2013">&lt;a href="/posts/span-stylecolorf00click-herespan" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 4933">&lt;span style="color:#F00;">CLICK HERE&lt;/span>&lt;/a> for update Dec 2013&lt;/h3>
&lt;h2 id="snapshot-on-vitamin-d-oct-2011">Snapshot on Vitamin D Oct 2011&lt;/h2>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/ct-symptoms.png" alt="image" style="max-width: 600px;">
&lt;p>&lt;strong>&lt;span style="color:#00F;">The darker the blue the more severe: minimal, mild, moderate, severe, extreme &lt;/span>&lt;/strong>&lt;/p>
&lt;p>Gray = not rated&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/ct-treatment-by-most-improvement.png" alt="image" style="max-width: 600px;">
&lt;h2 id="chart-is-sorted-by-improvement-top--best">Chart is sorted by improvement: top = best&lt;/h2>
&lt;p>&lt;span style="color:#090;">Light Green = Moderate improvement&lt;/span>; &lt;strong>&lt;span style="color:#090;">Dark green = major improvement&lt;/span>&lt;/strong> ; Gray = No effect&lt;/p></description></item><item><title>Learning about MS and vitamin D in offspring from mice</title><link>/posts/learning-about-ms-and-vitamin-d-in-offspring-from-mice.html</link><pubDate>Wed, 28 Sep 2011 00:00:00 +0000</pubDate><guid>/posts/learning-about-ms-and-vitamin-d-in-offspring-from-mice.html</guid><description>&lt;h1 id="seasonal-gestational-and-postnatal-influences-on-multiple-sclerosis-the-beneficial-role-of-a-vitamin-d-supplementation-during-early-life">Seasonal, gestational and postnatal influences on multiple sclerosis: The beneficial role of a vitamin D supplementation during early life.&lt;/h1>
&lt;p>J Neurol Sci. 2011 Sep 17.&lt;/p>
&lt;p>Fernandes de Abreu DA, Landel V, Féron F.&lt;/p>
&lt;p>There is now strong evidence linking vitamin D, the steroid hormone of sunlight, and Multiple Sclerosis (MS).&lt;/p>
&lt;p>Two of the most intriguing findings are the season of birth and childhood sun exposure effects.&lt;/p>
&lt;p>They both suggest that a vitamin D deficiency during these critical imprinting periods is a risk factor for MS.&lt;/p></description></item><item><title>Multiple Sclerosis etc. strongly associated with Epstein-Barr virus (and vitamin D)</title><link>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</link><pubDate>Thu, 25 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-etc-strongly-associated-with-epstein-barr-virus-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-for-the-role-of-a-virus-in-ms-httpswwwnationalmssocietyorgwhat-is-mswhat-causes-msviruses-national-ms-org-2021">&lt;a href="https://www.nationalmssociety.org/What-is-MS/What-Causes-MS/Viruses">Evidence for the role of a virus in MS &lt;/a> National MS Org 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epsteinbarr-virus-in-multiple-sclerosis-theory-and-emerging-immunotherapies---march-2020">Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies - March 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-epstein-barr-virus-in-multiple-sclerosis">The role of Epstein-Barr virus in multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#exploring-the-effect-of-vitamin-d3-supplementation-on-the-anti-ebv-antibody-response-in-relapsing-remitting-multiple-sclerosis---2018">Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis - 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epstein-barr-virus-and-mononucleosis">Epstein-Barr Virus and Mononucleosis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-diseases-associated-with-epstein-barr-virus">Other diseases associated with Epstein-Barr Virus&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-epstein-barr-virus-and-endogenous-retroviruses-in-multiple-sclerosis---facts-and-hypotheses---march-2021">Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses - March 2021&lt;/h4>
&lt;p>J Integr Neurosci. 2021 Mar 30;20(1):233-238. &lt;a href="https://doi.org/10.31083/j.jin.2021.01.392.">doi: 10.31083/j.jin.2021.01.392.&lt;/a>&lt;/p></description></item><item><title>There is more in UV than vitamin D which suppresses MS in mice</title><link>/posts/there-is-more-in-uv-than-vitamin-d-which-suppresses-ms-in-mice.html</link><pubDate>Mon, 22 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/there-is-more-in-uv-than-vitamin-d-which-suppresses-ms-in-mice.html</guid><description/></item><item><title>UV produces more than vitamin D</title><link>/posts/uv-produces-more-than-vitamin-d.html</link><pubDate>Sun, 21 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/uv-produces-more-than-vitamin-d.html</guid><description>&lt;h4 id="modulation-of-the-immune-system-by-uv-radiation-more-than-just-the-effects-of-vitamin-d">Modulation of the immune system by UV radiation: more than just the effects of vitamin D?&lt;/h4>
&lt;p>Nat Rev Immunol. 2011 Aug 19. &lt;a href="https://doi.org/10.1038/nri3045.">doi: 10.1038/nri3045.&lt;/a>&lt;/p>
&lt;p>Hart PH, Gorman S, Finlay-Jones JJ.&lt;/p>
&lt;p>Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, PO Box 855, Perth, Western Australia 6872, Australia.&lt;/p>
&lt;p>Humans obtain most of their vitamin D through the exposure of skin to sunlight. The immunoregulatory properties of vitamin D have been demonstrated in studies showing that vitamin D deficiency is associated with poor immune function and increased disease susceptibility.&lt;/p></description></item><item><title>MS associated with 29 new and 23 previously known gene variants</title><link>/posts/ms-associated-with-29-new-and-23-previously-known-gene-variants.html</link><pubDate>Wed, 10 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/ms-associated-with-29-new-and-23-previously-known-gene-variants.html</guid><description>&lt;p>&lt;strong>Following press release is translated from German, and is followed by abstract&lt;/strong>&lt;/p>
&lt;h3 id="multiple-sclerosis-is-a-disease-of-the-immune-system">Multiple sclerosis is a disease of the immune system&lt;/h3>
&lt;p>&lt;a href="http://translate.google.com/translate?js=n&amp;amp;prev=_t&amp;amp;hl=en&amp;amp;ie=UTF-8&amp;amp;layout=2&amp;amp;eotf=1&amp;amp;sl=de&amp;amp;tl=en&amp;amp;u=http%3A%2F%2Fidw-online.de%2Fen%2Fnews436197%20">Press Release&lt;/a> Master of Business Administration (FH) Caroline Bahnemann&lt;/p>
&lt;p>Office of Communications and Press&lt;/p>
&lt;p>University of Medicine of the Johannes Gutenberg University Mainz; 08/10/2011 19:00&lt;/p>
&lt;p>International consortium of researchers found 29 new MS gene variants - involved researchers from Mainz&lt;/p>
&lt;p>Scientists have identified &lt;strong>29 new genetic variants associated with disease multiple sclerosis&lt;/strong> . Many of the genes that were identified in the study belong to the immune system - so this is crucial in the development of the disease. Today the work of the international research consortium led by the Universities of Cambridge and Oxford in the &lt;strong>journal Nature&lt;/strong> , was published. It is the largest ever genetic study of multiple sclerosis.&lt;/p></description></item><item><title>Decreased winter sun speeded up subsequent MS development 2X – VA</title><link>/posts/decreased-winter-sun-speeded-up-subsequent-ms-development-2x-va.html</link><pubDate>Tue, 09 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/decreased-winter-sun-speeded-up-subsequent-ms-development-2x-va.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="sun-exposure-vitamin-d-intake-and-progression-to-disability-among-veterans-with-progressive-multiple-sclerosis">Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis.&lt;/h1>
&lt;p>Neuroepidemiology. 2011 Aug 5;37(1):52-57.&lt;/p>
&lt;p>McDowell TY, Amr S, Culpepper WJ, Langenberg P, Royal W, Bever C, Bradham DD.&lt;/p>
&lt;p>MS Center of Excellence-East, Baltimore VAMC, Baltimore, Md., USA.&lt;/p>
&lt;p>Background: Early life events have been suggested to influence multiple sclerosis (MS) susceptibility, and to potentially modulate its clinical course. We assessed vitamin D-related exposures from childhood to disease onset and their associations with MS progression.&lt;/p></description></item><item><title>High vitamin D in moms decreased MS incidence in daughters by 40%</title><link>/posts/high-vitamin-d-in-moms-decreased-ms-incidence-in-daughters-by-40-percent.html</link><pubDate>Tue, 26 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/high-vitamin-d-in-moms-decreased-ms-incidence-in-daughters-by-40-percent.html</guid><description>&lt;h4 id="gestational-vitamin-d-and-the-risk-of-multiple-sclerosis-in-offspring">Gestational vitamin D and the risk of multiple sclerosis in offspring.&lt;/h4>
&lt;p>Ann Neurol. 2011 Jul;70(1):30-40. &lt;a href="https://doi.org/10.1002/ana.22456.">doi: 10.1002/ana.22456.&lt;/a>&lt;/p>
&lt;p>Mirzaei F, Michels KB, Munger K, O&amp;rsquo;Reilly E, Chitnis T, Forman MR, Giovannucci E, Rosner B, Ascherio A.&lt;/p>
&lt;p>Department of Nutrition, Harvard School of Public Health, Boston, MA; Department of Epidemiology, Harvard School of Public Health, Boston, MA. &lt;a href="mailto:fmirzaei@hsph.harvard.edu">fmirzaei@hsph.harvard.edu&lt;/a>.&lt;/p>
&lt;p>OBJECTIVE:Vitamin D may have a protective role in the etiology of multiple sclerosis (MS), but the effect of gestational vitamin D on adult onset MS has not been studied.&lt;/p></description></item><item><title>MS new cases increased 2.5X in 2 years in Isfahan Iran</title><link>/posts/ms-new-cases-increased-25x-in-2-years-in-isfahan-iran.html</link><pubDate>Mon, 18 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/ms-new-cases-increased-25x-in-2-years-in-isfahan-iran.html</guid><description>&lt;h3 id="sharp-increase-in-the-incidence-and-prevalence-of-multiple-sclerosis-in-isfahan-iran">Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran&lt;/h3>
&lt;p>Masoud Etemadifar1,3&lt;/p>
&lt;p>Amir-Hadi Maghzi1,2? &lt;a href="mailto:Maghzi@edc.mui.ac.ir">Maghzi@edc.mui.ac.ir&lt;/a>&lt;/p>
&lt;p>1 Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p>
&lt;p>2 Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK.&lt;/p>
&lt;p>3 Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p>
&lt;p>Amir-Hadi Maghzi, Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Multiple Sclerosis Clinic, Al-Zahra Hospital, Isfahan University of Medical Sciences, Soffeh Street, Isfahan 81744, Iran&lt;/p></description></item><item><title>3X less Multiple Sclerosis with enough vitamin D - Veterans Administration</title><link>/posts/3x-less-multiple-sclerosis-with-enough-vitamin-d-veterans-administration.html</link><pubDate>Thu, 14 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/3x-less-multiple-sclerosis-with-enough-vitamin-d-veterans-administration.html</guid><description>&lt;h4 id="it-appears-that-after-a-hrefpostsmuch-study-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-1242much-studya-that-the-us-veterans-admin-has-decided-that-vitamin-d-does-indeed-help-ms">It appears that after &lt;a href="/posts/much-study" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 1242">much study&lt;/a> that the US Veterans Admin. has decided that Vitamin D does indeed help MS&lt;/h4>
&lt;h5 id="the-va-multiple-sclerosis-center-of-excellencehttpwwwvagovmsvideo_multiple_sclerosis_and_vitamin_dasp-has-a-video-on-the-web-july-2011">The VA &lt;a href="http://www.va.gov/MS/video_multiple_sclerosis_and_vitamin_D.asp">Multiple Sclerosis Center of Excellence&lt;/a> has a video on the web July 2011&lt;/h5>
&lt;h4 id="the-25-minute-video-is-just-people-talking-but-has-the-following-graph">The 2.5 minute video is just people talking, but has the following graph&lt;/h4>
&lt;p>from an unknown study - perhaps in 2011&lt;/p>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/png/ms-and-vitamin-d-va---2011.png" alt="image">
&lt;p>The horizontal axis shows the amount of vitamin D in the blood BEFORE getting MS&lt;/p></description></item><item><title>Yet again - more than 10000 IU of vitamin D treats MS</title><link>/posts/yet-again-more-than-10000-iu-of-vitamin-d-treats-ms.html</link><pubDate>Tue, 12 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/yet-again-more-than-10000-iu-of-vitamin-d-treats-ms.html</guid><description>&lt;h3 id="sunshine-vitamin-sheds-light-on-ms">Sunshine Vitamin Sheds Light on MS&lt;/h3>
&lt;p>&lt;a href="http://sciencemedicine.org/content/3/90/90ec102.short%20">Science Translational Medicine Home &amp;gt; 6 July 2011&lt;/a>&lt;/p>
&lt;p>Vol. 3, Issue 90, p. 90ec102&lt;/p>
&lt;p>Rebecca S. Boxer&lt;/p>
&lt;p>Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. E-mail: &lt;a href="mailto:Rebecca.Boxer@UHhospitals.org">Rebecca.Boxer@UHhospitals.org&lt;/a>&lt;/p>
&lt;p>Mother’s advice to get out into the sunshine may be better advice then many realize. Vitamin D, the sunshine vitamin, which is produced in skin exposed to ultraviolet (UVB) light, may have important down-regulatory effects on the inflammatory response in patients.&lt;/p></description></item><item><title>MS reduces vitamin D which then causes osteoporosis</title><link>/posts/ms-reduces-vitamin-d-which-then-causes-osteoporosis.html</link><pubDate>Fri, 08 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/ms-reduces-vitamin-d-which-then-causes-osteoporosis.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="multiple-sclerosis-a-cause-of-secondary-osteoporosis-what-is-the-evidence-and-what-are-the-clinical-implications">Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?&lt;/h1>
&lt;p>Acta Neurol Scand Suppl. 2011;(191):44-9. &lt;a href="https://doi.org/10.1111/j.1600-0404.2011.01543.x.">doi: 10.1111/j.1600-0404.2011.01543.x.&lt;/a>&lt;/p>
&lt;p>Kampman MT, Eriksen EF, Holmøy T.&lt;/p>
&lt;p>Centre for Clinical Research and Education, University Hospital of North Norway, Tromsø, Norway Department of Clinical Medicine, University of Tromsø, Tromsø, Norway Department of Clinical Endocrinology, Oslo University Hospital, Aker, Oslo, Norway Department of Neurology, Akershus University Hospital, Nordbyhagen, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway.&lt;/p></description></item><item><title>Vitamin D patent for treating immune system diseases</title><link>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</link><pubDate>Sun, 03 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-patent-for-treating-immune-system-diseases.html</guid><description>&lt;h2 id="wo2008039409httpwwwwipointpatentscopesearchenwo2008039409-world-wide-patent---2008">&lt;a href="http://www.wipo.int/patentscope/search/en/WO2008039409">(WO2008039409)&lt;/a> World-Wide patent - 2008&lt;/h2>
&lt;h4 id="treatment-and-prevention-of-diseases-or-conditions-of-the--immune-system-or-infectious-diseases">TREATMENT AND PREVENTION OF DISEASES OR CONDITIONS OF THE &lt;strong>IMMUNE SYSTEM OR INFECTIOUS DISEASES&lt;/strong>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>allergic rhinitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>eczema,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>psoriasis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>food allergy,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>type-1 diabetes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>ulcerative colitis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Crohn&amp;rsquo;s disease,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>rheumatoid arthritis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>multiple sclerosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>lupus,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>tuberculosis,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>parasitic infection, etc,&lt;/p>
&lt;/li>
&lt;/ul></description></item><item><title>Vitamin D targets 4 MS genes</title><link>/posts/vitamin-d-targets-4-ms-genes.html</link><pubDate>Thu, 02 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-targets-4-ms-genes.html</guid><description>&lt;h3 id="genetics-and-the-environment-converge-to-dysregulate-n-glycosylation-in-multiple-sclerosis">Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis&lt;/h3>
&lt;p>Nature Communications, Article number: 334, doi:10.1038/ncomms1333&lt;/p>
&lt;p>Haik Mkhikian, Ani Grigorian, Carey F. Li, Hung-Lin Chen, Barbara Newton, Raymond W. Zhou, Christine Beeton, Sevan Torossian, Gevork Grikor Tatarian, Sung-Uk Lee, Ken Lau, Erin Walker, Katherine A. Siminovitch, K. George Chandy, Zhaoxia Yu, James W. Dennis. &lt;strong>Michael Demetriou&lt;/strong> &lt;a href="mailto:mdemetri@uci.edu">mdemetri@uci.edu&lt;/a>&lt;/p>
&lt;p>Received – 02 February 2011, Accepted – 04 May 2011, Published – 31 May 2011&lt;/p></description></item><item><title>300000 IU vitamin D monthly may treat MS</title><link>/posts/300000-iu-vitamin-d-monthly-may-treat-ms.html</link><pubDate>Sun, 08 May 2011 00:00:00 +0000</pubDate><guid>/posts/300000-iu-vitamin-d-monthly-may-treat-ms.html</guid><description>&lt;h2 id="therapeutic-effect-of-vitamin-d3-in-multiple-sclerosis-patients">Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients.&lt;/h2>
&lt;p>Immunol Invest. 2011 May 4.&lt;/p>
&lt;p>Mosayebi G, Ghazavi A, Ghasami K, Jand Y, Kokhaei P.&lt;/p>
&lt;p>Molecular and Medicine Research Center, Department of Immunology, School of Medicine, Arak University of Medical Sciences, Arak, I.R. Iran.&lt;/p>
&lt;p>Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the central nervous system are damaged. The damage leads to demyelination and scarring as well as a broad spectrum of signs and symptoms. The epidemiological data suggest a possible influence of vitamin D as an immunomodulatory agent on multiple sclerosis susceptibility as well as on clinical course of the disease. We investigated the effects of short-term vitamin D3 therapy on Iranian patients with MS.&lt;/p></description></item><item><title>Reduced vitamin D and BMD and Neurological Conditions</title><link>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</link><pubDate>Wed, 04 May 2011 00:00:00 +0000</pubDate><guid>/posts/reduced-vitamin-d-and-bmd-and-neurological-conditions.html</guid><description>&lt;h1 id="bone-mineral-density-in-adults-disabled-through-acquired-neurological-conditions-a-review">Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/h1>
&lt;p>Journal of Clinical Densitometry&lt;/p>
&lt;p>Volume 14, Issue 2 , Pages 85-94, April 2011&lt;/p>
&lt;p>Bone Mineral Density in Adults Disabled Through Acquired Neurological Conditions: A Review&lt;/p>
&lt;p>Áine Carroll&lt;/p>
&lt;p>Received 10 June 2010; received in revised form 12 December 2010; accepted 13 December 2010. published online 07 April 2011.&lt;/p>
&lt;p>This article is a review of the changes in bone mineral density (BMD), which occur in a number of acquired neurological conditions resulting in disability.&lt;/p></description></item><item><title>MS is related to latitude – conclusion from 321 studies</title><link>/posts/ms-is-related-to-latitude-conclusion-from-321-studies.html</link><pubDate>Sun, 01 May 2011 00:00:00 +0000</pubDate><guid>/posts/ms-is-related-to-latitude-conclusion-from-321-studies.html</guid><description>&lt;h3 id="ms-is-significantly-associated-with-the-prevalence-of-multiple-sclerosis-a-meta-analysis">MS is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry. 2011 Apr 8. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B.&lt;/p>
&lt;p>Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.&lt;/p>
&lt;p>Background There is a striking latitudinal gradient in multiple sclerosis (MS) prevalence, but exceptions in Mediterranean Europe and northern Scandinavia, and some systematic reviews, have suggested that the gradient may be an artefact. The authors sought to evaluate the association between MS prevalence and latitude by meta-regression.&lt;/p></description></item><item><title>Vitamin D is a T-cell modulator in multiple sclerosis – April 2011.</title><link>/posts/vitamin-d-is-a-t-cell-modulator-in-multiple-sclerosis-april-2011.html</link><pubDate>Sun, 03 Apr 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-a-t-cell-modulator-in-multiple-sclerosis-april-2011.html</guid><description>&lt;h1 id="vitamin-d-as-a-t-cell-modulator-in-multiple-sclerosis">Vitamin D as a T-cell modulator in multiple sclerosis&lt;/h1>
&lt;p>Vitam Horm. 2011;86:401-28.&lt;/p>
&lt;p>Smolders J, Damoiseaux J.&lt;/p>
&lt;p>School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Internal Medicine, Division of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.&lt;/p>
&lt;p>Vitamin D is a potent immune modulator, keeping the T-cell compartment in a more tolerogenic state. Multiple sclerosis (MS), a disease in which an autoreactive T-cell response contributes to inflammation in the central nervous system, has been associated with vitamin D deficiency. The effects of vitamin D on the immune system are believed to be an important driver of this association. In this chapter, we elaborate on vitamin D as a modulator of the T-cell response. This discussion will be placed in the perspective of MS as a T-cell-mediated disease and in the perspective of the numerous association studies on vitamin D deficiency and multiple health outcomes.&lt;/p></description></item><item><title>2800 IU vitamin D daily did not decrease bone loss for those with MS</title><link>/posts/2800-iu-vitamin-d-daily-did-not-decrease-bone-loss-for-those-with-ms.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/2800-iu-vitamin-d-daily-did-not-decrease-bone-loss-for-those-with-ms.html</guid><description>&lt;h1 id="can-vitamin-d3-supplementation-prevent-bone-loss-in-persons-with-ms-a-placebo-controlled-trial">Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial.&lt;/h1>
&lt;p>J Neurol. 2011 Mar 13.&lt;/p>
&lt;p>Steffensen LH, Jørgensen L, Straume B, Mellgren SI, Kampman MT.&lt;/p>
&lt;p>Department of Neurology, University Hospital of North Norway, Tromsø, Norway, &lt;a href="mailto:linn.hofsoy.steffensen@unn.no">linn.hofsoy.steffensen@unn.no&lt;/a>.&lt;/p>
&lt;p>Multiple sclerosis (MS) is a possible cause of secondary osteoporosis. In this phase II trial we assessed whether a weekly dose of 20,000 IU vitamin D(3) prevents bone loss in ambulatory persons with MS age 18-50 years. ClinicalTrials.gov ID NCT00785473. All patients managed at the University Hospital of North Norway who fulfilled the main inclusion criteria were invited to participate in this double-blinded trial. Participants were randomised to receive &lt;strong>20,000 IU vitamin D(3) or placebo once a week&lt;/strong> and 500 mg calcium daily for 96 weeks. The primary outcome was the effect of the intervention on percentage change in bone mineral density (BMD) at the hip, the spine, and the ultradistal radius over the study period. Of 71 participants randomised, 68 completed. Mean serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels in the intervention group increased from 55 nmol/L at baseline to 123 nmol/L at week 96. After 96 weeks, percentage change in BMD did not differ between groups at any site. BMD decreased at the hip, by 1.4% in the placebo group (95% CI -2.3 to -0.4, SD 2.7, p = 0.006) and by 0.7% in the treatment group (-1.6 to 0.2, 2.7, p = 0.118), difference 0.7% (-1.9 to 0.7, p = 0.332). Findings were not altered by adjustment for sex or serum 25(OH)D.&lt;/p></description></item><item><title>Lack of sun and lack of vitamin D are both MS risk factors</title><link>/posts/lack-of-sun-and-lack-of-vitamin-d-are-both-ms-risk-factors.html</link><pubDate>Wed, 30 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/lack-of-sun-and-lack-of-vitamin-d-are-both-ms-risk-factors.html</guid><description>&lt;h1 id="sun-exposure-and-vitamin-d-are-independent-risk-factors-for-cns-demyelination">Sun exposure and vitamin D are independent risk factors for CNS demyelination.&lt;/h1>
&lt;p>Neurology. 2011 Feb 8;76(6):540-8.&lt;/p>
&lt;p>Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, Kilpatrick TJ, Dwyer T, Coulthard A, Chapman C, van der Mei I, Williams D, McMichael AJ.&lt;/p>
&lt;p>National Centre for Epidemiology and Population Health, The Australian National University, Canberra 0200, Australia. &lt;a href="mailto:Robyn.Lucas@anu.edu.au">Robyn.Lucas@anu.edu.au&lt;/a>&lt;/p>
&lt;p>OBJECTIVES: To examine whether past and recent sun exposure and vitamin D status (serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> levels) are associated with risk of first demyelinating events (FDEs) and to evaluate the contribution of these factors to the latitudinal gradient in FDE incidence in Australia.&lt;/p></description></item><item><title>Unable to find a gene linking vitamin D and MS</title><link>/posts/unable-to-find-a-gene-linking-vitamin-d-and-ms.html</link><pubDate>Tue, 29 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/unable-to-find-a-gene-linking-vitamin-d-and-ms.html</guid><description>&lt;h1 id="vitamin-d-metabolic-pathway-genes-and-risk-of-multiple-sclerosis-in-canadians">Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.&lt;/h1>
&lt;p>Neurol Sci. 2011 Mar 25.&lt;/p>
&lt;p>Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.&lt;/p>
&lt;p>Wellcome Trust Centre for Human Genetics and Department of Clinical Neurology, University of Oxford, Oxford, UK.&lt;/p>
&lt;p>BACKGROUND: Multiple sclerosis (MS) is determined by interactions between genes and environment and the influence of vitamin D adequacy has been proposed. Previous studies have shown that serum 25-hydroxyvitaminD (25(OH)D) levels are genetically influenced. Polymorphisms in vitamin D pathway genes are candidates for association with MS susceptibility.&lt;/p></description></item><item><title>Increased sun and vitamin D both reduced MS risk</title><link>/posts/increased-sun-and-vitamin-d-both-reduced-ms-risk.html</link><pubDate>Sun, 13 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/increased-sun-and-vitamin-d-both-reduced-ms-risk.html</guid><description>&lt;h3 id="sun-exposure-and-vitamin-d-are-independent-risk-factors-for-cns-demyelination">Sun exposure and vitamin D are independent risk factors for CNS demyelination&lt;/h3>
&lt;ol>
&lt;li>
&lt;p>R.M. Lucas, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A.-L. Ponsonby, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>K. Dear, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>P.C. Valery, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>M.P. Pender, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>B.V. Taylor, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>T.J. Kilpatrick, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>T. Dwyer, MD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A. Coulthard, FRANZCR,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>C. Chapman, FRACP,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>I. van der Mei, PhD,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>D. Williams, PhD and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>A.J. McMichael, PhD&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>From the National Centre for Epidemiology and Population Health (R.M.L., K.D., A.J.M.), The Australian National University, Canberra; Murdoch Childrens Research Institute (A.-L.P., T.D.), Melbourne; Queensland Institute of Medical Research (P.C.V.), Brisbane; The University of Queensland and Royal Brisbane and Women&amp;rsquo;s Hospital (M.P.P., A.C.), Brisbane; Menzies Research Institute (B.V.T., I.v.d.M.), Hobart; Centre for Neuroscience (T.J.K.), The University of Melbourne, Melbourne; Department of Neurology (C.C.), Barwon Health, Geelong; and Department of Neurophysiology (D.W.), John Hunter Hospital, Newcastle, Australia.&lt;/p></description></item><item><title>Vitamin D and MS - Correlation - Causality – Controversy</title><link>/posts/vitamin-d-and-ms-correlation-causality-controversy.html</link><pubDate>Sun, 13 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-ms-correlation-causality-controversy.html</guid><description>&lt;h1 id="vitamin-d-and-multiple-sclerosis-correlation-causality-and-controversy">Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy&lt;/h1>
&lt;p>Autoimmune Dis. 2011; 2011: 629538.&lt;/p>
&lt;p>Published online 2010 October 5. &lt;a href="https://doi.org/10.4061/2011/629538.">doi: 10.4061/2011/629538.&lt;/a>&lt;/p>
&lt;p>Copyright © 2011 Joost Smolders.&lt;/p>
&lt;p>Joost &lt;a href="mailto:Smoldersj.smolders@mumc.nl">Smoldersj.smolders@mumc.nl&lt;/a>, 2*&lt;/p>
&lt;p>1Division of Clinical and Experimental Immunology, Department of Internal Medicine and School for Mental Health and Neuroscience, Maastricht University Medical Center, Universiteitssingel 50, P.O. Box 616, 6200 MD Maastricht, The Netherlands&lt;/p>
&lt;p>2Academic MS Center Limburg, Orbis Medical Center, P.O. Box 5500, 6130 MB Sittard, The Netherlands&lt;/p></description></item><item><title>More females have MS – perhaps due to vitamin D deficiency</title><link>/posts/more-females-have-ms-perhaps-due-to-vitamin-d-deficiency.html</link><pubDate>Tue, 01 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/more-females-have-ms-perhaps-due-to-vitamin-d-deficiency.html</guid><description>&lt;h1 id="the-increasing-incidence-and-prevalence-of-female-multiple-sclerosis---a-critical-analysis-of-potential-environmental-factors">The increasing incidence and prevalence of female multiple sclerosis - a critical analysis of potential environmental factors.&lt;/h1>
&lt;p>Autoimmun Rev. 2011 Feb 24.&lt;/p>
&lt;p>Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O.&lt;/p>
&lt;p>Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany; Department of Neurology, Christian-Doppler Klinik, Paracelsus Medizinische Universität, Salzburg, Austria.&lt;/p>
&lt;p>Multiple sclerosis (MS) is the most common acquired inflammatory demyelinating disorder of the central nervous system (CNS). Not unlike many inflammatory diseases with a presumed autoimmune pathogenesis, it has been established that there is a female preponderance in prevalence. While in the past it was shown that there are &lt;strong>two women for every man with a diagnosis of MS&lt;/strong> , recent serial cross-sectional assessments provide compelling evidence for an increase of the female to male sex ratio in patients with relapsing-remitting MS over the last decades. An understanding of this phenomenon might provide key insights into the pathogenesis of the disease but also may have implications for health-care strategies and further research efforts.&lt;/p></description></item><item><title>20000 IU vitamin D and MS – less fatigue and relapse</title><link>/posts/20000-iu-vitamin-d-and-ms-less-fatigue-and-relapse.html</link><pubDate>Fri, 17 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/20000-iu-vitamin-d-and-ms-less-fatigue-and-relapse.html</guid><description>&lt;h1 id="safety-and-t-cell-modulating-effects-of-high-dose-vitamin-d3-supplementation-in-multiple-sclerosis">Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis&lt;/h1>
&lt;p>PLoS ONE 5(12): e15235. doi:10.1371/journal.pone.0015235, Clinicaltrials.gov NCT00940719&lt;/p>
&lt;p>Joost Smolders1,2,3*, Evelyn Peelen1,2,3, Mariëlle Thewissen2, Jan Willem Cohen Tervaert1,2,5, Paul Menheere4, Raymond Hupperts1,3, Jan Damoiseaux2,5&lt;/p>
&lt;p>1 School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands,&lt;/p>
&lt;p>2 Division of Clinical and Experimental Immunology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands,&lt;/p></description></item><item><title>Lack of sunshine associated with MS two years sooner – 2 VHA articles 2010</title><link>/posts/lack-of-sunshine-associated-with-ms-two-years-sooner-2-vha-articles-2010.html</link><pubDate>Thu, 16 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/lack-of-sunshine-associated-with-ms-two-years-sooner-2-vha-articles-2010.html</guid><description>&lt;p> &lt;/p>
&lt;h2 id="and--cod-liver-oil-associated-with-ms-4-years-later">And – Cod Liver oil associated with MS 4 years later&lt;/h2>
&lt;h1 id="sun-exposure-vitamin-d-and-age-at-disease-onset-in-relapsing-multiple-sclerosis">Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis&lt;/h1>
&lt;p>Vol. 36, No. 1, 2011&lt;/p>
&lt;p>Tzu-Yun McDowella, b, Sania Amrb, William J. Culpeppera, d, Patricia Langenbergb, Walter Royala, c, Christopher Bevera, c, Douglas D. Bradhama, e&lt;/p>
&lt;p>aMS Center of Excellence-East, Baltimore VAMC &lt;a href="mailto:tycmcdowell@hotmail.com">tycmcdowell@hotmail.com&lt;/a>&lt;/p>
&lt;p>Departments of&lt;/p>
&lt;p>bEpidemiology and Public Health and&lt;/p>
&lt;p>cNeurology, School of Medicine, and&lt;/p>
&lt;p>dDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Md., and&lt;/p></description></item><item><title>Lack of UV 20X more associated with MS than any other variable</title><link>/posts/lack-of-uv-20x-more-associated-with-ms-than-any-other-variable.html</link><pubDate>Thu, 16 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/lack-of-uv-20x-more-associated-with-ms-than-any-other-variable.html</guid><description>&lt;h4 id="a-quantitative-analysis-of-suspected-environmental-causes-of-ms">A Quantitative Analysis of Suspected Environmental Causes of MS.&lt;/h4>
&lt;p>Can J Neurol Sci 38(1):98-105 (2011)&lt;/p>
&lt;p>Scott Sloka, Claudia Silva, William Pryse-Phillips, Scott Patten, Luanne Metz and V Wee Yong&lt;/p>
&lt;p>Department of Neurology, Grand River Hospital, Kitchener, Ontario, Canada.&lt;/p>
&lt;p>Background: Multiple sclerosis (MS) is a disease with purported environmental causes. Consistent correlations have been found in various settings for &lt;strong>latitude, smoking exposure, sunlight, and vitamin D deficiency&lt;/strong> . We analysed the contribution of various environmental factors to the risk of developing MS from a population perspective.&lt;/p></description></item><item><title>MS Trust in UK is concerned about lack of vitamin D product</title><link>/posts/ms-trust-in-uk-is-concerned-about-lack-of-vitamin-d-product.html</link><pubDate>Thu, 18 Nov 2010 00:00:00 +0000</pubDate><guid>/posts/ms-trust-in-uk-is-concerned-about-lack-of-vitamin-d-product.html</guid><description>&lt;h1 id="vitamin-d-deficiency-and-insufficiency---available-products">Vitamin D deficiency and insufficiency - available products&lt;/h1>
&lt;p>from &lt;a href="http://www.mstrust.org.uk/news/article.jsp?id=4331">http://www.mstrust.org.uk/news/article.jsp?id=4331&lt;/a>&lt;/p>
&lt;p>16 November 2010&lt;/p>
&lt;p>There are currently a number of supply issues surrounding vitamin D preparations, with the limited number of licensed preparations available being confined to high strength injections for treatment of adult deficiency and oral vitamin drops for paediatric insufficiency.&lt;/p>
&lt;p>A recent BMJ article highlighted the problem of vitamin D insufficiency in the UK population. The article cites a survey in which more than 50% of the adult population had insufficiency and 16% had severe insufficiency, and goes on to discuss a large body of observational evidence associating such insufficiency with an increased risk of mortality. The authors report that expert consensus suggests vitamin D status measured by 25-hydroxyvitamin D (25-OHD) should be 75 nmol/L (30 ?g/L) or more, with deficiency represented by 25-OHD&amp;lt;25 nmol/L and insufficiency represented by 25-OHD of 25-50 nmol/L. We are aware that organisations have or are developing their own local guidance on vitamin D deficiency and insufficiency.&lt;/p></description></item><item><title>Vitamin D far better than fingolimod in reducing MS relapse rate</title><link>/posts/vitamin-d-far-better-than-fingolimod-in-reducing-ms-relapse-rate.html</link><pubDate>Sat, 25 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-far-better-than-fingolimod-in-reducing-ms-relapse-rate.html</guid><description>&lt;h2 id="wondered-about-the-characteristics-of-a-drug-which-was-approved-by-the-fda-sept-2010-to-reduce-the-ms-relapse-rate">Wondered about the characteristics of a drug which was approved by the FDA Sept 2010 to reduce the MS relapse rate.&lt;/h2>
&lt;h1 id="compared-to-vitamin-d-fingolimod">Compared to vitamin D, Fingolimod:&lt;/h1>
&lt;ul>
&lt;li>
&lt;p>is far less effective&lt;/p>
&lt;/li>
&lt;li>
&lt;p>is far more expensive&lt;/p>
&lt;/li>
&lt;li>
&lt;p>has major side-effects (2 people died!)&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h2 id="a-hrefpostsoverview-of-ms-and-vitamin-d-at-vitamindwiki-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-691overview-of-ms-and-vitamin-d-at-vitamindwikia">&lt;a href="/posts/overview-of-ms-and-vitamin-d-at-vitamindwiki" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 691">Overview of MS and Vitamin D at VitaminDWiki&lt;/a>&lt;/h2>
&lt;h2 id="example-peer-reviewed-paper-found-a-hrefpostsms-relapse-rate-for-children-was-34-percent-less-for-every-extra-10-ngml-of-vitamin-d-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-200ms-relapse-rate-for-children-was-34-less-for-every-extra-10-ngml-of-vitamin-da">Example: peer-reviewed paper found &lt;a href="/posts/ms-relapse-rate-for-children-was-34-percent-less-for-every-extra-10-ngml-of-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 200">MS relapse rate for children was 34% less for every extra 10 ng/ml of vitamin D&lt;/a>&lt;/h2>
&lt;h2 id="links-to-the-fda-approval-in-sept-2010--link1httpwwwfdagovnewseventsnewsroompressannouncementsucm226755htm-nbsp-nbsp-link2httpwwwnytimescom20100923business23novartishtml">Links to the FDA approval in Sept 2010 &lt;a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226755.htm">Link1&lt;/a>     &lt;a href="http://www.nytimes.com/2010/09/23/business/23novartis.html">Link2&lt;/a>&lt;/h2>
&lt;h2 id="it-is-a-shame-that-so-much-money-is-being-spent-by-big-pharma-on-drugs-which-are-not-nearly-as-good-as-vitamin-d-in-reducing-ms-relapse">It is a shame that so much money is being spent by big pharma on drugs which are not nearly as good as vitamin D in reducing MS relapse.&lt;/h2>
&lt;h3 id="but-vitamin-d-cannot-be-patented---or-can-it-a-hrefpostsnoticed-a-patent-application-of-ms-and-vitamin-d-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-972noticed-a-patent-application-of-ms-and-vitamin-d-sept-2010a">But, vitamin D cannot be patented - or can it? &lt;a href="/posts/noticed-a-patent-application-of-ms-and-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 972">Noticed a patent application of MS and vitamin D Sept 2010&lt;/a>&lt;/h3>
&lt;h2 id="category-multiple-sclerosishttpswwwvitamindwikicomtiki-browse_categoriesphpparentid18sort_modecreated_desc-84-items-as-of-sept-2010">&lt;a href="https://www.VitaminDWiki.com/tiki-browse_categories.php?parentId=18&amp;amp;sort_mode=created_desc">Category: Multiple Sclerosis&lt;/a> 84 items as of Sept 2010&lt;/h2>
&lt;h2 id="a-hrefpostsspan-stylecolor30foverview-at-vitamindwiki-of-msspan-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-691-span-stylecolor30foverview-at-vitamindwiki-of-msspan-a">&lt;a href="/posts/span-stylecolor30foverview-at-vitamindwiki-of-msspan" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 691"> &lt;strong>&lt;span style="color:#30F;">Overview at VitaminDWiki of MS&lt;/span>&lt;/strong> &lt;/a>&lt;/h2>
&lt;h1 id="the-following-are-a-few-of-the-abstracts-on--fingolimod-and-ms-from-pubmed">The following are a few of the abstracts on fingolimod and MS from PubMed&lt;/h1>
&lt;h2 id="also-there-is-one-pdf-attached-to-this-wiki-page">Also, there is one PDF attached to this Wiki Page&lt;/h2>
&lt;h1 id="treating-multiple-sclerosis-with-fingolimod-or-intramuscular-interferon">Treating multiple sclerosis with fingolimod or intramuscular interferon.&lt;/h1>
&lt;p>MS and Expert Opin Pharmacother. 2010 Aug;11(11):1957-60.&lt;/p></description></item><item><title>MS relapses 12 percent less frequent for every 4 ng increase in vitamin D</title><link>/posts/ms-relapses-12-percent-less-frequent-for-every-4-ng-increase-in-vitamin-d.html</link><pubDate>Wed, 11 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-relapses-12-percent-less-frequent-for-every-4-ng-increase-in-vitamin-d.html</guid><description>&lt;h1 id="higher-25-hydroxyvitamin-d-is-associated-with-lower-relapse-risk-in-multiple-sclerosis">Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.&lt;/h1>
&lt;p>Ann Neurol. 2010 Aug;68(2):193-203.&lt;/p>
&lt;p>Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.&lt;/p>
&lt;p>Menzies Research Institute Private Bag 23 Hobart TAS 7001 Australia.&lt;/p>
&lt;p>OBJECTIVE: A protective association between higher vitamin D levels and the onset of multiple sclerosis (MS) has been demonstrated; however, its role in modulating MS clinical course has been little studied. We investigated whether higher levels of serum 25-hydroxyvitamin D (25-OH-D) were associated with a lower risk of relapses in people with MS.&lt;/p></description></item><item><title>Low vitamin D is probably a risk factor for MS</title><link>/posts/low-vitamin-d-is-probably-a-risk-factor-for-ms.html</link><pubDate>Tue, 10 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-is-probably-a-risk-factor-for-ms.html</guid><description>&lt;h1 id="is-hypovitaminosis-d-one-of-the-environmental-risk-factors-for-multiple-sclerosis">Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?&lt;/h1>
&lt;p>Brain. 2010 Jul;133(Pt 7):1869-88.&lt;/p>
&lt;p>Pierrot-Deseilligny C, Souberbielle JC.&lt;/p>
&lt;p>Service de Neurologie 1, Hôpital de la Salpêtrière, 47 bd de l&amp;rsquo;Hôpital, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, Paris VI, 75653, Paris Cedex 13, France. &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>&lt;/p>
&lt;p>The role of hypovitaminosis D as a possible risk factor for multiple sclerosis is reviewed.&lt;/p>
&lt;p>First, it is emphasized that hypovitaminosis D could be only one of the risk factors for multiple sclerosis and that numerous other environmental and genetic risk factors appear to interact and combine to trigger the disease.&lt;/p></description></item><item><title>MS and vitamin D may be related by HLA gene</title><link>/posts/ms-and-vitamin-d-may-be-related-by-hla-gene.html</link><pubDate>Fri, 06 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-may-be-related-by-hla-gene.html</guid><description>&lt;p>Multiple sclerosis, vitamin D, and HLA-DRB1*15&lt;/p>
&lt;p>NEUROLOGY 2010;74:1905-1910&lt;/p>
&lt;p>Lahiru Handunnetthi, MSc, Sreeram V. Ramagopalan, DPhil and George C. Ebers, MD, FMedSci&lt;/p>
&lt;p>From the Wellcome Trust Centre for Human Genetics and the Department of Clinical Neurology, University of Oxford, Oxford, UK.&lt;/p>
&lt;p>Address correspondence and reprint requests to Professor George C. Ebers, University Department of Clinical Neurology, Level 3, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK &lt;a href="mailto:george.ebers@clneuro.ox.ac.uk">george.ebers@clneuro.ox.ac.uk&lt;/a>&lt;/p>
&lt;p>Background: Multiple sclerosis (MS) has a remarkable geographic distribution inversely paralleling that of regional ultraviolet radiation, supporting the hypothesis that vitamin D plays a central role in the disease etiology. The major histocompatibility complex exerts the largest genetic contribution to MS susceptibility, but much risk remains unexplained and direct gene-environment interaction is a strong candidate for this additional risk. Such interactions may hold the key for disease prevention.&lt;/p></description></item><item><title>MS due to low level of vitamin D may be due to a specific gene</title><link>/posts/ms-due-to-low-level-of-vitamin-d-may-be-due-to-a-specific-gene.html</link><pubDate>Thu, 05 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-due-to-low-level-of-vitamin-d-may-be-due-to-a-specific-gene.html</guid><description>&lt;h1 id="confirmation-of-association-between-multiple-sclerosis-and-cyp27b1">Confirmation of association between multiple sclerosis and CYP27B1.&lt;/h1>
&lt;p>Eur J Hum Genet. 2010 Jul 21.&lt;/p>
&lt;p>Sundqvist E, Bäärnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I.&lt;/p>
&lt;p>Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.&lt;/p>
&lt;p>Multiple sclerosis, MS (OMIM No. 126200), is a complex inflammatory disease that is characterized by lesions in the central nervous system. Both genes and other environmental factors influence disease susceptibility. One of the environmental factors that has been implicated in MS and autoimmune disease, such as type 1 diabetes, is vitamin D deficiency, in which patients have lower levels of 25-hydroxyvitamin D3 (25-OHD(3)) in blood than do controls. Previtamin D(3) is produced in the skin, and turned into 25-OHD(3) in the liver. In the kidney, skin and immune cells, 25-OHD(3) is turned into bioactive 1,25(OH)(2)D(3) &lt;strong>by the enzyme coded by CYP27B1&lt;/strong> (cytochrome P450 family 27 subfamily B peptide 1) on chromosome 12q13.1-3. 1,25(OH)(2)D(3) binds to the vitamin D receptor, expressed in T cells and antigen-presenting cells. 1,25(OH)(2)D(3) has a suppressive role in the adaptive immune system, decreasing T-cell and dendritic cell maturation, proliferation and differentiation, shifting the balance between T-helper 1 (Th1) and Th2 cells in favor of Th2 cells and increasing the suppressive function of regulatory T cells. Rs703842 in the 12q13-14 region was associated with MS in a recent study by the Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene).&lt;/p></description></item><item><title>MS risk factor is probably low level of vitamin D</title><link>/posts/ms-risk-factor-is-probably-low-level-of-vitamin-d.html</link><pubDate>Thu, 05 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-risk-factor-is-probably-low-level-of-vitamin-d.html</guid><description>&lt;h1 id="is-hypovitaminosis-d-one-of-the-environmental-risk-factors-for-multiple-sclerosis">Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?&lt;/h1>
&lt;p>Brain. 2010 Jul;133(Pt 7):1869-88.&lt;/p>
&lt;p>Pierrot-Deseilligny C, Souberbielle JC.&lt;/p>
&lt;p>Service de Neurologie 1, Hôpital de la Salpêtrière, 47 bd de l&amp;rsquo;Hôpital, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie, Paris VI, 75653, Paris Cedex 13, France. &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>&lt;/p>
&lt;p>The role of hypovitaminosis D as a possible risk factor for multiple sclerosis is reviewed. First, it is emphasized that &lt;strong>hypovitaminosis D could be only one of the risk factors for multiple sclerosis and that numerous other environmental and genetic risk factors appear to interact and combine to trigger the disease&lt;/strong> .&lt;/p></description></item><item><title>MS assessment of role of vitamin D</title><link>/posts/ms-assessment-of-role-of-vitamin-d.html</link><pubDate>Wed, 04 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-assessment-of-role-of-vitamin-d.html</guid><description>&lt;h1 id="assessment-of-evidence-for-a-protective-role-of-vitamin-d-in-multiple-sclerosis">Assessment of evidence for a protective role of vitamin D in multiple sclerosis.&lt;/h1>
&lt;p>Biochim Biophys Acta. 2010 Jul 29. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Hanwell HE, Banwell B.&lt;/p>
&lt;p>Department of Nutritional Sciences, University of Toronto and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada; Neurosciences and Mental Health, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.&lt;/p>
&lt;p>Evidence for a role of vitamin D insufficiency in determining risk in Multiple Sclerosis (MS) is supported by studies in both pediatric- and adult-onset patients. The potential role of vitamin D in modulating MS disease activity is an area of active clinical trials research, and the possibility of primary disease prevention with vitamin D supplementation in early life is an emerging concept.&lt;/p></description></item><item><title>MS and vitamin D from a KNOL</title><link>/posts/ms-and-vitamin-d-from-a-knol.html</link><pubDate>Tue, 03 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-from-a-knol.html</guid><description>&lt;p>from &lt;a href="http://knol.google.com/k/multiple-sclerosis#">http://knol.google.com/k/multiple-sclerosis#&lt;/a> of July 2008&lt;/p>
&lt;p>a KNOL is similar to WikiPedia&lt;/p>
&lt;h1 id="vitamin-d">Vitamin D&lt;/h1>
&lt;p>For a very long time it has been noted that MS occurs at a greater frequency at locations away from the equator. MS prevalence is strongly tied to geography, especially latitude. Although some of this so-called “latitudinal gradient” is related to genetic factors (people at the greatest genetic risk likely come from places distant from the equator), recent evidence has illustrated that exposure to sunlight and the related production of Vitamin D probably plays some role in determining risk for MS. After World War II, it was noted that the rate of MS was highest among those veterans who grew up in states from the northern part of the US (Minnesota, Washington). Furthermore, researchers noted twenty years ago that people who performed inside desk jobs had higher rates of MS than those who worked outdoors (and presumably had a greater level of sun exposure).&lt;/p></description></item><item><title>Overview MS and vitamin D</title><link>/posts/overview-ms-and-vitamin-d.html</link><pubDate>Tue, 03 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/overview-ms-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ms-and-vitamin-d-overview">MS and Vitamin D Overview&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#health-problems-which-occur-up-to-5-years-before-depression-constipation-utis-and-sexual-dysfunction">Health problems which occur up to 5 years before: Depression, constipation, UTIs, and sexual dysfunction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genes-ms-and-vitamin-d">Genes, MS, and Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-d-leads-to-ms-which-further-lowers-vitamin-d">Low D leads to MS which further lowers vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#as-ms-progresses-msers-tend-to-stop-working">As MS progresses, MSers tend to stop working&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#decreased-ms-relapse-rate-with-better-diet---2015">Decreased MS relapse rate with better diet - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#increasing-cost-of-ms-drugs---too-big-to-fail">Increasing cost of MS drugs - too big to fail?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ms-and-vitamin-d-overview">MS and Vitamin D Overview&lt;/h4>
&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;strong>&lt;span style="color:#00F;">Clinical interventions have shown that Vitamin D can prevent, treat, and even cure Multiple Sclerosis, at a tiny fraction of the cost of the drugs now used to treat it, and without side effects.&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>3X increase in MS in Denmark 1950 to 2005 Vitamin D is a possible reason</title><link>/posts/3x-increase-in-ms-in-denmark-1950-to-2005-vitamin-d-is-a-possible-reason.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/3x-increase-in-ms-in-denmark-1950-to-2005-vitamin-d-is-a-possible-reason.html</guid><description>&lt;h1 id="prevalence-of-multiple-sclerosis-in-denmark-1950-2005">Prevalence of multiple sclerosis in Denmark 1950-2005.&lt;/h1>
&lt;p>Mult Scler. 2010 Mar 9. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Bentzen J, Flachs EM, Stenager E, Brønnum-Hansen H, Koch-Henriksen N.&lt;/p>
&lt;p>National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.&lt;/p>
&lt;p>Multiple sclerosis is an inflammatory disease of the central nervous system of unknown aetiology. Its prevalence varies by ethnicity and place: persons of northern European descent are at increased risk while persons living at lower latitudes appear to be protected against the disease.The Danish Multiple Sclerosis Registry is a national registry established in 1956 after a population-based survey which receives information from numerous sources.&lt;/p></description></item><item><title>African-Americans and Multiple Sclerosis</title><link>/posts/african-americans-and-multiple-sclerosis.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/african-americans-and-multiple-sclerosis.html</guid><description>&lt;h4 id="update-from-web-june-2022">Update from web June 2022&lt;/h4>
&lt;p>&lt;a href="https://scholar.google.com/scholar?hl=en&amp;amp;as_sdt=0%2C48&amp;amp;q=African-Americans++%22multiple+sclerosis%22&amp;amp;btnG=">Google Search African-Americans &amp;ldquo;multiple sclerosis&amp;rdquo;&amp;rsquo; 20,000 hits as of June 2022&lt;/a>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Clinical Characteristics of Multiple Sclerosis in African-Americans - Nov 2019 &lt;a href="https://doi.org/10.1007/s11910-019-1000-5">https://doi.org/10.1007/s11910-019-1000-5&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Genetic susceptibility to multiple sclerosis in African Americans - Aug 2021 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/multiple-sclerosis-in-african-americans-compresspdf.pdf">PDF&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity Aug 2021&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/ms-race-etc.pdf">PDF&lt;/a>&lt;/p>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;h4 id="racial-differences-in-multiple-sclerosis">Racial Differences in Multiple Sclerosis&lt;/h4>
&lt;p>&lt;strong>Black and White Americans Experience MS Differently - 2009&lt;/strong>&lt;/p>
&lt;p>By Julie Stachowiak, Ph.D., &lt;a href="http://ms.about.com/od/multiplesclerosis101/a/racial_diff_utd.htm">About.com Guide&lt;/a> Updated March 10, 2009&lt;/p></description></item><item><title>Hypothesis - more in sunshine than vitamin D to reduce MS</title><link>/posts/hypothesis-more-in-sunshine-than-vitamin-d-to-reduce-ms.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/hypothesis-more-in-sunshine-than-vitamin-d-to-reduce-ms.html</guid><description>&lt;h4 id="new-hypotheses-on-sunlight-and-the-geographic-variability-of-multiple-sclerosis-prevalence">New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence.&lt;/h4>
&lt;p>Neurol Sci. 2010 Feb 26.&lt;/p>
&lt;p>Mehta BK.&lt;/p>
&lt;p>Department of Neurology, Jacobs Neurological Institute, State University of New York-Buffalo, 100 High Street, Buffalo, NY 14203, United States.&lt;/p>
&lt;p>Multiple sclerosis is an autoimmune demyelinating disorder of the central nervous system. Its etiology continues to be elucidated. The debate about the environmental impact on the disease etiology and progression has focused on sun light exposure in the recent past, but mainly as it applies to vitamin D and its derivatives.&lt;/p></description></item><item><title>MS and Vitamin D – VitD3 World</title><link>/posts/ms-and-vitamin-d-vitd3-world.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-vitd3-world.html</guid><description>&lt;p>From &lt;a href="http://www.vitamind3world.com/Multiple_sclerosis.html">http://www.vitamind3world.com/Multiple_sclerosis.html&lt;/a> Jan 03 2010&lt;/p>
&lt;h2 id="summary-of-findings">Summary of Findings&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Multiple Sclerosis (MS) is more common in Northern parts of the world which have less sunlight. (106)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Studies have shown that the risk of MS is decreased by exposure to sunlight in childhood. (107)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Epidemiology data suggests that Vitamin D deficiency in the last three months of pregnancy is particularly harmful to the fetus and raises the risk of MS in later life. (111)&lt;/p></description></item><item><title>MS prevented and treated with Vitamin D – 2009</title><link>/posts/ms-prevented-and-treated-with-vitamin-d-2009.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-prevented-and-treated-with-vitamin-d-2009.html</guid><description>&lt;h1 id="vitamin-d-treatment-in-multiple-sclerosis">Vitamin D treatment in multiple sclerosis.&lt;/h1>
&lt;p>J Neurol Sci. 2009 Nov 15;286(1-2):104-8. Epub 2009 Jun 23.&lt;/p>
&lt;p>Myhr KM.&lt;/p>
&lt;p>Department of Neurology, Haukeland University Hospital, Norwegian Multiple Sclerosis National Competence Centre, Bergen, Norway. &lt;a href="mailto:kjell-morten.myhr@helse-bergen.no">kjell-morten.myhr@helse-bergen.no&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis is an immune-mediated disease of the central nervous system caused by a complex interplay between several different genetic as well as environmental factors. &lt;strong>Vitamin D is one of the most attractive candidates&lt;/strong> among various environmental factors suggested to be involved in the development of the disease. Epidemiological evidence combined with clinical and laboratory analyses, and experimental animal models, suggest a possible influence of vitamin D on MS susceptibility as well as clinical disease activity.&lt;/p></description></item><item><title>MS UV and Vitamin D – 2009</title><link>/posts/ms-uv-and-vitamin-d-2009.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/ms-uv-and-vitamin-d-2009.html</guid><description>&lt;h1 id="revolutionary-advances-in-the-prevention-of-demyelinating-diseases">Revolutionary advances in the prevention of demyelinating diseases.&lt;/h1>
&lt;p>J Environ Pathol Toxicol Oncol. 2009;28(2):143-52.&lt;/p>
&lt;p>Edlich R, Mason SS, Chase ME, Fisher AL, Gubler K, Long WB 3rd, Newkirk AT.&lt;/p>
&lt;p>Legacy Verified Level I Shock Trauma Center Pediatrics and Adults, Legacy Emanual Hospital.&lt;/p>
&lt;p>This collective review focuses on three major factors that influence the incidences of multiple sclerosis (MS) to include ultraviolet radiation (UVR), vitamin D3 supplementation, and vitamin D receptor gene (VDRG) polymorphisms. In general, the rate of MS increases with latitude. Individuals tend to carry their original risk with them if they migrate to a different latitude after adolescence.&lt;/p></description></item><item><title>UV suppresses MS but vitamin D might not</title><link>/posts/uv-suppresses-ms-but-vitamin-d-might-not.html</link><pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/uv-suppresses-ms-but-vitamin-d-might-not.html</guid><description>&lt;h1 id="uv-radiation-suppresses-experimental-autoimmune-encephalomyelitis-independent-of-vitamin-d-production">UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.&lt;/h1>
&lt;p>Proc Natl Acad Sci U S A. 2010 Mar 22. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Becklund BR, Severson KS, Vang SV, Deluca HF.&lt;/p>
&lt;p>Department of Biochemistry, University of Wisconsin, Madison, WI 53706.&lt;/p>
&lt;p>Although the exact cause of multiple sclerosis (MS) is unknown, a number of genetic and environmental factors are thought to influence MS susceptibility. One potential environmental factor is sunlight and the subsequent production of vitamin D. A number of studies have correlated decreased exposure to UV radiation (UVR) and low serum 25-hydroxyvitamin D(3) &lt;span>[25(OH)D(3)]&lt;/span> levels with an increased risk for developing MS. Furthermore, both UVR and the active form of vitamin D, 1alpha,25-dihydroxyvitamin D(3), suppress disease in the experimental autoimmune encephalomyelitis (EAE) animal model of MS.&lt;/p></description></item><item><title>Effective Treatment for Multiple Sclerosis is Completely Free with the sun</title><link>/posts/effective-treatment-for-multiple-sclerosis-is-completely-free-with-the-sun.html</link><pubDate>Thu, 22 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/effective-treatment-for-multiple-sclerosis-is-completely-free-with-the-sun.html</guid><description>&lt;p>There are few effective treatments for the Neurologic problem called Multiple Sclerosis. Sufferers tend to get progressively worse and often end up in wheelchairs, unable to even perform the simplest tasks by themselves. But a new study is showing that effective treatment is right outside the door- in the form of the inexpensive and even FREE- Vitamin D.&lt;/p>
&lt;p>Multiple Sclerosis is a devastating disease with few treatment options except hope. It often strikes at a young age and leaves the afflicted unable to care for themselves when they should be in the prime of their lives. It gets its name from the &amp;lsquo;sclerosed&amp;rsquo; appearance that the fatty outer layer of the spinal cord, the myelin sheath, has when viewed on medical scans. These patches slow down- and even stop- electrical transmissions from the brain to the rest of the body and vice versa. Over time, strength and movement slow and are lost entirely.&lt;/p></description></item><item><title>Lack of UV increased offspring MS</title><link>/posts/lack-of-uv-increased-offspring-ms.html</link><pubDate>Mon, 19 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/lack-of-uv-increased-offspring-ms.html</guid><description>&lt;img src="/attachments/d3.mock.jpg" alt="image"> 
&lt;ul>
&lt;li>&lt;span>[tiki-download_file.php?fileId=1317]&lt;/span>&lt;/li>
&lt;/ul>
&lt;h1 id="lack-of-sunlight-exposure-causes-mothers-to-give-birth-to-babies-with-multiple-sclerosis">Lack of sunlight exposure causes mothers to give birth to babies with multiple sclerosis&lt;/h1>
&lt;p>July 16, 2010 by: Ethan A. Huff, staff writer &lt;a href="http://www.naturalnews.com/029217_multiple_sclerosis_sunlight.html">http://www.naturalnews.com/029217_multiple_sclerosis_sunlight.html&lt;/a>&lt;/p>
&lt;p>(NaturalNews) A recent study out of Australia has found that natural sunlight plays a very important role in the development of unborn children. According to the research, mothers who get little sunlight during the first 90 days of their pregnancies bear children with an increased risk of developing multiple sclerosis later on in their lives.&lt;/p></description></item><item><title>Assessing vitamin D in the central nervous system</title><link>/posts/assessing-vitamin-d-in-the-central-nervous-system.html</link><pubDate>Fri, 02 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/assessing-vitamin-d-in-the-central-nervous-system.html</guid><description>&lt;p>Acta Neurol Scand. 2010 Jul;122(s190):88-92.&lt;/p>
&lt;p>Holmøy T, Moen SM.&lt;/p>
&lt;p>Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway.&lt;/p>
&lt;p>Epidemiological and experimental evidence suggest that vitamin D deficiency is a risk factor for multiple sclerosis and other autoimmune diseases. The activated form of vitamin D exerts several immunomodulating properties in vitro and in vivo, that could contribute to explain the association with multiple sclerosis. Hypovitaminosis D is also associated with several other neurological diseases that is less likely mediated by dysregulated immune responses, including &lt;strong>Parkinson&amp;rsquo;s disease and Alzheimer&amp;rsquo;s disease, schizophrenia and affective disorders&lt;/strong> , suggesting a more diverse role for vitamin D in the maintenance of brain health.&lt;/p></description></item><item><title>Vitamin D deficiency probably a risk factor for MS</title><link>/posts/vitamin-d-deficiency-probably-a-risk-factor-for-ms.html</link><pubDate>Fri, 02 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-probably-a-risk-factor-for-ms.html</guid><description>&lt;h1 id="is-hypovitaminosis-d-one-of-the-environmental-risk-factors-for-multiple-sclerosis">Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?&lt;/h1>
&lt;p>Bruin 133(Pt 7):1869-88 (2010)&lt;/p>
&lt;p>profile Charles Pierrot-Deseilligny and profile Jean-Claude Souberbielle&lt;/p>
&lt;p>Service de Neurologie 1, Hôpital de la Salpêtrière, 47 bd de l&amp;rsquo;Hôpital, 75653, Paris Cedex 13, France. &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>.&lt;/p>
&lt;p>The role of hypovitaminosis D as a possible risk factor for multiple sclerosis is reviewed. First, it is emphasized that hypovitaminosis D could be only one of the risk factors for multiple sclerosis and that numerous other environmental and genetic risk factors appear to interact and combine to trigger the disease.&lt;/p></description></item><item><title>Disease Database - nice links for Multiple Sclerosis</title><link>/posts/disease-database-nice-links-for-multiple-sclerosis.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/disease-database-nice-links-for-multiple-sclerosis.html</guid><description>&lt;p>&lt;a href="http://www.diseasesdatabase.com/links1.asp?glngUserChoice=8412">&lt;a href="https://www.diseasesdatabase.com/links1.asp">www.diseasesdatabase.com/links1.asp&lt;/a>&lt;/a>&lt;br />&lt;/p>
&lt;p>July 2010&lt;br />&lt;/p>
&lt;table border="1">
&lt;tbody>
&lt;tr>
&lt;th>Site&lt;/th>
&lt;th>Link and description&lt;/th>
&lt;th>Content&lt;/th>
&lt;th>About&lt;/th>
&lt;/tr>
&lt;tr>
&lt;td>ADAM&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nlm.nih.gov/medlineplus/ency/article/000737.htm">Multiple sclerosis: MedlinePlus Medical Encyclopedia&lt;/a>&lt;/td>
&lt;td>Patient information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=27654">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>GeneReviews&lt;/td>
&lt;td>&lt;a class="external" href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=ms">GeneReviews: Multiple Sclerosis Overview&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=52799">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Online Mendelian Inheritance In Man&lt;/td>
&lt;td>&lt;a class="external" href="http://www.ncbi.nlm.nih.gov/omim/126200">MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS - OMIM Result&lt;/a>&lt;/td>
&lt;td>Subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=2562">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/793013-overview">Multiple Sclerosis: eMedicine Emergency Medicine&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=4841">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1146199-overview">Multiple Sclerosis: eMedicine Neurology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=19911">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/1214270-overview">Multiple Sclerosis: eMedicine Ophthalmology&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=19982">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>eMedicine.com&lt;/td>
&lt;td>&lt;a class="external" href="http://emedicine.medscape.com/article/310965-overview">Multiple Sclerosis: eMedicine Physical Medicine and Rehabilitation&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=36155">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>GPnotebook&lt;/td>
&lt;td>&lt;a class="external" href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=2107244547">multiple sclerosis - General Practice Notebook&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=23484">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002819.html">Cyclophosphamide for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=23854">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/topics/79.html">Cochrane Reviews - by topic 'Multiple Sclerosis'&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=22617">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001332.html">Anti-spasticity agents for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6716">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001331.html">Corticosteroids or ACTH for acute exacerbations in multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=6717">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002002.html">Interferon in relapsing-remitting multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=16879">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab001330.html">Aminopyridines for symptomatic treatment in multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=16880">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003057.html">Hyperbaric oxygen therapy for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=38216">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab004678.html">Glatiramer acetate for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=38250">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003208.html">Methotrexate for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=39621">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab004431.html">Psychological interventions for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=53084">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003982.html">Azathioprine for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=58953">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab002936.html">Intravenous immunoglobulins for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=35032">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab003980.html">Exercise therapy for multiple sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=48617">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006921/frame.html">Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=69203">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>NICE&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nice.org.uk/guidance/TA127">Multiple sclerosis - natalizumab&lt;/a>&lt;/td>
&lt;td>Cost effectiveness appraisal&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=59693">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>NICE&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nice.org.uk/Guidance/TA32">Multiple sclerosis - beta interferon and glatiramer acetate&lt;/a>&lt;/td>
&lt;td>Cost effectiveness appraisal&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=40031">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=2606">Multiple Sclerosis, MedPix™ : 2606 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=293">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=1497">Multiple sclerosis, MedPix™ : 1497 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=294">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=4669">Multiple Sclerosis, MedPix™ : 4669 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=295">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=1143">Multiple Sclerosis, MedPix™ : 1143 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=296">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=2216">Multiple Sclerosis, MedPix™ : 2216 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=297">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=1064">Multiple Sclerosis, MedPix™ : 1064 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=298">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=3974">Multiple Sclerosis, MedPix™ : 3974 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=299">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=66">Multiple sclerosis (MS), MedPix™ : 66 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=779">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=2548">multiple sclerosis (MS), MedPix™ : 2548 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=780">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MedPix™ Medical Image Database&lt;/td>
&lt;td>&lt;a class="external" href="http://rad.usuhs.edu/medpix/medpix.html?mode=single&amp;recnum=893">Multiple Sclerosis (MS), MedPix™ : 893 - Medical Image Database and Atlas&lt;/a>&lt;/td>
&lt;td>Images (radiological etc)&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=781">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;/tbody>
&lt;/table>
&lt;hr />
&lt;h3>Search elsewhere for Multiple sclerosis&lt;/h3>
&lt;p>&lt;noscript>&lt;b class='look'>JavaScript must be enabled for some links on this page.&lt;/b>&lt;/noscript>&lt;/p></description></item><item><title>Comment about vitamin D on a MS blog</title><link>/posts/comment-about-vitamin-d-on-a-ms-blog.html</link><pubDate>Tue, 29 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/comment-about-vitamin-d-on-a-ms-blog.html</guid><description>&lt;p>&lt;a href="http://ms.about.com/b/2009/02/09/the-vitamin-d-and-multiple-sclerosis-link-a-cure-for-ms-not.htm">http://ms.about.com/b/2009/02/09/the-vitamin-d-and-multiple-sclerosis-link-a-cure-for-ms-not.htm&lt;/a>&lt;/p>
&lt;p>(16) Jim Dyer says:&lt;/p>
&lt;p>I want to start with a disclaimer that I am not a doctor, and that I am not giving medical advice.&lt;/p>
&lt;p>I am a medical malpractice attorney in Tucson, Arizona, diagnosed with PPMS three years ago. I was told there was no effective treatment. I read hundreds of articles and studies. I ran across a META study by the Harvard School of Public Health. The study analyzed data from the “Nurses Health Studies” (230,000 nurses) for the last 20 years, and found that nurses who took any amount of vitamin D daily had a 40% lower incidence of MS.&lt;/p></description></item><item><title>Overcoming Multiple Sclerosis - book 2010, 2016</title><link>/posts/overcoming-multiple-sclerosis-book-2010-2016.html</link><pubDate>Tue, 29 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/overcoming-multiple-sclerosis-book-2010-2016.html</guid><description/></item><item><title>Patients like me survey found vitamin D to be number one supplement</title><link>/posts/patients-like-me-survey-found-vitamin-d-to-be-number-one-supplement.html</link><pubDate>Sat, 26 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/patients-like-me-survey-found-vitamin-d-to-be-number-one-supplement.html</guid><description>&lt;p>The website &lt;a href="http://www.patientslikeme.com/">http://www.patientslikeme.com/&lt;/a> has lots of information about what people take for various chronic problems&lt;/p>
&lt;p>There is a huge discussion section for each problem and treatment&lt;/p>
&lt;p>The following are some vitamin D examples - Go to their web site to get LOTS of user comments&lt;/p>
&lt;h1 id="it-is-the--1-supplement-across-all-problems">It is the # 1 supplement across ALL problems&lt;/h1>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/patients-like-me---vitamin-d-is-top-supplement.gif" alt="image">
&lt;h1 id="here-is-what-patients-use-it-for---and-what-they-what-kind-of-benefits-they-experience">Here is what patients use it for - and what they what kind of benefits they experience&lt;/h1>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/patients-like-me---what-vitamin-d-is-used-for.gif" alt="image">
&lt;h1 id="here-is-the-use-of-vitamin-d-for-fatigue">Here is the use of vitamin D for fatigue&lt;/h1>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/patients-like-me---fatigue.gif" alt="image"></description></item><item><title>MS causes explored - vitamin D is in 2 of the 4 - 2009</title><link>/posts/ms-causes-explored-vitamin-d-is-in-2-of-the-4-2009.html</link><pubDate>Sat, 19 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/ms-causes-explored-vitamin-d-is-in-2-of-the-4-2009.html</guid><description/></item><item><title>Lancet concludes that Vitamin D can protect against MS, but do know know why</title><link>/posts/lancet-concludes-that-vitamin-d-can-protect-against-ms-but-do-know-know-why.html</link><pubDate>Wed, 09 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/lancet-concludes-that-vitamin-d-can-protect-against-ms-but-do-know-know-why.html</guid><description>&lt;h1 id="vitamin-d-and-multiple-sclerosis">Vitamin D and multiple sclerosis&lt;/h1>
&lt;p>The Lancet Neurology, Volume 9, Issue 6, Pages 599 - 612, June 2010&lt;/p>
&lt;p>&amp;lt;Previous Article|Next Article&amp;gt;&lt;/p>
&lt;p>doi:10.1016/S1474-4422(10)70086-7Cite or Link Using DOI&lt;/p>
&lt;p>Prof Alberto Ascherio MD a b c Corresponding AuthorEmail Address, Kassandra L Munger ScD b, K Claire Simon ScD b&lt;/p>
&lt;p>The hypothesis that adequate vitamin D nutrition can contribute to the prevention of multiple sclerosis (MS) was originally proposed to explain the geographical distribution of MS, but only recently has the relation between various measures of vitamin D (eg, sun exposure, dietary sources, and serum concentrations of 25-hydroxyvitamin D) and risk of developing MS been rigorously investigated.&lt;/p></description></item><item><title>MS onset 2 years earlier in northern latitudes</title><link>/posts/ms-onset-2-years-earlier-in-northern-latitudes.html</link><pubDate>Wed, 09 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/ms-onset-2-years-earlier-in-northern-latitudes.html</guid><description>&lt;h1 id="cmsc-actrims-low-sunlight-linked-to-ms-onset-age">CMSC-ACTRIMS: Low Sunlight Linked to MS Onset Age&lt;/h1>
&lt;p>&lt;a href="http://www.medpagetoday.com/MeetingCoverage/CMSC-ACTRIMS/20479">http://www.medpagetoday.com/MeetingCoverage/CMSC-ACTRIMS/20479&lt;/a>&lt;/p>
&lt;p>This report is part of a 12-month Clinical Context series.&lt;/p>
&lt;p>By Richard Robinson, Contributing Writer, MedPage Today Published: June 04, 2010&lt;/p>
&lt;p>Reviewed by Ari Green, MD; Assistant Professor, University of California, San Francisco.&lt;/p>
&lt;h2 id="action-points">Action Points&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Explain to interested patients that childhood exposure to sunlight, or vitamin D intake, may influence the age at which MS symptoms begin.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.&lt;/p></description></item><item><title>Vitamin D Linked to Poor Learning Performance in Patients With MS</title><link>/posts/vitamin-d-linked-to-poor-learning-performance-in-patients-with-ms.html</link><pubDate>Wed, 09 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-linked-to-poor-learning-performance-in-patients-with-ms.html</guid><description>&lt;p>Jim Kling &lt;a href="http://www.medscape.com/viewarticle/723205">http://www.medscape.com/viewarticle/723205&lt;/a>&lt;/p>
&lt;p>June 9, 2010 (San Antonio, Texas) — A new study shows that serum vitamin D deficiency is associated with poor learning performance among patients with multiple sclerosis (MS). The research was presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.&lt;/p>
&lt;p>There is some evidence that vitamin D suppresses proinflammatory cytokines, and that low levels of these cytokines could contribute to MS. Other evidence suggests that vitamin D plays a role in cognitive function in older adults. Cognitive impairment is very common in MS, but few studies have examined the relationship between serum vitamin D and cognitive deficits in this population.&lt;/p></description></item><item><title>Low vitamin D associated with brain atrophy in MS</title><link>/posts/low-vitamin-d-associated-with-brain-atrophy-in-ms.html</link><pubDate>Tue, 25 May 2010 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-associated-with-brain-atrophy-in-ms.html</guid><description>&lt;h3 id="low-vitamin-d-levels-are-related-to-ms-brain-atrophy-cognitive-function-studies-show">Low vitamin D levels are related to ms brain atrophy, cognitive function, studies show&lt;/h3>
&lt;p>&lt;a href="http://www.scienceblog.com/cms/low-vitamin-d-levels-are-related-ms-brain-atrophy-cognitive-function-studies-show.html">http://www.scienceblog.com/cms/low-vitamin-d-levels-are-related-ms-brain-atrophy-cognitive-function-studies-show.html&lt;/a> April 2010&lt;/p>
&lt;p>BUFFALO, N.Y. &amp;ndash; Low vitamin D levels may be associated with more advanced physical disability and cognitive impairment in persons with multiple sclerosis, studies conducted by neurologists at the University at Buffalo have shown.&lt;/p>
&lt;p>Their results, reported at the American Academy of Neurology meeting, held earlier this month, indicated that:&lt;/p>
&lt;ul>
&lt;li>
&lt;p>The majority of MS patients and healthy controls had insufficient vitamin D levels.&lt;/p></description></item><item><title>Mouse MS: UVB but not Vitamin D reduced incidence</title><link>/posts/mouse-ms-uvb-but-not-vitamin-d-reduced-incidence.html</link><pubDate>Sat, 22 May 2010 00:00:00 +0000</pubDate><guid>/posts/mouse-ms-uvb-but-not-vitamin-d-reduced-incidence.html</guid><description>&lt;h1 id="when-vitamin-d-cant-replace-uvb-exposure-multiple-sclerosis">When Vitamin D can’t replace UVB exposure: multiple sclerosis&lt;/h1>
&lt;p>April 28, 2010 by Colby Vorland &lt;a href="http://recomp.com/blogma/2010/04/when-vitamin-d-cant-replace-uvb-exposure-multiple-sclerosis">http://recomp.com/blogma/2010/04/when-vitamin-d-cant-replace-uvb-exposure-multiple-sclerosis&lt;/a>&lt;/p>
&lt;p>Vitamin D is a hot topic lately, and many observational studies have linked it positively with a reduction in various disease risks. However, we should be careful not to tout it as a panacea without large controlled studies and a deeper understanding of how it regulates various endogenous processes.&lt;/p>
&lt;p>A recent publication studying UV radiation exposure in a model of multiple sclerosis (1) is a prime example of how correlation can lead us astray, as it suggests that UVB, but not vitamin D at concentrations obtained by UVB exposure, can inhibit a model of multiple sclerosis in mice.&lt;/p></description></item><item><title>Vitamin D and sunshine are two ways to reduce MS relapses</title><link>/posts/vitamin-d-and-sunshine-are-two-ways-to-reduce-ms-relapses.html</link><pubDate>Fri, 21 May 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-sunshine-are-two-ways-to-reduce-ms-relapses.html</guid><description>&lt;h1 id="modifiable-factors-influencing-relapses-and-disability-in-multiple-sclerosis">Modifiable factors influencing relapses and disability in multiple sclerosis.&lt;/h1>
&lt;p>Mult Scler. 2010 May 18. Epub ahead of print&lt;/p>
&lt;p>D&amp;rsquo;hooghe M, Nagels G, Bissay V, De Keyser J.&lt;/p>
&lt;p>National Center For Multiple Sclerosis, Melsbroek, Belgium/Department of Neurophysiology, Uni. Psychiatric Cen. Catholic Uni. Leuven Campus Kortenberg, Belgium.&lt;/p>
&lt;p>A growing body of literature indicates that the natural course of multiple sclerosis can be influenced by a number of factors. Strong evidence suggests that relapses can be triggered by infections, the postpartum period and stressful life events. Vaccinations against influenza, hepatitis B and tetanus appear to be safe. Surgery, general and epidural anaesthesia, and physical trauma are not associated with an increased risk of relapses. Factors that have been associated with a reduced relapse rate are pregnancy, exclusive breastfeeding, &lt;strong>sunlight exposure&lt;/strong> and &lt;strong>higher vitamin D levels&lt;/strong> . A number of medications, including hormonal fertility treatment, seem to be able to trigger relapses. Factors that may worsen progression of disability include stressful life events, radiotherapy to the head, low levels of physical activity and &lt;strong>low vitamin D levels&lt;/strong> . Strong evidence suggests that smoking promotes disease progression, both clinically and on brain magnetic resonance imaging. There is no evidence for an increased progression of disability following childbirth in women with multiple sclerosis. Moderate alcohol intake and exercise might have a neuroprotective effect, but this needs to be confirmed. PMID: 20483884&lt;/p></description></item><item><title>Lancet article: Vit D may provide hope for MS</title><link>/posts/lancet-article-vit-d-may-provide-hope-for-ms.html</link><pubDate>Thu, 20 May 2010 00:00:00 +0000</pubDate><guid>/posts/lancet-article-vit-d-may-provide-hope-for-ms.html</guid><description>&lt;h1 id="vitamin-d-hope-on-the-horizon-for-ms-prevention">Vitamin D: hope on the horizon for MS prevention?&lt;/h1>
&lt;p>The Lancet Neurology, Volume 9, Issue 6, Page 555, June 2010&lt;/p>
&lt;p>doi:10.1016/S1474-4422(10)70121-6Cite or Link Using DOI&lt;/p>
&lt;h2 id="the-lancet-neurology">The Lancet Neurology&lt;/h2>
&lt;p>&lt;a href="http://www.thelancet.com/journals/laneur/article/PIIS1474442210701216/">http://www.thelancet.com/journals/laneur/article/PIIS1474442210701216/&lt;/a>&lt;/p>
&lt;p>The worldwide prevalence and incidence of multiple sclerosis (MS) are on the increase. The need for strategies to prevent this devastating disease is therefore greater than ever. As highlighted in a Review in this issue of The Lancet Neurology, vitamin D deficiency might be an important modifiable risk factor for MS. This raises the question of whether population-wide supplementation programmes might be a reasonable prevention strategy.&lt;/p></description></item><item><title>MS relapse rate for children was 34% less for every extra 10 ng/ml of vit D</title><link>/posts/ms-relapse-rate-for-children-was-34-percent-less-for-every-extra-10-ngml-of-vit-d.html</link><pubDate>Tue, 04 May 2010 00:00:00 +0000</pubDate><guid>/posts/ms-relapse-rate-for-children-was-34-percent-less-for-every-extra-10-ngml-of-vit-d.html</guid><description>&lt;h4 id="vitamin-d-status-is-associated-with-relapse-rate-in-pediatric-onset-multiple-sclerosis">Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.&lt;/h4>
&lt;p>Annals Of Neurology 67(5):618-24 (2010) May;&lt;/p>
&lt;p>profile Ellen M Mowry, profile Lauren B Krupp, profile Maria Milazzo, profile Dorothee Chabas, profile Jonathan B Strober, profile Anita L Belman, profile Jamie C McDonald, profile Jorge R Oksenberg, profile Peter Bacchetti and profile Emmanuelle Waubant&lt;/p>
&lt;p>MS Center, Department of Neurology, University of California, San Francisco, San Francisco, CA 94117, USA. &lt;a href="mailto:ellen.mowry@ucsf.edu">ellen.mowry@ucsf.edu&lt;/a> PMID: 20437559&lt;/p></description></item><item><title>10,000 IU vitamin D plus Calcium trial for those with MS</title><link>/posts/10000-iu-vitamin-d-plus-calcium-trial-for-those-with-ms.html</link><pubDate>Fri, 30 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/10000-iu-vitamin-d-plus-calcium-trial-for-those-with-ms.html</guid><description>&lt;h1 id="a-phase-iii-dose-escalation-trial-of-vitamin-d3-and-calcium-in-multiple-sclerosis">A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.&lt;/h1>
&lt;p>Neurology. 2010 Apr 28.&lt;/p>
&lt;p>Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D&amp;rsquo;Souza C, Ursell M, O&amp;rsquo;Connor P.&lt;/p>
&lt;p>From the Division of Neurology (J.M.B., P.O.), St. Michael&amp;rsquo;s Hospital, Toronto; University of Toronto (J.M.B., S.K., R.V., H.-M.D., R.C., C.D., P.O.), Toronto; Department of Nutritional Sciences and Laboratory Medicine and Pathology (S.K., R.V.), Mount Sinai Hospital, Toronto; Montreal Neurological Institute (A.B.-O., D.G.), Montreal; McGill University (A.B.-O., D.G.), Montreal; The Neurosciences &amp;amp; Mental Health Program (H.-M.D., R.C.), Hospital for Sick Children, Toronto; Center for Research in Neurodegenerative Diseases (C.D.), University of Toronto; and Division of Neurology (M.U.), Etobicoke General Hospital, Toronto, Canada.&lt;/p></description></item><item><title>Scotland and Vitamin D - many studies</title><link>/posts/scotland-and-vitamin-d-many-studies.html</link><pubDate>Sun, 11 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/scotland-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#shine-on-scotland-a-2010-campaign-that-failed">Shine On Scotland (a 2010 campaign that failed)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#if-you-had-one-chance-to-help-reduce-multiple-sclerosis-in-scotland-what-would-you-do">If you had one chance to help reduce Multiple Sclerosis in Scotland, what would you do?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="shine-on-scotland-a-2010-campaign-that-failed">Shine On Scotland (a 2010 campaign that failed)&lt;/h4>
&lt;img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/gif/shine-on-scotland.gif" alt="image">
&lt;p>Their Home page &lt;a href="http://shineonms.com/">http://shineonms.com/&lt;/a> April 2010&lt;/p>
&lt;h4 id="if-you-had-one-chance-to-help-reduce-multiple-sclerosis-in-scotland-what-would-you-do">If you had one chance to help reduce Multiple Sclerosis in Scotland, what would you do?&lt;/h4>
&lt;p>This is the question which Ryan McLaughlin, aged 14, from Glasgow, has an answer to. Watch the video to find out more, and please share this video on your Bebo, Facebook and MySpace pages. You could help protect future generations of Scots from Multiple Sclerosis by writing to your MSP and asking them to support the campaign.&lt;/p></description></item><item><title>Vitamin D decreases incidence of disease</title><link>/posts/vitamin-d-decreases-incidence-of-disease.html</link><pubDate>Fri, 09 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-decreases-incidence-of-disease.html</guid><description>&lt;h4 id="wide-range-of-health-problems">Wide range of health problems&lt;/h4>
&lt;img src="/attachments/d3.mock.jpg" alt="image" style="max-width: 700px;">
&lt;h4 id="just-pregnancy-problems">Just pregnancy problems&lt;/h4>
&lt;img src="/attachments/d3.mock.jpg" alt="image" width="500"></description></item></channel></rss>